prednisone has been researched along with Recrudescence in 1720 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the clinical effect of full-dose prednisone for 4 or 6 weeks in the treatment of children with primary nephrotic syndrome and its effect on recurrence." | 9.51 | Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence. ( Chen, CY; DU, PW; Geng, HY; Li, HR; Tu, J; Xia, H; Yu, XN, 2022) |
| "Levamisole has been considered the least toxic and least expensive steroid-sparing drug for preventing relapses of steroid-sensitive idiopathic nephrotic syndrome (SSINS)." | 9.27 | A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. ( Bagga, A; Bouts, AH; Cornelissen, EAM; Davin, JC; Emma, F; Gruppen, MP; Gulati, A; Jansen-van der Weide, MC; Massella, L; Maternik, M; Merkus, MP; Niaudet, P; Raes, A; Schurmans, T; van de Walle, J; van Dyck, M; Zurowska, A, 2018) |
| "A single dose of oral dexamethasone did not demonstrate noninferiority to prednisone for 5 days by a very small margin for treatment of adults with mild to moderate asthma exacerbations." | 9.22 | A Randomized Controlled Noninferiority Trial of Single Dose of Oral Dexamethasone Versus 5 Days of Oral Prednisone in Acute Adult Asthma. ( Alter, HJ; Lam, J; Liu, B; Rehrer, MW; Rodriguez, M, 2016) |
| "Eighteen consecutive children with steroid- and tacrolimus (TAC)-resistant (n = 10) or TAC-sensitive but frequent relapsing nephrotic syndrome (n = 8) were randomly recruited in the present study." | 9.20 | Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. ( Du, L; Fu, H; Gu, W; Liu, A; Mao, J; Shen, H; Shu, Q; Wang, J; Wu, B, 2015) |
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 9.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "In elderly patients with newly diagnosed multiple myeloma (MM), the addition of bortezomib to standard, combined oral melphalan and prednisone (MP) significantly increases the response rate and event-free survival compared with MP alone." | 9.17 | Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study. ( Boccadoro, M; Bringhen, S; Foà, R; Gentilini, F; Grammatico, S; Larocca, A; Levi, A; Palumbo, A; Petrucci, MT; Russo, S; Scotti, S; Siniscalchi, A, 2013) |
| "The combination of melphalan, prednisone and thalidomide (MPT) has demonstrated efficacy and acceptable toxicity in newly diagnosed and relapsed/refractory patients with multiple myeloma (MM)." | 9.16 | Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma. ( Alesiani, F; Ballanti, S; Boccadoro, M; Caraffa, P; Catarini, M; Cavallo, F; Corvatta, L; Gentili, S; Leoni, P; Liberati, AM; Offidani, M; Palumbo, A; Polloni, C; Pulini, S, 2012) |
| "To evaluate long-term effects of 2-year treatment with interferon beta combined with low-dose azathioprine and prednisone in multiple sclerosis." | 9.16 | Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort. ( Dolezal, O; Havrdova, E; Horakova, D; Kalincik, T; Krasensky, J; Seidl, Z; Vaneckova, M, 2012) |
| "The purpose of this study was to confirm overall survival (OS) and other clinical benefits with bortezomib, melphalan, and prednisone (VMP) versus melphalan and prednisone (MP) in the phase III VISTA (Velcade as Initial Standard Therapy in Multiple Myeloma) trial after prolonged follow-up, and evaluate the impact of subsequent therapies." | 9.14 | Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial. ( Abdulkadyrov, KM; Cakana, A; Dimopoulos, MA; Dmoszynska, A; Esseltine, DL; Jiang, B; Khuageva, NK; Kropff, M; Liu, K; Mateos, MV; Palumbo, A; Petrucci, MT; Richardson, PG; Samoilova, OS; San Miguel, JF; Schlag, R; Schots, R; Shpilberg, O; Spicka, I; van de Velde, H, 2010) |
| "The aim of this study was to determine if 2 doses of oral dexamethasone are as effective as a 5-day course of oral prednisone in preventing relapse for pediatric asthma exacerbations." | 9.13 | A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. ( Greenberg, RA; Kerby, G; Roosevelt, GE, 2008) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 9.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "The aim of this study was to evaluate whether fluticasone propionate (FP) is effective as well as prednisone (P) in reducing sputum eosinophilia and in improving airway obstruction due to asthma exacerbations not requiring hospitalization." | 9.12 | Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. ( Bacci, E; Bartoli, ML; Cianchetti, S; Dente, FL; Di Franco, A; Paggiaro, PL; Taccola, M; Vagaggini, B; Zingoni, M, 2006) |
| "Previous studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie in children with steroid-sensitive nephrotic syndrome have shown that the length of initial prednisone therapy has an impact on the subsequent relapse rate." | 9.12 | Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. ( Brodeh, J; Hoyer, PF, 2006) |
| "In multiple myeloma (MM), the addition of thalidomide or bortezomib to the standard oral melphalan/prednisone combination significantly increased response rate and event-free survival." | 9.12 | Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma. ( Ambrosini, MT; Avonto, I; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Cangialosi, C; Caravita, T; Cavallo, F; Falco, P; Morabito, F; Musto, P; Palumbo, A; Pescosta, N; Pregno, P, 2007) |
| "To compare the efficacy of prednisone plus infliximab with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica." | 9.12 | Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. ( Boiardi, L; Cantini, F; Catanoso, MG; Cimmino, M; Gerli, R; Hunder, GG; Klersy, C; Macchioni, P; Manganelli, P; Manzini, C; Paolazzi, G; Salvarani, C; Trotta, A, 2007) |
| "We conducted a phase II trial in 19 chronic graft-versus-host disease (cGVHD) patients with rapamycin, calcineurin inhibitors, and prednisone with the goals of controlling cGVHD, reducing prednisone use, and defining the safety of this regimen." | 9.11 | Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. ( Blume, KG; Brown, J; Chao, NJ; Johnston, LJ; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ, 2005) |
| "Patients treated with prednisone experienced more rapid throat pain resolution than those in the placebo group." | 9.11 | Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. ( Bregman, J; Furst, AL; Kiderman, A; Yaphe, J; Zemel, T, 2005) |
| "Colchicine seems to be a good drug for treating recurrences of pericarditis after conventional treatment failure, but no clinical trial has tested the effects of colchicine as first-line drug for the treatment of the first recurrence of pericarditis." | 9.11 | Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. ( Belli, R; Bobbio, M; Cecchi, E; Demarie, D; Ghisio, A; Imazio, M; Moratti, M; Pomari, F; Trinchero, R, 2005) |
| "Mitoxantrone, etoposide and prednisone (MEP)-based regimens using granulocyte colony-stimulating factor (G-CSF) were designed for relapsed and CHOP-resistant diffuse large B-cell lymphomas in a single institution, and the therapeutic effects and adverse reactions were studied." | 9.10 | Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas. ( Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K, 2002) |
| "The objective was to determine whether 2 days of oral dexamethasone (DEX) is more effective than 5 days of oral prednisone/prednisolone (PRED) in improving symptoms and preventing relapse in children with acute asthma." | 9.09 | Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. ( Poirier, MP; Qureshi, F; Zaritsky, A, 2001) |
| "To compare nebulized dexamethasone with oral prednisone in the treatment of children with asthma." | 9.08 | Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. ( Decker, JM; Henretig, FM; Joffe, MD; Loiselle, JM; Scarfone, RJ; Wiley, JF, 1995) |
| "Eighteen children with steroid-resistant nephrotic syndrome received cyclosporine A (CsA), including 7 patients with minimal change disease, 4 with focal segmental glomerulosclerosis and 7 with mesangial hypercellurarity." | 9.08 | Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome. ( Hymes, LC, 1995) |
| "To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)." | 9.08 | Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996) |
| "), given to adult patients treated in the emergency department for mild to moderate exacerbation of asthma would decrease the rate of relapse during the following week, compared with a nontapering course of oral prednisone, 40 mg/day over 5 days." | 9.08 | Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. ( Blanda, M; DeJulius, AJ; DeJulius, DP; Gerson, LW; Rajaratnam, M; Schuckman, H, 1998) |
| "Seven newly diagnosed patients with Devic's neuromyelitis optica were treated with long-term prednisone and azathioprine, and were followed every 2 months for at least 18 months." | 9.08 | Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. ( Ahmed, W; Dencoff, JE; Mandler, RN, 1998) |
| "Sixty-five children with steroid-resistant idiopathic nephrosis were treated with cyclosporine, 150 to 200 mg/m2, in combination with prednisone, 30 mg/m2, daily for 1 month and on alternate days for 5 months." | 9.07 | Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. ( Niaudet, P, 1994) |
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 9.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| "One hundred twenty-two patients treated in the emergency room for acute exacerbations of asthma were assigned in a randomized, double-blind fashion to receive at discharge either prednisone for eight days (the dose being tapered from 40 to 0 mg per day) or matching placebo." | 9.07 | Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. ( Chapman, KR; Rebuck, AS; Verbeek, PR; White, JG, 1991) |
| "In 1971, Cancer and Leukemia Group B (CALGB) mounted a study of acute lymphocytic leukemia (ALL) that compared the effects of the two steroid hormones dexamethasone and prednisone." | 9.07 | Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. ( Chevalier, L; Freeman, AI; Jacquillat, C; Jones, B; Koch, K; Maurer, HM; Pochedly, C; Shuster, JJ; Sinks, L; Weil, M, 1991) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 9.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "23 children with frequently relapsing minimal-change nephrotic syndrome were treated with alternate-day prednisone (35 mg/m2/48 h) and 25 other patients were treated with intermittent prednisone (40 mg/m2 on three consecutive days out of seven) for six months." | 9.04 | Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie". ( , 1979) |
| "Fifty-four children with steroid-responsive nephrotic syndrome relapsing within 6 months of their initial response were randomly allocated to receive two different regimens of prednisone therapy." | 9.04 | Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. ( , 1979) |
| "Chlorambucil, in combination with prednisone, was compared with prednisone alone in a randomized controlled trial in 21 children with either steroid-dependent or frequently relapsing nephrotic syndrome to assess its effect on the duration of remission and the rate of relapse." | 9.04 | Chlorambucil treatment of frequently relapsing nephrotic syndrome. ( Grupe, WE; Ingelfinger, JR; Makker, SP, 1976) |
| "Colchicine significantly decreases the rate of pericarditis recurrence, regardless of prednisone use and the cause of pericarditis." | 8.93 | Colchicine in addition to conventional therapy for pericarditis recurrence : An update meta-analysis. ( Chen, YM; Li, YL; Luo, J; Qiao, SB; Wang, JY; Zhang, HF, 2016) |
| "To compare combination chemotherapy (CCT) versus melphalan plus prednisone (MP) as treatment for multiple myeloma." | 8.80 | Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group. ( , 1998) |
| "Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL), the optimal regimen remains unclear." | 8.02 | Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. ( Batlevi, CL; Bobillo, S; Caron, PC; Dogan, A; Ghione, P; Hamilton, A; Hamlin, PA; Horwitz, SM; Joffe, E; Kumar, A; Matasar, MJ; Mondello, P; Moskowitz, A; Noy, A; Owens, CN; Palomba, ML; Sermer, D; Seshan, VE; Straus, D; von Keudell, G; Younes, A; Zelenetz, AD, 2021) |
| "The proteinuria selectivity index (PSI) can predict the response to prednisone in the primary nephrotic syndrome (PNS)." | 7.96 | Proteinuria selectivity and prednisone response in children with nephrotic syndrome. ( Ochoa-Ponce, C; Ornelas-Álvarez, VM; Pérez-Cortés, G; Pérez-Molina, JJ; Ramírez-Godínez, S, 2020) |
| "To determine the effect of methotrexate (MTX) on relapse risk and glucocorticoid (GC) use in a large single-institution cohort of patients with giant cell arteritis (GCA)." | 7.91 | Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. ( Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K, 2019) |
| "The addition of colchicine to prednisone in patients admitted for acute idiopathic pericarditis does not reduce the risk of recurrence." | 7.88 | Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids? ( Chezar Azzerad, C; Hasdai, D; Iakobishvili, Z; Kornowski, R; Mager, A; Porter, A; Talmor, Y, 2018) |
| "Lenalidomide therapy represents meaningful progress in the treatment of anemic patients with myelodysplastic syndromes with del(5q)." | 7.88 | Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). ( Belickova, M; Cmunt, E; Fuchs, O; Jonasova, A; Michalova, K; Minarik, L; Moudra, A; Neuwirtova, R; Polackova, H; Siskova, M; Stopka, T; Zemanova, Z, 2018) |
| "Cyclophosphamide, bortezomib, and prednisone (CyBorP) is a highly effective, well-tolerated regimen in relapsed/refractory multiple myeloma." | 7.83 | Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma. ( Atenafu, EG; Chen, C; Kukreti, V; Masih-Khan, E; Prica, A; Reece, DE; Tiedemann, R; Trieu, Y; Trudel, S, 2016) |
| "Therapeutic drug monitoring of mycophenolic acid can improve clinical outcome in organ transplantation and lupus, but data are scarce in idiopathic nephrotic syndrome." | 7.83 | Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome. ( Bandin, F; Bouchet, S; Brochard, K; Dallocchio, A; Decramer, S; Gandia, P; Godron, A; Guigonis, V; Harambat, J; Ichay, L; Llanas, B; Marquet, P; Morin, D; Saint-Marcoux, F; Tellier, S, 2016) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 7.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "This is the first report describing HBV reactivation in an occult HBV infection patient treated with oral prednisone for nephrotic syndrome." | 7.79 | HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. ( Chen, S; Du, W; Han, S; Ma, S; Zheng, Z, 2013) |
| "Bortezomib (Velcade) is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination with other cytostatic agents in multiple myeloma (MM)." | 7.79 | Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma. ( Ali, HA; Aßmann, M; Becker, C; Bourgeois, M; Edelmann, T; Hensel, G; Heyn, S; Hoffmann, FA; Hurtz, HJ; Jäkel, N; Krahl, R; Löschcke, K; Mohren, M; Moll, B; Niederwieser, D; Pönisch, W; Rohrberg, R; Schmalfeld, M; Schönfelder, U; Schwarzer, A; Wagner, I; Zehrfeld, T, 2013) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 7.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "Eight patients with recurrent ischemic priapism were treated with ketoconazole and prednisone." | 7.75 | Ketoconazole and prednisone to prevent recurrent ischemic priapism. ( Abern, MR; Levine, LA, 2009) |
| "We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age." | 7.74 | Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. ( Anbar, RD; Awa, E; Santos, RP, 2007) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 7.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| "To evaluate the long-term efficacy and tolerance of tacrolimus for the treatment of uveitis." | 7.74 | Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. ( Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE, 2007) |
| " She had undergone a lung transplantation because of cystic fibrosis and was receiving maintenance treatment with tacrolimus and prednisone." | 7.72 | Acute headache as a presenting symptom of tacrolimus encephalopathy. ( de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J, 2003) |
| "The aim of the study was to determine the effectiveness and toxicity of cladribine (2-CdA) used alone or in combination with prednisone (P) or cyclophosphamide and mitoxantrone in re-treatment of patients with progressive B-cell chronic lymphocytic leukemia (B-CLL)." | 7.71 | Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment. ( Boński, JZ; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Hellmann, A; Kasznicki, M; Konopka, L; Robak, T; Wołowiec, D, 2002) |
| "A retrospective analysis comparing the first-time use of levamisole (L) or cyclophosphamide (C) as second-line therapy for children with frequently relapsing, steroid-dependent (FR/SD) nephrotic syndrome, was conducted at our center." | 7.71 | Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. ( Alsaran, K; Arbus, G; Grisaru, S; Stephens, D, 2001) |
| "The aim of the present study was to evaluate the efficacy and safety of combined treatment with prednisone and cyclosporine compared with prednisone alone in patients with pemphigus." | 7.69 | The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. ( Ben-Amitai, D; David, M; Katzenelson, V; Lapidoth, M; Lustig, S; Sandbank, M, 1994) |
| " We describe a 19-year-old man with osteogenic sarcoma who developed recurrent pericarditis despite treatment with prednisone and pericardiocentesis." | 7.69 | [Relief of recurrent pericarditis by colchicine]. ( Adler, Y; Aharon, A; Zandman-Goddard, G, 1994) |
| "Prednisone improves serum creatinine and proteinuria in a substantial proportion of adults with HIV-AN." | 7.69 | Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. ( Austen, JL; Carey, JT; Emancipator, SN; Gripshover, B; Herbener, T; Kalayjian, RC; Mbanefo, C; Phinney, M; Rahman, M; Salata, RA; Smith, MC; Weigel, K, 1996) |
| "To review the clinical course of 16 children with recalcitrant dermatomyositis (DM), who were treated with oral methotrexate (MTX) in addition to prednisone." | 7.68 | Methotrexate treatment of recalcitrant childhood dermatomyositis. ( DeNardo, BA; Miller, LC; Schaller, JG; Sisson, BA; Tucker, LB, 1992) |
| "The long-term results of four different regimens of prednisone therapy were compared in 32 children with steroid sensitive, frequently relapsing idiopathic nephrotic syndrome with minimal glomerular lesions on renal biopsy." | 7.68 | Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome. ( Müller-Wiefel, DE; Schärer, K; Wingen, AM, 1990) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 7.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| " The heavy proteinuria exhibited a striking steroid-dependent course during a three-year period of time, with ten relapses occurring whenever attempts were made to withdraw prednisone therapy." | 7.67 | Steroid-dependent nephrotic syndrome in lupus nephritis. Response to chlorambucil. ( Abuelo, JG; Esparza, AR; Garella, S, 1984) |
| "Forty-one women with advanced breast cancer were treated with cyclophosphamide, methotrexate, 5-FU, and prednisone." | 7.67 | Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer. ( Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG, 1984) |
| "Twenty-four patients with myasthenia gravis were treated with azathioprine." | 7.67 | Azathioprine in the treatment of myasthenia gravis. ( Cornblath, DR; Lisak, RP; Parry, GJ; Schatz, NJ; Witte, AS, 1984) |
| "A patient with an unusual variant of Sweet's syndrome, in which the course of the disease was chronic and relapsing, was treated successfully with intravenous methylprednisolone (pulse therapy)." | 7.67 | The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. ( Callen, JP; Case, JD; Smith, SZ, 1989) |
| "Five patients with a steroid-responsive, frequently relapsing nephrotic syndrome who had failed at least one course of treatment with cyclophosphamide were all put into a long term remission with chlorambucil." | 7.67 | Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. ( Bailey, RR, 1989) |
| "A prospective study was performed to evaluate the effect of long-term small-dose prednisone therapy in frequently relapsing nephrotic syndrome (NS); 37 patients were included, with a relapse rate 4." | 7.67 | Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. ( Elzouki, AY; Jaiswal, OP, 1988) |
| "Six patients with diffuse or nodular scleritis that did not respond satisfactorily to oral indomethacin or prednisone used alone required a combination of these two drugs to achieve a complete clinical response." | 7.67 | Treatment of scleritis with combined oral prednisone and indomethacin therapy. ( Mondino, BJ; Phinney, RB, 1988) |
| "Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 7.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 7.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Twenty-three children with idiopathic, relapsing minimal lesion nephrotic syndrome were divided according to their pattern of response to prednisone: (1) steroid dependent, if the relapse occurred while the dosage of prednisone was being decreased; and (2) frequent relapser, if the relapse occurred at variable periods of time (one week to two months) after discontinuing prednisone therapy." | 7.66 | Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. ( Fennell, RS; Garin, EH; Pryor, ND; Richard, GA, 1978) |
| "Imatinib mesylate is a multikinase inhibitor of several signaling pathways implicated in skin fibrosis with in vitro antifibrotic activity." | 6.80 | Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. ( Baird, K; Booher, S; Comis, LE; Cowen, EW; Figg, WD; Flanders, KC; Hakim, FT; Joe, GO; Mitchell, SA; Pavletic, SZ; Rose, JJ; Sarantopoulos, S; Steinberg, SM; Takebe, N; Yao, L, 2015) |
| "Patients with relapsed/refractory (R/R) multiple myeloma (MM) complicated by severe heart failure typically do not tolerate conventional chemotherapy." | 6.79 | Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure. ( Guo, L; Hou, J; Li, L; Ling, C; Shi, H; Wei, W; Zhou, F, 2014) |
| " Two toxic deaths were observed." | 6.78 | High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study. ( Alexis, M; Arakelyan, N; Banos, A; Cartron, G; Courby, S; Damotte, D; Dreyfus, F; Fontan, J; Gressin, R; Gyan, E; Lamy, T; Laribi, K; Le Gouill, S; Maisonneuve, H; Quittet, P; Schmidt-Tanguy, A; Sénécal, D; Solal-Céligny, P; Tournilhac, O, 2013) |
| "Pomalidomide was given at 1 to 2." | 6.78 | Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. ( Baldi, I; Boccadoro, M; Bringhen, S; Carella, AM; Corradini, P; Crippa, C; Galli, M; Giuliani, N; Guglielmelli, T; La Verde, G; Larocca, A; Magarotto, V; Marcatti, M; Mina, R; Montefusco, V; Omedé, P; Palumbo, A; Rossi, D; Rota-Scalabrini, D; Santagostino, A, 2013) |
| "Thalidomide has direct antimyeloma and immunomodulatory effects." | 6.73 | Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21. ( Abonour, R; Ansari, RH; Cripe, LD; Fausel, C; Fisher, WB; Juliar, BE; Smith, GG; Suvannasankha, A; Wood, LL; Yiannoutsos, CT, 2007) |
| "Symptom relapse was seen in 45% of patients by week 24." | 6.73 | Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. ( Corkins, MR; Croffie, JM; Fitzgerald, JF; Gupta, SK; Lim, JD; Molleston, JP; Pfefferkorn, MD; Schaefer, ET; Steiner, SJ, 2008) |
| " The patients received PTX at the initiating dosage until complete clinical cure." | 6.71 | [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]. ( Achirafi, A; de Carsalade, GY; Flageul, B, 2003) |
| "To study the clinical effect of full-dose prednisone for 4 or 6 weeks in the treatment of children with primary nephrotic syndrome and its effect on recurrence." | 5.51 | Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence. ( Chen, CY; DU, PW; Geng, HY; Li, HR; Tu, J; Xia, H; Yu, XN, 2022) |
| "Ponatinib treatment was well tolerated and considered safe with easily manageable side effects." | 5.46 | Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant. ( Bossio, S; De Stefano, L; Gentile, M; Greco, R; Mazzone, C; Morabito, F; Morelli, R; Musolino, C; Palummo, A; Petrungaro, A; Recchia, AG; Uccello, G; Vigna, E, 2017) |
| "Prednisone dose was increased to 0." | 5.43 | [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate]. ( Feki, NB; Ghorbel, IB; Houman, MH; Khanfir, MS; Said, F, 2016) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 5.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "Here we report a case of a 22-year-old systemic lupus erythematosus (SLE) patient with three years' disease duration, stable on prednisone and hydroxychloroquine, who was found to have prolactinoma and recurrent GM after she discontinued medication on her own accord." | 5.40 | An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. ( Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN, 2014) |
| "Although prophylaxis against CNS recurrence with either intrathecal or intravenous methotrexate is commonly used for such patients, to the authors' knowledge, there is no standard of care." | 5.36 | Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. ( Abramson, JS; Barnes, JA; Hammerman, P; Hellmann, M; Hochberg, EP; Muzikansky, A; Takvorian, T; Toomey, C, 2010) |
| "Colchicine has antifibrotic, anti-inflammatory, and immunosuppressive effects." | 5.35 | Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. ( Goecke, H; Labarca, E; Martínez, G; Santamarina, M; Tapia, H; Vega, J, 2009) |
| " In this case, once the dosage of oral prednisone was increased and methotrexate was added to the therapeutic scheme, inflammation was controlled within 1 month." | 5.33 | Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. ( Burnier, MN; Deschênes, J; Ozdal, PC; Vianna, RN, 2006) |
| " Two-hundred and forty patients with acute urticaria admitted to emergency department will be randomised in a 1:1 ratio to receive levocetirizine or an association of levocetirizine and prednisone." | 5.30 | Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial. ( Adnet, F; Bagot, M; Berard, F; Bouillet, L; Casalino, E; Caux, F; Chosidow, O; Descamps, V; Doutre, MS; Fain, O; Fontaine, JP; Gil-Jardine, C; Goulet, H; Javaud, N; Khellaf, M; Lapostolle, F; Maignan, M; Martin, L; Pateron, D; Roy, PM; Soria, A; Tazarourte, K; Vicaut, E, 2019) |
| "Collagenous colitis is a rare cause of chronic watery diarrhea." | 5.30 | Therapy of prednisone-refractory collagenous colitis with budesonide. ( Dienes, HP; Dries, V; Kruis, W; Lanyi, B, 1999) |
| "Pyoderma gangrenosum is an ulcerative skin condition of unknown cause." | 5.29 | Treatment of pyoderma gangrenosum with methotrexate. ( Teitel, AD, 1996) |
| "Naproxen, however, has only once been reported to cause meningitis." | 5.28 | Naproxen-induced recurrent aseptic meningitis. ( Lehany, AM; Weksler, BB, 1991) |
| "Levamisole has been considered the least toxic and least expensive steroid-sparing drug for preventing relapses of steroid-sensitive idiopathic nephrotic syndrome (SSINS)." | 5.27 | A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. ( Bagga, A; Bouts, AH; Cornelissen, EAM; Davin, JC; Emma, F; Gruppen, MP; Gulati, A; Jansen-van der Weide, MC; Massella, L; Maternik, M; Merkus, MP; Niaudet, P; Raes, A; Schurmans, T; van de Walle, J; van Dyck, M; Zurowska, A, 2018) |
| " 340 children with a first episode of steroid-sensitive nephrotic syndrome and who achieved remission by a standard prednisone regimen will be enrolled in the trial and randomised to one of two treatment arms." | 5.27 | Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil ( Benz, MR; Doetsch, J; Ehren, R; Fichtner, A; Gellermann, J; Haffner, D; Höcker, B; Hoyer, PF; Kästner, B; Kemper, MJ; Konrad, M; Luntz, S; Querfeld, U; Sander, A; Toenshoff, B; Weber, LT, 2018) |
| "Azathioprine was then considered as an alternative treatment." | 5.27 | Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis. ( Cogan, E; Fastrez, R, 1985) |
| "A single dose of oral dexamethasone did not demonstrate noninferiority to prednisone for 5 days by a very small margin for treatment of adults with mild to moderate asthma exacerbations." | 5.22 | A Randomized Controlled Noninferiority Trial of Single Dose of Oral Dexamethasone Versus 5 Days of Oral Prednisone in Acute Adult Asthma. ( Alter, HJ; Lam, J; Liu, B; Rehrer, MW; Rodriguez, M, 2016) |
| "Utility of combined-modality therapy for patients with limited-stage diffuse large B-cell lymphoma (DLBCL) was shown in the Southwest Oncology Group (SWOG) S8736 study, where three cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus radiotherapy (CHOP3RT) improved 5-year progression-free (PFS) and overall survival (OS) compared with eight cycles of CHOP (CHOP8)." | 5.22 | Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. ( Friedberg, JW; LeBlanc, ML; Li, H; Persky, D; Puvvada, SD; Smith, SM; Stephens, DM, 2016) |
| "Eighteen consecutive children with steroid- and tacrolimus (TAC)-resistant (n = 10) or TAC-sensitive but frequent relapsing nephrotic syndrome (n = 8) were randomly recruited in the present study." | 5.20 | Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. ( Du, L; Fu, H; Gu, W; Liu, A; Mao, J; Shen, H; Shu, Q; Wang, J; Wu, B, 2015) |
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 5.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "A prospective study was designed to evaluate the efficacy of azithromycin (AZM) when combined with prednisone therapy compared with prednisone therapy alone in children with primary nephrotic syndrome (PNS) undergoing induction treatment." | 5.19 | A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome. ( Fan, S; Liu, T; Liu, Z; Wang, W; Wu, X; Zhang, B; Zhang, X, 2014) |
| "Subjects with acute exacerbation of asthma (FEV1 <50% predicted following 30 min of standardized treatment: 5 mg nebulized albuterol; 0." | 5.19 | Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation. ( Ferguson, I; House, SL; Johnson, K; Lewis, LM; Liu, J; Matsuda, K; Schneider, JE, 2014) |
| "In elderly patients with newly diagnosed multiple myeloma (MM), the addition of bortezomib to standard, combined oral melphalan and prednisone (MP) significantly increases the response rate and event-free survival compared with MP alone." | 5.17 | Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study. ( Boccadoro, M; Bringhen, S; Foà, R; Gentilini, F; Grammatico, S; Larocca, A; Levi, A; Palumbo, A; Petrucci, MT; Russo, S; Scotti, S; Siniscalchi, A, 2013) |
| "The combination of melphalan, prednisone and thalidomide (MPT) has demonstrated efficacy and acceptable toxicity in newly diagnosed and relapsed/refractory patients with multiple myeloma (MM)." | 5.16 | Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma. ( Alesiani, F; Ballanti, S; Boccadoro, M; Caraffa, P; Catarini, M; Cavallo, F; Corvatta, L; Gentili, S; Leoni, P; Liberati, AM; Offidani, M; Palumbo, A; Polloni, C; Pulini, S, 2012) |
| "To evaluate long-term effects of 2-year treatment with interferon beta combined with low-dose azathioprine and prednisone in multiple sclerosis." | 5.16 | Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort. ( Dolezal, O; Havrdova, E; Horakova, D; Kalincik, T; Krasensky, J; Seidl, Z; Vaneckova, M, 2012) |
| "The purpose of this study was to confirm overall survival (OS) and other clinical benefits with bortezomib, melphalan, and prednisone (VMP) versus melphalan and prednisone (MP) in the phase III VISTA (Velcade as Initial Standard Therapy in Multiple Myeloma) trial after prolonged follow-up, and evaluate the impact of subsequent therapies." | 5.14 | Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial. ( Abdulkadyrov, KM; Cakana, A; Dimopoulos, MA; Dmoszynska, A; Esseltine, DL; Jiang, B; Khuageva, NK; Kropff, M; Liu, K; Mateos, MV; Palumbo, A; Petrucci, MT; Richardson, PG; Samoilova, OS; San Miguel, JF; Schlag, R; Schots, R; Shpilberg, O; Spicka, I; van de Velde, H, 2010) |
| "The aim of this study was to determine if 2 doses of oral dexamethasone are as effective as a 5-day course of oral prednisone in preventing relapse for pediatric asthma exacerbations." | 5.13 | A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. ( Greenberg, RA; Kerby, G; Roosevelt, GE, 2008) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 5.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "The aim of this study was to evaluate whether fluticasone propionate (FP) is effective as well as prednisone (P) in reducing sputum eosinophilia and in improving airway obstruction due to asthma exacerbations not requiring hospitalization." | 5.12 | Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. ( Bacci, E; Bartoli, ML; Cianchetti, S; Dente, FL; Di Franco, A; Paggiaro, PL; Taccola, M; Vagaggini, B; Zingoni, M, 2006) |
| "Previous studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie in children with steroid-sensitive nephrotic syndrome have shown that the length of initial prednisone therapy has an impact on the subsequent relapse rate." | 5.12 | Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. ( Brodeh, J; Hoyer, PF, 2006) |
| "In multiple myeloma (MM), the addition of thalidomide or bortezomib to the standard oral melphalan/prednisone combination significantly increased response rate and event-free survival." | 5.12 | Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma. ( Ambrosini, MT; Avonto, I; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Cangialosi, C; Caravita, T; Cavallo, F; Falco, P; Morabito, F; Musto, P; Palumbo, A; Pescosta, N; Pregno, P, 2007) |
| "To compare the efficacy of prednisone plus infliximab with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica." | 5.12 | Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. ( Boiardi, L; Cantini, F; Catanoso, MG; Cimmino, M; Gerli, R; Hunder, GG; Klersy, C; Macchioni, P; Manganelli, P; Manzini, C; Paolazzi, G; Salvarani, C; Trotta, A, 2007) |
| "For patients with proliferative lupus nephritis, short-term therapy with intravenous cyclophosphamide followed by maintenance therapy with mycophenolate mofetil or azathioprine appears to be more efficacious and safer than long-term therapy with intravenous cyclophosphamide." | 5.11 | Sequential therapies for proliferative lupus nephritis. ( Contreras, G; Leclercq, B; Lenz, O; O'Nan, P; Pardo, V; Roth, D; Tozman, E, 2004) |
| "We conducted a phase II trial in 19 chronic graft-versus-host disease (cGVHD) patients with rapamycin, calcineurin inhibitors, and prednisone with the goals of controlling cGVHD, reducing prednisone use, and defining the safety of this regimen." | 5.11 | Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. ( Blume, KG; Brown, J; Chao, NJ; Johnston, LJ; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ, 2005) |
| "Patients treated with prednisone experienced more rapid throat pain resolution than those in the placebo group." | 5.11 | Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. ( Bregman, J; Furst, AL; Kiderman, A; Yaphe, J; Zemel, T, 2005) |
| "Colchicine seems to be a good drug for treating recurrences of pericarditis after conventional treatment failure, but no clinical trial has tested the effects of colchicine as first-line drug for the treatment of the first recurrence of pericarditis." | 5.11 | Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. ( Belli, R; Bobbio, M; Cecchi, E; Demarie, D; Ghisio, A; Imazio, M; Moratti, M; Pomari, F; Trinchero, R, 2005) |
| "Mitoxantrone, etoposide and prednisone (MEP)-based regimens using granulocyte colony-stimulating factor (G-CSF) were designed for relapsed and CHOP-resistant diffuse large B-cell lymphomas in a single institution, and the therapeutic effects and adverse reactions were studied." | 5.10 | Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas. ( Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K, 2002) |
| "The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)." | 5.10 | CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. ( Bouabdallah, R; Briere, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lederlin, P; Lepage, E; Morel, P; Reyes, F; Salles, G; Tilly, H; Van Den Neste, E, 2002) |
| "Among the 188 patients with extensive bullous pemphigoid, topical corticosteroids were superior to oral prednisone (P=0." | 5.10 | A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. ( Bedane, C; Benichou, J; Bernard, P; D'Incan, M; Delaporte, E; Dreno, B; Joly, P; Picard, C; Plantin, P; Roujeau, JC; Vaillant, L; Young, P, 2002) |
| "We conducted a randomized trial in 51 biopsy-proven idiopathic MGN patients with nephrotic-range proteinuria comparing 26 weeks of cyclosporine treatment plus low-dose prednisone to placebo plus prednisone." | 5.09 | Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. ( Appel, GB; Cattran, DC; Hebert, LA; Hoy, WE; Hunsicker, LG; Kunis, CL; Maxwell, DR; Pohl, MA, 2001) |
| "The objective was to determine whether 2 days of oral dexamethasone (DEX) is more effective than 5 days of oral prednisone/prednisolone (PRED) in improving symptoms and preventing relapse in children with acute asthma." | 5.09 | Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. ( Poirier, MP; Qureshi, F; Zaritsky, A, 2001) |
| "To compare nebulized dexamethasone with oral prednisone in the treatment of children with asthma." | 5.08 | Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. ( Decker, JM; Henretig, FM; Joffe, MD; Loiselle, JM; Scarfone, RJ; Wiley, JF, 1995) |
| "Patients with pemphigus vulgaris may occasionally present the highly active, widespread form of the disease, and/or maybe resistant to conventional oral steroid therapy, and/or manifest significant side effects from the prolonged use of high oral prednisone dosage." | 5.08 | Steroid-pulse therapy in pemphigus vulgaris long term follow-up. ( Chaidemenos, GC; Chryssomallis, F; Dimitriades, A; Karakatsanis, G; Panagiotides, D, 1995) |
| "Eighteen children with steroid-resistant nephrotic syndrome received cyclosporine A (CsA), including 7 patients with minimal change disease, 4 with focal segmental glomerulosclerosis and 7 with mesangial hypercellurarity." | 5.08 | Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome. ( Hymes, LC, 1995) |
| "To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)." | 5.08 | Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? ( Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ, 1996) |
| "This study was designed to determine whether treatment with prednisone and trimethoprim-sulfamethoxazole would reduce first year post-operative morbidity in children with chronic otitis media with effusion undergoing tympanostomy tube insertion (intubation)." | 5.08 | Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity. ( Buran, D; Daly, KA; Giebink, GS; Hunter, LL; Le, CT; Lindgren, B; Margolis, RH; Westover, D, 1995) |
| " Recurrences were more frequent in patients with multiple sclerosis and in those treated with oral prednisone alone." | 5.08 | Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. ( , 1997) |
| "), given to adult patients treated in the emergency department for mild to moderate exacerbation of asthma would decrease the rate of relapse during the following week, compared with a nontapering course of oral prednisone, 40 mg/day over 5 days." | 5.08 | Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. ( Blanda, M; DeJulius, AJ; DeJulius, DP; Gerson, LW; Rajaratnam, M; Schuckman, H, 1998) |
| "To determine whether low-dose prednisone reduces flu-like symptoms at the initiation of interferon beta 1-b (IFNbeta-1b), we studied 71 patients with clinically definite, relapsing-remitting multiple sclerosis who were started on IFNbeta-1b." | 5.08 | Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS. ( Marzo, ME; Montalban, X; Nos, C; Río, J; Tintoré, M, 1998) |
| "Seven newly diagnosed patients with Devic's neuromyelitis optica were treated with long-term prednisone and azathioprine, and were followed every 2 months for at least 18 months." | 5.08 | Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. ( Ahmed, W; Dencoff, JE; Mandler, RN, 1998) |
| "Prednisone therapy is highly efficacious for the treatment of idiopathic esophageal ulcer resulting in a rapid clinical response and endoscopic healing." | 5.07 | Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. ( Schwartz, DA; Wilcox, CM, 1994) |
| "Sixty-five children with steroid-resistant idiopathic nephrosis were treated with cyclosporine, 150 to 200 mg/m2, in combination with prednisone, 30 mg/m2, daily for 1 month and on alternate days for 5 months." | 5.07 | Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. ( Niaudet, P, 1994) |
| "We conducted a multicenter study in which 389 patients with acute optic neuritis (and without known multiple sclerosis) were randomly assigned to receive intravenous methylprednisolone (250 mg every six hours) for 3 days followed by oral prednisone (1 mg per kilogram of body weight) for 11 days, oral prednisone (1 mg per kilogram) alone for 14 days, or placebo for 14 days." | 5.07 | The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. ( Beck, RW; Brown, CH; Cleary, PA; Kaufman, DI; Kupersmith, MJ; Paty, DW; Trobe, JD, 1993) |
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 5.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| "Intravenous methylprednisolone followed by oral prednisone speeds the recovery of visual loss due to optic neuritis and results in slightly better vision at six months." | 5.07 | A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. ( Anderson, MM; Beck, RW; Buckley, EG; Cleary, PA; Corbett, JJ; Kaufman, DI; Keltner, JL; Kupersmith, MJ; Miller, NR; Shults, WT, 1992) |
| "One hundred twenty-two patients treated in the emergency room for acute exacerbations of asthma were assigned in a randomized, double-blind fashion to receive at discharge either prednisone for eight days (the dose being tapered from 40 to 0 mg per day) or matching placebo." | 5.07 | Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. ( Chapman, KR; Rebuck, AS; Verbeek, PR; White, JG, 1991) |
| "In 1971, Cancer and Leukemia Group B (CALGB) mounted a study of acute lymphocytic leukemia (ALL) that compared the effects of the two steroid hormones dexamethasone and prednisone." | 5.07 | Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. ( Chevalier, L; Freeman, AI; Jacquillat, C; Jones, B; Koch, K; Maurer, HM; Pochedly, C; Shuster, JJ; Sinks, L; Weil, M, 1991) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 5.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "A randomized, controlled clinical trial was conducted in 76 children to evaluate the efficacy of trimethoprim-sulfamethoxazole for 4 weeks, prednisone for 2 weeks and aluminum ibuprofen suspension for 2 weeks in resolving chronic otitis media with effusion which had persisted for more than 8 weeks." | 5.06 | A controlled trial comparing three treatments for chronic otitis media with effusion. ( Batalden, PB; Buran, DJ; Giebink, GS; Lassman, FM; Le, CT; Seltz, AE, 1990) |
| "Thirty-two evaluable good risk patients with multiple myeloma received a 70-day tapering course of prednisone beginning at a dose of 1." | 5.05 | Response rate and survival in myeloma patients receiving prednisone alone. ( Cornwell, GG; Kyle, RA; Leone, L; McIntyre, OR; Pajak, TF, 1985) |
| "23 children with frequently relapsing minimal-change nephrotic syndrome were treated with alternate-day prednisone (35 mg/m2/48 h) and 25 other patients were treated with intermittent prednisone (40 mg/m2 on three consecutive days out of seven) for six months." | 5.04 | Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie". ( , 1979) |
| "Fifty-four children with steroid-responsive nephrotic syndrome relapsing within 6 months of their initial response were randomly allocated to receive two different regimens of prednisone therapy." | 5.04 | Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. ( , 1979) |
| " protocol consisting of: vincristine-prednisone plus surgery and/or radiotherapy as induction treatment, craniocervical radiotherapy and intrathecal methotrexate as CNS preventive treatment and anti-leukemia (6-mercaptopurine, methotrexate and vincristine-prednisone pulses) or anti-lymphoma (COPP) treatment as maintenance, in a randomized trial." | 5.04 | Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina. ( Cebrian-Bonesana, A; Kvicala, R; Lein, JM; Ojeda, FG; Pavlovsky, S; Penchansky, L; Pependieck, C; Roca-Garcia, C; Sackmann-Muriel, S; Schvartzman, E, 1978) |
| "Chlorambucil, in combination with prednisone, was compared with prednisone alone in a randomized controlled trial in 21 children with either steroid-dependent or frequently relapsing nephrotic syndrome to assess its effect on the duration of remission and the rate of relapse." | 5.04 | Chlorambucil treatment of frequently relapsing nephrotic syndrome. ( Grupe, WE; Ingelfinger, JR; Makker, SP, 1976) |
| "The effects of various regimens of melphalan combination chemotherapy were evaluated in 508 patients with multiple myeloma." | 5.04 | Remission maintenance therapy for multiple myeloma. ( , 1975) |
| "Colchicine significantly decreases the rate of pericarditis recurrence, regardless of prednisone use and the cause of pericarditis." | 4.93 | Colchicine in addition to conventional therapy for pericarditis recurrence : An update meta-analysis. ( Chen, YM; Li, YL; Luo, J; Qiao, SB; Wang, JY; Zhang, HF, 2016) |
| " Herpes zoster was suspected and valacyclovir was administered." | 4.93 | Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions. ( Mori, K; Noda, T; Ozaki, S; Sekimoto, E; Shibata, H; Shigekiyo, T; Shikiji, T; Sumitani, R; Yamashita, K, 2016) |
| "Although rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment for patients with diffuse large B-cell lymphoma (DLBCL), ∼30% to 50% of patients are not cured by this treatment, depending on disease stage or prognostic index." | 4.93 | Diffuse large B-cell lymphoma: R-CHOP failure-what to do? ( Coiffier, B; Sarkozy, C, 2016) |
| " Three months or more of prednisone significantly reduced the risk of frequently relapsing nephrotic syndrome (FRNS) (6 studies, 582 children: RR 0." | 4.91 | Corticosteroid therapy for nephrotic syndrome in children. ( Craig, JC; Hahn, D; Hodson, EM; Willis, NS, 2015) |
| "Central nervous system (CNS) prophylaxis for diffuse large B-cell lymphoma (DLBCL) is controversial with even less evidence in the era of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy." | 4.88 | Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. ( Berinstein, N; Buckstein, R; Cheung, MC; Guirguis, HR; Imrie, KR; Mahrous, M; Piliotis, E; Zhang, L, 2012) |
| "Normally, Kimura disease-associated nephrotic syndrome patients are sensitive to prednisone therapy but are likely to relapse." | 4.85 | Kimura disease: a case report and review of the Chinese literature. ( Chen, YF; Gu, WZ; Liu, AM; Mao, JH; Wang, DY; Zhang, Y; Zhao, SA, 2009) |
| " It is proposed that patients with frequently relapsing nephrotic syndrome should, at the first instance, be treated with long-term, alternate-day prednisolone." | 4.84 | Management of steroid sensitive nephrotic syndrome: revised guidelines. ( Ali, U; Bagga, A; Banerjee, S; Kanitkar, M; Phadke, KD; Senguttuvan, P; Sethi, S; Shah, M, 2008) |
| "Combination therapy with aspirin and heparin may reduce pregnancy loss in women with antiphospholipid antibodies by 54%." | 4.81 | Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. ( Craig, JC; Empson, M; Lassere, M; Scott, JR, 2002) |
| "To compare combination chemotherapy (CCT) versus melphalan plus prednisone (MP) as treatment for multiple myeloma." | 4.80 | Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group. ( , 1998) |
| "Children in their first episode of steroid responsive nephrotic syndrome should be treated with prednisone for at least three months, with an increase in benefit being shown for up to seven months of treatment." | 4.80 | Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. ( Craig, JC; Hodson, EM; Knight, JF; Willis, NS, 2000) |
| " This patient with granulomatous gastroenteritis had a clinical and histologic response to medical therapy with prednisone and recurrence of symptoms when prednisone was tapered." | 4.79 | Granulomatous gastroenteritis. Case report with comparison to idiopathic isolated granulomatous gastritis. ( al-Samman, M; Boman, DA; Zuckerman, MJ, 1994) |
| " A laparotomy revealed multiple granulomas containing Fusarium sp." | 4.78 | Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. ( Amselem, S; Ben-Yehuda, D; Eldor, A; Engelhard, D; Hardan, I; Lopez-Berestein, G; Polacheck, I; Rachmilewitz, EA; Sacks, T; Salkin, IF, 1993) |
| "A Markov model was constructed to compare four strategies for patients with newly diagnosed intermediate- to high-risk diffuse large B-cell lymphoma: strategy 1: polatuzumab-rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP) plus second-line CAR-T for early relapse (< 12 months); strategy 2: polatuzumab-R-CHP plus second-line salvage therapy ± autologous stem-cell transplant; strategy 3: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone plus second-line CAR-T for early relapse; strategy 4: SOC (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone plus second-line salvage therapy ± autologous stem-cell transplant)." | 4.31 | Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Dif ( Crump, M; Jain, M; Kuruvilla, J; Prica, A; Vijenthira, A, 2023) |
| "The objective is to investigate whether initial therapy with intravenous methylprednisolone pulses (ivMTP) or oral glucocorticoid (OG) influences the relapse rate in giant cell arteritis (GCA) patients." | 4.31 | Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study. ( Álvaro-Gracia, JM; Anzola-Alfaro, AM; Castrejón, I; López, K; Martínez-Barrio, J; Molina-Collada, J; Rivera, J; Serrano-Benavente, B; Trives-Folguera, L, 2023) |
| " Outcome measures included changes in the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) score (primary endpoint), changes in the modified Rankin Scale (mRS), the Mini-mental State Examination (MMSE), the patient and caregiver Neuropsychiatric Inventory (NPI) score at each visit (baseline, discharge, 6 months, 12 months and last follow-up) between two groups (secondary endpoint), as well as oral prednisone dosage, relapse and adverse effects during follow-up." | 4.12 | Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. ( Du, Y; Hao, Y; Li, C; Li, L; Liu, J; Si, H; Yan, Q; Yao, D; Zhang, W; Zhao, C; Zhao, Y, 2022) |
| "Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL), the optimal regimen remains unclear." | 4.02 | Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. ( Batlevi, CL; Bobillo, S; Caron, PC; Dogan, A; Ghione, P; Hamilton, A; Hamlin, PA; Horwitz, SM; Joffe, E; Kumar, A; Matasar, MJ; Mondello, P; Moskowitz, A; Noy, A; Owens, CN; Palomba, ML; Sermer, D; Seshan, VE; Straus, D; von Keudell, G; Younes, A; Zelenetz, AD, 2021) |
| "The proteinuria selectivity index (PSI) can predict the response to prednisone in the primary nephrotic syndrome (PNS)." | 3.96 | Proteinuria selectivity and prednisone response in children with nephrotic syndrome. ( Ochoa-Ponce, C; Ornelas-Álvarez, VM; Pérez-Cortés, G; Pérez-Molina, JJ; Ramírez-Godínez, S, 2020) |
| "To determine the effect of methotrexate (MTX) on relapse risk and glucocorticoid (GC) use in a large single-institution cohort of patients with giant cell arteritis (GCA)." | 3.91 | Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study. ( Crowson, CS; Koster, MJ; Labarca, C; Muratore, F; Warrington, KJ; Yeruva, K, 2019) |
| " We analyzed the rates of remission (defined on the basis of the Birmingham Vasculitis Activity Score [BVAS]) and relapse as well as the variations over time in estimated glomerular filtration rate (GFR), proteinuria, C-reactive protein (CRP) level, BVAS, and prednisone dose." | 3.88 | Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein). ( Emmi, G; Eriksson, P; Fenoglio, R; Goldoni, M; Harris, H; Incerti, M; Jayne, D; Maritati, F; Mohammad, AJ; Nicastro, M; Novikov, P; Pillebout, E; Roccatello, D; Rocco, R; Segelmark, M; Silvestri, E; Trivioli, G; Urban, ML; Vaglio, A, 2018) |
| "The addition of colchicine to prednisone in patients admitted for acute idiopathic pericarditis does not reduce the risk of recurrence." | 3.88 | Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids? ( Chezar Azzerad, C; Hasdai, D; Iakobishvili, Z; Kornowski, R; Mager, A; Porter, A; Talmor, Y, 2018) |
| " Repeat CT chest after 2 weeks for recurrent cough showed a small PE, treated with oral prednisone for suspected postablation pericarditis, with complete resolution of cough." | 3.88 | Cough as the sole manifestation of pericardial effusion. ( Abdullah, O; Fong, HK; Gautam, S, 2018) |
| "Combining prednisone with antibiotics for the treatment of erysipelas should be considered, especially in severe cases." | 3.88 | Corticosteroid Therapy in Combination with Antibiotics for Erysipelas. ( Barzilai, A; Baum, S; Elphasy, H; Solomon, M; Trau, H, 2018) |
| "Lenalidomide therapy represents meaningful progress in the treatment of anemic patients with myelodysplastic syndromes with del(5q)." | 3.88 | Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). ( Belickova, M; Cmunt, E; Fuchs, O; Jonasova, A; Michalova, K; Minarik, L; Moudra, A; Neuwirtova, R; Polackova, H; Siskova, M; Stopka, T; Zemanova, Z, 2018) |
| "Prognostic models for primary diffuse large B-cell lymphoma (DLBCL) resistant to or relapsing after initial therapy with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) have not been well-established." | 3.85 | Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study. ( Fukuda, T; Miura, O; Watanabe, K; Yamamoto, M, 2017) |
| "Cyclophosphamide, bortezomib, and prednisone (CyBorP) is a highly effective, well-tolerated regimen in relapsed/refractory multiple myeloma." | 3.83 | Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma. ( Atenafu, EG; Chen, C; Kukreti, V; Masih-Khan, E; Prica, A; Reece, DE; Tiedemann, R; Trieu, Y; Trudel, S, 2016) |
| "Therapeutic drug monitoring of mycophenolic acid can improve clinical outcome in organ transplantation and lupus, but data are scarce in idiopathic nephrotic syndrome." | 3.83 | Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome. ( Bandin, F; Bouchet, S; Brochard, K; Dallocchio, A; Decramer, S; Gandia, P; Godron, A; Guigonis, V; Harambat, J; Ichay, L; Llanas, B; Marquet, P; Morin, D; Saint-Marcoux, F; Tellier, S, 2016) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 3.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "The objectives of this study are to compare the initial clinical, laboratory, and imaging features in primary central nervous system vasculitis (PCNSV) vs secondary central nervous system vasculitis (SCNSV) and follow up after treatment with intravenous cyclophosphamide (IV-CYC) plus glucocorticosteroids (GCS): methylprednisolone (MP)." | 3.81 | Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis. ( Casarrubias-Ramírez, M; Cruz-Domínguez, Mdel P; Hernández-Gonzalez, C; Jara, LJ; Medina, G; Molina-Carrión, LE; Olvera-Acevedo, A; Pineda-Galindo, LF; Sepúlveda-Delgado, J; Vera-Lastra, O, 2015) |
| " Combined immunosuppressive therapy with prednisone and cyclophosphamide might be needed to treat recurrent thrombosis due to Behçet disease." | 3.80 | Recurrent right atrial thrombosis due to Behçet disease. ( Fukuda, K; Kuno, T; Kuwana, M; Murata, M; Ono, T; Satoh, T; Tamura, Y, 2014) |
| "In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission with withdrawal of prednisone and calcineurin inhibitors." | 3.79 | Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. ( Belingheri, M; Bodria, M; Caridi, G; Edefonti, A; Fornoni, A; Ghiggeri, GM; Ghio, L; Magnasco, A; Martorana, D; Merscher-Gomez, S; Montini, G; Murtas, C; Muruve, D; Pani, A; Pasini, A; Ponticelli, A; Ravani, P; Reiser, J; Scolari, F; Sica, F; Siciliano, C; Vaglio, A; Wang, X; Wei, C, 2013) |
| "This is the first report describing HBV reactivation in an occult HBV infection patient treated with oral prednisone for nephrotic syndrome." | 3.79 | HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. ( Chen, S; Du, W; Han, S; Ma, S; Zheng, Z, 2013) |
| "Bortezomib (Velcade) is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination with other cytostatic agents in multiple myeloma (MM)." | 3.79 | Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma. ( Ali, HA; Aßmann, M; Becker, C; Bourgeois, M; Edelmann, T; Hensel, G; Heyn, S; Hoffmann, FA; Hurtz, HJ; Jäkel, N; Krahl, R; Löschcke, K; Mohren, M; Moll, B; Niederwieser, D; Pönisch, W; Rohrberg, R; Schmalfeld, M; Schönfelder, U; Schwarzer, A; Wagner, I; Zehrfeld, T, 2013) |
| "Nine patients with recalcitrant pemphigus were treated with prednisone, immunosuppressive agents, and/or intravenous immunoglobulin." | 3.78 | Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients. ( Knowles, SR; Matsukura, S; Shear, NH; Walsh, S, 2012) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 3.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| " We retrospectively studied the risk factors for CNS involvement in patients with diffuse large B-cell lymphoma (DLBCL) treated by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab (R) -CHOP chemotherapy." | 3.76 | Central nervous system involvement in diffuse large B-cell lymphoma. ( Hashimoto, C; Hattori, Y; Hyo, R; Ishigatsubo, Y; Motomura, S; Nakajima, Y; Tomita, N; Watanabe, R; Yamamoto, W, 2010) |
| "Eight patients with recurrent ischemic priapism were treated with ketoconazole and prednisone." | 3.75 | Ketoconazole and prednisone to prevent recurrent ischemic priapism. ( Abern, MR; Levine, LA, 2009) |
| "The aim of this study was to assess the serum concentration of high-sensitivity C-reactive protein (hs-CRP) in children with nephrotic syndrome (NS) treated with prednisone and cyclosporine A (CyA)." | 3.74 | High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. ( Tenderenda, E; Tobolczyk, J; Wasilewska, A; Zoch-Zwierz, W, 2007) |
| "We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age." | 3.74 | Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. ( Anbar, RD; Awa, E; Santos, RP, 2007) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 3.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| "To evaluate the long-term efficacy and tolerance of tacrolimus for the treatment of uveitis." | 3.74 | Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. ( Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE, 2007) |
| "Predictive factors for both decreased graft and patient survival included patients recently transplanted (2000-2004), induction without azathioprine, short-term therapy with mycophenolate mofetil and prednisone (< or =6 months), presence of early cholestasis, histologically proven early recurrence of hepatitis C." | 3.74 | Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. ( Beckebaum, S; Broelsch, CE; Cicinnati, VR; Frilling, A; Gerken, G; Gheorghe, LS; Hilgard, P; Iacob, RA; Iacob, S; Malago, M; Popescu, I, 2007) |
| " Although her symptoms deteriorated as pregnancy progressed, she drastically improved by treatment with prednisone." | 3.73 | Acute onset of polymyalgia rheumatica in pregnancy. ( Maruo, T; Ohara, N; Sasaki, H; Washio, M, 2005) |
| "The present study aimed to analyse the treatment outcome of IMVP-16/Pd (ifosfamide, methotrexate, etoposide and prednisone) followed by high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) for patients with peripheral T-cell lymphomas (PTCLs) who were previously treated with CHOP." | 3.73 | IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas. ( Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS, 2005) |
| " Of 33 SL cases, 14 consecutive diffuse large B-cell lymphomas were treated with CHOP (adriamycin, cyclophosphamide, vincristine and prednisone) or CHOP-like chemotherapy regimen." | 3.73 | Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. ( Assaf, E; Azoulay, R; Bosq, J; Cainap, C; Jabbour, E; Koscielny, S; Lapusan, S; Oprea, C; Ribrag, V; Vanel, D, 2005) |
| " A 68-year-old man with concurrent PTCL and diffuse large B-cell lymphoma was treated effectively with 3-course CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy, but PTCL relapse occurred and was resistant to ESHAP (etoposide, methylprednisolone, cytarabine, and cisplatin) therapy." | 3.73 | Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. ( Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M, 2006) |
| "A retrospective review of 30 patients with recurrent idiopathic neuroretinitis identified 7 who received ongoing immunosuppression with prednisone and/or azathioprine for whom adequate follow-up information was available." | 3.72 | Idiopathic recurrent neuroretinitis: effects of long-term immunosuppression. ( Kawasaki, A; Purvin, V; Ranson, N, 2003) |
| " She had undergone a lung transplantation because of cystic fibrosis and was receiving maintenance treatment with tacrolimus and prednisone." | 3.72 | Acute headache as a presenting symptom of tacrolimus encephalopathy. ( de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J, 2003) |
| "Because of the high relapse rate, AIHA and Evans syndrome should be treated according to the class of autoantibodies, and with longer course of prednisone and cyclosporin and prophylaxis of infection." | 3.72 | [An analysis of relapse and risk factors of autoimmune hemolytic anemia and Evans syndrome]. ( Bai, J; Cao, YR; Cui, ZZ; Fu, R; He, GS; Liu, H; Qin, TJ; Shao, ZH; Shi, J; Wu, YH; Yang, CL; Yang, TY, 2003) |
| "Based on its efficacy for the treatment of human asthma, the corticosteroid prednisone is commonly used in horses for treatment of recurrent airway obstruction." | 3.71 | Prednisone per os is likely to have limited efficacy in horses. ( Kollias-Baker, C; Peroni, DL; Robinson, NE; Stanley, S, 2002) |
| "Intensive and prolonged systemic treatment with corticosteroids is recommended for the patients with first attack of VKH syndrome, where as regular treatment with chlorambucil is useful for control of chronic and recurrent uveitis seen in VKH syndrome." | 3.71 | [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome]. ( Fu, T; Huang, X; Li, F; Wang, H; Yang, P; Zhong, H; Zhou, H, 2002) |
| "The aim of the study was to determine the effectiveness and toxicity of cladribine (2-CdA) used alone or in combination with prednisone (P) or cyclophosphamide and mitoxantrone in re-treatment of patients with progressive B-cell chronic lymphocytic leukemia (B-CLL)." | 3.71 | Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment. ( Boński, JZ; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Hellmann, A; Kasznicki, M; Konopka, L; Robak, T; Wołowiec, D, 2002) |
| "A retrospective analysis comparing the first-time use of levamisole (L) or cyclophosphamide (C) as second-line therapy for children with frequently relapsing, steroid-dependent (FR/SD) nephrotic syndrome, was conducted at our center." | 3.71 | Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. ( Alsaran, K; Arbus, G; Grisaru, S; Stephens, D, 2001) |
| "The aim of the study was to evaluate, in a white population with chronic sarcoidosis, the rate and pattern of relapses, the correlated factors, and the course of disease after prednisone withdrawal." | 3.70 | The late follow-up of chronic sarcoid patients previously treated with corticosteroids. ( Colombo, P; Montemurro, L; Rizzato, G, 1998) |
| "This case study illustrates the usefulness of serial induced sputum cell counts from cytospins to investigate the nature of airway inflammation in a patient presumed to have prednisone-dependent asthma for 30 yrs." | 3.70 | Serial sputum cell counts in the management of chronic airflow limitation. ( Hargreave, FE; Jeffery, PK; Li, D; Parameswaran, K; Pizzichini, E; Pizzichini, MM, 1998) |
| "In a randomized trial conducted by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), interferon alpha-2b (IFN) maintenance therapy (2 mU/m2 subcutaneously three times per week) after successful induction with melphalan and prednisone was found to prolong time to progression in patients with multiple myeloma." | 3.70 | Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. ( Browman, G; Cole, B; James, K; Johnston, D; Li, T; Pater, J; Sugano, D; Zee, B, 1998) |
| " Three of them occurred during pregnancy in prednisone-treated patients with active sarcoidosis." | 3.70 | [Sarcoidosis and pregnancy. A retrospective study of 11 cases]. ( Biousse, V; Chapelon Abric, C; Darbois, Y; de Gennes, C; Ginsburg, C; Godeau, P; Janse Marec, J; Piette, JC; Wechsler, B, 1998) |
| " Three groups of patients were prospectively evaluated: Group I: 15 patients with Wegener's granulomatosis and 4 patients with severe scleritis received a single dose cyclophosphamide (15 mg/kg bw/day) and 250 mg prednisone i." | 3.70 | Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). ( Jockenhövel, F; Kummer, G; Mann, K; Philipp, T; Reinhardt, W; Reinwein, D; Sauter, V; Uppenkamp, M; Witzke, O, 1999) |
| "A new study indicates that patients who have an acute asthma episode in the emergency department may experience a 50% decline in relapse when high-dose inhaled budesonide is used in combination with the standard oral prednisone alone." | 3.70 | Combined oral, inhaled steroids prevent relapse in acute asthma. ( , 1999) |
| "Four children with acquired immunodeficiency syndrome and aphthous oral ulcers with severe odynophagia were treated with a short oral course of prednisone." | 3.69 | Treatment of resistant oral aphthous ulcers in children with acquired immunodeficiency syndrome. ( Bernstein, LJ; de Asis, ML; Schliozberg, J, 1995) |
| "In a longitudinal prospective study, we followed 56 patients (17 men, 29 women) with definite multiple sclerosis (MS), who were treated with high-dose intravenous methylprednisolone (IVMP), 10 consecutive days with 1000 mg IVMP daily." | 3.69 | Follow-up study of MS patients treated with high-dose intravenous methylprednisolone. ( Barkhof, F; Borm, GF; Frequin, ST; Hommes, OR; Lamers, KJ, 1994) |
| "We report a patient who developed recurrent acute inflammatory demyelinating polyradiculitis (AIDP) receiving immunosuppressive treatment with cyclosporin and prednisone for secondary chronic graft versus host disease (GVHD) following allogeneic bone marrow transplantation (BMT) from an unrelated donor for chronic myelogenous leukemia (CML)." | 3.69 | Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation. ( Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V, 1994) |
| "The aim of the present study was to evaluate the efficacy and safety of combined treatment with prednisone and cyclosporine compared with prednisone alone in patients with pemphigus." | 3.69 | The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. ( Ben-Amitai, D; David, M; Katzenelson, V; Lapidoth, M; Lustig, S; Sandbank, M, 1994) |
| " We describe a 19-year-old man with osteogenic sarcoma who developed recurrent pericarditis despite treatment with prednisone and pericardiocentesis." | 3.69 | [Relief of recurrent pericarditis by colchicine]. ( Adler, Y; Aharon, A; Zandman-Goddard, G, 1994) |
| "Prednisone improves serum creatinine and proteinuria in a substantial proportion of adults with HIV-AN." | 3.69 | Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. ( Austen, JL; Carey, JT; Emancipator, SN; Gripshover, B; Herbener, T; Kalayjian, RC; Mbanefo, C; Phinney, M; Rahman, M; Salata, RA; Smith, MC; Weigel, K, 1996) |
| " In 1982, it was suggested for the first time low doses of aspirin and prednisone for treatment of recurrent fetal death associated to this syndrome, heparin therapy was reported in 1984, recommended a doses of 15,000 U/day during first pregnancy trimester and 20,000 U/day posteriorly." | 3.69 | [Recurrent fetal death and antiphospholipid antibody syndrome. A case report]. ( Bustos López, HH; Hernández Andrade, E; Ramírez Peredo, J; Rojas-Poceros, G, 1997) |
| "It is now well established that clinically stable patients with relapsing-remitting multiple sclerosis have ongoing disease activity when evaluated by serial gadolinium-enhanced (Gd-DTPA) magnetic resonance imaging (MRI) scans." | 3.68 | Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. ( Albert, PS; Armstrong, M; Frank, JA; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Smith, ME; Stone, LA, 1993) |
| " 1, 1973, and May 30, 1989, 36 patients (37 eyes) with ocular toxoplasmosis seen at a uveitis clinic received quadruple therapy (pyrimethamine, trisulfapyrimidines, clindamycin and prednisone)." | 3.68 | Quadruple therapy for ocular toxoplasmosis. ( Lam, S; Tessler, HH, 1993) |
| "To review the clinical course of 16 children with recalcitrant dermatomyositis (DM), who were treated with oral methotrexate (MTX) in addition to prednisone." | 3.68 | Methotrexate treatment of recalcitrant childhood dermatomyositis. ( DeNardo, BA; Miller, LC; Schaller, JG; Sisson, BA; Tucker, LB, 1992) |
| "We report a case of eosinophilic cystitis that was responsive to prednisone but that recurred when the drug was withdrawn." | 3.68 | Recurrent eosinophilic cystitis: a case responsive to steroids. ( Coffield, KS; Hermans, MR; Keegan, GT; Singh, EO; Watson, HS, 1992) |
| "We have studied a patient with recurrent bouts of angioedema, myalgia, and eosinophilia that was not due to L-tryptophan ingestion." | 3.68 | Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. ( Bochner, BS; Friedman, B; Krishnaswami, G; Kroegel, C; Lichtenstein, LM; Schleimer, RP, 1991) |
| " We treated 23 patients with acute toxoplasma chorioretinitis with sulfonamides, pyrimethamine and corticosteroids for a period of 4 weeks." | 3.68 | [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis]. ( Aspiotis, M; Petroutsos, G; Psilas, K, 1990) |
| " Fifty-eight patients were prepared for transplantation with a combination of cyclophosphamide and fractionated total body irradiation (FTBI) and received acute graft-versus-host disease (GVHD) prophylaxis consisting of methotrexate alone or in combination with cyclosporine, prednisone, or antithymocyte globulin (ATG)." | 3.68 | Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. ( Ash, R; Beatty, P; Hows, JM; McGlave, PB, 1990) |
| "The long-term results of four different regimens of prednisone therapy were compared in 32 children with steroid sensitive, frequently relapsing idiopathic nephrotic syndrome with minimal glomerular lesions on renal biopsy." | 3.68 | Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome. ( Müller-Wiefel, DE; Schärer, K; Wingen, AM, 1990) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 3.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| " The heavy proteinuria exhibited a striking steroid-dependent course during a three-year period of time, with ten relapses occurring whenever attempts were made to withdraw prednisone therapy." | 3.67 | Steroid-dependent nephrotic syndrome in lupus nephritis. Response to chlorambucil. ( Abuelo, JG; Esparza, AR; Garella, S, 1984) |
| "Forty-one women with advanced breast cancer were treated with cyclophosphamide, methotrexate, 5-FU, and prednisone." | 3.67 | Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer. ( Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG, 1984) |
| "Twenty-four patients with myasthenia gravis were treated with azathioprine." | 3.67 | Azathioprine in the treatment of myasthenia gravis. ( Cornblath, DR; Lisak, RP; Parry, GJ; Schatz, NJ; Witte, AS, 1984) |
| "A patient with an unusual variant of Sweet's syndrome, in which the course of the disease was chronic and relapsing, was treated successfully with intravenous methylprednisolone (pulse therapy)." | 3.67 | The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. ( Callen, JP; Case, JD; Smith, SZ, 1989) |
| "Growth velocity measurements were assessed in 12 children with steroid responsive but frequent relapsing or dependent nephrotic syndrome prior to and following treatment with either cyclophosphamide or chlorambucil and alternate day prednisone." | 3.67 | Linear growth of children with nephrotic syndrome: effect of alkylating agents. ( Brem, AS; Padilla, R, 1989) |
| "Five patients with a steroid-responsive, frequently relapsing nephrotic syndrome who had failed at least one course of treatment with cyclophosphamide were all put into a long term remission with chlorambucil." | 3.67 | Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. ( Bailey, RR, 1989) |
| "The immunosuppressive effects of three herpesviruses--cytomegalovirus (CMV), Epstein-Barr virus (EBV), and herpes simplex virus (HSV)--were assessed in 29 renal transplant recipients treated with cyclosporine and prednisone." | 3.67 | Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine. ( DeBiasio, RL; Hakala, TR; Hamoudi, WH; Liebert, M; Rabin, B; Rinaldo, CR, 1986) |
| "A prospective study was performed to evaluate the effect of long-term small-dose prednisone therapy in frequently relapsing nephrotic syndrome (NS); 37 patients were included, with a relapse rate 4." | 3.67 | Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. ( Elzouki, AY; Jaiswal, OP, 1988) |
| "Six patients with diffuse or nodular scleritis that did not respond satisfactorily to oral indomethacin or prednisone used alone required a combination of these two drugs to achieve a complete clinical response." | 3.67 | Treatment of scleritis with combined oral prednisone and indomethacin therapy. ( Mondino, BJ; Phinney, RB, 1988) |
| "In a selected group of 69 patients with myasthenia gravis treated with prednisone, the factors were studied that might have influenced the reoccurrence or exacerbation of clinical signs after initial improvement in two-thirds of the patients." | 3.67 | Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis. ( Oosterhuis, HJ; Scherpbier, HJ, 1987) |
| "Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 3.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
| " The median period between the beginning of significant proteinuria and the start of prednisone therapy was 5 days (range 0-194 days)." | 3.67 | Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome. ( Müller-Wiefel, DE; Schärer, K; Wingen, AM, 1985) |
| " Adequate control of thrombocytopenia could not be obtained with prednisone therapy, and splenectomy produced a clinical remission." | 3.66 | Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause. ( Logue, GL; Rosse, WF; Shimm, DS, 1980) |
| "In order to ascertain whether multiple myeloma patients resistant to one alkylating agent would respond to a second one, high-dose intermittent cyclophosphamide was administered to 12 patients showing resistance to melphalan and prednisone." | 3.66 | Cross-resistance to alkylating agents in multiple myeloma. ( Bladé, J; Estapé, J; Feliú, E; Millá, A; Montserrat, E; Rozman, C, 1983) |
| " Urine samples from 94 of them became protein-free during the initial 8-week course of prednisone, and the outcome for these children was good: 74 of them have been free of symptoms for at least 3 years, 18 have had relapses during the last 3 years, and only one child still has proteinuria." | 3.66 | Long-term outcome of primary nephrotic syndrome. ( Hallman, N; Koskimies, O; Rapola, J; Vilska, J, 1982) |
| "Three patients with epithelial cell crescents and rapid progressive glomerulonephritis (RPGN) had prolonged remission, presumably induced by treatment with maintenance oral prednisone and cyclophosphamide plus plasmapheresis." | 3.66 | Rapid progressive glomerulonephritis: relapse after prolonged remission. ( Adler, S; Bruns, FJ; Fraley, DS; Segel, DP, 1981) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 3.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Twenty-three children with idiopathic, relapsing minimal lesion nephrotic syndrome were divided according to their pattern of response to prednisone: (1) steroid dependent, if the relapse occurred while the dosage of prednisone was being decreased; and (2) frequent relapser, if the relapse occurred at variable periods of time (one week to two months) after discontinuing prednisone therapy." | 3.66 | Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. ( Fennell, RS; Garin, EH; Pryor, ND; Richard, GA, 1978) |
| ") test was given to 23 children in their first attack of idiopathic nephrotic syndrome, after treatment with prednisone according to the schedule of the International Study of Kidney Disease in Children." | 3.65 | Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. ( Hallman, N; Koskimies, O; Leisti, S; Perheentupa, J; Rapola, J; Vilska, J, 1977) |
| " In a comparison of these children with SLE, with and without AN, with a group of patients with nephrosis treated with corticosteroids and a group with glomerulonephritis treated with azathioprine, AN was related to the duration of daily steroid therapy rather than the total duration of steroid treatment; this was not true for azathioprine." | 3.65 | A vascular necrosis of the femoral head in childhood systemic lupus erythematosus. ( Drummond, KN; Hurley, RM; Patriquin, H; Steinberg, RH, 1974) |
| "Relapse is common after discontinuation of infliximab." | 3.11 | Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis. ( Beattie, K; Cox, G; Hambly, N; Khalidi, N; Kolb, M; Kouranos, V; Larche, M; Morar, N; Renzoni, EA; Sakkat, A, 2022) |
| "Relapse was defined as the recurrence of GCA symptoms requiring treatment intensification." | 3.01 | Ustekinumab for the Treatment of Giant Cell Arteritis. ( Fernandes, AD; Matza, MA; Stone, JH; Unizony, SH, 2021) |
| "Prednisone was started at 0." | 2.87 | Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. ( Audia, S; Besancenot, JF; Bienvenu, B; Binquet, C; Bonnotte, B; Charles, P; Devilliers, H; Fauchais, AL; Guillevin, L; Liozon, E; Loffroy, R; Ly, KH; Mariette, X; Maurier, F; Samson, M; Seror, R; Terrier, B, 2018) |
| "The idarubicin dose was adjusted according to the degree of myelosuppression." | 2.84 | Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. ( Ahn, HS; Im, HJ; Kang, HJ; Kim, H; Koh, KN; Koo, HH; Lee, JW; Lim, YT; Park, BK; Park, HJ; Park, JE; Park, KD; Seo, JJ; Shin, HY; Sung, KW; Yoo, KH, 2017) |
| " Thus, salvage Ox-P chemotherapy for patients with relapsed or refractory MZL at the stated dosage and schedule showed moderate clinical activity and was considerable in very few selected patients (NCT01068392)." | 2.82 | A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. ( Chae, YS; Eom, HS; Hong, J; Hong, JY; Kim, HJ; Kim, JS; Kim, SJ; Kim, WS; Lee, GW; Lee, S; Lee, SM; Oh, SY; Park, E; Park, J; Ryoo, HM; Suh, C; Won, JH; Yang, DH; Yoon, DH, 2016) |
| "Relapses were characterized without respect to site (initial, new, or both; and initial bulk or initial nonbulk), and involved field radiation therapy field (in-field, out-of-field, or both)." | 2.80 | Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. ( Chen, L; Constine, LS; Dharmarajan, KV; FitzGerald, TJ; Friedman, DL; Iandoli, M; Kessel, SK; McCarten, KM; Schwartz, CL; Wolden, SL, 2015) |
| "Prednisone was tapered in both groups after 1 month." | 2.80 | Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. ( Barbano, G; Belingheri, M; Bodria, M; Bonanni, A; De Giovanni, D; Degl'Innocenti, L; Edefonti, A; Fornoni, A; Ghiggeri, GM; Montini, G; Murer, L; Pasini, A; Quinn, RR; Ravani, P; Reiser, J; Rossi, R; Scolari, F; Sica, F, 2015) |
| "Imatinib mesylate is a multikinase inhibitor of several signaling pathways implicated in skin fibrosis with in vitro antifibrotic activity." | 2.80 | Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. ( Baird, K; Booher, S; Comis, LE; Cowen, EW; Figg, WD; Flanders, KC; Hakim, FT; Joe, GO; Mitchell, SA; Pavletic, SZ; Rose, JJ; Sarantopoulos, S; Steinberg, SM; Takebe, N; Yao, L, 2015) |
| "A prednisone increase led to remission in 35 patients (80%)." | 2.80 | Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids. ( Brunetta, P; Ding, L; Fervenza, FC; Hoffman, GS; Iklé, D; Kallenberg, CG; Langford, CA; Lim, N; Merkel, PA; Miloslavsky, EM; Monach, PA; Seo, P; Specks, U; Spiera, R; St Clair, EW; Stone, JH; Tchao, NK; Villareal, M, 2015) |
| "Patients with relapsed/refractory (R/R) multiple myeloma (MM) complicated by severe heart failure typically do not tolerate conventional chemotherapy." | 2.79 | Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure. ( Guo, L; Hou, J; Li, L; Ling, C; Shi, H; Wei, W; Zhou, F, 2014) |
| "Prednisone was tapered to discontinuation after 5." | 2.79 | Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. ( Allen, NB; Brunetta, P; Ding, L; Fervenza, FC; Geetha, D; Hoffman, GS; Iklé, D; Jepson, B; Kallenberg, CG; Keogh, K; Kissin, EY; Langford, CA; Merkel, PA; Miloslavsky, EM; Monach, PA; Peikert, T; Seo, P; Specks, U; Spiera, R; St Clair, EW; Stegeman, C; Stone, JH; Tchao, NK; Villarreal, M; Viviano, L; Ytterberg, SR, 2014) |
| " Two toxic deaths were observed." | 2.78 | High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study. ( Alexis, M; Arakelyan, N; Banos, A; Cartron, G; Courby, S; Damotte, D; Dreyfus, F; Fontan, J; Gressin, R; Gyan, E; Lamy, T; Laribi, K; Le Gouill, S; Maisonneuve, H; Quittet, P; Schmidt-Tanguy, A; Sénécal, D; Solal-Céligny, P; Tournilhac, O, 2013) |
| "Pomalidomide was given at 1 to 2." | 2.78 | Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. ( Baldi, I; Boccadoro, M; Bringhen, S; Carella, AM; Corradini, P; Crippa, C; Galli, M; Giuliani, N; Guglielmelli, T; La Verde, G; Larocca, A; Magarotto, V; Marcatti, M; Mina, R; Montefusco, V; Omedé, P; Palumbo, A; Rossi, D; Rota-Scalabrini, D; Santagostino, A, 2013) |
| "Localized lymphoblastic lymphoma (LL) is rare in pediatric patients." | 2.77 | Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group. ( Abromowitch, M; Finlay, JL; Gross, TG; Lones, M; Perkins, SL; Smith, LM; Termuhlen, AM; Weinstein, H, 2012) |
| "Of the 57 patients in this phase I trial, 55 participated in 1 of 2 dosing schedules that included rituximab (375 mg/m(2)) and cyclophosphamide (750 or 1,000 mg/m(2)) administered on day 1 of each 21-day cycle and prednisone (100 mg orally) days 2 to 6." | 2.76 | Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. ( Dumitrescu, O; Gerecitano, J; Hamlin, P; Horanlli, E; Iasonos, A; Mo, Q; Moskowitz, CH; Noy, A; O'Connor, OA; Pappanicholaou, J; Portlock, C; Rojas, CN; Sarasohn, D; Schulman, P; Straus, D; Zelenetz, AD; Zhang, Z, 2011) |
| "Pixantrone is a potentially more effective, less cardiotoxic alternative to doxorubicin for patients with aggressive non-Hodgkin lymphoma (aNHL)." | 2.76 | Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma. ( Borchmann, P; Cernohous, P; Engert, A; Herbrecht, R; Hess, G; Morschhauser, F; Singer, JW; Veals, SA; Wilhelm, M, 2011) |
| "Approximately 20% of all Hodgkin lymphoma (HL) patients are older than 60 years and have a poor prognosis, mainly because of increased treatment-related toxicity resulting in reduced overall dose intensity and more treatment-related mortality." | 2.76 | Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. ( Böll, B; Borchmann, P; Bredenfeld, H; Eich, HT; Eichenauer, DA; Engert, A; Fuchs, M; Geissler, M; Görgen, H; Graeven, U; Halbsguth, T; Keller, U; Kremers, S; Markova, J; Soekler, M; Trenn, G; von Tresckow, B, 2011) |
| "coli asparaginase in children with acute lymphoblastic leukemia in second bone marrow relapse." | 2.76 | Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). ( Asselin, B; Bernstein, M; Buchanan, GR; Camitta, BM; Kurtzberg, J; Pollock, BH, 2011) |
| "Orchitis affected 17/122 (14%) of the boys." | 2.75 | Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. ( Ala-Houhala, M; Arikoski, P; Hölttä, T; Jahnukainen, T; Jauhola, O; Koskimies, O; Nuutinen, M; Ormälä, T; Rajantie, J; Ronkainen, J, 2010) |
| "Thalidomide has direct antimyeloma and immunomodulatory effects." | 2.73 | Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21. ( Abonour, R; Ansari, RH; Cripe, LD; Fausel, C; Fisher, WB; Juliar, BE; Smith, GG; Suvannasankha, A; Wood, LL; Yiannoutsos, CT, 2007) |
| "Cure rates for adult acute lymphoblastic leukemia (ALL) in developing countries are significantly lower because of problems unique to these countries." | 2.73 | Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting. ( Ahluwalia, J; Das, R; Jain, S; Kumari, S; Mahi, S; Malhotra, P; Radhika, S; Sharma, SC; Varma, N; Varma, S, 2007) |
| "Symptom relapse was seen in 45% of patients by week 24." | 2.73 | Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. ( Corkins, MR; Croffie, JM; Fitzgerald, JF; Gupta, SK; Lim, JD; Molleston, JP; Pfefferkorn, MD; Schaefer, ET; Steiner, SJ, 2008) |
| "Relapses are common in patients with PMR." | 2.72 | Predicting the risk of relapse in polymyalgia rheumatica: novel insights. ( Atienza-Mateo, B; Blanco, R; Castañeda, S; González-Gay, MA; Prieto-Peña, D, 2021) |
| " Four trials included European cohorts using dosing schedules according to the regimens studied." | 2.72 | Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis. ( Dorresteijn, EM; Schijvens, AM; Schreuder, MF; Teeninga, N; Teerenstra, S; Webb, NJ, 2021) |
| "Immunosuppression without steroids is safe and reduces infection and metabolic complications." | 2.72 | Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. ( Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Gonzalez-Pinto, I; Lladó, L; Memba, R; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X, 2006) |
| "To study the effect of Shenbing Mistura (SM) combined with glucocorticoid on recurrent nephrotic syndrome (RNS) in children and levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in blood and urine." | 2.72 | [Clinical effect of shenbing mistura combined with glucocorticoid on recurrent nephrotic syndrome in children and levels of interleukin-6 and tumor necrosis factor-alpha in blood and urine]. ( Dang, XQ; Hu, GH; Wang, JH, 2006) |
| "Relapse was diagnosed in 17." | 2.71 | [Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic]. ( Blazek, B; Cerná, Z; Dembická, D; Gajdos, P; Hak, J; Hrstková, H; Hrusák, O; Jabali, Y; Kopecná, L; Mihál, V; Mydlil, J; Pospísilová, D; Procházková, D; Ptoszková, H; Slavík, Z; Starý, J; Timr, P; Trka, J; Vávra, V; Zahálka, F, 2003) |
| "One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD." | 2.71 | Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004) |
| "Patients with idiopathic membranous nephropathy (iMN) and renal insufficiency have a high risk for progression to end-stage renal disease (ESRD)." | 2.71 | Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. ( Branten, AJ; du Buf-Vereijken, PW; Wetzels, JF, 2004) |
| " The patients received PTX at the initiating dosage until complete clinical cure." | 2.71 | [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]. ( Achirafi, A; de Carsalade, GY; Flageul, B, 2003) |
| " If patients were receiving cytotoxic agents, the dosage was not increased." | 2.71 | Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. ( Brasington, RD; Hoffman, GS; Lenschow, DJ; Liang, P; Merkel, PA, 2004) |
| " In this multicenter study, THP (pirarubicin)-COP (cyclophosphamide, vincristine, and prednisolone) was compared to two thirds dosage of full CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen with regard to both adverse events and efficacy." | 2.71 | Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. ( Harada, M; Hotta, T; Kitamura, K; Masaoka, T; Masuda, M; Matsuda, T; Miura, AB; Miyazaki, T; Mizoguchi, H; Mori, M; Niho, Y; Saito, H; Shibata, A; Takaku, F, 2005) |
| "to explore the mechanism of leeching in treating systemic lupus erythematosus (SLE)." | 2.71 | Study of the effect of leeching on plasma endothelin and soluble interleukin-2 receptor in patients with systemic lupus erythematosus. ( Cheng, SP; Liu, JL; Yuan, J, 2005) |
| "Three patients had grade 3 infections." | 2.71 | Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. ( Dührsen, U; Kasper, C; Müller-Beissenhirtz, H; Nückel, H, 2005) |
| "The visual results, frequency of recurrence of uveitis and incidence of ocular complications were compared between the two groups." | 2.70 | [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis]. ( Du, H; Hu, T; Liu, Q; Min, H; Zhang, M, 2002) |
| "Thirty-three evaluable patients with Hodgkin's disease who failed radiotherapy were treated on this phase II study with bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone given every 28 days for a minimum of eight courses." | 2.70 | Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). ( Bennett, JM; Glick, JH; Habermann, TM; Leong, T; Neiman, RS; Oken, MM; Schuster, S; Wiernik, PH, 2001) |
| "Oral prednisone alone was used in 50 of the 59 patients (mean initial dose 1 mg/kg body weight/day)." | 2.70 | Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. ( Arnal, C; Bierling, P; Godeau, B; Hachulla, E; Léone, J; Papo, T; Piette, JC; Roudot-Thoraval, F; Schaeffer, A; Taillan, B, 2002) |
| "Testicular recurrence varied from 2-8% in comparison with 20% in the historic group." | 2.69 | Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group. ( Bleyer, WA; Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME; Uckun, FM, 1998) |
| "The idiotype (Id) determinant on the multiple myeloma (MM) protein can be regarded as a tumor-specific marker." | 2.69 | Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. ( Benike, CJ; Blume, KG; Engleman, EG; Levy, R; Liso, A; Okada, CY; Reichardt, VL; Stockerl-Goldstein, KE, 1999) |
| "Patients with refractory or recurrent acute lymphoblastic leukemia (ALL) were treated with a combination of methotrexate (MTX), vincristine, PEG-asparaginase, and prednisone (MOAP)." | 2.69 | Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. ( Aguayo, A; Cortes, J; Kantarjian, H; Keating, M; Pierce, S; Thomas, D, 1999) |
| "Relapses were treated with prednisolone, 2 mg/kg daily for 2 weeks, then 1." | 2.69 | Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. ( Bagga, A; Hari, P; Srivastava, RN, 1999) |
| "Children with acute lymphoblastic leukemia (ALL) who experience hematologic recurrence while receiving chemotherapy or within 6 months after its cessation have a low cure rate." | 2.69 | Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. ( Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H, 2000) |
| "Patients with Crohn's disease often have relapses." | 2.69 | A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. ( Feagan, BG; Fedorak, RN; Greenberg, GR; Hanauer, SB; Hopkins, M; Irvine, EJ; Koval, J; McDonald, JW; Steinhart, AH; Sutherland, L; Wild, G; Wong, CJ, 2000) |
| "Relapses are common in children with idiopathic nephrotic syndrome, and this prospective study looks into the possibility of decreasing the frequency of relapses in a selected group of such patients." | 2.69 | Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. ( Mahmoud, MA; Mattoo, TK, 2000) |
| "Mitoxantrone is an active agent in lymphoma that is not generally used in first-line treatment." | 2.69 | CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma. ( Kraszewska, E; Krzyzanowska, JB; Lampka, E; Meder, J; Miśkiewicz, Z; Romejko-Jarosińska, J; Walewski, J, 2000) |
| "Disease progression, which includes recurrence at the primary tumor site, is a major cause of treatment failure in patients with mediastinal presentations." | 2.68 | Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. ( Kadin, M; Kersey, JH; King, D; Krailo, MD; Meadows, AT; Morse, M; Rosenstock, J; Steinherz, PG; Tubergen, DG, 1995) |
| "The results showed that in WM group the recurrence rate was 11." | 2.68 | [Observation of therapy of integrated TCM-WM on repeatedly relapsed primary nephrotic syndrome in adults]. ( Li, HQ; Ren, GH; Ye, RG, 1995) |
| "Six patients (4 with Hodgkin's disease) achieved a complete response (CR) (35%; 95% CI: 14-62%)." | 2.68 | Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma. ( Carrión, JR; García Arroyo, FR; Salinas, P, 1995) |
| "The article studied 61 patients with idiopathic thrombocytopenic purpura, they were classified and treated with Chinese herbal medicine Zhinu (ZN) -I, -II, in comparison with 30 cases of patients treated with prednisone." | 2.68 | [Clinical study of zhinu-I,-II in treating 61 patients with idiopathic thrombocytopenic purpura]. ( Hong, F; Yang, YQ; Zeng, FC, 1996) |
| "Idiopathic BOOP is a clinicopathological entity defined histopathologically by the presence of granulation tissue in bronchioles, alveolar ducts and alveoli." | 2.68 | [Bronchiolitis obliterans organizing pneumonia]. ( Korzeniewska-Koseła, M; Kuś, J; Meleniewska-Maciszewska, A; Stelmaszczyk, W; Słodkowska, J; Wesołowski, S; Zołnowska, B, 1997) |
| "Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV." | 2.67 | Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994) |
| "Oral pemphigus is considered to represent either an initial stage of pemphigus vulgaris that should be treated with high doses of immunosuppressive drugs to prevent its spread to the skin or a variety of the disease that does not need aggressive treatment." | 2.67 | Treatment of oral pemphigus vulgaris. ( Chrysomallis, F; Ioannides, D; Minas, A; Panagiotidou, D; Teknetzis, A, 1994) |
| "Treatment of Langerhans cell histiocytosis (LCH) remains problematic." | 2.67 | Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. ( Gadner, H; Gatterer-Menz, I; Grois, N; Heitger, A; Ladisch, S, 1994) |
| "Relapses were most frequent in previously involved unirradiated areas." | 2.67 | Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991) |
| "Initial treatment and relapse therapy were similar in all patients according to the BFM- and CoALL-protocols (front line: 38 patients according to BFM-protocols and 13 patients according to CoALL-protocols; relapse: 12 patients in study ALL-REZ-BFM 83, 17 in ALL-REZ-BFM 85, 20 in ALL-REZ-BFM 87, and two in ALL-REZ-BFM 90)." | 2.67 | Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. ( Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H, 1991) |
| "Boys with acute lymphoblastic leukemia (ALL) who have overt testicular relapse (OTR) during initial continuation chemotherapy or within 6 months thereafter have poor outcomes, with long-term survival similar to patients with marrow relapse during treatment." | 2.67 | Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. ( Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA, 1991) |
| "A total of 333 patients with AIDS and pneumocystis pneumonia received standard treatment and were randomly assigned to receive either corticosteroids (beginning with the equivalent of 40 mg of prednisone twice daily) or no additional therapy." | 2.67 | A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Abramson, I; Bartok, A; Bozzette, SA; Chiu, J; Coffman, J; Gluckstein, D; Kemper, C; Niosi, J; Sattler, FR; Wu, AW, 1990) |
| "They also discuss treatment for relapsed disease including targeted therapies." | 2.66 | Perspectives on chemotherapy for the management of double-hit lymphoma. ( Al-Juhaishi, T; Mckay, J; Sindel, A; Yazbeck, V, 2020) |
| "After the first discharge, she got a recurrence of COVID-19 during her home isolation, and then returned to hospital and continued the previous therapy." | 2.66 | Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. ( Cao, J; Fan, L; He, F; Hu, K; Lei, M; Luo, Q; Qin, S; Shao, X; Yang, L; Yu, N, 2020) |
| "Audiogram was normal." | 2.66 | RECURRENT BRANCH RETINAL ARTERY OCCLUSION FROM SUSAC SYNDROME: CASE REPORT AND REVIEW OF LITERATURE. ( Ammar, MJ; Bhatt, N; Brucker, AJ; Kolomeyer, AM; Mullen, MT; Tamhankar, MA, 2020) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| "The course of 205 patients with Crohn's disease at one gastroenterological center was studied in patients with conservative drug treatment or with operative management of their disease." | 2.66 | Clinical relapse of Crohn's disease under standardized conservative treatment and after excisional surgery. ( Dirks, E; Eigler, FW; Förster, S; Goebell, H; Quebe-Fehling, E; Schaarschmidt, K, 1989) |
| "From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy." | 2.66 | Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985) |
| "A standard clinical grading system, the Crohn's Disease Activity Index (CDAI) was developed to allow uniform decentralized clinical evaluation and decision-making throughout the 5 yr of the study." | 2.65 | National Cooperative Crohn's Disease Study: study design and conduct of the study. ( Becktel, JM; Best, WR; Kern, F; Lenk, LF; Singleton, JW; Summers, RW; Winship, DH, 1979) |
| "The response of active and quiescent Crohn's disease to prednisone, sulfasalazine, or azathioprine has been studied in 569 patients in a placebo-controlled, randomized, multicenter cooperative trial." | 2.65 | National Cooperative Crohn's Disease Study: results of drug treatment. ( Becktel, JM; Best, WR; Kern, F; Sessions, JT; Singleton, JW; Summers, RW; Switz, DM, 1979) |
| "Nevertheless, influenza vaccination can be safely carried out in patients with systemic lupus erythematosus." | 2.64 | Influenza immunization in systemic lupus eruthematosus. A double-blind trial. ( Decker, JL; Dolin, R; Klassen, LW; Reinertsen, JL; Steinberg, AD; Williams, GW, 1978) |
| "The long-term effect of prednisone in Crohn's disease has been examined in a double-blind controlled trial." | 2.64 | Low dose steroids and clinical relapse in Crohn's disease: a controlled trial. ( Crosby, DL; Evans, KT; Heatley, RV; Hughes, LE; Jones, H; Lawrie, BW; Rees, BI; Rhodes, J; Smith, RC, 1978) |
| " The mean reduction in steriod dosage in the azathioprine group at the end of the trial (-15." | 2.64 | A controlled trial of azathioprine in Crohn's disease. ( Kirsner, JB; Levin, B; Rosenberg, JL; Wall, AJ, 1975) |
| " oral dexamethasone versus oral prednisone), with consideration for dosing and pharmacokinetic properties, to better identify the optimal IM or oral corticosteroid regimens to improve patient outcomes." | 2.58 | Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma. ( Campbell, S; Cross, E; Kirkland, SW; Rowe, BH; Villa-Roel, C, 2018) |
| "Infection and venous thromboembolism are the main complications of NS with also increased risk of acute kidney injury." | 2.58 | Idiopathic nephrotic syndrome in children. ( Iijima, K; Noone, DG; Parekh, R, 2018) |
| "Idiopathic granulomatous mastitis is a distinct benign breast condition of unknown etiology but several triggers are suspected, including inflammatory, infectious, and hormonal factors." | 2.52 | Treatment for and clinical characteristics of granulomatous mastitis. ( Gharib, M; Naderi, H; Sarvghad, M; Sheybani, F, 2015) |
| "For reducing the rate of recurrence, 3 treatments were ranked as follows: radioiodine therapy, therapy with antithyroid drugs and surgery." | 2.52 | Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis. ( Li, J; Li, Y; Qin, L; Ren, Z; Wang, JQ; Zhang, RG, 2015) |
| "Immunoglobulin G4 (IgG4)-associated autoimmune hepatitis (AIH) was recognized as a new disease entity; however, IgG4-associated de novo AIH after the liver transplantation had not been reported yet." | 2.49 | Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. ( Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY, 2013) |
| "Four patients had orbital myositis of one extraocular muscle at the initial episode and recurrent myositis of a different extraocular muscle on the contralateral orbit." | 2.48 | Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. ( Avni-Zauberman, N; Ben Simon, GJ; Rosen, N; Tripathy, D, 2012) |
| "Autoimmune hepatitis is a chronic inflammatory disease of the liver with a dismal prognosis when left untreated." | 2.46 | Autoimmune hepatitis. ( Strassburg, CP, 2010) |
| "Relapses have long been treated with steroids to reduce inflammation and hasten recovery." | 2.45 | Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. ( Beyene, J; Burton, JM; Hohol, M; O'Connor, PW, 2009) |
| "Case reports of OM with abducens nerve palsy were also reviewed." | 2.44 | Ophthalmoplegic migraine: a case with recurrent palsy of the abducens nerve. ( da Silva, A; Gómez, RS; Leal, JC; Stancioli, FG; Teixeira, AL; Vasconcelos, LP, 2008) |
| " In case of steroid responsiveness, the risk is the relapse when the steroid dosage is tapered or stopped and the complications related to the treatment which is given to maintain remission." | 2.42 | [Lipoid nephrosis in childhood]. ( Niaudet, P, 2003) |
| "Eosinophilic cystitis is an uncommon disease in children, and its association with chronic granulomatous disease (CGD) has been previously reported in only five patients." | 2.42 | Recurrent eosinophilic cystitis in a child with chronic granulomatous disease. ( Barese, CN; Litvak, E; Podestá, M; Rivas, EM; Villa, M, 2004) |
| "Three days later a new recurrence of disseminated lichen planus occurred." | 2.42 | Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. ( Calista, D; Morri, M, 2004) |
| "Myasthenia gravis is an autoimmune disease mediated by auto-antibodies direct against the nicotinic receptor for acetylcholine." | 2.41 | Plasma exchange for myasthenia gravis. ( Chevret, S; Gajdos, P; Toyka, K, 2002) |
| "Pulmonary sarcoidosis has a variable natural course from an asymptomatic state to a progressive life-threatening condition." | 2.41 | Clinical aspects of pulmonary sarcoidosis. ( Judson, MA, 2000) |
| "Nephrotic patients with primary focal segmental glomerulosclerosis (FSGS) have a poor prognosis with 50% progressing to end stage renal disease (ESRD) over 3 to 8 years." | 2.41 | The treatment of primary focal segmental glomerulosclerosis. ( Korbet, SM, 2000) |
| " Oral controlled-release budesonide has demonstrated comparable efficacy to prednisolone with less risk for adverse effects, although many questions remain regarding the long-term use of this agent." | 2.41 | Conventional treatment of Crohn's disease: objectives and outcomes. ( Rutgeerts, PJ, 2001) |
| "Treatment with melphalan and prednisone results in an objective response in 50%-60% of patients." | 2.41 | Management of patients with multiple myeloma: emphasizing the role of high-dose therapy. ( Kyle, RA, 2001) |
| "Autoimmune hepatitis has a global distribution and affects all ages." | 2.41 | Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. ( Al-Khalidi, JA; Czaja, AJ, 2001) |
| "Relapses have been recorded from three years to twenty years, although few very late forms are registered." | 2.40 | Relapse of Hodgkin's disease after 10 years of complete remission: case report. ( Mwanda, OW; Othieno-Abinya, N, 1998) |
| "A new case of hepatic inflammatory pseudotumor (HIP) is reported." | 2.40 | [Hepatic inflammatory pseudotumor: apropos a case with a response to steroid treatment]. ( Blanco Molina, MA; Fernández de la Puebla Giménez, RA; García Alegría, J; Lechuga Varona, MT, 1999) |
| "There were no recurrences at discontinuation of the treatment." | 2.39 | [Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients]. ( Coustals, P; Dromer, C; Fournié, B; Le Guennec, P; Marc, V; Sixou, L, 1994) |
| "In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative." | 2.39 | Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996) |
| "Relapse is usually clinically milder than the first phase, with variable liver function abnormalities and a tendency toward more marked cholestatic features." | 2.38 | Relapsing hepatitis A. Review of 14 cases and literature survey. ( Galun, E; Glikson, M; Oren, R; Shouval, D; Tur-Kaspa, R, 1992) |
| "Although varicella is one of the most common infectious diseases in the United States, systemic and ocular complications are rare." | 2.38 | Delayed onset of varicella keratitis. ( de Freitas, D; Kelly, LD; Pavan-Langston, D; Sato, EH, 1992) |
| "Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP." | 2.37 | Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988) |
| "Crohn's disease is a perplexing disease with a high rate of morbidity and complications." | 2.35 | The protean manifestations of Crohn's disease. ( Farmer, RG, 1975) |
| " The primary outcome was to evaluate cumulative prednisone dosage at 12 and 24 months of follow-up in the two groups." | 1.91 | Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice. ( Emma, F; Gatto, A; Gianviti, A; Lucchetti, L; Massella, L; Vivarelli, M, 2023) |
| "Prednisone was discontinued in 76." | 1.91 | Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. ( Dagincourt, N; Han, J; Matza, MA; Mohan, SV; Pavlov, A; Stone, JH; Unizony, SH, 2023) |
| "028) and prednisone dosage during pregnancy ≥12." | 1.72 | Good pregnancy outcomes in lupus nephritis patients with complete renal remission. ( Chen, D; Chen, Y; Hu, W; Li, K; Liu, Z; Yang, L; Zhang, H, 2022) |
| "The prognosis of childhood acute lymphoblastic leukemia (ALL) in Indonesia, a lower-middle-income country (LMIC), is lower than in high income countries (HICs)." | 1.72 | Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country. ( Adelin, CP; Ardianto, B; Christian, SD; Kaspers, GJL; Kors, WA; Lestari, RP; Mulatsih, S; Pangarso, AWS; Purwanto, I; Sabrina, DS; Sagoro, L; Supriyadi, E; Sutaryo, S; Veerman, AJP; Verena, N; Widjajanto, PH, 2022) |
| "Prednisone was tapered/stopped." | 1.72 | Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study. ( Bettini, C; Colucci, M; Emma, F; Gargiulo, A; Lo Russo, A; Vivarelli, M, 2022) |
| "To present an unusual case of recurrent multiple evanescent white dot syndrome (MEWDS) following the coronavirus 2019 (Covid-19) vaccination." | 1.62 | Presumed Recurrent MEWDS following Covid-19 Vaccination. ( Shen, W; Xu, Y, 2021) |
| "Rituximab treatment for pemphigus has only recently been introduced to the Israeli health basket." | 1.62 | Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience. ( Hodak, E; Leshem, YA; Levi, A; Mimouni, D; Snast, I; Spitzer, L, 2021) |
| "After contemporary treatment of ES-HL, relapse mostly occurred > 12 months after first diagnosis." | 1.62 | Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. ( Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B, 2021) |
| "We report on a patient with recurrence of anti-GBM disease after SARS-CoV-2 infection." | 1.62 | SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report. ( Cejna, M; Lhotta, K; Soleiman, A; Sprenger-Mähr, H; Winkler, A; Zitt, E, 2021) |
| "Prednisone was discontinued when DAS ≤2." | 1.62 | Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies. ( Allaart, CF; Bergstra, SA; Dos Santos Sobrín, R; Goekoop, R; Huizinga, TWJ; Maassen, JM, 2021) |
| "Although the standard treatment for relapsed DLBCL is high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), the efficacy of this approach for primary refractory DLBCL is not well understood." | 1.62 | Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy. ( Fukuhara, S; Hatta, S; Ito, Y; Izutsu, K; Kobayashi, Y; Makita, S; Maruyama, D; Miyagi-Maeshima, A; Munakata, W; Nomoto, J; Suzuki, T; Tajima, K; Taniguchi, H; Tobinai, K; Yuda, S, 2021) |
| " The administration of intratympanic infliximab is an effective and safe technique." | 1.56 | Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss. ( García-Fernández, A; Mata-Castro, N; Sanz-López, L; Varillas-Delgado, D, 2020) |
| " Clinical manifestation, IgG4-RD responder index (IgG-RD RI), serological indexes, gland ultrasound findings, and adverse drug effect were recorded." | 1.56 | Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease. ( Bian, W; Chen, D; Chen, J; Fu, J; Li, Y; Li, Z; Liu, Y; Sun, X; Zhang, W; Zhang, Y; Zhao, X, 2020) |
| "Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
| "Survival is limited by recurrent cancer and organ toxicity." | 1.56 | Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts. ( Appelbaum, FR; Boeckh, M; Cheng, GS; Deeg, HJ; Flowers, MD; Gooley, TA; Hingorani, S; Lee, SJ; Martin, PJ; McDonald, GB; Mielcarek, M; Pergam, SA; Sandmaier, BM; Schoch, G; Sorror, M; Storb, R, 2020) |
| "He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations." | 1.56 | Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient. ( Jeng, A; Kalinoski, T; Malenfant, J; Yim, C, 2020) |
| "An important goal in the management of systemic lupus erythematosus (SLE) is the prediction of relapses." | 1.56 | Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus. ( Alcaraz-Lopez, MF; Bonilla-Lara, D; Diaz-Rizo, V; Fajardo-Robledo, NS; Gamez-Nava, JI; Gonzalez-Lopez, L; Muñoz-Valle, JF; Perez-Guerrero, EE; Rodriguez-Jimenez, NA; Saldaña-Cruz, AM; Sanchez-Mosco, DI, 2020) |
| "Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases." | 1.56 | Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas. ( Argyle, DJ; Ávila, ACFCM; Costa, MT; de Nardi, AB; Fukumasu, H; Garnica, TK; Lesbon, JCC; Matiz, ORS; Nishiya, AT; Ribeiro, RCS; Rochetti, AL; Silveira, JC; Strefezzi, RF; Zoppa, A, 2020) |
| "Disease recurrence in patients on and off immunosuppression support need for ongoing radiologic surveillance regardless of immunosuppression regimen." | 1.51 | Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis. ( Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J, 2019) |
| "With suspected recurrence of DLBCL, FDG-PET/CT was performed that showed no lymphadenopathy or abnormal FDG uptake." | 1.51 | [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions]. ( Fukumi, T; Ishikawa, T; Makita, M; Moriyama, T; Murakami, H; Nagakita, K; Shinno, Y; Sunami, K; Yoshioka, T, 2019) |
| "Three-year OS was 91." | 1.51 | Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG. ( Ahmed, S; Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, YM; Levis, M; MacManus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J, 2019) |
| "Goodpasture Syndrome is described as a single episode disease entity." | 1.51 | [Recurrence of goodpasture syndrome with negative antiglomerular basement antibodies. Report of one case]. ( Arancibia, T; Chahuán, J; Fischman, A; Huidobro E, JP; Méndez, GP; Tagle, R; Vázquez, S, 2019) |
| "To investigate the effectiveness, visual outcome, and prognostic factors of Vogt-Koyanagi-Harada (VKH) disease treatment with a reduced dose of corticosteroids combined with immunosuppressive agents." | 1.48 | Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. ( Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q, 2018) |
| "Lymphopenia is related to an increased risk of opportunistic infections." | 1.48 | Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. ( Bakker, DS; Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Leavis, HL; van den Broek, MPH; van der Schaft, J, 2018) |
| "In Tunisia, the management of Adult Hodgkin's Lymphoma (HL) has been standardized since 1999." | 1.48 | [Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients]. ( Ben Lakhal, R; BenAhmed, S; BenOthmen, T; BenSalah, H; BenYoussef, Y; Bouaouina, N; Daoued, J; Elloumi, M; Ezzaier, F; Frikha, H; Frikha, M; Hdiji, S; Khelif, A; Laatiri, MA; Ladeb, S; Maalej, M; Meddeb, B; Messai, T; Mezlini, A; Mokrani, A; Msaddek, F; Tebra, S; Toumi, N; Zriba, S, 2018) |
| "Relapses are common in type 1 AIP after steroid treatment." | 1.48 | Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China. ( Hao, L; Hu, LH; Li, ZS; Lin, H; Liu, PP; Meng, QQ; Pan, J; Qian, W; Wang, LW; Xin, L, 2018) |
| "Children with acute lymphoblastic leukemia (ALL) in low-income countries have disproportionately lower cure rates than those in high-income countries." | 1.48 | Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda. ( Driscoll, C; Elmore, S; Fehr, AE; Gilbert, UD; Hategekimana, V; Larrabee, K; Lehmann, L; May, L; Moore, M; Mpunga, T; Muhayimana, C; Rubagumya, F; Shulman, LN; Shyirambere, C; Uwizeye, FR; Xu, MJ, 2018) |
| "Among these optic neuritis is a rare presentation with only a handful of cases reported in the literature thus far." | 1.48 | Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report. ( Asif, A; Campbell, N; Curras-Martin, D; Haroon, A; Hossain, MA, 2018) |
| "The guidelines agree on treating acute gout with a corticosteroid, nonsteroidal anti-inflammatory drug, or colchicine and on not initiating long-term urate-lowering therapy (ULT) for most patients after a first gout attack and in those whose attacks are infrequent (<2 per year)." | 1.48 | How Would You Manage This Patient With Gout?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. ( Burns, RB; Shmerling, RH; Smith, CC; Tess, A, 2018) |
| "More than half of patients with Crohn's disease [CD] develop disease complications requiring aggressive medical therapy or surgery over time." | 1.46 | Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course. ( Drylewicz, J; Groenen, MJM; Horjus Talabur Horje, CS; Nierkens, S; Smids, C; van Lochem, EG; Wahab, PJ, 2017) |
| "In case of symptoms recurrence during tapering, 14% re-increase the dose and try tapering again." | 1.46 | The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey. ( Fascì-Spurio, F; Meucci, G; Papi, C; Saibeni, S, 2017) |
| "Ponatinib treatment was well tolerated and considered safe with easily manageable side effects." | 1.46 | Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant. ( Bossio, S; De Stefano, L; Gentile, M; Greco, R; Mazzone, C; Morabito, F; Morelli, R; Musolino, C; Palummo, A; Petrungaro, A; Recchia, AG; Uccello, G; Vigna, E, 2017) |
| "Background Nephrotic syndrome is related to immune system dysfunction." | 1.46 | Elevation of plasma-soluble HLA-G in childhood nephrotic syndrome is associated with IgE. ( Chen, M; Han, Q; Lai, M; Li, J; Liu, Y; Lou, Y; Wang, H; Yan, W; Yang, Q; Zheng, X, 2017) |
| "To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease." | 1.46 | Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. ( Abu El-Asrar, AM; Al-Muammar, A; Dosari, M; Gikandi, PW; Hemachandran, S, 2017) |
| "A MALT lymphoma has a small probability of occurring in Trousseau syndrome." | 1.46 | A case of Trousseau syndrome associated with a mucosa-associated lymphoid tissue lymphoma disseminated to the mesenteric adipose tissue. ( Aoyagi, H; Aritsuka, A; Fujinaga, H; Hasatani, K; Hayashi, Y; Ibe, N; Kaizaki, Y; Miyanaga, T; Naito, Y; Utsunomiya, M, 2017) |
| "Relapse was confirmed by biopsy or consecutive imaging." | 1.43 | Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma. ( Avivi, I; Bar-Shalom, R; Benyamini, N; Dann, EJ; Farbstein, D; Lavi, N; Shapira, G; Zilberlicht, A, 2016) |
| "Oral prednisone was stopped and tacrolimus was decreased, without any cutaneous or digestive relapse." | 1.43 | Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease. ( Allez, M; Bagot, M; Baudry, C; Hurabielle, C; Schneider, P; Viguier, M, 2016) |
| "Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs)." | 1.43 | Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases. ( Çavdar, A; Ceyhan, K; Deda, H; Gökçora, İH; Gözdaşoğlu, S; Işıkman, E; Pamir, A; Taçyıldız, N; Uluoğlu, Ö; Ünal, E; Yavuz, G, 2016) |
| "Fever was present in 76% of the cases, with a median duration of 9 days (IQR 0." | 1.43 | Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. ( Choi, EH; Kang, HM; Kim, JY; Lee, H; Lee, HJ; Yun, KW, 2016) |
| " Compared with the results before MMF therapy, the steroid dosage in both groups was significantly reduced at the 6- and 12-month follow-ups." | 1.43 | The Value of Monitoring the Serum Concentration of Mycophenolate Mofetil in Children with Steroid-Dependent/Frequent Relapsing Nephrotic Syndrome. ( Du, L; Fu, H; Liu, A; Mao, J; Shen, H; Shu, Q; Tong, K, 2016) |
| "Gender, age, and hypertension are associated with KD recurrence." | 1.43 | Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. ( Chen, Y; Liu, Z; Wang, J; Xu, F; Zeng, C, 2016) |
| "Psoriasis is a potential complication in kidney recipients that may recur when belatacept is used and/or tacrolimus is withdrawn as it could have happened in the first patient." | 1.43 | Recurrent Psoriasis After Introduction of Belatacept in 2 Kidney Transplant Recipients. ( Cicora, F; Roberti, J, 2016) |
| "Prednisone dose was increased to 0." | 1.43 | [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate]. ( Feki, NB; Ghorbel, IB; Houman, MH; Khanfir, MS; Said, F, 2016) |
| "Azathioprine is a DMARD that has been reported to be effective in HSP nephritis and in adult cutaneous leukocytoclastic vasculitis, a condition with cutaneous histology similar to HSP." | 1.43 | Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases. ( Baszis, KW; Fotis, L; Moore, TL; Pepmueller, PH; Tuttle, PV; White, AJ, 2016) |
| "The analysis of the recurrence rate involved 352 patients who had completed 6-month secondary prophylaxis (P/S one 25 mg/500mg tablet twice a week)." | 1.43 | The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence. ( Basiak, W; Borkowski, PK; Brydak-Godowska, J; Kajfasz, P; Olszyńska-Krowicka, M; Rabczenko, D; Świtaj, K; Żarnowska-Prymek, H, 2016) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 1.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "Fewer than 300 cases of tubulointerstitial nephritis and uveitis (TINU) syndrome have been reported." | 1.43 | A Rare Case of Tubulointerstitial Nephritis and Uveitis Syndrome Treated with a Multi-Specialty Approach. ( Erzurum, S; Hiremath, S; Purt, B; Sarac, E; Smith, S, 2016) |
| "Treatment with tacrolimus and mTORi is the most diabetogenic immunosuppressive regimen." | 1.43 | Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. ( Bautista, J; Calvo, M; Calvo, N; de la Manzanara, V; Delgado, J; Moreno, A; Perez-Flores, I; Rodriguez Cubillo, B; Rodriguez, B; Sanchez-Fructuoso, AI; Shabaka, A, 2016) |
| "Severity of Clostridium difficile infection (CDI) varies from one patient to another." | 1.43 | Medical ( Church, JM; Hull, TL; Messick, C; Silva-Velazco, J, 2016) |
| "An autoimmune disease was present in seven (29%) cases." | 1.42 | Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015) |
| "To analyse the rate of clinical recurrences in Brazilian patients with Vogt-Koyanagi-Harada (VKH) disease after early high-dose corticosteroid treatment." | 1.42 | High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. ( Costa, RA; da Silva, FT; Hirata, CE; Kalil, J; Marin, ML; Rodrigues, H; Sakata, VM; Yamamoto, JH, 2015) |
| "IPO and ureterohydronephrosis are severe complications of SLE." | 1.42 | Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study. ( Fang, W; Hou, Y; Huang, X; Li, M; Liu, J; Tian, X; Wang, Q; Wu, D; Xu, N; Zeng, X; Zhang, F; Zhang, W; Zhang, X; Zhao, J; Zhao, L; Zhao, Y, 2015) |
| "Treatment with prednisone alone was associated with more frequent relapses (odds ratio [OR] 2." | 1.42 | Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients. ( Brown, RD; Christianson, TJ; Giannini, C; Hunder, GG; Huston, J; Miller, DV; Salvarani, C, 2015) |
| "The treatment with prednisone resulted in a rapid resolution of clinical symptoms." | 1.42 | Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report. ( Gawroński, K; Kisiel, B; Rzepecki, P; Tłustochowicz, W, 2015) |
| "The median duration from initiation of treatment to relapse was 14." | 1.42 | Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era. ( Advani, RH; Hiniker, SM; Hoppe, RT; Khodadoust, MS; Kozak, MM; Pollom, EL; Quon, A; Xu, G, 2015) |
| "Relapse was defined as either new disease activity after a period of remission or worsening disease activity." | 1.42 | Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. ( Carette, S; Cuthbertson, D; Hoffman, GS; Kermani, TA; Khalidi, NA; Koening, CL; Langford, CA; Maksimowicz-McKinnon, K; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Warrington, KJ; Ytterberg, SR, 2015) |
| "Adaptation of patients with Hodgkin's lymphoma can take place only after successful treatment, the probability of relapse and fear of repeated courses strongly interfere with this process, especially in the first years after its closure." | 1.42 | [Hodgkin's lymphoma and radiotherapy]. ( Datsenko, PV; Panshin, GA, 2015) |
| "Three relapses were successfully retreated with rituximab again, after induction therapy with 60 mg prednisone per day." | 1.42 | A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood. ( Betjes, MG; Dekkers, MJ; Groothoff, JW; Zietse, R, 2015) |
| "Prednisone response has been confirmed to be still great prognostic value and PPR children patients have poor outcomes generally." | 1.42 | [Prognostic Value of Prednisone Response in CCLG-ALL 2008]. ( An, WB; Chang, LX; Liu, TF; Ren, YY; Wan, Y; Zhang, JL; Zhu, XF; Zou, Y, 2015) |
| "Among these abnormalities, minimal change nephrotic syndrome (MCNS) is the most common." | 1.42 | The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome. ( Dinçel, N; Hacıkara, Ş; Kaplan Bulut, İ; Mir, S; Yılmaz, E, 2015) |
| "We describe a patient with metastatic renal cell carcinoma and a history of Crohn's disease who was treated with sunitinib and developed a severe exacerbation of Crohn's disease." | 1.40 | Severe exacerbation of Crohn's disease during sunitinib treatment. ( Boers-Sonderen, MJ; Hoentjen, F; Jacobs, JF; Mulder, SF; Nagtegaal, ID; van Herpen, CM; Wanten, GJ, 2014) |
| "Here we report a case of a 22-year-old systemic lupus erythematosus (SLE) patient with three years' disease duration, stable on prednisone and hydroxychloroquine, who was found to have prolactinoma and recurrent GM after she discontinued medication on her own accord." | 1.40 | An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. ( Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN, 2014) |
| "Hodgkin's disease has been associated with a variety of cutaneous symptoms." | 1.40 | [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?]. ( Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M, 2014) |
| "Oral prednisone 2 mg/(kg·d) was the main treatment of the first episode cases (92." | 1.40 | [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome]. ( , 2014) |
| "Polymyalgia rheumatica is characterized by aching and stiffness of the shoulder, the pelvic girdles and the neck." | 1.40 | [Peripheral arthritis in polymyalgia rheumatica]. ( Manovitch, Z; Mouallem, M, 2014) |
| "Osteoporosis was more common in patients with relapses compared to those without (65% vs 32%, p = 0." | 1.40 | Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. ( Alba, MA; Butjosa, M; Cid, MC; Corbera-Bellalta, M; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Planas-Rigol, E; Prieto-González, S; Tavera-Bahillo, I, 2014) |
| "Steroid was given as the treatment after relapse in most of the patients and the total remission rate at the end of follow-up was 96." | 1.40 | Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. ( Chang, XJ; He, YX; Hu, LH; Jin, G; Jin, ZD; Li, ZS; Liao, Z; Shao, CW; Xin, L; Zhang, QH; Zheng, JM; Zhu, XF; Zou, DW; Zuo, CJ, 2014) |
| " There were no adverse drug-related events and its use resulted in a significant reduction in steroid dosage during follow-up." | 1.39 | Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases. ( Barzilai, A; Baum, S; Gilboa, S; Greenberger, S; Pavlotsky, F; Trau, H, 2013) |
| "The BFM studies for relapsed childhood acute lymphoblastic leukemia (ALL) were started in 1983, at a time when cure rates for ALL were still lower and the number of children with ALL relapse equaled about the number of children with newly diagnosed neuroblastoma." | 1.39 | ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia. ( Eckert, C; Henze, G; v Stackelberg, A, 2013) |
| "Severe neonatal thrombocytopenia below 50 × 10(9) /l is reported in 8-13% of the neonates from mothers with ITP and intracranial haemorrhage (ICH) in 0-2·9%." | 1.39 | Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. ( Brand, A; Lopriore, E; van der Lugt, NM; van Kampen, A; Walther, FJ, 2013) |
| " No serious adverse events were observed." | 1.39 | Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety. ( Lu, W; Xie, L; Xue, W; Yang, S; Yin, A, 2013) |
| "Pemphigus is a severe and life-threatening autoimmune bullous dermatosis." | 1.39 | The course and prognosis of pemphigus in 47 Tunisian patients. ( Ben Alaya, N; Fazaa, B; Kaffel, N; Khaled, A; Kharfi, M; Souissi, A; Taazayet, SB; Zeglaoui, F; Zermani, R, 2013) |
| "We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX)." | 1.39 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. ( Chari, ST; Clain, JE; Gleeson, FC; Hart, PA; Klebig, RR; Levy, MJ; Pearson, RK; Petersen, BT; Smyrk, TC; Sugumar, A; Takahashi, N; Topazian, MD; Vege, SS; Witzig, TE, 2013) |
| " No adverse events were recorded." | 1.39 | Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. ( Audard, V; Bouachi, K; Dahan, KY; Deschênes, G; Lang, P; Mojaat, R; Munyentwali, H; Plaisier, EM; Remy, P; Ronco, PM, 2013) |
| "Prednisone was used by 94% of TA patients and immunosuppressive agents were prescribed for 51 (98%) patients." | 1.38 | Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. ( Arraes, AE; Camargo, CZ; de Souza, AW; Freitas, DS; Mariz, HA, 2012) |
| "Early relapse is a parameter that affects clinical outcomes in relapsed diffuse large B cell lymphoma (DLBCL)." | 1.38 | Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma. ( Aoki, T; Imahashi, N; Kitamura, K; Nishiyama, T, 2012) |
| "Given the overall low rate of CNS recurrence and lack of prophylaxis-associated survival benefit, the current data called into question the practice of CNS prophylaxis in the rituximab era." | 1.38 | Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database. ( Abel, GA; Crosby, AL; Czuczman, MS; Friedberg, JW; Gordon, LI; Kumar, A; LaCasce, AS; Lepisto, E; Millenson, M; Nademanee, A; Niland, J; Rodriguez, MA; Vanderplas, A; Zelenetz, AD, 2012) |
| "A total of 58 patients (49%) sustained recurrence of carditis because of neglected secondary prophylaxis." | 1.38 | Follow-up of rheumatic carditis treated with steroids. ( Gomes, RS; Herdy, GV; Lopes, VG; Silva, AE; Silva, LS, 2012) |
| "Non-autoimmune hypothyroidism has been reported in children with congenital nephrotic syndrome." | 1.38 | Hypothyroidism in children with steroid-resistant nephrotic syndrome. ( Blumenthal, D; Cleper, R; Dagan, A; Davidovits, M; Krause, I, 2012) |
| "We herein report a patient with erythema induratum/nodular vasculitis (EI/NV) associated with Crohn's disease (CD), which is considered to be a rare type of metastatic CD." | 1.38 | Erythema induratum (nodular vasculitis) associated with Crohn's disease: a rare type of metastatic Crohn's disease. ( Misago, N; Narisawa, Y, 2012) |
| "Every relapse was treated with rituximab (500 mg) without corticosteroids, which induced a new complete response." | 1.38 | Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. ( Cianchini, G; Corona, R; De Pità, O; Lupi, F; Masini, C; Puddu, P, 2012) |
| "Relapses were treated in the same manner as the first attack in both groups." | 1.38 | Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis. ( Matsumoto, K; Umegae, S; Yamamoto, T, 2012) |
| "These three new cases of Van Buchem disease are of interest because of exceptionally early presentation of symptoms." | 1.38 | A rare cause of facial nerve palsy in children: hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review. ( Boot, AM; Brouwer, OF; Dikkers, FG; Papapoulos, SE; van Egmond, ME; van Lierop, AH, 2012) |
| " Longer incubation period of blood culture is needed to detect the microbe and long-term use of antimicrobials is required to prevent recurrent cellulitis." | 1.38 | [Recurrent cellulitis due to Helicobacter cinaedi after chemotherapy for malignant lymphoma]. ( Ishizawa, J; Iwata, S; Matsuki, E; Mori, T; Murata, M; Okamoto, S; Shimizu, T; Sugita, K; Tsukada, Y; Yokoyama, K, 2012) |
| "The relationship between angiolymphoid hyperplasia with eosinophilia (ALHE) and Kimura's disease has always been contentious." | 1.38 | Angiolymphoid hyperplasia with eosinophilia and Kimura's disease coexisting in the same patient: evidence for a spectrum of disease. ( Li, XS; Liu, XK; Ren, J; Wang, XH; Zeng, K; Zhang, HP, 2012) |
| "Clinical relapse was not statistically linked to the initial dose of corticoids." | 1.37 | Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica. ( Garrot, JF; Gérard, N; Gros, F; Guillibert-Karras, C; Julien, L; Maillefert, JF; Ornetti, P; Pascaud, F; Peere, T; Petit-Perrin, M; Piroth, C; Tavernier, C, 2011) |
| "Orbital lymphoma is a very rare type of primary Non-Hodgkin lymphoma." | 1.37 | Treatment of a patient with adnexal lymphoma with Rituximab. ( Bilgir, F; Bilgir, O; Calan, M; Oztekin, O; Sari, F; Yuksel, A, 2011) |
| "Treatment with prednisone and azathioprine, plus, in three children, cyclosporine, resulted in complete remission in eight, partial remission in six, and failure in two." | 1.37 | Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children. ( Bernard, O; Choulot, JJ; Fabre, M; Gori, L; Jacquemin, E; Maggiore, G; Pacifico, L; Resti, M; Sciveres, M, 2011) |
| "The probability of AIP recurrence was assessed by using Kaplan-Meier curves and the unadjusted Cox model." | 1.37 | Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. ( Bonatti, M; Frulloni, L; Graziani, R; Manfredi, R; Mantovani, W; Pozzi Mucelli, R, 2011) |
| "No patients showed recurrence in the combination treatment group." | 1.37 | Hormone administration promotes the epithelium healing in patients with recurrent corneal epithelial exfoliation. ( Hou, G; Ji, H; Xue, Y, 2011) |
| "There were no CNS recurrences in the three patients who received CNS prophylaxis." | 1.37 | Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. ( Fukuhara, S; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Taniguchi, H; Tanosaki, R; Tobinai, K; Watanabe, T, 2011) |
| "Even with proper immunosuppressive treatment, SLE can relapse." | 1.37 | Lupus relapse presented as frosted branch retinal angiitis: case report. ( Arellanes-Garcia, L; Cornejo-Ballesteros, H; Hernandez-Da Mota, SE; Melgoza-del-Angel, C; Recillas-Gispert, C; Sanchez-Gonzalez, R; Teran-Estrada, L, 2011) |
| "Pyoderma gangrenosum is a rare neutrophilic dermatosis that affects 4% of children." | 1.37 | [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases]. ( Benchikhi, H; Bouayad, K; Chiheb, S; Hali, F; Khadir, K; Mikou, N, 2011) |
| "While hypercalcemia is one of the complications of various types of cancerous diseases, it has rarely been reported as the first presentation of IVLBCL." | 1.37 | Intravascular B-cell lymphoma with hypercalcemia as the initial presentation. ( Chinen, Y; Horiike, S; Kiyota, M; Kuroda, J; Nakao, M; Sugitani-Yamamoto, M; Taniwaki, M, 2011) |
| "Methotrexate is a key drug in acute lymphoblastic leukemia (ALL) treatment; it inhibits DNA replication by blocking the conversion of 5,10 methylene tetrahydrofolate to 5-methylene tetrahydrofolate by methylene tetrahydrofolate reductase (MTHFR)." | 1.36 | Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. ( Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA, 2010) |
| "Risperidone is an effective short-term pharmacologic agent for controlling steroid-related psychiatric adverse effects when cessation or dose reduction of steroid therapy is not an option." | 1.36 | Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. ( Dahl, G; Shaw, RJ; Tzuang, D; Ularntinon, S, 2010) |
| "Eight patients died due to disease progression, and the median overall survival was 70." | 1.36 | Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea. ( Kim, K; Kim, SJ; Kim, WS; Ko, YH; Won, YW, 2010) |
| "Although prophylaxis against CNS recurrence with either intrathecal or intravenous methotrexate is commonly used for such patients, to the authors' knowledge, there is no standard of care." | 1.36 | Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. ( Abramson, JS; Barnes, JA; Hammerman, P; Hellmann, M; Hochberg, EP; Muzikansky, A; Takvorian, T; Toomey, C, 2010) |
| "Prednisone was the conventional medicine and electroacupuncture was applied at GV07 and GV02-1 at 0." | 1.36 | Clinical effect of additional electroacupuncture on thoracolumbar intervertebral disc herniation in 80 paraplegic dogs. ( Choi, SH; Han, HJ; Jang, HY; Jeong, SW; Kim, JY; Lee, B; Yoon, HY, 2010) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| "Adolescent patients with Hodgkin's lymphoma (HL) are treated either in pediatric, or in adult oncological wards." | 1.35 | [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?]. ( Csóka, M; Deák, B; Gergely, L; Illés, A; Jakab, Z; Keresztes, K; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Schneider, T; Simon, Z; Várady, E, 2008) |
| "IFN-alpha2a is efficient and safe for the long-term management of severe uveitis associated with Behçet disease." | 1.35 | Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. ( Bodaghi, B; Cassoux, N; Fardeau, C; Gendron, G; Gueudry, J; Lehoang, P; Piette, JC; Terrada, C; Wechsler, B, 2008) |
| "Colchicine has antifibrotic, anti-inflammatory, and immunosuppressive effects." | 1.35 | Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. ( Goecke, H; Labarca, E; Martínez, G; Santamarina, M; Tapia, H; Vega, J, 2009) |
| "Records of 50 patients treated for myasthenia gravis at Children's Memorial Hospital, Chicago, were reviewed." | 1.35 | Graded response to thymectomy in children with myasthenia gravis. ( McRae, W; Millichap, JG; Tracy, MM, 2009) |
| "Extraintestinal manifestations of Crohn's disease such as erythema nodosum and pyoderma gangrenosum are well recognized and appreciated." | 1.35 | Clinical spectrum of vulva metastatic Crohn's disease. ( Buchman, AL; Collyer, J; Leu, S; Mirowski, GW; Schlosser, B; Smidt, A; Stika, CS; Sun, PK; Vanagunas, A, 2009) |
| "During CsA treatment severe headaches and pains in orbits with nausea appeared." | 1.35 | [Neurological symptoms in patient with focal segmental glomerulosclerosis treated with cyclosporin A--case report]. ( Kuźma-Mroczkowska, E; Pańczyk-Tomaszewska, M; Roszkowska-Blaim, M, 2009) |
| "Mean prednisone dose was reduced to 11." | 1.35 | Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. ( Guillevin, L; Lafforgue, P; Marcelli, C; Mariette, X; Mejjad, O; Miceli-Richard, C; Puéchal, X; Solau-Gervais, E; Steinfeld, S; Trèves, R; Villoutreix, C, 2008) |
| "In January 2006 after severe recurrences of panuveitis a diagnostic vitrectomy was performed." | 1.35 | Ocular involvement in nasal natural killer T-cell lymphoma. ( Asioli, S; Cappuccini, L; Chan, CC; Cimino, L; Ilariucci, F; Masetti, M; Masini, L; Sartori, A; Shen, D, 2009) |
| "Herein we report a girl who developed autoimmune thyroiditis insidiously during the course of minimal change nephrotic syndrome." | 1.35 | Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome. ( Angjeleska, M; Gucev, Z; Petrusevska, G; Ristoska-Bojkovska, N; Tasic, V, 2009) |
| "Posterior scleritis is an unusual disease that may cause serious ocular inflammation and potentially blinding consequences." | 1.34 | Isolated bilateral posterior scleritis after eye trauma. ( Ramirez-Ortiz, MA; Vasquez-Resendis, A, 2007) |
| "Optic neuropathy is an uncommon complication of MFCPU that may result in substantial visual morbidity." | 1.34 | Optic neuropathy complicating multifocal choroiditis and panuveitis. ( Dunn, JP; Jabs, DA; Kedhar, SR; Thorne, JE; Wittenberg, S, 2007) |
| "Optic neuropathy is an uncommon manifestation of relapsing polychondritis (RPC), a rare systemic disease affecting cartilaginous and proteoglycan-rich structures." | 1.34 | Optic neuropathy associated with periostitis in relapsing polychondritis. ( Hirunwiwatkul, P; Trobe, JD, 2007) |
| "Syringes associated with myelitis shared some common features: they developed during the acute phase of myelitis and disappeared after steroids, were all non-communicating cavitations involving the central canal, and occurred in the same spinal segment affected by myelitis." | 1.34 | Pathogenetic role of myelitis for syringomyelia. ( Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S, 2007) |
| "The patient was treated with an increased dosage of prednisone." | 1.34 | [Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient]. ( Strecker, T; Wiest, GH; Zimmermann, I, 2007) |
| "Vulvar involvement in Crohn's disease is uncommon." | 1.34 | [Crohn's disease affecting only vulvoperineal area]. ( Arnaud, L; Bletry, O; Girszyn, N; Kahn, JE; Leport, J; Piette, AM, 2007) |
| " Non-steroidal anti-inflammatory drugs and colchicine are first-choice drugs, whereas corticosteroids should be considered only in patients with a frequent crisis unresponsive to non-steroidal anti-inflammatory drugs, and by using proper dosage and a careful slow tapering." | 1.34 | Treatment of refractory recurrent pericarditis. ( Cecchi, E; Correndo, L; D'Oulx, EA; Doronzo, B; Imazio, M; Trinchero, R, 2007) |
| "Pemphigus is a rare, life-threatening, acquired autoimmune bullous dermatosis." | 1.34 | Pemphigus vulgaris and pemphigus foliaceus: similar prognosis? ( Boubaker, S; Dhahri, AB; Hsairi, M; Makni, S; Mokni, M; Sellami, M; Zaraa, I; Zitouni, M, 2007) |
| "Cutaneous periarteritis nodosa is a localized form middle-sized arteriolitis." | 1.33 | [Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa]. ( Haicault de la Regontais, G; Hanslik, T; Stoyanova, M; Vasseur, E; Vignes, S, 2005) |
| "Between 15% and 30% of children with acute lymphoblastic leukemia (ALL) experience disease recurrence." | 1.33 | Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. ( Barrette, S; Bernstein, ML; Champagne, J; Champagne, MA; Dalle, JH; David, M; Demers, J; Duval, M; Hume, H; Leclerc, JM; Meyer, P; Moghrabi, A; Rousseau, P, 2005) |
| "We present 4 patients with CIDP who required respiratory assistance and mechanical ventilation." | 1.33 | Chronic inflammatory demyelinating polyneuropathy and respiratory failure. ( Henderson, RD; Sandroni, P; Wijdicks, EF, 2005) |
| " She had received several bouts of steroids and had been in clinical remission for 12 weeks under a dosage of 40 mg/d prednisone." | 1.33 | [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?]. ( Dienes, HP; Kruis, W; Lanyi, B, 2005) |
| "Fourteen patients with early recurrence were treated with a protracted high-dose prednisone or IV methylprednisolone, oral cyclophosphamide, high-dose oral or IV cyclosporine, and plasma exchanges." | 1.33 | Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression. ( André, JL; Cochat, P; Deschênes, G; Guyot, C; Loirat, C; Nathanson, S; Nivet, H, 2005) |
| "Patients with follicular lymphoma (FL) in advanced stages are currently deemed incurable with standard treatments." | 1.33 | Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. ( Arenillas, L; Balaguer, O; Bosch, F; Campo, E; Colomo, L; Ferrer, A; Giné, E; López-Guillermo, A; Montoto, S; Montserrat, E; Muntañola, A; Plancarte, F; Villamor, N, 2006) |
| "Prednisone was used at a starting dose from about 0." | 1.33 | Muscle involvement in sarcoidosis: a retrospective and followup studies. ( Bardin, T; Berenbaum, F; Fayad, F; Lioté, F; Orcel, P, 2006) |
| "The overall recurrence rate was three per 100 person-years, with an expected recurrence-free proportion of 73% with a 180 months median follow-up." | 1.33 | Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases. ( Broussolle, C; Gomard-Mennesson, E; Koenig, M; Magy, N; Ninet, J; Rousset, H; Ruivard, M; Salles, G; Sève, P; Woods, A, 2006) |
| "The granulomatous mastitis is an inflammatory pseudotumor of the breast of which evolution benign but likely to generate important morphological after-effects among young women." | 1.33 | [A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of these disease]. ( Bouhala, M; Dukic, R; Hueber, M; Kieffer, C; Kieffer, P; Riegel, P; Wilhelm, JM, 2006) |
| " In this case, once the dosage of oral prednisone was increased and methotrexate was added to the therapeutic scheme, inflammation was controlled within 1 month." | 1.33 | Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. ( Burnier, MN; Deschênes, J; Ozdal, PC; Vianna, RN, 2006) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "The ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (ataxic-CIDP) has been recently described as a subtype of chronic ataxic neuropathy, distinguished by steroid responsiveness and relative preservation of myelinated fibres at sural nerve biopsy." | 1.33 | Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy. ( Bertolasi, L; Ferrari, S; Mazzucco, S; Mezzina, C; Rizzuto, N; Tomelleri, G, 2006) |
| "Although scleritis has not been reported as a tubulointerstitial nephritis-associated ocular inflammation, it may be part of the possible spectrum of ocular inflammation occurring as part of the TINU syndrome." | 1.33 | Recurrent nodular scleritis preceding an adult TINU syndrome. ( Daniel, E; Gangaputra, S; Jabs, DA; Kempen, JH, 2006) |
| "Local relapse was observed to be higher in the chemotherapy alone group compared to the chemoradiotherapy group." | 1.33 | Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. ( Choi, CW; Jung, KY; Kim, BS; Kim, CY; Kim, IS; Kim, JS; Kim, SJ; Seo, HY; Seol, HR; Sung, HJ, 2006) |
| "Azathioprine was introduced early following the diagnosis (range, 1-35 days)." | 1.33 | Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. ( Banerjee, S; Bishop, WP; Rahhal, R, 2006) |
| "Intracraneal manifestations of Hodgkin's Disease (HD) are extremely rare, with an estimated incidence rate of approximately 0." | 1.33 | [Limphomatous meningitis as recurrence site in Hodgkin's disease]. ( Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M, 2006) |
| "The median time to recurrence was 33 months (range 4-120)." | 1.33 | Recurrent immune thrombocytopenic purpura in children. ( Jayabose, S; Levendoglu-Tugal, O; Ozkaynak, MF; Sandoval, C, 2006) |
| "Hypersensitivity pneumonitis was suspected." | 1.33 | Recurrent episodes of dermatomyositis-associated pneumonitis masquerading as hypersensitivity pneumonitis. ( Marik, PE; Vahid, B, 2006) |
| "Minimal residual disease was monitored by qualitative and real-time quantitative PCR." | 1.33 | Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma. ( Astolfi, M; Boccadoro, M; Bodoni, CL; De Marco, F; Drandi, D; Gianni, AM; Guidetti, A; Ladetto, M; Magni, M; Mantoan, B; Matteucci, P; Pagliano, G; Ricca, I; Tarella, C; Zanni, M, 2006) |
| "As no data on this topic exist for MALT lymphoma, we have retrospectively analysed our experience with R plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone (R-CHOP/R-CNOP) in patients with relapsed MALT lymphoma." | 1.33 | Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. ( Chott, A; Drach, J; Jager, U; Puspok, A; Raderer, M; Streubel, B; Troch, M; Turetschek, K; Wohrer, S; Zielinski, CC, 2006) |
| "The treatment of recurrent eosinophilic granuloma is challenging." | 1.32 | Treatment of recurrent eosinophilic granuloma with systemic therapy. ( Dubovy, SR; Johnson, TE; Song, A; Toledano, S, 2003) |
| "Treatment of recurrence of renal disease on graft remains controversial." | 1.32 | Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation. ( Badid, C; Fouque, D; Harzallah, K; Laville, M; Lefrancois, N; Touraine, JL, 2003) |
| "Relapse of type 1 autoimmune hepatitis after drug withdrawal may relate to incomplete histological improvement during corticosteroid therapy and/or persistence of pathogenic mechanisms." | 1.32 | Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. ( Carpenter, HA; Czaja, AJ, 2003) |
| "Early transient hypothyroidism is common in SAT." | 1.32 | Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. ( Aniszewski, JP; Atkinson, EJ; Fatourechi, GZ; Fatourechi, V; Jacobsen, SJ, 2003) |
| "A young woman presented with facial myokymia in association with dermatomyositis." | 1.32 | Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies. ( Alapati, A; Claussen, GC; Oh, SJ; Vernino, S, 2003) |
| "Osteoporosis is defined as a bone mineral density (BMD) value evaluated by dual-energy X-linked absorptiometry of the lumbar spine of a z score of 2." | 1.32 | Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? ( Godbole, M; Gulati, K; Gulati, S; Singh, U; Srivastava, A, 2003) |
| "Treatment strategies in Hodgkin's disease have an impact on different risk factors." | 1.32 | Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. ( Dieckmann, K; Heinzl, H; Hofmann, J; Pötter, R; Schellong, G; Wagner, W, 2003) |
| "The in-field and out of field recurrence rates were 18 and 31%, respectively, for the entire group and 22 and 44%, respectively, for the palliative group." | 1.32 | Abdominal irradiation after chemotherapy in non-Hodgkin's lymphoma: review of 32 patients. ( Akoum, R; Brihi, E; Chahine, G; Saade, M, 2003) |
| "Generalized or systemic Wegener granulomatosis has a worse prognosis than those limited to the respiratory tracts." | 1.32 | A case report of wegener granulomatosis treated only with corticosteroids for 30 years. ( Cockcroft, DW; PausJenssen, ES, 2003) |
| "All patients were treated with GCs and responded rapidly (median initial dosage 60 mg prednisone/day)." | 1.32 | Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. ( Gabriel, SE; Hunder, GG; O'Fallon, WM; Orces, C; Proven, A, 2003) |
| "Sirolimus was used in association with mycofenolate mofetil and prednisone." | 1.32 | [Calcineurin-inhibitor-free immunosuppression in early renal transplantation]. ( Escuín, F; García de Miguel, A; Jiménez, C; Olea, T; Ros, S; Sanz, A, 2004) |
| "One year later, the patient had a new recurrence and was treated with mycophenolate mofetil , improving his clinical situation." | 1.32 | [Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis]. ( Bueno, B; Espejo, B; González, E; Gutiérrez, E; Martínez, A; Torres, A; Valentín, M, 2004) |
| "Although nondiabetic nephropathies are common among type 2 diabetic patients, very few cases of minimal change nephrotic syndrome have been reported in diabetic patients." | 1.32 | [Relapsing nephrotic syndrome in a diabetic patient with minimal change]. ( Espejo, B; García Donaire, JA; Gutiérrez Martínez, E; Manzanera, MI; Praga, M; Valentín, MO, 2004) |
| "The incidence of acute rheumatic fever has seen a dramatic decline over the last 15 to 20 years in most developed countries and treatment of this disease has changed little since." | 1.32 | Recurrent acute rheumatic fever: a forgotten diagnosis? ( Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS, 2004) |
| "Abdominal pain was the most frequent symptom (100%), and hypoalbuminemia was the most frequent sign (70%)." | 1.32 | Gastrointestinal involvement in chronic granulomatous disease. ( Anaya-O'Brien, S; Anderson, VL; Darnell, DN; Gallin, JI; Hilligoss, DM; Holland, SM; Kleiner, DE; Malech, HL; Marciano, BE; Rosenzweig, SD, 2004) |
| "At the age of 26 there was a transitory recurrence of the goitre during a pregnancy, during which time the thyroid peroxidase antibodies became strongly positive." | 1.32 | [A pregnant woman with autoimmune thyroiditis and recurrent goiter]. ( Berghout, A; Muller, AF; Santoe, MF; Van Houten, AA, 2004) |
| "Azathioprine (AZA) was given as maintenance therapy in 117 patients (75%)." | 1.32 | Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. ( Lau, CS; Lee, KW; Leung, CY; Mok, CC; Ng, WL; Tang, S; Wong, RW; Ying, KY, 2004) |
| "Scleritis was the first manifestation of sarcoidosis in two of the patients and the diagnosis of sarcoidosis was confirmed with a conjunctival biopsy." | 1.32 | Scleritis associated with sarcoidosis. ( Akova, YA; Bilezikçi, B; Dursun, D, 2004) |
| "Multivariate analysis retained enlarged spleen, involvement of three or more lymph node areas, and bulky disease as significant risk factors for spleen involvement." | 1.32 | Significance of splenomegaly in childhood Hodgkin disease. ( Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Singh, R; Thavaraj, V, 2004) |
| "Hemoptysis was the presenting symptom in all cases." | 1.32 | [Pulmonary arterial aneurysms in Behçet's syndrome. Report of 4 cases]. ( Ben Ghorbel, I; Houman, MH; Ibn Elhadj, Z; Khanfir, M, 2004) |
| "To determine the risk of seizure recurrence after a first seizure due to neurocysticercosis (NC) and to evaluate risk factors for seizure recurrence, including the influence of antihelminthic treatment." | 1.31 | Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. ( Carpio, A; Hauser, WA, 2002) |
| "The incidence of recurrent type I membranoproliferative glomerulonephritis (MPGN) after renal transplant is approximately 30%, and the rate of graft loss due to recurrent MPGN type I is higher than 50%." | 1.31 | Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. ( Lien, YH; Scott, K, 2000) |
| "Hematuria was present initially in 26 patients (46." | 1.31 | Predicting first-year relapses in children with nephrotic syndrome. ( Constantinescu, AR; Foote, EF; Shah, HB; Weiss, LS, 2000) |
| "A patient with chronic lymphocytic leukemia and an undetectable plasma level of protein S (PS), associated with recurrent venous thrombosis, is described." | 1.31 | Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency. ( Antunović, P; Basara, N; Bosković, D; Miljić, P; Milosević-Jovicić, N; Rolović, Z, 2000) |
| "Reported cases of gastrointestinal hemorrhage have been in the form of coffee ground emesis, melena, or hematochezia." | 1.31 | Polyarteritis nodosa presenting as massive upper gastrointestinal hemorrhage. ( Banerjee, B; Perez, RA; Silver, D, 2000) |
| "Patients with monoclonal gammopathy of undetermined significance/smoldering MM had intermediate values." | 1.31 | Expression of BAX in plasma cell dyscrasias. ( Krajewska, M; Krajewski, S; Lichtenstein, A; Reed, JC; Renner, S; Weisz, J, 2000) |
| "Classic polyarteritis nodosa is a multisystem inflammatory disease associated with necrotizing vasculitis of small and medium arteries." | 1.31 | Juvenile relapsing periarteritis nodosa and streptococcal infection. ( Ansart, S; Pennec, YL; Tilly-Gentric, A; Tonnelier, JM, 2000) |
| "We transplanted 42 patients with Hodgkin's disease between 1990-1998." | 1.31 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000) |
| "We present three cases of Kikuchi's disease that benefited significantly from systemic administration of prednisone." | 1.31 | Management of Kikuchi's disease using glucocorticoid. ( Jang, YJ; Park, KH; Seok, HJ, 2000) |
| "Acute pericarditis is a frequent complication after cardiac and/or thoracic surgery." | 1.31 | Recurrent pericarditis after thoracic surgery. ( Lane, JE; Morin, AF; Parish, DC, 2000) |
| "Th rate of recurrence of pyoderma gangrenosum was 46% independently of treatment." | 1.31 | [Pyoderma gangrenosum. 15 cases]. ( Azaiz, MI; Ben Osman-Dhahri, A; Cherif, F; El Euch, D; Haouet, S; Mokni, M; Riahi, I; Zitouna, MM, 2001) |
| "Wegener relapse was diagnosed and the combination of three methylprednisolone perfusions followed by oral prednisone (1 mg/kg/d) and a monthly bolus of cyclophosphamide led to a new remission." | 1.31 | Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission. ( Bourgeois, P; de Person, JF; de Sauverzac, C; Fautrel, B; Foltz, V; Koeger, AC, 2001) |
| "We have treated eight patients with Burkitt's lymphoma with a modified BFM protocol." | 1.31 | Burkitt's lymphoma: single-centre experience with modified BFM protocol. ( Harris, E; Jackson, N; Jones, L; Mahendra, P; Paneesha, S, 2002) |
| "Childhood acute lymphoblastic leukemia (ALL) has a 5-year disease-free survival (DFS) of more than 70%." | 1.30 | Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis. ( Aziz, Z; Mahmood, R; Maqbool, S; Zahid, M, 1997) |
| "First relapse was treated with high-dose BEAM chemotherapy and autologous peripheral blood stem cell transplantation (PBSCT)." | 1.30 | Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation. ( Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R, 1997) |
| "Orbital myositis is described as exquisitely sensitive to therapy with systemic corticosteroids." | 1.30 | Current status in the treatment of orbital myositis. ( Koornneef, L; Mombaerts, I, 1997) |
| "We defined relapse as a recurrence of symptoms of sufficient severity to warrant treatment with corticosteroids, following a remission without treatment lasting greater than 1 month." | 1.30 | Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. ( Gottlieb, JE; Israel, HL; Patrick, H; Steiner, RM; Triolo, J, 1997) |
| "Low-grade relapse is not uncommon in patients who initially presented with diffuse large cell lymphoma." | 1.30 | Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. ( Connors, JM; Gascoyne, RD; Hoskins, PJ; Klasa, R; Le, N; O'Reilly, S; Shenkier, T, 1997) |
| "Two patients with Crohn's disease who had hypercalcemia, hypercalciuria, and excessively high serum levels of 1,25-dihydroxyvitamin D [1,25(OH)2D] are described." | 1.30 | Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease. ( Bosch, X, 1998) |
| "Chronic ulcerative stomatitis (CUS), a rare disease of oral mucosa found to be associated with unusual antinuclear antibodies reactive exclusively with squamous epithelia (squamous epithelium-specific antinuclear antibodies - SES-ANA), has been reported to occur almost exclusively in older females and to respond dramatically to antimalarials." | 1.30 | Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. ( Chorzelski, TP; Jablonska, S; Jarzabek-Chorzelska, M; Olszewska, M, 1998) |
| "In this study 7 patients with severe ulcerative colitis and 4 patients with active Crohn's disease unresponsive to prednisone were treated with high dose intravenous cyclosporine." | 1.30 | [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases]. ( Dejaco, C; Gangl, A; Gasché, C; Moser, G; Novacek, G; Reinisch, W; Tillinger, W; Vogelsang, H, 1998) |
| "We prospectively assessed the pharmacokinetics of methotrexate, mercaptopurine, and erythrocyte thioguanine nucleotide levels in a homogenous population of children with lower risk acute lymphoblastic leukemia and correlated pharmacokinetic parameters with disease outcome." | 1.30 | Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. ( Ames, MM; Balis, FM; Bleyer, WA; Ge, J; Gilchrist, GS; Holcenberg, JS; Murphy, RF; Poplack, DG; Sather, HN; Tubergen, DG; Waskerwitz, MJ; Zimm, S, 1998) |
| "Reports of bronchiolitis obliterans organizing pneumonia (BOOP) occurring in women after radiation therapy for breast cancer have suggested that radiation to the lung could participate in the development of BOOP." | 1.30 | Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P) ( Cordier, JF; Crestani, B; Dalphin, JC; Roden, S; Valeyre, D; Wallaert, B, 1998) |
| "Primary biliary cirrhosis was suspected, but the patient refused liver biopsy." | 1.30 | [Primary biliary cirrhosis with sarcoid-like infiltrations in the lung]. ( Orłowski, T; Pawlicka, L; Płodziszewska, M; Rowińska-Zakrzewska, E; Słodkowska, J, 1998) |
| "Recurrence of autoimmune hepatitis after liver transplantation is not rare, but there is little information about its time of onset, risk factors, response to treatment and prognosis." | 1.30 | Outcome of autoimmune hepatitis after liver transplantation. ( Casanovas, T; Clemente, G; Cuervas-Mons, V; de la Mata, M; Fabrega, E; Fraga, E; Prados, E; Prieto, M; Rimola, A; Vicente, E, 1998) |
| "Prednisone was added after another episode of paralysis." | 1.30 | Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy. ( González-Treviño, O; Rosas-Guzmán, J, 1999) |
| "Those who relapsed were mainly from the symptomatic follow-up group." | 1.30 | Acute disseminated encephalomyelitis in childhood: report of 10 cases. ( Anlar, B; Apak, RA; Köse, G; Ozdirim, E; Topaloğlu, H; Turanli, G, 1999) |
| "Collagenous colitis is a rare cause of chronic watery diarrhea." | 1.30 | Therapy of prednisone-refractory collagenous colitis with budesonide. ( Dienes, HP; Dries, V; Kruis, W; Lanyi, B, 1999) |
| "Relapses are frequent after treatment withdrawal." | 1.30 | [Treatment of myasthenia: role of corticoids and immunosuppressive agents]. ( Gajdos, P, 1999) |
| "infusions in the treatment of B cell chronic lymphocytic leukemia (B-CLL) in patients 55 years old and younger." | 1.30 | 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger. ( Błasińska-Morawiec, M; Błoński, JZ; Robak, T; Skotnicki, AB; Urbańska-Ryś, H, 1999) |
| "Relapses were frequent in both isolated PMR and PMR associated with GCA." | 1.30 | The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. ( Dababneh, A; García-Porrúa, C; González-Gay, MA; Hajeer, A; Ollier, WE; Vázquez-Caruncho, M, 1999) |
| "Idiopathic chronic eosinophilic pneumonia is a rare disease first described by Carrington 30 years ago." | 1.30 | [Idiopathic chronic eosinophilic pneumonia]. ( Arteaga, C; Bonnet, D; Cuguilliere, A; Miltgen, J; Thuy, GN, 1998) |
| "After treatment, all relapses remitted (third remission) in 3." | 1.30 | Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease. ( Frommer, JP; Suki, WN; Trimarchi, H, 1999) |
| "Patients with types I and III MPGN did not differ in age at apparent onset, age at diagnosis, or interval from apparent onset of symptoms to diagnosis (biopsy)." | 1.30 | Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. ( Braun, MC; Strife, CF; West, CD, 1999) |
| "After 12 months recurrences were observed in 14 of 15 patients initially treated with steroids and in 7 of 15 subjects who were had received transdermal nicotine (P = 0." | 1.30 | Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. ( Guslandi, M, 1999) |
| "Patients whose Hodgkin's disease is refractory to standard combination chemotherapy usually have a poor prognosis." | 1.29 | Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. ( al-Katib, A; Andersen, J; Bishop, CR; Hussein, ME; Karanes, C; Khanuja, PS; Smith, MR, 1994) |
| "When a neuroblastoma was present, tumor removal did not improve symptoms." | 1.29 | Outcome of children with opsoclonus-myoclonus regardless of etiology. ( Hammer, MS; Larsen, MB; Stack, CV, 1995) |
| "Four of these patients had an isolated recurrence, in 3 patients < or = 3 months and in 1 patient < or = 6 months after the initial event." | 1.29 | Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. ( Eviatar, L; Grossman, R; Karayalycin, G; Lanzkowsky, P; Maytal, J; Schaul, N; Shende, AC; Yusuf, FH, 1995) |
| " When the glucocorticoid dosage was reduced or the drug discontinued, the nephrotic syndrome recurred." | 1.29 | [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome]. ( Schollmeyer, P; Späth, M, 1995) |
| "Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year." | 1.29 | Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993) |
| "Pain is not usually considered a symptom of chronic relapsing demyelinating polyneuropathy." | 1.29 | Upper limb pain in chronic demyelinating polyneuropathy: electrophysiological correlates. ( Brunet, DG; Zochodne, DW, 1994) |
| "Prednisone was administered in adequate doses in 51 (52." | 1.29 | Treatment of nephrotic syndrome. ( Elhence, R; Gulati, S; Gupta, A; Kher, V; Kumar, P; Sharma, RK, 1994) |
| "The pattern of relapses is described in a consecutive series of 150 patients with vasculitis." | 1.29 | Necrotizing vasculitis--relapse despite cytotoxic therapy. ( Adu, D; Bacon, PA; Emery, P; Gordon, M; Greaves, I; Luqmani, RA; Michael, J; Richards, N, 1993) |
| " This was associated with delivery of 100% of the planned dosage of vincristine, prednisone, and daunorubicin at induction." | 1.29 | Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect. ( Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D, 1994) |
| "Treatment with sulfasalazine and prednisone resulted in a clinical remission after seven weeks." | 1.29 | [Clostridium difficile in early childhood ulcerative pancolitis]. ( Hoppen, T; Keller, KM; Rister, M; Stolte, M, 1993) |
| "Acute febrile neutrophilic dermatosis (Sweet's syndrome) is a rare inflammatory disease of unknown cause characterized by painful, erythematous plaques and a dermal infiltrate of mature neutrophils." | 1.29 | Sweet's syndrome in children. ( Boatman, BW; Cohen, BA; Klein, LE; Taylor, RC, 1994) |
| "The association of Hodgkin's disease and minimal-change nephrotic syndrome is well established." | 1.29 | The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994) |
| "Pharyngeal dysphagia can be the only clinical manifestation of polymyositis, usually a systemic disease." | 1.29 | [Pharyngeal dysphagia and polymyositis]. ( Bernades, P; Chemtob, A; Lévy, H; Lévy, P; Malka, D; Ponsot, P, 1993) |
| "In the past 16 years, 2004 children with acute lymphoblastic leukemia (ALL) have been treated in the Polish Pediatric Group centers." | 1.29 | Relapses after termination of therapy of acute lymphoblastic leukemia in children. ( Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Jackowska, T; Jakowicka, M; Kulus, M; Matysiak, M; Michalewska, D; Ochocka, M, 1993) |
| "A patient is described in whom a recurrence of vasculitis was observed in the kidney allograft six years after transplantation and one year after withdrawal of corticosteroid therapy." | 1.29 | Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft. ( Allegri, L; Banfi, G; Bignardi, L; Fogazzi, GB, 1993) |
| "Neuroretinitis is a distinct clinical entity consisting of moderate to severe visual loss, optic nerve head edema, macular exudate in a stellate pattern, and variable vitreous inflammation." | 1.29 | Toxoplasmosis neuroretinitis. ( Fish, RH; Hoskins, JC; Kline, LB, 1993) |
| "Neurosarcoidosis is exceedingly rare in the pediatric age groups." | 1.29 | [Neural sarcoidosis in children. A case report]. ( Bader-Meunier, B; Dommergues, JP; Jullien, M; Parker, F; Rey, C, 1993) |
| "In November 1991, recurrence was found in the peripheral lymph node and the colon." | 1.29 | [Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy]. ( Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M, 1993) |
| "Prednisone was added 2 months after thymectomy due to continued worsening and development of oropharyngeal weakness." | 1.29 | Single fiber electromyography in myasthenia gravis during pregnancy. ( Massey, JM; Sanders, DB, 1993) |
| "There has been only one isolated CNS recurrence." | 1.29 | Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. ( Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Ganesan, TS; Gregory, W; Johnson, PW; Matthews, J; Richards, MA; Rohatiner, AZ; Whelan, JS, 1993) |
| "A 49-year-old woman developed acute renal failure secondary to interstitial nephritis." | 1.29 | Relapsing steroid-responsive idiopathic acute interstitial nephritis. ( Cabezuelo, JB; Enriquez, R; Gonzalez, C; Lacueva, J; Niembro, E; Ruiz, JA; Tovar, JV, 1993) |
| "We studied 10 patients with Graves' disease to clarify whether transfrontal decompression is effective after prior failure of transantral orbital decompression." | 1.29 | Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. ( Bartley, GB; Bergstralh, EJ; Ebersold, MJ; Fatourechi, V; Garrity, JA; Gorman, CA, 1993) |
| "The case of an idiopathic polymyositis preceded by several episodes compatible with the diagnosis of bronchiolitis obliterans organizing pneumonia is herein reported." | 1.29 | [Recurrent bronchiolitis obliterans organizing pneumonia as first manifestation of polymyositis]. ( Cucurull Canosa, E; Falga Tirado, C; Ordi Ros, J; Pérez Pemán, P; Valero Rovira, S, 1995) |
| "Severe obesity is a greater risk factor for incisional hernia and hernia recurrence than chronic steroid use in nonobese colitis patients." | 1.29 | Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. ( DeMaria, EJ; Kellum, JM; Lowry, JW; Newsome, HH; Reines, HD; Sugerman, HJ, 1996) |
| " After our early experience with group 1, we attempted to use a lower cyclosporine dosage in group 2." | 1.29 | Heart transplantation for chronic Chagas' heart disease. ( Amato-Neto, V; Bacal, F; Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, AD; Mocelin, AO; Pileggi, F; Stolf, NA; Uip, D, 1996) |
| "In this study three new cases of recurrence of membranous nephropathy are reported." | 1.29 | Membranous nephropathy: recurrence after kidney transplantation. ( Mampaso, F; Marcen, R; Navarro-Antolin, J; Orofino, L; Ortuño, J; Rivera, ME; Teruel, JL, 1996) |
| "We describe a case of a recurrence of ALL in the uterine cervix during hematopoietic remission." | 1.29 | Childhood acute lymphoblastic leukemia relapse in the uterine cervix. ( Okamura, J; Tsuruchi, N, 1996) |
| "Pyoderma gangrenosum is an ulcerative skin condition of unknown cause." | 1.29 | Treatment of pyoderma gangrenosum with methotrexate. ( Teitel, AD, 1996) |
| "Open lung biopsy revealed chronic interstitial pneumonitis and bronchiolitis obliterans with organizing pneumonia." | 1.29 | Suspected hypersensitivity pneumonitis after exposure to a biologic forage inoculant. ( Geiss, R; Hodous, T; Lapp, NL; Mannino, D, 1996) |
| "To determine the long term outcome of ulcerative colitis in patients treated with 6-MP." | 1.29 | The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. ( Bodian, C; George, J; Pou, R; Present, DH; Rubin, PH, 1996) |
| "A 10-year-old male with severe aplastic anemia following allogeneic BMT developed a hemolytic crisis on post-BMT day 67." | 1.29 | Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide. ( Azuma, E; Hanada, M; Hiratake, S; Komada, Y; Nagai, M; Nishihara, H; Sakurai, M, 1996) |
| "Both recurrences were treated with oral acyclovir and systemic steroids." | 1.29 | Multiple recurrent branch retinal artery occlusions associated with varicella zoster virus. ( del Priore, LV; Gelb, LD; Sharp, J; Storch, GA; Zamora, RL, 1996) |
| "To characterize the features of systemic lupus erythematosus (SLE) in patients who flare after a period of inactive disease, we conducted a retrospective chart review." | 1.29 | Reactivation of inactive systemic lupus erythematosus. ( Aranow, C; Barland, P; Emy, J, 1996) |
| "Cutaneous polyarteritis nodosa is a benign form of the disease with cutaneous involvement and occasional systemic manifestations." | 1.29 | [A case of benign cutaneous polyarteritis nodosa]. ( Amaro, P; Benedetto, A; López de Maturana, D; Moreno, F, 1996) |
| "In 74% of the acute myeloid leukemia patients, the truncated inhibitor was detected." | 1.29 | Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. ( Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A, 1995) |
| "Cyclic neutropenia is a rare hematological disorder consisting of recurrent episodes of aphthous stomatitis and skin infections caused by a periodic decrease in blood neutrophil counts." | 1.28 | Cyclic neutropenia: a cause of recurrent aphthous stomatitis not to be missed. ( Herranz, MT; Ortego, N; Pinar, A; Quero, JH; Ródenas, JM; Tercedor, J, 1992) |
| " Mean daily dosage of CsA was 4." | 1.28 | Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood. ( Burger, HR; Fanconi, A; Klingler, M; Leumann, EP; Neuhaus, TJ, 1992) |
| "We report the cases of three AIDS patients who developed major recurrent oral ulcers with severe odynophagia and weight loss." | 1.28 | Major recurrent oral ulcers in AIDS: report of three cases. ( De la Rosa, E; González-Guevara, M; Ponce de León, S; Ramírez-Amador, V; Reyes-Terán, G, 1992) |
| "The pulmonary eosinophilias are characterised by radiographic lung shadows with either a peripheral blood eosinophilia of more than 450/microliter or histologic abnormalities consisting of both interstitial and intraalveolar accumulations of eosinophils and macrophages." | 1.28 | [Pulmonary infiltrations with eosinophilia (pulmonary eosinophilia)]. ( Ferlinz, R; Fischer, BM; Gerharz, CD; Schadmand, S; Steppling, H, 1992) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| "Nine of the controls reaching ESRD had persistent nephrotic syndrome, whereas of the seven controls who have not yet reached ESRD, only two have persistent nephrotic syndrome (chi 2, P less than 0." | 1.28 | Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. ( Bear, R; Goldstein, M; Jindal, K; West, M, 1992) |
| "Of the 180 patients with Wegener granulomatosis referred to the National Institute of Allergy and Infectious Diseases during the past 24 years, 158 have been followed for 6 months to 24 years (a total of 1229 patient-years)." | 1.28 | Wegener granulomatosis: an analysis of 158 patients. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, RS; Rottem, M; Travis, WD, 1992) |
| "Naproxen, however, has only once been reported to cause meningitis." | 1.28 | Naproxen-induced recurrent aseptic meningitis. ( Lehany, AM; Weksler, BB, 1991) |
| "This study documents that occult myocardial diseases (myocarditis, cardiomyopathy, and nonspecific necrosis or fibrosis) can underlie "primary" AF." | 1.28 | Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. ( Bellocci, F; Buffon, A; Caldarulo, M; Fenici, R; Frustaci, A; Melina, D, 1991) |
| " Newly diagnosed patients with ITP received the usual prednisone therapy, 1 mg/kg/day, for 3 weeks, after which period the dosage was tapered off." | 1.28 | Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP). ( Dubbeld, P; Hillen, HF; van der Heul, C, 1991) |
| "Treatment with mesalamine enemas allowed patients to decrease or discontinue glucocorticoid treatment." | 1.28 | Long-term use of mesalamine enemas to induce remission in ulcerative colitis. ( Biddle, WL; Miner, PB, 1990) |
| "A relapse was defined as an unscheduled revisit to the ED within 14 days of initial treatment." | 1.28 | Treatment of decompensated chronic obstructive pulmonary disease in the emergency department--correlation between clinical features and prognosis. ( Chick, TW; Gorby, MS; Halperin, AK; Murata, GH, 1991) |
| "Treatment with isotretinoin resulted in rapid clinical improvement in all cases." | 1.28 | Isotretinoin for refractory lupus erythematosus. ( Formica, N; Parke, AL; Shornick, JK, 1991) |
| " Higher dosage of prednisolone or prednisone more than 120 mg/day has never been used." | 1.28 | Treatment of pemphigus. ( Ophaswongse, S; Piamphongsant, T, 1991) |
| "Postinfectious encephalomyelitis is an acute demyelinating illness that usually has its onset 3 to 7 days after the onset of a viral exanthem and has a monophasic course over 2 to 4 weeks." | 1.28 | Steroid-dependent postvaricella encephalomyelitis. ( Tenorio, G; Whitaker, JN, 1991) |
| "Weight gain was correlated positively with several psychologic measures but not with assessed biologic measures." | 1.28 | Weight gain with breast cancer adjuvant treatment. ( Carpenter, JT; Levine, EG; Raczynski, JM, 1991) |
| "A recurrence was observed in two patients, at 12 and 39 months respectively." | 1.28 | [Intensified therapy of severe lupus erythematosus]. ( Euler, HH; Gutschmidt, HJ; Harten, P; Löffler, H; Schröder, JO; Stueber, F; Zeuner, RA, 1991) |
| "Familial pemphigus vulgaris was found in a Jewish woman and her son who developed the disease within a period of 18 months from one another." | 1.28 | Familial pemphigus vulgaris. ( David, M; Idises, C; Katzenelson, V; Mellibovsky, J; Sandbank, M; Zamir, R, 1990) |
| "We report here a 41-year-old woman with Wegener's granulomatosis, in whom renal transplantation was performed after a 10-month period of hemodialysis during which no signs of disease activity were detected." | 1.28 | Hemodialysis does not always protect against recurrence of Wegener's granulomatosis. ( Aunsholt, NA; Pedersen, RS, 1990) |
| " Maintenance with the same drugs in a modified dosage schedule continued for approximately 2 years." | 1.28 | Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children. ( Belasco, JB; Luery, N; Scher, C, 1990) |
| " Long-term follow-up studies did not disclose any recurrence of the pituitary granulomatous process nor objective evidence of underlying disease even after steroid dosage has been tapered." | 1.28 | Pituitary granuloma and pyoderma gangrenosum. ( Chanson, P; Derome, PJ; Guillausseau, PJ; Kujas, M; Lubetzki, J; Timsit, J; Violante, A; Warnet, A, 1990) |
| " There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)." | 1.28 | Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990) |
| "Thirty-nine patients with relapsed acute lymphoblastic leukemia (ALL) and four with primarily refractory ALL were treated with a regimen that included cytarabine 1 gm/m2 (2-hour infusion) twice daily days 1 to 5, mitoxantrone 12mg/m2 daily days 1 to 5, prednisone 0." | 1.28 | Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy. ( Auzanneau, G; Gisselbrecht, C; Gratecos, N; Harousseau, JL; LeBlond, V; Michallet, M; Milpied, N; Sebban, C; Troussard, X; Witz, F, 1990) |
| "Twenty children with acute lymphoblastic leukemia (ALL) in relapse were treated with various combinations of anti-leukemic agents in approach to the induction of remission." | 1.28 | [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia]. ( Ikeda, Y; Ito, E; Ito, R; Miyano, T; Onodera, N; Saito, T; Sato, Y; Suto, Y; Tachibana, N; Tateoka, N, 1989) |
| "Seven patients have had no recurrence of obstruction after an average follow-up of 52 months." | 1.27 | Prognosis for nonoperative management of small-bowel obstruction in Crohn's disease. ( Korelitz, BI; Yaffe, BH, 1983) |
| "A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
| "Two cases of patients with relapsing polyradiculoneuropathy with high protein level in cerebrospinal fluid are reported." | 1.27 | [Recurrent polyradiculoneuritis: report of 2 cases]. ( Callegaro, D; de Assis, JL; Marchiori, PE; Scaff, M; Zambon, AA, 1983) |
| "Goodpasture's syndrome was diagnosed in a 17-year-old boy with glomerulonephritis and hemoptysis." | 1.27 | Recurrent Goodpasture's syndrome. ( Bear, RA; Burke, BR, 1983) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases." | 1.27 | [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983) |
| "The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate." | 1.27 | Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983) |
| "The correct diagnosis of facial paralysis is not easily made but is important for proper management, since such paralysis is a sign or symptom of an underlying disorder." | 1.27 | Facial nerve paralysis. 1. General evaluation, Bell's palsy. ( Olsen, KD, 1984) |
| "All patients had ileocolitis or pancolitis." | 1.27 | Metronidazole therapy for Crohn's disease and associated fistulae. ( Jakobovits, J; Schuster, MM, 1984) |
| "An unusual autoimmune agranulocytosis featured intense plasmacytosis, hyperglobulinemia, and total absence of myeloid precursors." | 1.27 | An unusual case of autoimmune agranulocytosis with total absence of myeloid precursors: demonstration of diverse sources of R binder for cobalamin in plasma and secretions. ( Carmel, R, 1983) |
| "All had recurrences with five having two or more." | 1.27 | Acute and subacute orbital myositis. ( Dresner, SC; Kennerdell, JS; Slamovits, TL; Weinstein, GS, 1983) |
| " Nineteen patients had ocular manifestations of giant cell arteritis always from the onset, except for a fall in visual acuity; 26 relapses were observed in 18 patients, either during reduction of steroid dosage (21 cases) or after withdrawal (5 cases)." | 1.27 | [Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. ( Alcalay, M; Becq-Giraudon, B; Boissonnot, L; Bontoux, D; Gil, R; Gouet, D; Le Berre, D; Lefevre, JP; Maréchaud, R; Risse, JF, 1986) |
| " At the dosage of 2." | 1.27 | Clinical efficacy of levamisole in the treatment of primary nephrosis in children. ( Mongeau, JG; Robitaille, PO; Roy, F, 1988) |
| "Blood and tissue eosinophilia are usually present." | 1.27 | Sterile eosinophilic pustulosis in dog and man: comparative aspects. ( Scott, DW, 1987) |
| "Seven patients with autoimmune hemolytic anemia (AIHA) associated with an underlying lymphoproliferative disorder were treated with intravenous immunoglobulin." | 1.27 | Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. ( Besa, EC, 1988) |
| "Pulmonary disease was the major manifestation in 70% and was present in 88%." | 1.27 | Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. ( Johns, CJ; MacGregor, MI; Schonfeld, SA; Scott, PP; Zachary, JB, 1986) |
| "These findings suggest systemic lupus erythematosus although she had no symptoms other than those of ATM." | 1.27 | Recurrent transverse myelitis associated with collagen disease. ( Yamamoto, M, 1986) |
| "The hypothesis of a recurrence of sarcoidosis was evoked, and, after a few days course of corticosteroid, the patient recovered; he had no functional sequelae, and did not present any recurrence 2 years after having stopped the treatment." | 1.27 | [Isolated spinal cord involvement. Recurrence of sarcoidosis]. ( Leys, D; Parent, M; Petit, H, 1986) |
| "Of 244 patients with Hodgkin's disease, 126 (52%) had an abnormal mediastinum." | 1.27 | Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987) |
| "Giant cell arteritis was suspected because of a markedly elevated erythrocyte sedimentation rate and confirmed by temporal artery biopsy." | 1.27 | Giant cell arteritis causes recurrent posterior circulation transient ischemic attacks which respond to corticosteroid. ( Lipton, RB; Mehler, MF; Rosenbaum, D, 1987) |
| "Therefore, we conclude that chronic eosinophilic pneumonia is an important entity to recognize as a potentially fatal cause of the adult respiratory distress syndrome." | 1.27 | Chronic eosinophilic pneumonia: a cause of adult respiratory distress syndrome. ( Donohue, JF; Ivanick, MJ, 1986) |
| "The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied." | 1.27 | [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986) |
| " We are uncertain about the pharmacologic basis of these results but suggest that the increased dosage and more frequent administration of VP-16, relative to that of VM-26, was sufficient to overcome apparent resistance to the latter compound." | 1.27 | Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia. ( Abromowitch, M; Bowman, WP; Ochs, J; Rivera, G, 1985) |
| "Treatment with prednisone and azathioprine improved the liver condition in 16 of the 18 patients given treatment." | 1.27 | Liver disease associated with anti-liver-kidney microsome antibody in children. ( Alagille, D; Alvarez, F; Bernard, O; Hadchouel, M; Hadchouel, P; Homberg, JC; Maggiore, G; Odièvre, M, 1986) |
| "Thrombosis was treated by surgery, during which 3 large thrombi from veins were removed." | 1.27 | [Thrombosis of the inferior vena cava with successive lung embolization in a 15-year-old boy with nephrotic syndrome]. ( Janda, J; Spatenka, J; Tůma, S; Zábrodský, V, 1986) |
| "Progressive diaphyseal dysplasia is characterized clinically by crippling leg pain, fatigue, headache, poor appetite, muscle weakness, and waddling gait." | 1.27 | Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy. ( Alon, U; Berant, M; Kaftori, JK; Naveh, Y, 1985) |
| "Fourteen patients with systemic lupus erythematosus had splenectomies done between 1960 and 1982 for treatment of severe thrombocytopenia." | 1.27 | Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. ( Greipp, PR; Hall, S; McCormick, JL; McKenna, CH; Michet, CJ, 1985) |
| "Azathioprine was then considered as an alternative treatment." | 1.27 | Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis. ( Cogan, E; Fastrez, R, 1985) |
| "Patient 1 has been free of recurrence for 11 years, six of them without treatment." | 1.27 | [Long-term observations of Wegener's disease. Results of treating recurrences]. ( Bohn, T; Ho, AD; Hunstein, W, 1985) |
| " Seventy-five patients received corticosteroids, with a mean prednisone dosage of 22." | 1.27 | Polymyalgia rheumatica. Duration of therapy and long-term outcome. ( Ayoub, WT; Franklin, CM; Torretti, D, 1985) |
| "Bilateral exophthalmos, unilateral hearing loss, and nasal obstruction accompanied fever, severe asthma, and palpable purpura." | 1.26 | Recurrent Churg-Strauss vasculitis. With exophthalmos, hearing loss, nasal obstruction, amyloid deposits, hyperimmunoglobulinemia E, and circulating immune complexes. ( Patterson, R; Sale, S, 1981) |
| "Twenty-two children with acute lymphocytic leukemia (ALL) who had relapsed while on therapy and for whom remissions were successfully reinduced were maintained with a combination of methotrexate, daunomycin, 6-mercaptopurine, prednisone, and vincristine (Djerassi-methotrexate with BOMB)." | 1.26 | Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia. ( Herson, J; Kimball, JC; Sullivan, MP, 1980) |
| "Five stages of allergic bronchopulmonary aspergillosis were identified in 40 patients studied for several years." | 1.26 | Allergic bronchopulmonary aspergillosis: staging as an aid to management. ( Greenberger, PA; Patterson, R; Radin, RC; Roberts, M, 1982) |
| "Six nephrotic children with primary peritonitis and two with pneumococcal meningitis are reported." | 1.26 | Primary peritonitis and meningitis in nephrotic syndrome in Riyadh. ( Elidrissy, AT, 1982) |
| "Acute febrile neutrophilic dermatosis (AFND) (Sweet's syndrome) is characterized by warm, erythematous plaques, accompanied by arthralgias, fever, and leukocytosis." | 1.26 | Acute febrile neutrophilic dermatosis. Sweet's syndrome. ( Bechtel, MA; Callen, JP, 1981) |
| "Subsequent courses of treatment after relapse were equally effective in again inducing remission, but the probability of another relapse increased after each successive therapy and was 86% after three treatments." | 1.26 | Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. ( Ammon, HV; Czaja, AJ; Summerskill, WH, 1980) |
| "The pancytopenia was reversed by glucocorticosteroid therapy but recurred when steroids were tapered." | 1.26 | Hodgkin's disease presenting as steroid-responsive pancytopenia. ( Doolittle, CH; Kaplan, HG, 1980) |
| "Ileocolitis was the most (52%) and colitis the least (9%) common form of disease with diffuse small bowel or ileal disease each comprising nearly 20% of the study group." | 1.26 | Prognosis in children with Crohn's disease. ( Gryboski, JD; Spiro, HM, 1978) |
| "Recurrent Crohn's disease and that characterized by small bowel obstruction each displayed a characteristic appearance." | 1.26 | Radiographic findings of the National Cooperative Crohn's Disease Study. ( Caruthers, SB; Goldberg, HI; Nelson, JA; Singleton, JW, 1979) |
| "Fifteen patients with stage III and IV diffuse histiocytic lymphoma were treated with combination chemotherapy: cyclophosphamide, vincristine sulfate, prednisone, and procarbazine hydrochloride (COPP)." | 1.26 | Diffuse histiocytic lymphoma. The need for aggressive restaging. ( Babick, T; Levitt, M; Weinerman, BH, 1977) |
| "Twelve cases of allergic bronchopulmonary aspergillosis in the pediatric age group are reported." | 1.26 | Allergic bronchopulmonary aspergillosis in pediatric practice. ( Mintzer, R; Patterson, R; Roberts, M; Rosenberg, M; Wang, JL, 1979) |
| "Patients with a history of anaphylactoid reaction to radiographic contrast medium (RCM) are at increased risk for subsequent reaction." | 1.26 | Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone. ( Madowitz, JS; Schweiger, MJ, 1979) |
| "Twenty-five patients with allergic bronchopulmonary aspergillosis (ABPA) were observed for periods of 12 months to 10 years (average duration, 2." | 1.26 | The management of allergic bronchopulmonary aspergillosis. ( Ghory, AC; Patterson, R; Roberts, M; Wang, JL, 1979) |
| "This unusual manifestation of ankylosing spondylitis responded to treatment with moderate doses of prednisone, but it recurred when the cortiocosteroid therapy was discontinued." | 1.26 | Cricoarytenoid arthritis in a patient with ankylosing spondylitis. ( Bienenstock, H; Lanyi, VF, 1977) |
| "Chronic eosinophilic pneumonia is a subacute-to-chronic pulmonary disorder occurring most commonly in nonatopic women with cough, fever, dyspnea, weight loss, and night sweats." | 1.26 | Chronic eosinophilic pneumonia (Carrington's): a follow-up study. ( Pearson, DL; Rosenow, EC, 1978) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| "Of 8 patients with Crohn's disease 4 remained unoperated and free of symptoms 22-35 months after the study." | 1.26 | Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. ( Axelsson, C; Jarnum, S, 1977) |
| "A 58-year-old white female who had regional enteritis for many years insidiously developed scleroderma." | 1.26 | Systemic sclerosis and regional enteritis occurring simultaneously. ( Shaps, RS; Stoopler, M, 1976) |
| "Such relapses were observed in 70% of the patients." | 1.26 | Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. ( Ball, WC; Johns, CJ; Macgregor, MI; Zachary, JB, 1976) |
| " Serious complications and mortality could be related to high dosage of steroids and severe leukopenia." | 1.25 | Influence of rejection on graft survival after renal transplantation. ( Black, HR; Finkelstein, FO; Lytton, B; Schiff, M, 1975) |
| "Neurologic complications of systemic lupus erythematosus (SLE) are common, but chorea is rare." | 1.25 | Clinical features of chorea associated with systemic lupus erythematosus. ( Lusins, JO; Szilagyi, PA, 1975) |
| "Headache was present in almost all patients and visual symptoms occurred in 35%." | 1.25 | Benign intracranial hypertension. ( Weisberg, LA, 1975) |
| "At autopsy, generalized Hodgkin's disease of mixed cellularity was found." | 1.25 | Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease. ( Bastarache, A; Cazenave, JP; Gagnon, JA; Girouard, E, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 419 (24.36) | 18.7374 |
| 1990's | 394 (22.91) | 18.2507 |
| 2000's | 424 (24.65) | 29.6817 |
| 2010's | 388 (22.56) | 24.3611 |
| 2020's | 95 (5.52) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 4 |
| Li, K | 1 |
| Zhang, H | 4 |
| Liu, Z | 11 |
| Chen, D | 2 |
| Yang, L | 3 |
| Hu, W | 2 |
| Xu, Y | 3 |
| Shen, W | 2 |
| Sakkat, A | 1 |
| Cox, G | 1 |
| Khalidi, N | 1 |
| Larche, M | 1 |
| Beattie, K | 1 |
| Renzoni, EA | 1 |
| Morar, N | 1 |
| Kouranos, V | 1 |
| Kolb, M | 1 |
| Hambly, N | 1 |
| Crowell, EL | 1 |
| France, R | 1 |
| Majmudar, P | 1 |
| Jabs, DA | 4 |
| Thorne, JE | 3 |
| Pavlovsky, M | 1 |
| Cubero, D | 1 |
| Agreda-Vásquez, GP | 1 |
| Enrico, A | 1 |
| Mela-Osorio, MJ | 1 |
| San Sebastián, JA | 1 |
| Fogliatto, L | 1 |
| Ovilla, R | 1 |
| Avendano, O | 1 |
| Machnicki, G | 1 |
| Barreyro, P | 1 |
| Trufelli, D | 1 |
| Villanova, P | 1 |
| Sutaryo, S | 1 |
| Widjajanto, PH | 1 |
| Mulatsih, S | 1 |
| Ardianto, B | 1 |
| Pangarso, AWS | 1 |
| Supriyadi, E | 1 |
| Purwanto, I | 1 |
| Adelin, CP | 1 |
| Lestari, RP | 1 |
| Sagoro, L | 1 |
| Christian, SD | 1 |
| Sabrina, DS | 1 |
| Verena, N | 1 |
| Kors, WA | 1 |
| Kaspers, GJL | 1 |
| Veerman, AJP | 1 |
| Leckey, R | 1 |
| Borsellino, L | 1 |
| Rawlings, AM | 1 |
| Ashkenas, J | 1 |
| Suri, A | 1 |
| Hodson, E | 1 |
| Hahn, D | 2 |
| Craig, JC | 7 |
| Geng, HY | 1 |
| Chen, CY | 1 |
| Tu, J | 1 |
| Li, HR | 1 |
| DU, PW | 1 |
| Xia, H | 1 |
| Yu, XN | 1 |
| Du, Y | 1 |
| Zhao, C | 1 |
| Liu, J | 5 |
| Li, C | 1 |
| Yan, Q | 1 |
| Li, L | 2 |
| Hao, Y | 1 |
| Yao, D | 1 |
| Si, H | 1 |
| Zhao, Y | 3 |
| Zhang, W | 9 |
| Vijenthira, A | 1 |
| Kuruvilla, J | 2 |
| Crump, M | 3 |
| Jain, M | 1 |
| Prica, A | 2 |
| Ratajczak-Enselme, M | 1 |
| Mutoni, GC | 1 |
| Desmeules, J | 1 |
| Favet, L | 1 |
| Ing Lorenzini, K | 1 |
| Vivarelli, M | 8 |
| Emma, F | 8 |
| Lucchetti, L | 3 |
| Gatto, A | 3 |
| Gianviti, A | 3 |
| Massella, L | 5 |
| Dahan, E | 3 |
| El Ghazal, N | 3 |
| Nakanishi, H | 3 |
| El Haddad, J | 3 |
| Matar, RH | 3 |
| Tosovic, D | 3 |
| Beran, A | 3 |
| Than, CA | 3 |
| Stiasny, D | 3 |
| Matza, MA | 2 |
| Dagincourt, N | 1 |
| Mohan, SV | 1 |
| Pavlov, A | 1 |
| Han, J | 1 |
| Stone, JH | 4 |
| Unizony, SH | 2 |
| Trives-Folguera, L | 1 |
| Molina-Collada, J | 1 |
| López, K | 1 |
| Rivera, J | 1 |
| Serrano-Benavente, B | 1 |
| Anzola-Alfaro, AM | 1 |
| Castrejón, I | 1 |
| Álvaro-Gracia, JM | 1 |
| Martínez-Barrio, J | 1 |
| Zhang, J | 3 |
| Zhao, H | 2 |
| Li, X | 3 |
| Qian, R | 1 |
| Gao, P | 1 |
| Lu, S | 1 |
| Ma, Z | 1 |
| Lantz, J | 1 |
| Portell, CA | 1 |
| Ayers, EC | 1 |
| Wu, W | 4 |
| Hou, C | 2 |
| Zeng, Y | 2 |
| Chen, L | 2 |
| Liao, Y | 2 |
| Zhu, H | 2 |
| Tian, Y | 2 |
| Peng, B | 2 |
| Zheng, K | 1 |
| Shi, K | 1 |
| Li, Y | 6 |
| Gao, Y | 1 |
| Zhang, Y | 5 |
| Lin, H | 4 |
| Chen, WX | 2 |
| Epperla, N | 2 |
| Kumar, A | 4 |
| Abutalib, SA | 1 |
| Awan, FT | 1 |
| Chen, YB | 1 |
| Gopal, AK | 2 |
| Holter-Chakrabarty, J | 1 |
| Kekre, N | 1 |
| Lee, CJ | 1 |
| Lekakis, L | 1 |
| Lin, Y | 2 |
| Mei, M | 1 |
| Nathan, S | 2 |
| Nastoupil, L | 1 |
| Oluwole, O | 1 |
| Phillips, AA | 2 |
| Reid, E | 1 |
| Rezvani, AR | 1 |
| Trotman, J | 1 |
| Zurko, J | 1 |
| Kharfan-Dabaja, MA | 2 |
| Sauter, CS | 1 |
| Perales, MA | 1 |
| Locke, FL | 1 |
| Carpenter, PA | 3 |
| Hamadani, M | 2 |
| Wu, SY | 1 |
| Chu, XR | 1 |
| Ji, Q | 1 |
| Lin, XC | 1 |
| Bai, ZJ | 1 |
| Li, JQ | 1 |
| Pan, J | 2 |
| Chen, ZX | 1 |
| Hu, SY | 1 |
| Barnbrock, AE | 1 |
| Hutter, C | 1 |
| Bochennek, K | 1 |
| Minkov, M | 2 |
| Lehrnbecher, T | 1 |
| Lu, Y | 2 |
| He, Y | 2 |
| Sun, Y | 1 |
| Cavalcante, MB | 1 |
| Barini, R | 1 |
| Rozen, G | 1 |
| Polyakov, A | 1 |
| Gurunthalingam, MP | 1 |
| Katiyara, V | 1 |
| Singh, MP | 1 |
| Molina, B | 1 |
| Padoan, R | 1 |
| Urban, ML | 3 |
| Novikov, P | 2 |
| Caminati, M | 1 |
| Taillé, C | 1 |
| Néel, A | 1 |
| Bouillet, L | 2 |
| Fraticelli, P | 1 |
| Schleinitz, N | 1 |
| Christides, C | 1 |
| Moi, L | 1 |
| Godeau, B | 2 |
| Knight, A | 1 |
| Schroeder, JW | 1 |
| Marchand-Adam, S | 1 |
| Gil, H | 1 |
| Cottin, V | 1 |
| Durel, CA | 1 |
| Gelain, E | 1 |
| Lerais, B | 1 |
| Ruivard, M | 2 |
| Groh, M | 1 |
| Samson, M | 3 |
| Moroni, L | 1 |
| Thiel, J | 1 |
| Kernder, A | 1 |
| Cohen Tervaert, JW | 1 |
| Costanzo, G | 1 |
| Folci, M | 1 |
| Rizzello, S | 1 |
| Cohen, P | 3 |
| Emmi, G | 3 |
| Terrier, B | 3 |
| Spiera, RF | 1 |
| Unizony, S | 1 |
| Warrington, KJ | 4 |
| Sloane, J | 1 |
| Giannelou, A | 1 |
| Nivens, MC | 1 |
| Akinlade, B | 1 |
| Wong, W | 1 |
| Bhore, R | 1 |
| Buttgereit, F | 1 |
| Devauchelle-Pensec, V | 1 |
| Rubbert-Roth, A | 1 |
| Yancopoulos, GD | 1 |
| Marrache, F | 1 |
| Patel, N | 1 |
| Dasgupta, B | 1 |
| Sharma, A | 3 |
| Das, A | 1 |
| Bal, A | 1 |
| Srinivasan, R | 1 |
| Malhotra, P | 3 |
| Prakash, G | 1 |
| Kumar, R | 1 |
| Chen, Z | 1 |
| Wang, ZJ | 1 |
| Qiu, YN | 1 |
| Yu, H | 1 |
| Tan, LF | 1 |
| Qu, P | 1 |
| Jin, RM | 1 |
| Kowalczyk, JR | 1 |
| Zawitkowska, J | 1 |
| Lejman, M | 1 |
| Drabko, K | 1 |
| Samardakiewicz, M | 1 |
| Matysiak, M | 5 |
| Romiszewski, M | 1 |
| Balwierz, W | 5 |
| Ćwiklińska, M | 1 |
| Kazanowska, B | 1 |
| Owoc-Lempach, J | 1 |
| Wachowiak, J | 3 |
| Derwich, K | 1 |
| Adamkiewicz-Drożyńska, E | 1 |
| Niedźwiecki, M | 1 |
| Trelińska, J | 1 |
| Młynarski, W | 1 |
| Wysocki, M | 3 |
| Kołtan, A | 3 |
| Szczepański, T | 1 |
| Krawczuk-Rybak, M | 3 |
| Kitszel, A | 1 |
| Wieczorek, M | 1 |
| Urasiński, T | 1 |
| Ociepa, T | 1 |
| Sobol-Milejska, G | 1 |
| Mizia-Malarz, A | 1 |
| Karolczyk, G | 1 |
| Stary, J | 2 |
| Javaud, N | 1 |
| Soria, A | 1 |
| Maignan, M | 1 |
| Martin, L | 1 |
| Descamps, V | 1 |
| Fain, O | 3 |
| Berard, F | 1 |
| Tazarourte, K | 1 |
| Roy, PM | 1 |
| Fontaine, JP | 1 |
| Bagot, M | 2 |
| Khellaf, M | 1 |
| Goulet, H | 1 |
| Lapostolle, F | 1 |
| Casalino, E | 1 |
| Doutre, MS | 1 |
| Gil-Jardine, C | 1 |
| Caux, F | 2 |
| Chosidow, O | 3 |
| Pateron, D | 1 |
| Vicaut, E | 1 |
| Adnet, F | 1 |
| Carriles, C | 1 |
| Ordóñez-Fernández, L | 1 |
| Arias-Martínez, A | 1 |
| Menárguez-Blanc, R | 1 |
| Rosado-María, MC | 1 |
| Rosenthal, DG | 1 |
| Parwani, P | 1 |
| Murray, TO | 1 |
| Petek, BJ | 1 |
| Benn, BS | 1 |
| De Marco, T | 1 |
| Gerstenfeld, EP | 1 |
| Janmohamed, M | 1 |
| Klein, L | 1 |
| Lee, BK | 1 |
| Moss, JD | 1 |
| Scheinman, MM | 1 |
| Hsia, HH | 1 |
| Selby, V | 1 |
| Koth, LL | 1 |
| Pampaloni, MH | 1 |
| Zikherman, J | 1 |
| Vedantham, V | 1 |
| Gehring, C | 1 |
| Starkebaum, GA | 1 |
| Voelzke, BB | 1 |
| Liew, JW | 1 |
| Mata-Castro, N | 1 |
| Sanz-López, L | 1 |
| Varillas-Delgado, D | 1 |
| García-Fernández, A | 1 |
| Ishikawa, T | 1 |
| Fukumi, T | 1 |
| Moriyama, T | 1 |
| Murakami, H | 1 |
| Nagakita, K | 1 |
| Yoshioka, T | 1 |
| Makita, M | 1 |
| Shinno, Y | 1 |
| Sunami, K | 1 |
| Kersten, MJ | 1 |
| van Ettekoven, CN | 1 |
| Heijink, DM | 1 |
| Borovitz, Y | 1 |
| Alfandary, H | 1 |
| Haskin, O | 1 |
| Levi, S | 1 |
| Kaz, S | 1 |
| Davidovits, M | 2 |
| Dagan, A | 2 |
| Liu, Y | 5 |
| Bian, W | 1 |
| Fu, J | 1 |
| Sun, X | 1 |
| Chen, J | 4 |
| Zhao, X | 1 |
| Li, Z | 1 |
| Bravo-Perez, C | 1 |
| Pajares, I | 1 |
| Muiña, B | 1 |
| Escobar, H | 1 |
| Amigo, ML | 1 |
| Garcia-Malo, MD | 1 |
| Garcia, J | 1 |
| Rodriguez-Pinilla, SM | 1 |
| Piris, MA | 1 |
| Ortuño, FJ | 1 |
| Lee, HS | 1 |
| Kim, K | 3 |
| Kim, SJ | 6 |
| Lee, JJ | 2 |
| Kim, I | 1 |
| Kim, JS | 3 |
| Eom, HS | 2 |
| Yoon, DH | 3 |
| Suh, C | 3 |
| Shin, HJ | 2 |
| Mun, YC | 1 |
| Kim, MK | 1 |
| Lim, SN | 1 |
| Choi, CW | 3 |
| Kang, HJ | 3 |
| Yoon, SS | 1 |
| Min, CK | 1 |
| Qasrawi, A | 1 |
| Arora, R | 1 |
| Ramlal, R | 1 |
| Munker, R | 1 |
| Hildebrandt, GC | 1 |
| Wang, W | 4 |
| Zhang, L | 4 |
| Yang, C | 2 |
| Feng, J | 2 |
| Cai, H | 1 |
| Chen, M | 3 |
| Cao, X | 1 |
| Zhuang, J | 1 |
| Zhu, T | 1 |
| Duan, M | 1 |
| Li, J | 7 |
| Zhou, D | 1 |
| Plazinska, MT | 1 |
| Sawicka-Gutaj, N | 1 |
| Czarnywojtek, A | 1 |
| Wolinski, K | 1 |
| Kobylecka, M | 1 |
| Karlińska, M | 1 |
| Prasek, K | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Borowska, M | 1 |
| Gut, P | 1 |
| Ruchala, M | 1 |
| Krolicki, L | 1 |
| McDonald, GB | 1 |
| Sandmaier, BM | 1 |
| Mielcarek, M | 1 |
| Sorror, M | 1 |
| Pergam, SA | 1 |
| Cheng, GS | 1 |
| Hingorani, S | 1 |
| Boeckh, M | 1 |
| Flowers, MD | 1 |
| Lee, SJ | 2 |
| Appelbaum, FR | 2 |
| Storb, R | 2 |
| Martin, PJ | 3 |
| Deeg, HJ | 2 |
| Schoch, G | 1 |
| Gooley, TA | 1 |
| Salvarani, C | 6 |
| Brown, RD | 2 |
| Christianson, TJH | 1 |
| Huston, J | 2 |
| Giannini, C | 2 |
| Hunder, GG | 4 |
| Al-Juhaishi, T | 1 |
| Mckay, J | 1 |
| Sindel, A | 1 |
| Yazbeck, V | 1 |
| Huang, SJ | 1 |
| Gerrie, AS | 2 |
| Young, S | 1 |
| Tucker, T | 1 |
| Bruyere, H | 1 |
| Hrynchak, M | 1 |
| Galbraith, P | 1 |
| Al Tourah, AJ | 1 |
| Dueck, G | 1 |
| Noble, MC | 1 |
| Ramadan, KM | 1 |
| Tsang, P | 1 |
| Hardy, E | 1 |
| Sehn, L | 1 |
| Toze, CL | 1 |
| Zawati, I | 1 |
| Adouni, O | 1 |
| Finetti, P | 1 |
| Manai, M | 2 |
| Gamoudi, A | 1 |
| Birnbaum, D | 1 |
| Bertucci, F | 1 |
| Mezlini, A | 2 |
| Mignard, C | 1 |
| Maho-Vaillant, M | 1 |
| Golinski, ML | 1 |
| Balayé, P | 1 |
| Prost-Squarcioni, C | 1 |
| Houivet, E | 1 |
| Calbo, SB | 1 |
| Labeille, B | 1 |
| Picard-Dahan, C | 1 |
| Konstantinou, MP | 1 |
| Chaby, G | 1 |
| Richard, MA | 1 |
| Bouaziz, JD | 1 |
| Duvert-Lehembre, S | 1 |
| Delaporte, E | 2 |
| Bernard, P | 4 |
| Alexandre, M | 1 |
| Ingen-Housz-Oro, S | 1 |
| Vabres, P | 1 |
| Quereux, G | 1 |
| Dupuy, A | 1 |
| Debarbieux, S | 1 |
| Avenel-Audran, M | 1 |
| D'Incan, M | 2 |
| Bédane, C | 2 |
| Bénéton, N | 1 |
| Jullien, D | 1 |
| Dupin, N | 1 |
| Misery, L | 1 |
| Machet, L | 1 |
| Beylot-Barry, M | 1 |
| Dereure, O | 2 |
| Sassolas, B | 1 |
| Benichou, J | 2 |
| Joly, P | 5 |
| Hébert, V | 1 |
| Fernandes, AD | 1 |
| Larkins, NG | 1 |
| Liu, ID | 1 |
| Willis, NS | 5 |
| Hodson, EM | 5 |
| Kalinoski, T | 1 |
| Malenfant, J | 1 |
| Yim, C | 1 |
| Jeng, A | 1 |
| Sortais, C | 1 |
| Lok, A | 1 |
| Tessoulin, B | 1 |
| Gastinne, T | 1 |
| Mahé, B | 1 |
| Dubruille, V | 1 |
| Blin, N | 1 |
| Touzeau, C | 1 |
| Moreau, A | 1 |
| Bossard, C | 1 |
| Peterlin, P | 1 |
| Garnier, A | 1 |
| Guillaume, T | 1 |
| Le Bourgeois, A | 1 |
| Chevallier, P | 1 |
| Moreau, P | 1 |
| Leux, C | 1 |
| Le Gouill, S | 3 |
| Muratore, F | 3 |
| Boiardi, L | 4 |
| Restuccia, G | 2 |
| Cavazza, A | 2 |
| Catanoso, M | 2 |
| Macchioni, P | 4 |
| Spaggiari, L | 1 |
| Cimino, L | 3 |
| Aldigeri, R | 2 |
| Pipitone, N | 3 |
| Fontana, A | 1 |
| Casali, M | 1 |
| Croci, S | 1 |
| Janikova, A | 1 |
| Michalka, J | 1 |
| Bortlicek, Z | 1 |
| Chloupkova, R | 1 |
| Campr, V | 1 |
| Kopalova, N | 1 |
| Klener, P | 1 |
| Benesova, K | 1 |
| Hamouzova, J | 1 |
| Belada, D | 1 |
| Prochazka, V | 1 |
| Pytlik, R | 1 |
| Pirnos, J | 1 |
| Duras, J | 1 |
| Mocikova, H | 1 |
| Trneny, M | 1 |
| Shi, Q | 1 |
| Xing, G | 1 |
| Qi, M | 1 |
| Xing, Y | 1 |
| Lucijanic, M | 1 |
| Jaksic, O | 1 |
| Kuitunen, H | 1 |
| Kaprio, E | 1 |
| Karihtala, P | 1 |
| Makkonen, V | 1 |
| Kauppila, S | 1 |
| Haapasaari, KM | 1 |
| Kuusisto, M | 1 |
| Jantunen, E | 2 |
| Turpeenniemi-Hujanen, T | 1 |
| Kuittinen, O | 2 |
| He, F | 1 |
| Luo, Q | 1 |
| Lei, M | 1 |
| Fan, L | 1 |
| Shao, X | 2 |
| Hu, K | 1 |
| Qin, S | 1 |
| Yu, N | 1 |
| Cao, J | 1 |
| Rodriguez-Jimenez, NA | 1 |
| Perez-Guerrero, EE | 1 |
| Gamez-Nava, JI | 1 |
| Sanchez-Mosco, DI | 1 |
| Saldaña-Cruz, AM | 1 |
| Alcaraz-Lopez, MF | 1 |
| Fajardo-Robledo, NS | 1 |
| Muñoz-Valle, JF | 1 |
| Bonilla-Lara, D | 1 |
| Diaz-Rizo, V | 1 |
| Gonzalez-Lopez, L | 1 |
| Snast, I | 1 |
| Spitzer, L | 1 |
| Hodak, E | 1 |
| Levi, A | 2 |
| Mimouni, D | 2 |
| Leshem, YA | 1 |
| Landsburg, DJ | 2 |
| Koike, A | 1 |
| Nasta, SD | 1 |
| Svoboda, J | 2 |
| Schuster, SJ | 1 |
| Wasik, MA | 1 |
| Caponetti, GC | 1 |
| Okubo, Y | 1 |
| Hosotani, K | 1 |
| Taniguchi, Y | 1 |
| Hara, S | 1 |
| Inokuma, T | 2 |
| de Paiva Leite, SH | 1 |
| Morton, RP | 1 |
| Ahmad, Z | 1 |
| Marchal, F | 1 |
| Bröckelmann, PJ | 1 |
| Müller, H | 1 |
| Guhl, T | 1 |
| Behringer, K | 1 |
| Fuchs, M | 2 |
| Moccia, AA | 1 |
| Rank, A | 1 |
| Soekler, M | 2 |
| Vieler, T | 1 |
| Pabst, T | 1 |
| Baues, C | 2 |
| von Tresckow, B | 2 |
| Borchmann, P | 3 |
| Engert, A | 6 |
| Cook, LB | 1 |
| Gargiulo, A | 2 |
| Ruggiero, B | 1 |
| Ravà, L | 1 |
| Ciofi Degli Atti, M | 1 |
| Materassi, M | 1 |
| Lugani, F | 1 |
| Benetti, E | 1 |
| Morello, W | 1 |
| Molino, D | 1 |
| Mattozzi, F | 1 |
| Pennesi, M | 1 |
| Maringhini, S | 1 |
| Pasini, A | 3 |
| Gianoglio, B | 1 |
| Pecoraro, C | 1 |
| Montini, G | 3 |
| Murer, L | 2 |
| Ghiggeri, GM | 4 |
| Romagnani, P | 1 |
| Durgin, JS | 1 |
| Rodriguez, O | 1 |
| Sollecito, T | 1 |
| Tanaka, T | 1 |
| English, JC | 1 |
| Shields, BE | 1 |
| Rosenbach, M | 1 |
| Wang, H | 6 |
| Zhang, X | 4 |
| Si, X | 1 |
| Song, P | 1 |
| Xiao, Y | 1 |
| Yang, X | 1 |
| Song, L | 1 |
| Shi, J | 2 |
| Garnica, TK | 1 |
| Lesbon, JCC | 1 |
| Ávila, ACFCM | 1 |
| Rochetti, AL | 1 |
| Matiz, ORS | 1 |
| Ribeiro, RCS | 1 |
| Zoppa, A | 1 |
| Nishiya, AT | 1 |
| Costa, MT | 1 |
| de Nardi, AB | 1 |
| Argyle, DJ | 1 |
| Strefezzi, RF | 1 |
| Silveira, JC | 1 |
| Fukumasu, H | 1 |
| Mathian, A | 1 |
| Pha, M | 1 |
| Amoura, Z | 2 |
| Peretto, G | 1 |
| Barzaghi, F | 1 |
| Cicalese, MP | 1 |
| Di Resta, C | 1 |
| Slavich, M | 1 |
| Benedetti, S | 1 |
| Giangiobbe, S | 1 |
| Rizzo, S | 1 |
| Palmisano, A | 2 |
| Esposito, A | 1 |
| De Cobelli, F | 1 |
| Gulletta, S | 1 |
| Basso, C | 1 |
| Casari, G | 1 |
| Aiuti, A | 1 |
| Della Bella, P | 1 |
| Sala, S | 1 |
| Hsu, D | 1 |
| Martin, B | 1 |
| Forgó, E | 1 |
| Greene, E | 1 |
| Hassan, M | 1 |
| Bass, D | 1 |
| Fernández-Miranda, JJ | 1 |
| Díaz-Fernández, S | 1 |
| López-Muñoz, F | 1 |
| Mahan, JD | 1 |
| Kallash, M | 1 |
| Smoyer, WE | 1 |
| Prieto-Peña, D | 1 |
| Castañeda, S | 1 |
| Atienza-Mateo, B | 1 |
| Blanco, R | 1 |
| González-Gay, MA | 2 |
| Jayne, DRW | 1 |
| Merkel, PA | 6 |
| Schall, TJ | 1 |
| Bekker, P | 1 |
| Borretta, L | 1 |
| Walsh, NM | 1 |
| Bakowsky, V | 1 |
| Arnason, T | 1 |
| Croul, S | 1 |
| Pasternak, S | 1 |
| de Andrade, VP | 1 |
| De Souza, FHC | 1 |
| Behrens Pinto, GL | 1 |
| Shinjo, SK | 1 |
| Winkler, A | 1 |
| Zitt, E | 1 |
| Sprenger-Mähr, H | 1 |
| Soleiman, A | 1 |
| Cejna, M | 1 |
| Lhotta, K | 1 |
| Susanibar-Adaniya, S | 1 |
| Barta, SK | 2 |
| Zotta, F | 1 |
| Zecca, C | 1 |
| Disanto, G | 1 |
| Riccitelli, GC | 1 |
| Candrian, U | 1 |
| Deandrea, M | 1 |
| Limone, PP | 1 |
| Sacco, R | 1 |
| Gobbi, C | 2 |
| Schijvens, AM | 1 |
| Teeninga, N | 1 |
| Dorresteijn, EM | 1 |
| Teerenstra, S | 1 |
| Webb, NJ | 1 |
| Schreuder, MF | 1 |
| Sheehan, JL | 1 |
| Brandler, J | 1 |
| Rice, MD | 1 |
| Zhu, X | 1 |
| Shi, Z | 2 |
| Gao, S | 1 |
| Wang, X | 4 |
| Wang, P | 1 |
| Kang, C | 1 |
| Zhao, F | 1 |
| Hou, P | 1 |
| Zen, M | 1 |
| Fuzzi, E | 1 |
| Loredo Martinez, M | 1 |
| Depascale, R | 1 |
| Fredi, M | 1 |
| Gatto, M | 1 |
| Larosa, M | 1 |
| Saccon, F | 1 |
| Iaccarino, L | 1 |
| Doria, A | 2 |
| Pérez-Cortés, G | 1 |
| Pérez-Molina, JJ | 1 |
| Ochoa-Ponce, C | 1 |
| Ramírez-Godínez, S | 1 |
| Ornelas-Álvarez, VM | 1 |
| Maassen, JM | 1 |
| Dos Santos Sobrín, R | 1 |
| Bergstra, SA | 1 |
| Goekoop, R | 1 |
| Huizinga, TWJ | 1 |
| Allaart, CF | 2 |
| Suzuki, T | 5 |
| Maruyama, D | 2 |
| Miyagi-Maeshima, A | 1 |
| Nomoto, J | 1 |
| Tajima, K | 2 |
| Ito, Y | 1 |
| Hatta, S | 1 |
| Yuda, S | 1 |
| Makita, S | 1 |
| Fukuhara, S | 2 |
| Munakata, W | 2 |
| Taniguchi, H | 2 |
| Izutsu, K | 1 |
| Kobayashi, Y | 2 |
| Tobinai, K | 3 |
| Bobillo, S | 1 |
| Joffe, E | 1 |
| Sermer, D | 1 |
| Mondello, P | 1 |
| Ghione, P | 1 |
| Caron, PC | 1 |
| Hamilton, A | 1 |
| Hamlin, PA | 1 |
| Horwitz, SM | 1 |
| Matasar, MJ | 1 |
| Batlevi, CL | 1 |
| Moskowitz, A | 1 |
| Noy, A | 2 |
| Owens, CN | 1 |
| Palomba, ML | 1 |
| Straus, D | 2 |
| von Keudell, G | 1 |
| Dogan, A | 2 |
| Zelenetz, AD | 3 |
| Seshan, VE | 1 |
| Younes, A | 2 |
| Lolli, G | 1 |
| Casadei, B | 1 |
| Pellegrini, C | 2 |
| Argnani, L | 2 |
| Cocito, F | 1 |
| Zinzani, PL | 7 |
| Buddingh, EP | 1 |
| Vossen, ACTM | 1 |
| Lamb, HJ | 1 |
| van der Palen, RLF | 1 |
| Brinkman, DMC | 1 |
| Colucci, M | 1 |
| Bettini, C | 1 |
| Lo Russo, A | 1 |
| Kahl, BS | 1 |
| Flowers, CR | 2 |
| Martin, P | 4 |
| Ansell, SM | 2 |
| Abella-Dominicis, E | 1 |
| Koh, B | 1 |
| Ye, W | 1 |
| Barr, PM | 1 |
| Salles, GA | 1 |
| Friedberg, JW | 3 |
| Smids, C | 1 |
| Horjus Talabur Horje, CS | 1 |
| Nierkens, S | 1 |
| Drylewicz, J | 1 |
| Groenen, MJM | 1 |
| Wahab, PJ | 1 |
| van Lochem, EG | 1 |
| Grammatico, S | 2 |
| Bringhen, S | 5 |
| Vozella, F | 1 |
| Siniscalchi, A | 2 |
| Boccadoro, M | 8 |
| Petrucci, MT | 4 |
| Xu, H | 1 |
| Li, YM | 1 |
| Ma, H | 1 |
| Gu, WT | 1 |
| Chen, ZQ | 1 |
| Lavi, N | 1 |
| Shapira, G | 1 |
| Zilberlicht, A | 2 |
| Benyamini, N | 1 |
| Farbstein, D | 1 |
| Dann, EJ | 2 |
| Bar-Shalom, R | 2 |
| Avivi, I | 2 |
| Falkiewicz, MK | 1 |
| Maly, J | 1 |
| Blum, KA | 1 |
| Howlett, C | 1 |
| Feldman, T | 1 |
| Mato, AR | 1 |
| Hill, BT | 1 |
| Li, S | 3 |
| Medeiros, LJ | 1 |
| Torka, P | 1 |
| Hernandez-Ilizaliturri, F | 1 |
| Reddy, NM | 1 |
| Singavi, A | 1 |
| Fenske, TS | 3 |
| Chavez, JC | 1 |
| Kaplan, JB | 1 |
| Behdad, A | 1 |
| Petrich, AM | 1 |
| Bast, MA | 1 |
| Vose, JM | 2 |
| Olszewski, AJ | 1 |
| Costa, C | 1 |
| Lansigan, F | 1 |
| Gerson, JN | 1 |
| Calzada, O | 2 |
| Cohen, JB | 2 |
| Lue, JK | 1 |
| Amengual, JE | 1 |
| Rivera, X | 1 |
| Persky, DO | 1 |
| Peace, DJ | 1 |
| Cassaday, RD | 1 |
| Yamamoto, M | 3 |
| Watanabe, K | 1 |
| Fukuda, T | 1 |
| Miura, O | 1 |
| Storer, BE | 2 |
| Inamoto, Y | 1 |
| Flowers, MED | 1 |
| Pidala, J | 1 |
| Palmer, J | 1 |
| Arora, M | 2 |
| Jagasia, M | 1 |
| Arai, S | 1 |
| Cutler, CS | 1 |
| Hodkoff, A | 1 |
| Bentley, P | 1 |
| Xu, X | 1 |
| Nakazato, S | 1 |
| Ujiie, H | 1 |
| Inamura, Y | 1 |
| Nishimura, M | 1 |
| Iwata, H | 1 |
| Shimizu, H | 1 |
| Yunyun, F | 1 |
| Yu, C | 1 |
| Panpan, Z | 1 |
| Hua, C | 1 |
| Di, W | 1 |
| Lidan, Z | 1 |
| Linyi, P | 1 |
| Li, W | 1 |
| Qingjun, W | 1 |
| Xuan, Z | 1 |
| Yan, Z | 1 |
| Xiaofeng, Z | 1 |
| Fengchun, Z | 1 |
| Wen, Z | 1 |
| Zhou, M | 1 |
| Xing, C | 1 |
| Ni, Z | 3 |
| Fu, P | 1 |
| Liu, F | 1 |
| Chen, N | 2 |
| Zeng, C | 3 |
| Fascì-Spurio, F | 1 |
| Meucci, G | 1 |
| Papi, C | 1 |
| Saibeni, S | 1 |
| Petrungaro, A | 1 |
| Gentile, M | 1 |
| Mazzone, C | 1 |
| Greco, R | 1 |
| Uccello, G | 1 |
| Recchia, AG | 1 |
| De Stefano, L | 1 |
| Bossio, S | 1 |
| Palummo, A | 1 |
| Morelli, R | 1 |
| Musolino, C | 1 |
| Morabito, F | 2 |
| Vigna, E | 1 |
| Maritati, F | 2 |
| Fenoglio, R | 1 |
| Pillebout, E | 1 |
| Rocco, R | 1 |
| Nicastro, M | 1 |
| Incerti, M | 1 |
| Goldoni, M | 1 |
| Trivioli, G | 1 |
| Silvestri, E | 1 |
| Mohammad, AJ | 1 |
| Jayne, D | 1 |
| Eriksson, P | 1 |
| Segelmark, M | 1 |
| Harris, H | 1 |
| Roccatello, D | 1 |
| Vaglio, A | 3 |
| Gruppen, MP | 1 |
| Bouts, AH | 1 |
| Jansen-van der Weide, MC | 1 |
| Merkus, MP | 1 |
| Zurowska, A | 1 |
| Maternik, M | 1 |
| Niaudet, P | 7 |
| Cornelissen, EAM | 1 |
| Schurmans, T | 1 |
| Raes, A | 1 |
| van de Walle, J | 1 |
| van Dyck, M | 1 |
| Gulati, A | 1 |
| Bagga, A | 4 |
| Davin, JC | 1 |
| Tawfik, P | 1 |
| Arndt, P | 1 |
| Yang, P | 2 |
| Ye, Z | 1 |
| Du, L | 3 |
| Zhou, Q | 2 |
| Qi, J | 1 |
| Liang, L | 1 |
| Wu, L | 2 |
| Wang, C | 2 |
| Kijlstra, A | 1 |
| Schrappe, M | 5 |
| Bleckmann, K | 1 |
| Zimmermann, M | 2 |
| Biondi, A | 3 |
| Möricke, A | 1 |
| Locatelli, F | 2 |
| Cario, G | 1 |
| Rizzari, C | 4 |
| Attarbaschi, A | 2 |
| Valsecchi, MG | 4 |
| Bartram, CR | 1 |
| Barisone, E | 1 |
| Niggli, F | 2 |
| Niemeyer, C | 2 |
| Testi, AM | 5 |
| Mann, G | 2 |
| Ziino, O | 1 |
| Schäfer, B | 1 |
| Panzer-Grümayer, R | 1 |
| Beier, R | 1 |
| Parasole, R | 1 |
| Göhring, G | 1 |
| Ludwig, WD | 3 |
| Casale, F | 1 |
| Schlegel, PG | 1 |
| Basso, G | 6 |
| Conter, V | 4 |
| Liu, C | 1 |
| Xie, L | 4 |
| Peng, J | 1 |
| Zheng, X | 2 |
| Zhong, X | 1 |
| Liu, D | 1 |
| Liu, L | 1 |
| Xia, Z | 1 |
| Mager, A | 1 |
| Talmor, Y | 1 |
| Chezar Azzerad, C | 1 |
| Iakobishvili, Z | 1 |
| Porter, A | 1 |
| Kornowski, R | 1 |
| Hasdai, D | 1 |
| Marriott, JJ | 1 |
| Chen, H | 1 |
| Fransoo, R | 1 |
| Marrie, RA | 1 |
| Yang, HJ | 1 |
| Paik, JS | 1 |
| Yang, SW | 1 |
| Shah, NN | 1 |
| Szabo, A | 1 |
| Huntington, SF | 1 |
| Reddy, N | 1 |
| Ganguly, S | 1 |
| Vose, J | 1 |
| Obiozor, C | 1 |
| Faruqi, F | 1 |
| Kovach, AE | 1 |
| Costa, LJ | 1 |
| Xavier, AC | 1 |
| Okal, R | 1 |
| Kanate, AS | 1 |
| Ghosh, N | 1 |
| Strelec, L | 1 |
| Chavez, J | 1 |
| Rastogi, U | 1 |
| Sergie, Z | 1 |
| Pinney, S | 1 |
| Moss, N | 1 |
| Oliveira, B | 1 |
| Sheaff, M | 1 |
| Blunden, M | 1 |
| Ng, AK | 3 |
| Yahalom, J | 2 |
| Goda, JS | 1 |
| Constine, LS | 4 |
| Pinnix, CC | 1 |
| Kelsey, CR | 1 |
| Hoppe, B | 1 |
| Oguchi, M | 3 |
| Suh, CO | 3 |
| Wirth, A | 3 |
| Qi, S | 1 |
| Davies, A | 1 |
| Moskowitz, CH | 2 |
| Laskar, S | 1 |
| Mauch, PM | 2 |
| Specht, L | 1 |
| Illidge, T | 1 |
| Fong, HK | 1 |
| Abdullah, O | 1 |
| Gautam, S | 1 |
| Bakker, DS | 1 |
| Garritsen, FM | 1 |
| Leavis, HL | 1 |
| van der Schaft, J | 1 |
| Bruijnzeel-Koomen, CAFM | 1 |
| van den Broek, MPH | 1 |
| de Bruin-Weller, MS | 1 |
| Solomon, M | 1 |
| Barzilai, A | 4 |
| Elphasy, H | 1 |
| Trau, H | 4 |
| Baum, S | 4 |
| Iriki, H | 1 |
| Ouchi, T | 1 |
| Ito, H | 1 |
| Sawada, M | 1 |
| Mukai, M | 1 |
| Nomura, H | 1 |
| Baba, Y | 1 |
| Adachi, T | 1 |
| Funakoshi, T | 1 |
| Amagai, M | 1 |
| Takahashi, H | 1 |
| Kriegsmann, K | 1 |
| Rieger, M | 2 |
| Schwarzbich, MA | 1 |
| Sitter, S | 1 |
| Kriegsmann, M | 1 |
| Bruckner, T | 1 |
| Hensel, M | 2 |
| Ho, AD | 3 |
| Witzens-Harig, M | 2 |
| Wuchter, P | 1 |
| Wu, X | 2 |
| Wang, S | 3 |
| Lu, X | 1 |
| Qiao, C | 1 |
| Wu, Y | 2 |
| Lu, R | 1 |
| Hong, M | 1 |
| Zhu, Y | 1 |
| He, G | 1 |
| Jonasova, A | 1 |
| Neuwirtova, R | 1 |
| Polackova, H | 1 |
| Siskova, M | 1 |
| Stopka, T | 1 |
| Cmunt, E | 1 |
| Belickova, M | 1 |
| Moudra, A | 1 |
| Minarik, L | 1 |
| Fuchs, O | 1 |
| Michalova, K | 1 |
| Zemanova, Z | 1 |
| Kirkland, SW | 2 |
| Vandermeer, B | 1 |
| Campbell, S | 2 |
| Villa-Roel, C | 2 |
| Newton, A | 1 |
| Ducharme, FM | 1 |
| Rowe, BH | 4 |
| Ben Lakhal, R | 1 |
| Hdiji, S | 1 |
| Zriba, S | 1 |
| Mokrani, A | 1 |
| Laatiri, MA | 1 |
| BenYoussef, Y | 1 |
| Ezzaier, F | 1 |
| Toumi, N | 2 |
| Ladeb, S | 1 |
| BenSalah, H | 1 |
| Tebra, S | 1 |
| Frikha, H | 1 |
| Messai, T | 1 |
| Daoued, J | 1 |
| Bouaouina, N | 1 |
| Maalej, M | 1 |
| Frikha, M | 1 |
| BenOthmen, T | 1 |
| BenAhmed, S | 1 |
| Khelif, A | 1 |
| Msaddek, F | 1 |
| Elloumi, M | 1 |
| Meddeb, B | 1 |
| Parzuchowski, A | 1 |
| Bush, R | 2 |
| Pei, Q | 2 |
| Friedman, DL | 2 |
| FitzGerald, TJ | 2 |
| Wolden, SL | 2 |
| Dharmarajan, KV | 2 |
| Laurie, F | 1 |
| Kessel, SK | 2 |
| Appel, B | 1 |
| Fernandez, K | 1 |
| Punnett, A | 1 |
| Schwartz, CL | 2 |
| Cox, J | 2 |
| Terezakis, SA | 1 |
| Cross, E | 1 |
| Ammar, MJ | 1 |
| Kolomeyer, AM | 1 |
| Bhatt, N | 1 |
| Tamhankar, MA | 1 |
| Mullen, MT | 1 |
| Brucker, AJ | 2 |
| Noone, DG | 1 |
| Iijima, K | 1 |
| Parekh, R | 1 |
| Shida, H | 1 |
| Hashimoto, N | 1 |
| Kusunoki, Y | 1 |
| Hattanda, F | 1 |
| Ogawa, Y | 1 |
| Hayashi, T | 1 |
| Nakazawa, D | 1 |
| Masuda, S | 1 |
| Tomaru, U | 1 |
| Ishizu, A | 1 |
| Paganin, M | 2 |
| Grillo, MF | 1 |
| Silvestri, D | 1 |
| Scapinello, G | 1 |
| Buldini, B | 1 |
| Cazzaniga, G | 1 |
| Te Kronnie, G | 1 |
| Pennella, CL | 1 |
| Rossi, JG | 1 |
| Baialardo, EM | 1 |
| Alonso, CN | 1 |
| Guitter, MR | 1 |
| Sánchez La Rosa, CG | 1 |
| Millán, NC | 1 |
| Alfaro, EM | 1 |
| Zubizarreta, PA | 1 |
| Felice, MS | 1 |
| Devilliers, H | 1 |
| Ly, KH | 1 |
| Maurier, F | 1 |
| Bienvenu, B | 2 |
| Charles, P | 2 |
| Guillevin, L | 7 |
| Besancenot, JF | 1 |
| Liozon, E | 5 |
| Fauchais, AL | 1 |
| Loffroy, R | 1 |
| Binquet, C | 1 |
| Audia, S | 1 |
| Seror, R | 1 |
| Mariette, X | 2 |
| Bonnotte, B | 2 |
| Simpson, K | 1 |
| Chapman, P | 1 |
| Klag, A | 1 |
| Kamal, WSA | 1 |
| Affandi, AM | 1 |
| Bhullar, A | 1 |
| Kamal, WSZ | 1 |
| Fujinaga, S | 1 |
| Sakuraya, K | 1 |
| Xin, L | 2 |
| Meng, QQ | 1 |
| Hu, LH | 2 |
| Hao, L | 1 |
| Liu, PP | 1 |
| Qian, W | 2 |
| Wang, LW | 1 |
| Li, ZS | 2 |
| Deng, X | 1 |
| Fang, R | 1 |
| Li, R | 1 |
| Rubagumya, F | 1 |
| Xu, MJ | 1 |
| May, L | 1 |
| Driscoll, C | 1 |
| Uwizeye, FR | 1 |
| Shyirambere, C | 1 |
| Larrabee, K | 1 |
| Fehr, AE | 1 |
| Gilbert, UD | 1 |
| Muhayimana, C | 1 |
| Hategekimana, V | 1 |
| Elmore, S | 1 |
| Mpunga, T | 1 |
| Moore, M | 1 |
| Shulman, LN | 2 |
| Lehmann, L | 1 |
| McCarthy, M | 1 |
| Anderson, E | 1 |
| DeBrito, P | 1 |
| Tavares Rodrigues, F | 1 |
| Pereira Cardozo, MR | 1 |
| da Costa Nery, JA | 1 |
| Ehren, R | 1 |
| Benz, MR | 1 |
| Doetsch, J | 1 |
| Fichtner, A | 1 |
| Gellermann, J | 1 |
| Haffner, D | 1 |
| Höcker, B | 1 |
| Hoyer, PF | 4 |
| Kästner, B | 1 |
| Kemper, MJ | 2 |
| Konrad, M | 1 |
| Luntz, S | 1 |
| Querfeld, U | 1 |
| Sander, A | 1 |
| Toenshoff, B | 1 |
| Weber, LT | 1 |
| Curras-Martin, D | 1 |
| Campbell, N | 1 |
| Haroon, A | 1 |
| Hossain, MA | 1 |
| Asif, A | 1 |
| DeWeerdt, S | 1 |
| Burns, RB | 1 |
| Smith, CC | 1 |
| Shmerling, RH | 1 |
| Tess, A | 1 |
| Rodriguez-Gonzalez, M | 1 |
| Ruiz-Gonzalez, E | 1 |
| Castellano-Martinez, A | 1 |
| Tajudeen, BA | 1 |
| Ganti, A | 1 |
| Kuhar, HN | 1 |
| Mahdavinia, M | 1 |
| Heilingoetter, A | 1 |
| Gattuso, P | 1 |
| Ghai, R | 1 |
| Batra, PS | 1 |
| Koster, MJ | 1 |
| Yeruva, K | 1 |
| Crowson, CS | 2 |
| Labarca, C | 1 |
| Eyre, TA | 3 |
| Martinez-Calle, N | 2 |
| Hildyard, C | 2 |
| Eyre, DW | 2 |
| Plaschkes, H | 2 |
| Griffith, J | 2 |
| Wolf, J | 3 |
| Fields, P | 1 |
| Gunawan, A | 2 |
| Oliver, R | 2 |
| Djebbari, F | 1 |
| Booth, S | 2 |
| McMillan, A | 2 |
| Fox, CP | 3 |
| Bishton, MJ | 2 |
| Collins, GP | 2 |
| Hatton, CSR | 2 |
| Turkowski, Y | 1 |
| Konnikov, N | 1 |
| Mahalingam, M | 1 |
| Binkley, MS | 1 |
| Brady, JL | 1 |
| Hajj, C | 1 |
| Chelius, M | 1 |
| Chau, K | 1 |
| Balogh, A | 2 |
| Levis, M | 1 |
| Filippi, AR | 1 |
| Jones, M | 1 |
| Ahmed, S | 2 |
| MacManus, M | 2 |
| Vistisen, AK | 1 |
| Andraos, TY | 1 |
| Aleman, BMP | 1 |
| Choi, SH | 2 |
| Kirova, YM | 1 |
| Hardy, S | 1 |
| Reinartz, G | 2 |
| Eich, HT | 3 |
| Bratman, SV | 1 |
| Dabaja, B | 1 |
| El-Galaly, TC | 1 |
| Hodgson, DC | 3 |
| Ricardi, U | 3 |
| Mikhaeel, NG | 1 |
| Hoppe, RT | 6 |
| Korbet, SM | 2 |
| Whittier, WL | 1 |
| Fields, PA | 1 |
| Bishton, M | 1 |
| Toyonaga, H | 1 |
| Fukushima, M | 1 |
| Shimeno, N | 1 |
| Skrzypczyk, P | 1 |
| Kuźma-Mroczkowska, E | 2 |
| Kułagowska, J | 1 |
| Brzewski, M | 1 |
| Okarska-Napierała, M | 1 |
| Pańczyk-Tomaszewska, M | 2 |
| Bagnasco, D | 1 |
| Aloè, T | 1 |
| Sclifò, F | 1 |
| Ferrantino, MG | 1 |
| Marugo, F | 1 |
| Arcadipane, F | 1 |
| Manfredi, A | 1 |
| Canonica, GW | 1 |
| Passalacqua, G | 1 |
| Appleby, N | 1 |
| Cabes, M | 1 |
| Jackson, A | 1 |
| Boucher, R | 1 |
| Yates, F | 1 |
| Fox, S | 1 |
| Rawstron, A | 1 |
| Hillmen, P | 2 |
| Schuh, A | 1 |
| Berger, CT | 1 |
| Daikeler, T | 1 |
| Kelly, KM | 1 |
| Cole, PD | 1 |
| Roberts, KB | 2 |
| McCarten, KM | 2 |
| Cho, SY | 1 |
| Schwartz, C | 1 |
| Atarbashi-Moghadam, S | 1 |
| Lotfi, A | 1 |
| Atarbashi-Moghadam, F | 1 |
| Mimery, A | 1 |
| De Clercq, S | 1 |
| Lee, JJY | 1 |
| Alsaleem, A | 1 |
| Chiang, GPK | 1 |
| Limenis, E | 1 |
| Sontichai, W | 1 |
| Yeung, RSM | 1 |
| Akikusa, J | 1 |
| Laxer, RM | 1 |
| Bukhari, A | 1 |
| El Chaer, F | 1 |
| Koka, R | 1 |
| Singh, Z | 1 |
| Hutnick, E | 1 |
| Ruehle, K | 1 |
| Lee, ST | 1 |
| Kocoglu, MH | 1 |
| Shanholtz, C | 1 |
| Badros, A | 1 |
| Hardy, N | 1 |
| Yared, J | 1 |
| Rapoport, AP | 1 |
| Dahiya, S | 1 |
| Tagle, R | 1 |
| Arancibia, T | 1 |
| Fischman, A | 1 |
| Vázquez, S | 1 |
| Chahuán, J | 1 |
| Méndez, GP | 1 |
| Huidobro E, JP | 1 |
| Leiba, R | 1 |
| Faibish, T | 1 |
| Rowe, JM | 1 |
| Zhao, XY | 1 |
| Rakhda, MI | 1 |
| Wang, TI | 1 |
| Jia, JD | 1 |
| Gilboa, S | 2 |
| Greenberger, S | 1 |
| Pavlotsky, F | 1 |
| Latta, S | 1 |
| Cygan, PH | 1 |
| Fried, W | 1 |
| Nabhan, C | 1 |
| Gadner, H | 6 |
| Grois, N | 2 |
| Pötschger, U | 2 |
| Thiem, E | 1 |
| Aricò, M | 3 |
| Astigarraga, I | 1 |
| Braier, J | 1 |
| Donadieu, J | 1 |
| Henter, JI | 1 |
| Janka-Schaub, G | 1 |
| McClain, KL | 2 |
| Weitzman, S | 2 |
| Windebank, K | 1 |
| Ladisch, S | 3 |
| Berrang, T | 1 |
| Holloway, C | 1 |
| Hart, J | 1 |
| Yee, A | 1 |
| Berry, B | 1 |
| Kotb, R | 1 |
| Picco, P | 1 |
| Naselli, A | 1 |
| Pala, G | 1 |
| Marsciani, A | 1 |
| Buoncompagni, A | 1 |
| Martini, A | 1 |
| Lunning, MA | 1 |
| Moskowitz, AJ | 1 |
| Horwitz, S | 1 |
| Ishimoto, T | 1 |
| Cara-Fuentes, G | 1 |
| Shimada, M | 1 |
| Wasserfall, CH | 1 |
| Winter, WE | 1 |
| Rivard, CJ | 1 |
| Araya, CE | 1 |
| Saleem, MA | 1 |
| Mathieson, PW | 1 |
| Johnson, RJ | 1 |
| Garin, EH | 2 |
| Gyan, E | 1 |
| Damotte, D | 1 |
| Courby, S | 1 |
| Sénécal, D | 1 |
| Quittet, P | 1 |
| Schmidt-Tanguy, A | 1 |
| Banos, A | 1 |
| Lamy, T | 2 |
| Fontan, J | 1 |
| Maisonneuve, H | 1 |
| Alexis, M | 1 |
| Dreyfus, F | 1 |
| Tournilhac, O | 1 |
| Laribi, K | 2 |
| Solal-Céligny, P | 2 |
| Arakelyan, N | 1 |
| Cartron, G | 2 |
| Gressin, R | 1 |
| Alberici, F | 1 |
| Oliva, E | 1 |
| Manenti, L | 1 |
| Ferretti, S | 1 |
| Cobelli, R | 1 |
| Buzio, C | 1 |
| Henze, G | 5 |
| v Stackelberg, A | 1 |
| Eckert, C | 2 |
| Lee, E | 1 |
| Kim, TM | 1 |
| Lim, Y | 1 |
| Jeon, YK | 1 |
| Go, H | 1 |
| Kim, CW | 1 |
| Heo, DS | 1 |
| Piccin, A | 1 |
| Amaddii, G | 1 |
| Natolino, F | 1 |
| Billio, A | 1 |
| Cortelazzo, S | 2 |
| Ravani, P | 2 |
| Ponticelli, A | 1 |
| Siciliano, C | 1 |
| Fornoni, A | 2 |
| Magnasco, A | 1 |
| Sica, F | 2 |
| Bodria, M | 2 |
| Caridi, G | 2 |
| Wei, C | 1 |
| Belingheri, M | 2 |
| Ghio, L | 1 |
| Merscher-Gomez, S | 1 |
| Edefonti, A | 3 |
| Murtas, C | 1 |
| Muruve, D | 1 |
| Martorana, D | 1 |
| Pani, A | 1 |
| Scolari, F | 2 |
| Reiser, J | 2 |
| van der Lugt, NM | 1 |
| van Kampen, A | 1 |
| Walther, FJ | 1 |
| Brand, A | 1 |
| Lopriore, E | 1 |
| Wu, B | 2 |
| Chen, P | 1 |
| Li, F | 2 |
| Zou, S | 1 |
| Cheng, Y | 1 |
| González-Barca, E | 1 |
| Canales, M | 1 |
| Cortés, M | 1 |
| Vidal, MJ | 1 |
| Salar, A | 1 |
| Oriol, A | 1 |
| Bargay, J | 1 |
| Bello, JL | 1 |
| Sánchez, JJ | 1 |
| Tomás, JF | 1 |
| Donato, E | 1 |
| Ferrer, S | 1 |
| Caballero, D | 1 |
| Yang, S | 2 |
| Xue, W | 1 |
| Yin, A | 1 |
| Lu, W | 1 |
| Back, AR | 1 |
| Schleis, SE | 1 |
| Smrkovski, OA | 1 |
| Lee, J | 2 |
| Smith, AN | 1 |
| Phillips, JC | 1 |
| Larocca, A | 2 |
| Montefusco, V | 1 |
| Rossi, D | 1 |
| Crippa, C | 1 |
| Mina, R | 1 |
| Galli, M | 2 |
| Marcatti, M | 1 |
| La Verde, G | 1 |
| Giuliani, N | 1 |
| Magarotto, V | 1 |
| Guglielmelli, T | 1 |
| Rota-Scalabrini, D | 1 |
| Omedé, P | 1 |
| Santagostino, A | 1 |
| Baldi, I | 2 |
| Carella, AM | 1 |
| Corradini, P | 1 |
| Palumbo, A | 7 |
| Du, W | 1 |
| Zheng, Z | 1 |
| Han, S | 1 |
| Ma, S | 1 |
| Chen, S | 2 |
| Boers-Sonderen, MJ | 1 |
| Mulder, SF | 1 |
| Nagtegaal, ID | 1 |
| Jacobs, JF | 1 |
| Wanten, GJ | 1 |
| Hoentjen, F | 1 |
| van Herpen, CM | 1 |
| Hoffmeister, PA | 1 |
| Baker, KS | 1 |
| Hingorani, SR | 1 |
| García Juárez, I | 1 |
| Miquel, R | 1 |
| Forns, X | 1 |
| Bruguera, M | 2 |
| Zhang, B | 1 |
| Liu, T | 1 |
| Fan, S | 1 |
| Lévy-Sitbon, C | 1 |
| Reguiaï, Z | 1 |
| Durlach, A | 1 |
| Goeldel, AL | 1 |
| Grange, F | 2 |
| Alba, MA | 2 |
| García-Martínez, A | 2 |
| Prieto-González, S | 2 |
| Espígol-Frigolé, G | 2 |
| Butjosa, M | 2 |
| Tavera-Bahillo, I | 2 |
| Rodríguez-Pintó, I | 1 |
| Hernández-Rodríguez, J | 2 |
| Cid, MC | 2 |
| Langford, CA | 7 |
| Monach, PA | 4 |
| Specks, U | 4 |
| Seo, P | 4 |
| Cuthbertson, D | 2 |
| McAlear, CA | 2 |
| Ytterberg, SR | 3 |
| Hoffman, GS | 8 |
| Krischer, JP | 1 |
| Levine, A | 2 |
| Turner, D | 1 |
| Pfeffer Gik, T | 1 |
| Amil Dias, J | 1 |
| Veres, G | 1 |
| Shaoul, R | 1 |
| Staiano, A | 1 |
| Escher, J | 1 |
| Kolho, KL | 1 |
| Paerregaard, A | 1 |
| Martin de Carpi, J | 1 |
| Veereman Wauters, G | 1 |
| Koletzko, S | 1 |
| Shevah, O | 1 |
| Finnby, L | 1 |
| Sladek, M | 1 |
| Cao, XX | 2 |
| Duan, MH | 2 |
| Shen, T | 1 |
| Zhou, DB | 2 |
| Yan-Li, L | 1 |
| Kang-Sheng, G | 1 |
| Yue-Yin, P | 1 |
| Yang, J | 1 |
| Zhi-Min, Z | 1 |
| Zhang, LN | 1 |
| Shi, TY | 1 |
| Yang, YJ | 1 |
| Zhang, FC | 1 |
| Zhou, F | 1 |
| Ling, C | 1 |
| Guo, L | 1 |
| Wei, W | 1 |
| Shi, H | 1 |
| Hou, J | 1 |
| Sureshkumar, P | 1 |
| Barzi, F | 1 |
| Schoeffler, A | 1 |
| Levy, E | 1 |
| Weinborn, M | 1 |
| Cuny, JF | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Cribier, B | 1 |
| Bursztejn, AC | 1 |
| Ruiz-Medrano, J | 1 |
| Peralta-Díaz, LM | 1 |
| Santos-Bueso, E | 1 |
| Bao, H | 1 |
| Koketsu, H | 1 |
| Ricotti, C | 1 |
| Kerdel, FA | 1 |
| Baguley, C | 1 |
| Brownlow, A | 1 |
| Yeung, K | 1 |
| Pratt, E | 1 |
| Sacks, R | 1 |
| Harvey, R | 1 |
| Broccoli, A | 1 |
| Celli, M | 1 |
| Agostinelli, C | 1 |
| Pileri, S | 1 |
| Camellino, D | 1 |
| Morbelli, S | 1 |
| Paparo, F | 1 |
| Massollo, M | 1 |
| Sambuceti, G | 1 |
| Cimmino, MA | 1 |
| Yan, J | 1 |
| Wu, P | 1 |
| Ghose, A | 1 |
| Kundu, R | 1 |
| Latif, T | 1 |
| Calich, AL | 1 |
| Puéchal, X | 3 |
| Pugnet, G | 1 |
| London, J | 1 |
| Mouthon, L | 2 |
| Thanou, A | 1 |
| Chakravarty, E | 1 |
| James, JA | 1 |
| Merrill, JT | 1 |
| Shankar, A | 2 |
| Hayward, J | 1 |
| Kirkwood, A | 1 |
| McCarthy, K | 2 |
| Hewitt, M | 2 |
| Morland, B | 1 |
| Daw, S | 2 |
| Heidari, P | 1 |
| Verdijk, RM | 1 |
| van den Bosch, WA | 1 |
| Paridaens, D | 1 |
| Jin, JG | 1 |
| Mekinian, A | 1 |
| Costedoat-Chalumeau, N | 1 |
| Masseau, A | 1 |
| Botta, A | 1 |
| Chudzinski, A | 1 |
| Theulin, A | 1 |
| Emmanuelli, V | 1 |
| Hachulla, E | 3 |
| De Carolis, S | 1 |
| Revaux, A | 1 |
| Nicaise, P | 1 |
| Cornelis, F | 1 |
| Subtil, D | 1 |
| Montestruc, F | 1 |
| Bucourt, M | 1 |
| Chollet-Martin, S | 1 |
| Carbillon, L | 1 |
| Craig, M | 1 |
| Hanna, WT | 1 |
| Cabanillas, F | 4 |
| Chen, CS | 1 |
| Esseltine, DL | 2 |
| Neuwirth, R | 1 |
| O'Connor, OA | 2 |
| Miloslavsky, EM | 2 |
| Spiera, R | 2 |
| Kallenberg, CG | 2 |
| St Clair, EW | 2 |
| Tchao, NK | 2 |
| Viviano, L | 1 |
| Ding, L | 2 |
| Iklé, D | 2 |
| Villarreal, M | 1 |
| Jepson, B | 1 |
| Brunetta, P | 2 |
| Allen, NB | 1 |
| Fervenza, FC | 3 |
| Geetha, D | 1 |
| Keogh, K | 1 |
| Kissin, EY | 1 |
| Peikert, T | 1 |
| Stegeman, C | 1 |
| Stingeni, L | 1 |
| Tramontana, M | 1 |
| Bassotti, G | 1 |
| Bianchi, L | 1 |
| Lisi, P | 1 |
| Cheah, CY | 1 |
| Herbert, KE | 1 |
| O'Rourke, K | 1 |
| Kennedy, GA | 1 |
| George, A | 1 |
| Fedele, PL | 1 |
| Gilbertson, M | 1 |
| Tan, SY | 1 |
| Ritchie, DS | 1 |
| Opat, SS | 1 |
| Prince, HM | 1 |
| Dickinson, M | 1 |
| Burbury, K | 1 |
| Wolf, M | 2 |
| Januszewicz, EH | 1 |
| Tam, CS | 1 |
| Westerman, DA | 1 |
| Carney, DA | 1 |
| Harrison, SJ | 1 |
| Seymour, JF | 3 |
| Schneider, JE | 1 |
| Lewis, LM | 1 |
| Ferguson, I | 1 |
| House, SL | 1 |
| Matsuda, K | 1 |
| Johnson, K | 1 |
| Manovitch, Z | 1 |
| Mouallem, M | 1 |
| Kuno, T | 1 |
| Tamura, Y | 1 |
| Ono, T | 1 |
| Murata, M | 2 |
| Kuwana, M | 1 |
| Satoh, T | 1 |
| Fukuda, K | 1 |
| Corbera-Bellalta, M | 1 |
| Planas-Rigol, E | 1 |
| Langerbeins, P | 1 |
| Busch, R | 2 |
| Anheier, N | 1 |
| Dürig, J | 1 |
| Bergmann, M | 1 |
| Goebeler, ME | 1 |
| Hurtz, HJ | 2 |
| Stauch, MB | 1 |
| Stilgenbauer, S | 1 |
| Döhner, H | 1 |
| Fink, AM | 1 |
| Cramer, P | 1 |
| Fischer, K | 1 |
| Wendtner, CM | 1 |
| Hallek, M | 1 |
| Eichhorst, B | 1 |
| Englund, A | 1 |
| Hopstadius, C | 1 |
| Enblad, G | 1 |
| Gustafsson, G | 1 |
| Ljungman, G | 1 |
| Caso, F | 1 |
| Rigante, D | 2 |
| Vitale, A | 2 |
| Costa, L | 1 |
| Bascherini, V | 1 |
| Latronico, E | 1 |
| Franceschini, R | 1 |
| Cantarini, L | 2 |
| Din, B | 1 |
| Shi, Y | 1 |
| Mao, J | 2 |
| Shen, H | 2 |
| Fu, H | 2 |
| Wang, J | 4 |
| Liu, A | 2 |
| Gu, W | 1 |
| Shu, Q | 2 |
| Ferreri, AJ | 4 |
| Bruno-Ventre, M | 1 |
| Donadoni, G | 1 |
| Ponzoni, M | 1 |
| Citterio, G | 1 |
| Foppoli, M | 1 |
| Vignati, A | 1 |
| Scarfò, L | 1 |
| Sassone, M | 1 |
| Govi, S | 1 |
| Caligaris-Cappio, F | 1 |
| Benadiba, J | 1 |
| Robitaille, N | 1 |
| Lambert, G | 1 |
| Itaj, NK | 1 |
| Pastore, Y | 1 |
| Kamath, S | 1 |
| Arkader, A | 1 |
| Jubran, RF | 1 |
| Bhagat, P | 1 |
| Sachdeva, MU | 1 |
| Sharma, P | 1 |
| Naseem, S | 1 |
| Ahluwalia, J | 2 |
| Das, R | 2 |
| Varma, N | 2 |
| Law, A | 1 |
| Vera-Lastra, O | 1 |
| Sepúlveda-Delgado, J | 1 |
| Cruz-Domínguez, Mdel P | 1 |
| Medina, G | 1 |
| Casarrubias-Ramírez, M | 1 |
| Molina-Carrión, LE | 1 |
| Pineda-Galindo, LF | 1 |
| Olvera-Acevedo, A | 1 |
| Hernández-Gonzalez, C | 1 |
| Jara, LJ | 1 |
| Arends, S | 1 |
| Berden, JH | 1 |
| Grootscholten, C | 1 |
| Derksen, RH | 1 |
| Berger, SP | 1 |
| de Sévaux, RG | 1 |
| Voskuyl, AE | 1 |
| Bijl, M | 1 |
| He, YX | 1 |
| Zhu, XF | 2 |
| Zhang, QH | 1 |
| Zou, DW | 1 |
| Jin, ZD | 1 |
| Chang, XJ | 1 |
| Zheng, JM | 1 |
| Zuo, CJ | 1 |
| Shao, CW | 1 |
| Jin, G | 1 |
| Liao, Z | 1 |
| Ishihara, T | 1 |
| Kanagawa, M | 1 |
| Koyama, J | 1 |
| Hasegawa, K | 1 |
| Hirayama, Y | 1 |
| Terui, T | 1 |
| Arcaini, L | 2 |
| Morello, L | 1 |
| Tucci, A | 1 |
| Rusconi, C | 1 |
| Ladetto, M | 2 |
| Rattotti, S | 1 |
| Bonfichi, M | 1 |
| Bottelli, C | 2 |
| Gabutti, C | 1 |
| Bernasconi, P | 3 |
| Varettoni, M | 1 |
| Gotti, M | 1 |
| Troletti, D | 1 |
| Guerrera, ML | 1 |
| Fiaccadori, V | 1 |
| Sciarra, R | 1 |
| Ferretti, VV | 1 |
| Alessandrino, EP | 3 |
| Rossi, G | 1 |
| Morra, E | 4 |
| Iandoli, M | 1 |
| Sakata, VM | 1 |
| da Silva, FT | 1 |
| Hirata, CE | 1 |
| Marin, ML | 1 |
| Rodrigues, H | 1 |
| Kalil, J | 1 |
| Costa, RA | 1 |
| Yamamoto, JH | 1 |
| Rossi, R | 1 |
| Bonanni, A | 1 |
| Quinn, RR | 1 |
| De Giovanni, D | 1 |
| Barbano, G | 1 |
| Degl'Innocenti, L | 1 |
| Kervarrec, T | 1 |
| Binois, R | 1 |
| Bléchet, C | 1 |
| Estève, É | 1 |
| Xu, N | 1 |
| Zhao, J | 1 |
| Wu, D | 1 |
| Zhao, L | 1 |
| Wang, Q | 2 |
| Hou, Y | 1 |
| Li, M | 2 |
| Zeng, X | 2 |
| Fang, W | 3 |
| Huang, X | 2 |
| Tian, X | 1 |
| Zhang, F | 1 |
| Ataya, A | 1 |
| Faruqi, I | 1 |
| Salgado, JC | 1 |
| Knudsen, S | 1 |
| Hother, C | 1 |
| Grønbæk, K | 1 |
| Jensen, T | 1 |
| Hansen, A | 1 |
| Mazin, W | 1 |
| Dahlgaard, J | 1 |
| Møller, MB | 1 |
| Ralfkiær, E | 1 |
| Brown, Pde N | 1 |
| Adamama-Moraitou, KK | 1 |
| Soubasis, N | 1 |
| Pardali, D | 1 |
| Psalla, D | 1 |
| Papazoglou, LG | 1 |
| Prassinos, NN | 1 |
| Anagnostou, TL | 1 |
| Rallis, TS | 1 |
| Christianson, TJ | 1 |
| Miller, DV | 1 |
| Sheybani, F | 1 |
| Sarvghad, M | 1 |
| Naderi, H | 1 |
| Gharib, M | 1 |
| Fornecker, LM | 1 |
| Aurran-Schleinitz, T | 1 |
| Michallet, AS | 1 |
| Cazin, B | 2 |
| Guieze, R | 1 |
| Dilhuydy, MS | 1 |
| Zini, JM | 1 |
| Tomowiak, C | 1 |
| Lepretre, S | 2 |
| Cymbalista, F | 1 |
| Brion, A | 1 |
| Feugier, P | 1 |
| Delmer, A | 1 |
| Leblond, V | 3 |
| Ysebaert, L | 1 |
| Baird, K | 1 |
| Comis, LE | 1 |
| Joe, GO | 1 |
| Steinberg, SM | 2 |
| Hakim, FT | 1 |
| Rose, JJ | 1 |
| Mitchell, SA | 1 |
| Pavletic, SZ | 1 |
| Figg, WD | 1 |
| Yao, L | 1 |
| Flanders, KC | 1 |
| Takebe, N | 1 |
| Sarantopoulos, S | 1 |
| Booher, S | 1 |
| Cowen, EW | 1 |
| Villareal, M | 1 |
| Lim, N | 1 |
| Sedrak, M | 1 |
| Muthukumar, A | 1 |
| Elghetany, MT | 1 |
| Qian, YW | 1 |
| Kisiel, B | 1 |
| Gawroński, K | 1 |
| Rzepecki, P | 1 |
| Tłustochowicz, W | 1 |
| Prior-Español, Á | 1 |
| Martínez-Morillo, M | 1 |
| Riveros-Frutos, A | 1 |
| Olivé, A | 1 |
| Kriz, J | 1 |
| Dietlein, M | 1 |
| Kobe, C | 1 |
| Kuhnert, G | 1 |
| Haverkamp, H | 1 |
| Haverkamp, U | 1 |
| Engenhart-Cabillic, R | 1 |
| Herfarth, K | 2 |
| Lukas, P | 1 |
| Schmidberger, H | 1 |
| Staar, S | 1 |
| Hegerfeld, K | 1 |
| Hiniker, SM | 1 |
| Pollom, EL | 1 |
| Khodadoust, MS | 1 |
| Kozak, MM | 1 |
| Xu, G | 1 |
| Quon, A | 2 |
| Advani, RH | 1 |
| Jegadeesh, N | 1 |
| Rajpara, R | 1 |
| Esiashvili, N | 1 |
| Okwan-Duodu, D | 1 |
| Khan, MK | 1 |
| Kermani, TA | 2 |
| Carette, S | 1 |
| Khalidi, NA | 1 |
| Koening, CL | 1 |
| Maksimowicz-McKinnon, K | 1 |
| Hurabielle, C | 1 |
| Schneider, P | 1 |
| Baudry, C | 1 |
| Allez, M | 1 |
| Viguier, M | 1 |
| Pedersen, MØ | 1 |
| Poulsen, TS | 1 |
| Gang, AO | 1 |
| Knudsen, H | 1 |
| Lauritzen, AF | 1 |
| Pedersen, M | 1 |
| Nielsen, SL | 1 |
| Brown, P | 1 |
| Høgdall, E | 1 |
| Nørgaard, P | 1 |
| Ellin, F | 1 |
| Landström, J | 1 |
| Jerkeman, M | 1 |
| Relander, T | 1 |
| Ren, Z | 1 |
| Qin, L | 1 |
| Wang, JQ | 1 |
| Zhang, RG | 1 |
| Datsenko, PV | 2 |
| Panshin, GA | 1 |
| Dekkers, MJ | 1 |
| Groothoff, JW | 1 |
| Zietse, R | 1 |
| Betjes, MG | 1 |
| Ren, YY | 1 |
| Zou, Y | 1 |
| Chang, LX | 1 |
| An, WB | 1 |
| Wan, Y | 1 |
| Zhang, JL | 1 |
| Liu, TF | 1 |
| Sedky, MS | 1 |
| Rahman, HA | 1 |
| Moussa, E | 1 |
| Taha, H | 1 |
| Raafat, T | 1 |
| Hassanein, O | 1 |
| Deegens, JK | 2 |
| Wetzels, JF | 4 |
| Majithia, N | 1 |
| Vincent Rajkumar, S | 1 |
| Lacy, MQ | 2 |
| Buadi, FK | 1 |
| Dispenzieri, A | 1 |
| Gertz, MA | 2 |
| Hayman, SR | 1 |
| Dingli, D | 2 |
| Kapoor, P | 1 |
| Hwa, L | 1 |
| Lust, JA | 1 |
| Russell, SJ | 1 |
| Go, RS | 2 |
| Kyle, RA | 4 |
| Kumar, SK | 1 |
| Dinçel, N | 1 |
| Yılmaz, E | 1 |
| Kaplan Bulut, İ | 1 |
| Hacıkara, Ş | 1 |
| Mir, S | 1 |
| Bachmeyer, C | 1 |
| Moguelet, P | 1 |
| Rein, C | 1 |
| Girot, R | 1 |
| Gajendra, S | 1 |
| Jha, B | 1 |
| Goel, S | 1 |
| Sahni, T | 1 |
| Dorwal, P | 1 |
| Sachdev, R | 1 |
| Gözdaşoğlu, S | 1 |
| Pamir, A | 1 |
| Ünal, E | 2 |
| Gökçora, İH | 1 |
| Uluoğlu, Ö | 1 |
| Ceyhan, K | 1 |
| Deda, H | 1 |
| Işıkman, E | 2 |
| Yavuz, G | 2 |
| Taçyıldız, N | 2 |
| Çavdar, A | 1 |
| Shamriz, O | 1 |
| Toker, O | 1 |
| Fridlender, ZG | 1 |
| Tal, Y | 1 |
| Oh, SY | 1 |
| Kim, WS | 4 |
| Chae, YS | 1 |
| Lee, GW | 1 |
| Ryoo, HM | 1 |
| Lee, S | 2 |
| Won, JH | 1 |
| Hong, J | 1 |
| Park, J | 1 |
| Lee, SM | 1 |
| Hong, JY | 1 |
| Park, E | 1 |
| Kim, HJ | 2 |
| Yang, DH | 1 |
| Romo, ML | 1 |
| Wyka, K | 1 |
| Carpio, A | 3 |
| Leslie, D | 2 |
| Andrews, H | 2 |
| Bagiella, E | 2 |
| Hauser, WA | 3 |
| Kelvin, EA | 2 |
| Giridhar, P | 1 |
| Mallick, S | 1 |
| Bhasker, S | 1 |
| Pathy, S | 1 |
| Mohanti, BK | 1 |
| Biswas, A | 1 |
| Mourah, S | 1 |
| Lorillon, G | 1 |
| Meignin, V | 1 |
| Vercellino, L | 1 |
| de Margerie-Mellon, C | 1 |
| Pages, C | 1 |
| Goldwirt, L | 1 |
| How-Kit, A | 1 |
| Tost, J | 1 |
| Lebbe, C | 1 |
| Tazi, A | 1 |
| Peng, W | 1 |
| Wu, J | 2 |
| Hughes, S | 1 |
| Richardson, F | 1 |
| James, E | 1 |
| Bessell, E | 1 |
| Sovani, V | 1 |
| Ganatra, R | 1 |
| Haynes, AP | 1 |
| McMillan, AK | 1 |
| Sari, S | 1 |
| Dogu, F | 2 |
| Hwa, V | 1 |
| Haskologlu, S | 1 |
| Dauber, A | 1 |
| Rosenfeld, R | 1 |
| Polat, M | 1 |
| Kuloglu, Z | 1 |
| Kansu, A | 1 |
| Dalgic, B | 1 |
| Ikinciogullari, A | 2 |
| Watnick, CS | 1 |
| Fabbri, D | 1 |
| Arnold, DH | 1 |
| Ma, XR | 1 |
| Zhang, WG | 1 |
| Chen, YX | 1 |
| Cao, XM | 1 |
| He, AL | 1 |
| Wang, JL | 3 |
| Zhao, WH | 1 |
| Yang, Y | 1 |
| Lei, B | 1 |
| Zhang, PY | 1 |
| Wang, FX | 1 |
| Gu, LF | 1 |
| Ali, SH | 1 |
| Ali, AM | 1 |
| Najim, AH | 1 |
| Savage, KJ | 4 |
| Slack, GW | 2 |
| Mottok, A | 1 |
| Sehn, LH | 3 |
| Villa, D | 3 |
| Kansara, R | 2 |
| Kridel, R | 2 |
| Steidl, C | 1 |
| Ennishi, D | 1 |
| Tan, KL | 1 |
| Ben-Neriah, S | 1 |
| Johnson, NA | 1 |
| Connors, JM | 5 |
| Farinha, P | 1 |
| Scott, DW | 3 |
| Gascoyne, RD | 5 |
| Kang, HM | 1 |
| Kim, JY | 2 |
| Choi, EH | 1 |
| Lee, HJ | 1 |
| Yun, KW | 1 |
| Lee, H | 1 |
| Han, X | 1 |
| Zhu, TN | 1 |
| Han, B | 1 |
| Zhuang, JL | 1 |
| Wang, SJ | 1 |
| Cai, HC | 1 |
| Li, YL | 1 |
| Qiao, SB | 1 |
| Wang, JY | 1 |
| Chen, YM | 1 |
| Luo, J | 1 |
| Zhang, HF | 1 |
| Tong, K | 1 |
| Chen, R | 1 |
| Sanchez, J | 1 |
| Rosen, ST | 1 |
| Öneç, B | 1 |
| Öneç, K | 1 |
| Esbah, AÜ | 1 |
| Esbah, O | 1 |
| Rehrer, MW | 1 |
| Liu, B | 1 |
| Rodriguez, M | 1 |
| Lam, J | 1 |
| Alter, HJ | 1 |
| Lai, M | 1 |
| Lou, Y | 1 |
| Han, Q | 1 |
| Yang, Q | 2 |
| Yan, W | 1 |
| Xu, F | 1 |
| Crescentini, F | 1 |
| Martínez, C | 2 |
| Díaz-López, A | 1 |
| Rodriguez-Calvillo, M | 1 |
| García-Sanz, R | 1 |
| Terol, MJ | 1 |
| Pérez-Ceballos, E | 1 |
| Jiménez, MJ | 1 |
| Cantalapiedra, A | 1 |
| Domingo-Domenech, E | 1 |
| Rodriguez, MJ | 1 |
| Sampol, A | 1 |
| Espeso, M | 1 |
| López, FJ | 1 |
| Briones, J | 1 |
| García, JF | 1 |
| Sureda, A | 1 |
| Cicora, F | 1 |
| Roberti, J | 1 |
| Rodriguez-Lojo, R | 1 |
| Castiñeiras, I | 1 |
| Sánchez-Blas, M | 1 |
| Fernández-Diaz, ML | 1 |
| Wang, SL | 3 |
| Liao, AT | 1 |
| Natale, MF | 1 |
| Lopalco, G | 1 |
| Andreozzi, L | 1 |
| Frediani, B | 1 |
| D'Errico, F | 1 |
| Iannone, F | 1 |
| Dehoux, L | 1 |
| Hogan, J | 1 |
| Dossier, C | 1 |
| Fila, M | 1 |
| Niel, O | 1 |
| Maisin, A | 1 |
| Macher, MA | 2 |
| Kwon, T | 2 |
| Baudouin, V | 2 |
| Deschênes, G | 5 |
| Sumitani, R | 1 |
| Mori, K | 1 |
| Sekimoto, E | 1 |
| Shibata, H | 1 |
| Noda, T | 1 |
| Shikiji, T | 1 |
| Yamashita, K | 1 |
| Shigekiyo, T | 1 |
| Ozaki, S | 1 |
| Baetz, T | 1 |
| Chen, BE | 1 |
| Couban, S | 1 |
| Tom Kouroukis, C | 1 |
| Buckstein, R | 2 |
| Howson-Jan, K | 1 |
| Szwajcer, D | 1 |
| Federico, M | 3 |
| Meyer, RM | 1 |
| Djurfeldt, MS | 1 |
| Hay, AE | 1 |
| Shepherd, L | 1 |
| Feki, NB | 1 |
| Khanfir, MS | 1 |
| Ghorbel, IB | 1 |
| Said, F | 1 |
| Houman, MH | 2 |
| Fotis, L | 1 |
| Tuttle, PV | 1 |
| Baszis, KW | 1 |
| Pepmueller, PH | 1 |
| Moore, TL | 1 |
| White, AJ | 1 |
| Reich, M | 1 |
| Girard, E | 1 |
| Le Rhun, E | 1 |
| Reece, DE | 1 |
| Trieu, Y | 1 |
| Masih-Khan, E | 1 |
| Atenafu, EG | 1 |
| Chen, C | 1 |
| Tiedemann, R | 1 |
| Trudel, S | 1 |
| Kukreti, V | 1 |
| Kanemasa, Y | 1 |
| Shimoyama, T | 1 |
| Sasaki, Y | 1 |
| Tamura, M | 1 |
| Sawada, T | 1 |
| Omuro, Y | 1 |
| Hishima, T | 1 |
| Maeda, Y | 1 |
| Byun, JM | 1 |
| Lee, JO | 1 |
| Kang, B | 1 |
| Kim, JW | 2 |
| Kim, SH | 1 |
| Kim, YJ | 1 |
| Lee, KW | 2 |
| Bang, SM | 1 |
| Lee, JS | 1 |
| Schmitz, N | 3 |
| Zeynalova, S | 1 |
| Nickelsen, M | 2 |
| Glass, B | 1 |
| Ziepert, M | 1 |
| Pfreundschuh, M | 2 |
| Loeffler, M | 2 |
| Stephens, DM | 1 |
| Li, H | 1 |
| LeBlanc, ML | 1 |
| Puvvada, SD | 1 |
| Persky, D | 1 |
| Smith, SM | 1 |
| Valenzuela, RM | 1 |
| Byrd, J | 1 |
| Kramer, GD | 1 |
| Palmer, CA | 1 |
| Osborn, AG | 1 |
| Digre, KB | 1 |
| Warner, JE | 1 |
| Patton, PH | 1 |
| Parker, CE | 1 |
| MacDonald, JK | 1 |
| Chande, N | 1 |
| Tellier, S | 1 |
| Dallocchio, A | 1 |
| Guigonis, V | 1 |
| Saint-Marcoux, F | 1 |
| Llanas, B | 1 |
| Ichay, L | 1 |
| Bandin, F | 1 |
| Godron, A | 1 |
| Morin, D | 1 |
| Brochard, K | 1 |
| Gandia, P | 1 |
| Bouchet, S | 1 |
| Marquet, P | 1 |
| Decramer, S | 1 |
| Harambat, J | 1 |
| Banh, THM | 1 |
| Hussain-Shamsy, N | 1 |
| Patel, V | 1 |
| Vasilevska-Ristovska, J | 1 |
| Borges, K | 1 |
| Sibbald, C | 1 |
| Lipszyc, D | 1 |
| Brooke, J | 1 |
| Geary, D | 1 |
| Langlois, V | 1 |
| Reddon, M | 1 |
| Pearl, R | 1 |
| Levin, L | 1 |
| Piekut, M | 1 |
| Licht, CPB | 1 |
| Radhakrishnan, S | 1 |
| Aitken-Menezes, K | 1 |
| Harvey, E | 1 |
| Hebert, D | 1 |
| Piscione, TD | 1 |
| Parekh, RS | 1 |
| Nakanuma, Y | 1 |
| Ishizu, Y | 1 |
| Zen, Y | 1 |
| Harada, K | 1 |
| Umemura, T | 1 |
| Kamisawa, T | 1 |
| Kuruma, S | 1 |
| Chiba, K | 1 |
| Tanyildiz, HG | 1 |
| Dincaslan, H | 1 |
| Abu El-Asrar, AM | 1 |
| Dosari, M | 1 |
| Hemachandran, S | 1 |
| Gikandi, PW | 1 |
| Al-Muammar, A | 1 |
| Borkowski, PK | 1 |
| Brydak-Godowska, J | 1 |
| Basiak, W | 1 |
| Świtaj, K | 1 |
| Żarnowska-Prymek, H | 1 |
| Olszyńska-Krowicka, M | 1 |
| Kajfasz, P | 1 |
| Rabczenko, D | 1 |
| Zeng, J | 1 |
| Huang, F | 1 |
| Hong, T | 1 |
| He, Z | 1 |
| Lei, J | 1 |
| Sun, H | 1 |
| Hao, X | 1 |
| Debby, A | 1 |
| Liu, G | 1 |
| Luan, J | 1 |
| Li, Q | 1 |
| Telio, D | 1 |
| Shenkier, T | 2 |
| Klasa, R | 3 |
| Tan, K | 1 |
| Sah, BP | 1 |
| Sharma, B | 1 |
| Iannuzzi, MC | 1 |
| Camus, V | 1 |
| Tilly, H | 3 |
| Ceriani, L | 1 |
| Martelli, M | 3 |
| Gospodarowicz, MK | 3 |
| Chiappella, A | 2 |
| Stelitano, C | 2 |
| Balzarotti, M | 5 |
| Cabrera, ME | 1 |
| Cunningham, D | 1 |
| Guarini, A | 1 |
| Giovanella, L | 1 |
| Johnson, PW | 2 |
| Zucca, E | 2 |
| Purt, B | 1 |
| Hiremath, S | 1 |
| Smith, S | 2 |
| Erzurum, S | 1 |
| Sarac, E | 1 |
| Coiffier, B | 3 |
| Sarkozy, C | 1 |
| Rodriguez Cubillo, B | 1 |
| Rodriguez, B | 1 |
| Calvo, M | 1 |
| de la Manzanara, V | 1 |
| Bautista, J | 1 |
| Perez-Flores, I | 1 |
| Calvo, N | 1 |
| Moreno, A | 2 |
| Shabaka, A | 1 |
| Delgado, J | 1 |
| Sanchez-Fructuoso, AI | 1 |
| Wang, L | 1 |
| Zhang, M | 2 |
| Zhou, W | 1 |
| Qi, C | 1 |
| Mou, S | 1 |
| Hayashi, Y | 1 |
| Kaizaki, Y | 1 |
| Utsunomiya, M | 1 |
| Aritsuka, A | 1 |
| Naito, Y | 1 |
| Fujinaga, H | 1 |
| Hasatani, K | 1 |
| Aoyagi, H | 1 |
| Ibe, N | 1 |
| Miyanaga, T | 1 |
| Silva-Velazco, J | 1 |
| Hull, TL | 1 |
| Messick, C | 1 |
| Church, JM | 1 |
| Koh, KN | 1 |
| Im, HJ | 1 |
| Kim, H | 2 |
| Park, KD | 2 |
| Shin, HY | 2 |
| Ahn, HS | 2 |
| Lee, JW | 3 |
| Yoo, KH | 1 |
| Sung, KW | 1 |
| Koo, HH | 1 |
| Lim, YT | 1 |
| Park, JE | 1 |
| Park, BK | 1 |
| Park, HJ | 1 |
| Seo, JJ | 1 |
| Chiang, LY | 1 |
| Crawford, JR | 1 |
| Kuo, DJ | 1 |
| Short, NJ | 1 |
| Kantarjian, HM | 2 |
| Ko, H | 1 |
| Khoury, JD | 1 |
| Ravandi, F | 1 |
| Thomas, DA | 1 |
| Garcia-Manero, G | 1 |
| Khouri, M | 1 |
| Cortes, JE | 1 |
| Wierda, WG | 1 |
| Verstovsek, S | 1 |
| Estrov, Z | 1 |
| Ferrajoli, A | 1 |
| Thompson, PA | 1 |
| Pierce, S | 2 |
| O'Brien, SM | 1 |
| Jabbour, E | 3 |
| Kuye, IO | 1 |
| Smith, GP | 1 |
| Peruzzi, L | 1 |
| Vingerhoedt, NM | 1 |
| Janssen, S | 1 |
| Mravunac, M | 1 |
| Wauters, CA | 1 |
| Strobbe, LJ | 1 |
| Vasconcelos, LP | 1 |
| Stancioli, FG | 1 |
| Leal, JC | 1 |
| da Silva, A | 1 |
| Gómez, RS | 1 |
| Teixeira, AL | 1 |
| Benjilali, L | 1 |
| Harmouche, H | 1 |
| El Bied, S | 1 |
| Raffali, J | 1 |
| Tazi Mezalek, Z | 1 |
| Adnaoui, M | 1 |
| Aouni, M | 1 |
| Maaouni, A | 1 |
| Olin, RL | 1 |
| Nichols, KE | 1 |
| Naghashpour, M | 1 |
| Wasik, M | 1 |
| Shelly, B | 1 |
| Stadtmauer, EA | 1 |
| Vogl, DT | 1 |
| Volpe, NJ | 1 |
| Beck, RW | 3 |
| Gal, RL | 1 |
| Matas, AJ | 3 |
| Molloy, ES | 1 |
| Clark, TM | 1 |
| Gota, CE | 1 |
| Zecca, M | 1 |
| Fabbri, G | 1 |
| Polato, K | 1 |
| Momose, S | 1 |
| Tamaru, J | 1 |
| Kishi, H | 1 |
| Mikata, I | 1 |
| Mori, M | 3 |
| Toyozumi, Y | 1 |
| Itoyama, S | 1 |
| Cordero-Coma, M | 1 |
| Benito, MF | 1 |
| Hernández, AM | 1 |
| Antolín, SC | 1 |
| Ruíz, JM | 1 |
| Dworzak, MN | 1 |
| Schumich, A | 1 |
| Printz, D | 1 |
| Husak, Z | 1 |
| Gaipa, G | 1 |
| Ratei, R | 1 |
| Han, HS | 1 |
| Escalón, MP | 1 |
| Hsiao, B | 1 |
| Serafini, A | 1 |
| Lossos, IS | 1 |
| Tabbara, KF | 1 |
| Al-Hemidan, AI | 1 |
| Woreta, FA | 1 |
| Anhalt, GJ | 2 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| Müller, J | 1 |
| Molnár, Z | 1 |
| Illés, A | 2 |
| Csóka, M | 1 |
| Jakab, Z | 1 |
| Deák, B | 1 |
| Schneider, T | 1 |
| Várady, E | 1 |
| Rosta, A | 1 |
| Simon, Z | 2 |
| Keresztes, K | 1 |
| Gergely, L | 2 |
| Kovács, G | 1 |
| Pollock, T | 1 |
| Laliberté, I | 1 |
| Lyons, C | 1 |
| Gueudry, J | 1 |
| Wechsler, B | 2 |
| Terrada, C | 1 |
| Gendron, G | 1 |
| Cassoux, N | 1 |
| Fardeau, C | 1 |
| Lehoang, P | 1 |
| Piette, JC | 4 |
| Bodaghi, B | 1 |
| Wang, DY | 1 |
| Mao, JH | 1 |
| Gu, WZ | 1 |
| Zhao, SA | 1 |
| Chen, YF | 1 |
| Liu, AM | 1 |
| Vega, J | 1 |
| Goecke, H | 1 |
| Tapia, H | 1 |
| Labarca, E | 1 |
| Santamarina, M | 1 |
| Martínez, G | 2 |
| Andrès, E | 1 |
| Alt, M | 1 |
| Gandemer, V | 1 |
| Auclerc, MF | 1 |
| Perel, Y | 4 |
| Vannier, JP | 1 |
| Le Gall, E | 1 |
| Demeocq, F | 1 |
| Schmitt, C | 2 |
| Piguet, C | 1 |
| Stephan, JL | 1 |
| Lejars, O | 2 |
| Debre, M | 1 |
| Jonveaux, P | 1 |
| Cayuela, JM | 1 |
| Chevret, S | 3 |
| Leverger, G | 4 |
| Baruchel, A | 2 |
| Horakova, D | 3 |
| Dwyer, MG | 2 |
| Havrdova, E | 3 |
| Cox, JL | 2 |
| Dolezal, O | 3 |
| Bergsland, N | 2 |
| Rimes, B | 1 |
| Seidl, Z | 3 |
| Vaneckova, M | 3 |
| Zivadinov, R | 2 |
| Hanno, E | 1 |
| Gay, D | 1 |
| Boyer, S | 1 |
| Kose, F | 1 |
| Abali, H | 1 |
| Sezer, A | 1 |
| Mertsoylu, H | 1 |
| Disel, U | 1 |
| Ozyilkan, O | 1 |
| Hota, SS | 1 |
| Chow, CM | 1 |
| Bonneau, D | 1 |
| Chisholm, RJ | 1 |
| Zhang, XX | 1 |
| Xie, CH | 1 |
| Deng, D | 1 |
| Zhao, YH | 1 |
| Zou, BW | 1 |
| Zhou, L | 1 |
| Liu, WP | 1 |
| Huang, MJ | 1 |
| Tracy, MM | 1 |
| McRae, W | 1 |
| Millichap, JG | 1 |
| Ueda, Y | 1 |
| Marusawa, H | 1 |
| Ichinohe, T | 1 |
| Kadowaki, N | 1 |
| Uchiyama, T | 1 |
| Chiba, T | 1 |
| Cohen, M | 1 |
| Rocher, F | 1 |
| Brunschwig, C | 1 |
| Lebrun, C | 1 |
| Scott, KM | 1 |
| Parker, F | 2 |
| Heckmann, JM | 1 |
| Leu, S | 1 |
| Sun, PK | 1 |
| Collyer, J | 1 |
| Smidt, A | 1 |
| Stika, CS | 1 |
| Schlosser, B | 1 |
| Mirowski, GW | 1 |
| Vanagunas, A | 1 |
| Buchman, AL | 1 |
| Chakour, R | 1 |
| Leimgruber, A | 1 |
| Bart, PA | 1 |
| Spertini, F | 1 |
| Abasq, C | 1 |
| Mouquet, H | 1 |
| Gilbert, D | 1 |
| Tron, F | 1 |
| Grassi, V | 1 |
| Musette, P | 1 |
| Onal, S | 1 |
| Kazokoglu, H | 1 |
| Direskeneli, H | 1 |
| Yavuz, S | 1 |
| Krasensky, J | 2 |
| Novakova, I | 1 |
| Ticha, V | 1 |
| Dusek, L | 1 |
| Houzvickova, E | 1 |
| Hussein, S | 1 |
| Svobodnik, A | 1 |
| Roszkowska-Blaim, M | 1 |
| Burton, JM | 2 |
| O'Connor, PW | 2 |
| Hohol, M | 2 |
| Beyene, J | 2 |
| Zhen, ZJ | 1 |
| Xia, Y | 1 |
| Ling, JY | 1 |
| Tong, GL | 1 |
| Lin, L | 1 |
| Cai, Y | 1 |
| Sun, XF | 2 |
| Abern, MR | 1 |
| Levine, LA | 1 |
| Eckrich, MJ | 1 |
| Domm, J | 1 |
| Ho, R | 1 |
| Whitlock, JA | 1 |
| Frangoul, H | 1 |
| De Felice, E | 1 |
| Allen, B | 1 |
| Edalati, K | 1 |
| Roesch, MT | 1 |
| Buchanan, ML | 1 |
| Teeter, M | 1 |
| Maberley, DA | 1 |
| Catanoso, MG | 2 |
| De, S | 1 |
| Waters, AM | 1 |
| Segal, AO | 1 |
| Trautmann, A | 1 |
| Harvey, EA | 1 |
| Licht, C | 1 |
| Cavalieri, E | 1 |
| Matturro, A | 1 |
| Annechini, G | 1 |
| De Angelis, F | 1 |
| Frattarelli, N | 1 |
| Gentilini, F | 2 |
| Grapulin, L | 1 |
| Sacco, M | 1 |
| Torelli, F | 1 |
| Vignetti, M | 1 |
| Mandelli, F | 8 |
| Foà, R | 2 |
| Pulsoni, A | 2 |
| Eichenauer, DA | 2 |
| Fernández de Larrea, C | 1 |
| Gaya, A | 1 |
| López-Guillermo, A | 3 |
| Rovira, M | 1 |
| Fernández-Avilés, F | 1 |
| Lozano, M | 1 |
| Bosch, F | 2 |
| Esteve, J | 1 |
| Nomdedeu, B | 1 |
| Montserrat, E | 3 |
| Carreras, E | 1 |
| Sathyan, S | 1 |
| Khan, FN | 1 |
| Ranga, KV | 1 |
| Tantawy, AA | 1 |
| El-Bostany, EA | 1 |
| Adly, AA | 1 |
| Abou El Asrar, M | 1 |
| El-Ghouroury, EA | 1 |
| Abdulghaffar, EE | 1 |
| Yu, JI | 1 |
| Nam, H | 1 |
| Ahn, YC | 1 |
| Park, K | 2 |
| Bayraktar, S | 1 |
| Bassini, W | 1 |
| Goodman, M | 1 |
| Silva, F | 1 |
| Kalra, S | 1 |
| Hogan, MC | 1 |
| Leung, N | 1 |
| Sethi, S | 2 |
| Pisoni, CN | 1 |
| Brucato, A | 1 |
| Ruffatti, A | 1 |
| Espinosa, G | 1 |
| Cervera, R | 1 |
| Belmonte-Serrano, M | 1 |
| Sánchez-Román, J | 1 |
| García-Hernández, FG | 1 |
| Tincani, A | 1 |
| Bertero, MT | 1 |
| Hughes, GR | 1 |
| Khamashta, MA | 1 |
| Ruan, J | 2 |
| Coleman, M | 3 |
| Furman, RR | 1 |
| Cheung, K | 1 |
| Faye, A | 1 |
| Elstrom, R | 2 |
| Lachs, M | 1 |
| Hajjar, KA | 1 |
| Leonard, JP | 1 |
| Yamamoto, W | 1 |
| Tomita, N | 1 |
| Watanabe, R | 1 |
| Hattori, Y | 1 |
| Nakajima, Y | 1 |
| Hyo, R | 1 |
| Hashimoto, C | 1 |
| Motomura, S | 1 |
| Ishigatsubo, Y | 1 |
| McClanahan, F | 1 |
| Hielscher, T | 1 |
| Neben, K | 1 |
| Hillengass, J | 1 |
| Muñoz Bertrán, E | 1 |
| Pérez Ceballos, E | 1 |
| Gómez Espín, R | 1 |
| Ortega González, I | 1 |
| Mateos, MV | 1 |
| Richardson, PG | 1 |
| Schlag, R | 1 |
| Khuageva, NK | 1 |
| Dimopoulos, MA | 2 |
| Shpilberg, O | 3 |
| Kropff, M | 1 |
| Spicka, I | 1 |
| Samoilova, OS | 1 |
| Dmoszynska, A | 2 |
| Abdulkadyrov, KM | 1 |
| Schots, R | 1 |
| Jiang, B | 1 |
| Liu, K | 1 |
| Cakana, A | 1 |
| van de Velde, H | 1 |
| San Miguel, JF | 1 |
| van Oers, MH | 1 |
| Tönnissen, E | 1 |
| Van Glabbeke, M | 1 |
| Giurgea, L | 1 |
| Jansen, JH | 1 |
| Marcus, RE | 1 |
| Kimby, E | 1 |
| Vranovsky, A | 1 |
| Holte, H | 1 |
| Hagenbeek, A | 3 |
| van der Reijden, BA | 1 |
| Jauhola, O | 3 |
| Ronkainen, J | 3 |
| Koskimies, O | 6 |
| Ala-Houhala, M | 3 |
| Arikoski, P | 3 |
| Hölttä, T | 3 |
| Jahnukainen, T | 3 |
| Rajantie, J | 3 |
| Ormälä, T | 3 |
| Nuutinen, M | 3 |
| Ularntinon, S | 1 |
| Tzuang, D | 1 |
| Dahl, G | 1 |
| Shaw, RJ | 1 |
| Beccastrini, E | 1 |
| Chiodi, M | 1 |
| Di Paolo, C | 1 |
| Benedetta Silvestri, E | 1 |
| Massi, D | 1 |
| Maggi, E | 1 |
| Liotta, F | 1 |
| Emmi, L | 1 |
| Kagoya, Y | 1 |
| Takahashi, T | 2 |
| Yoshimoto, T | 1 |
| Ichikawa, M | 1 |
| Hangaishi, A | 1 |
| Fukayama, M | 1 |
| Kurokawa, M | 1 |
| Andersen, RF | 1 |
| Thrane, N | 1 |
| Noergaard, K | 1 |
| Rytter, L | 1 |
| Jespersen, B | 1 |
| Rittig, S | 1 |
| Won, YW | 1 |
| Ko, YH | 2 |
| Choi, DR | 1 |
| Ahn, HJ | 1 |
| Kim, S | 1 |
| Lee, DH | 1 |
| Kim, SW | 2 |
| Park, BH | 1 |
| Yoon, SO | 1 |
| Huh, J | 1 |
| Lee, SW | 1 |
| Smith, SD | 2 |
| Bolwell, BJ | 1 |
| Rybicki, LA | 1 |
| Kang, T | 1 |
| Dean, R | 1 |
| Advani, A | 1 |
| Thakkar, S | 1 |
| Sobecks, R | 1 |
| Kalaycio, M | 1 |
| Pohlman, B | 1 |
| Sweetenham, JW | 1 |
| DiJoseph, JF | 1 |
| Dougher, MM | 1 |
| Evans, DY | 1 |
| Zhou, BB | 1 |
| Damle, NK | 1 |
| Caterson, SA | 1 |
| Nyame, T | 1 |
| Phung, T | 1 |
| Lee, B | 2 |
| Tobias, AM | 1 |
| Kurokawa, T | 1 |
| Hase, M | 1 |
| Tokuman, N | 1 |
| Yoshida, T | 1 |
| Caramaschi, P | 1 |
| Ravagnani, V | 1 |
| Bambara, LM | 1 |
| Biasi, D | 1 |
| Abramson, JS | 1 |
| Hellmann, M | 1 |
| Barnes, JA | 1 |
| Hammerman, P | 1 |
| Toomey, C | 1 |
| Takvorian, T | 1 |
| Muzikansky, A | 1 |
| Hochberg, EP | 1 |
| Picardi, M | 1 |
| Soricelli, A | 1 |
| Grimaldi, F | 1 |
| Nicolai, E | 1 |
| Gallamini, A | 1 |
| Pane, F | 1 |
| Canova, F | 1 |
| Marino, D | 1 |
| Trentin, C | 1 |
| Soldà, C | 1 |
| Ghiotto, C | 1 |
| Aversa, SM | 3 |
| Turtinen, J | 1 |
| Strassburg, CP | 1 |
| Scharl, M | 1 |
| Rogler, G | 1 |
| Arantes, TE | 1 |
| Matos, K | 1 |
| Garcia, CR | 1 |
| Silva, TG | 1 |
| Sabrosa, AS | 1 |
| Muccioli, C | 1 |
| Tempescul, A | 1 |
| Ianotto, JC | 1 |
| Eveillard, JR | 1 |
| Guillerm, G | 1 |
| Berthou, C | 2 |
| Han, HJ | 1 |
| Yoon, HY | 1 |
| Jang, HY | 1 |
| Jeong, SW | 1 |
| Klarenbeek, NB | 1 |
| van der Kooij, SM | 1 |
| Güler-Yüksel, M | 1 |
| van Groenendael, JH | 1 |
| Han, KH | 1 |
| Kerstens, PJ | 1 |
| Huizinga, TW | 1 |
| Dijkmans, BA | 1 |
| Berenguer, M | 4 |
| Aguilera, V | 2 |
| San Juan, F | 2 |
| Benlloch, S | 2 |
| Rubin, A | 1 |
| López-Andujar, R | 1 |
| Moya, A | 1 |
| Pareja, E | 1 |
| Montalva, E | 1 |
| Yago, M | 1 |
| de Juan, M | 1 |
| Mir, J | 2 |
| Prieto, M | 4 |
| Ornetti, P | 1 |
| Guillibert-Karras, C | 1 |
| Garrot, JF | 1 |
| Gros, F | 1 |
| Gérard, N | 1 |
| Julien, L | 1 |
| Pascaud, F | 1 |
| Peere, T | 1 |
| Petit-Perrin, M | 1 |
| Piroth, C | 1 |
| Tavernier, C | 1 |
| Maillefert, JF | 1 |
| Yuan, J | 2 |
| Qian, J | 1 |
| Guettrot-Imbert, G | 1 |
| Haroche, J | 1 |
| Grimon, G | 1 |
| Charlotte, F | 1 |
| Ninet, J | 2 |
| Possenti, S | 1 |
| Kelly, A | 1 |
| Aumaître, O | 2 |
| André, M | 1 |
| Wrench, D | 1 |
| Montoto, S | 2 |
| Soini, EJO | 1 |
| Martikainen, JA | 1 |
| Nousiainen, T | 1 |
| Freitas, DS | 1 |
| Camargo, CZ | 1 |
| Mariz, HA | 1 |
| Arraes, AE | 1 |
| de Souza, AW | 1 |
| Wurster, VM | 1 |
| Carlucci, JG | 1 |
| Edwards, KM | 1 |
| Tai, WM | 2 |
| Chung, J | 1 |
| Tang, PL | 1 |
| Koo, YX | 2 |
| Hou, X | 1 |
| Tay, KW | 2 |
| Quek, R | 2 |
| Tao, M | 2 |
| Lim, ST | 2 |
| Quah, D | 1 |
| Yap, SP | 1 |
| Tan, SH | 1 |
| Tang, T | 1 |
| González-Aramburu, I | 1 |
| Ruiz-Pérez, E | 1 |
| Gómez-Román, J | 1 |
| Quirce, R | 1 |
| Larrosa, D | 1 |
| Pascual, J | 1 |
| Colotto, M | 1 |
| Maranghi, M | 1 |
| Durante, C | 1 |
| Rossetti, M | 1 |
| Renzi, A | 1 |
| Anatra, MG | 1 |
| Bilgir, O | 1 |
| Bilgir, F | 1 |
| Calan, M | 1 |
| Yuksel, A | 1 |
| Sari, F | 1 |
| Oztekin, O | 1 |
| Gómez-Herruz, P | 1 |
| Gil-Fernández, JJ | 1 |
| Guillen, H | 1 |
| Arizcorreta, A | 1 |
| Gerecitano, J | 1 |
| Portlock, C | 1 |
| Hamlin, P | 1 |
| Schulman, P | 1 |
| Dumitrescu, O | 1 |
| Sarasohn, D | 1 |
| Pappanicholaou, J | 1 |
| Iasonos, A | 1 |
| Zhang, Z | 2 |
| Mo, Q | 1 |
| Horanlli, E | 1 |
| Rojas, CN | 1 |
| Maggiore, G | 2 |
| Sciveres, M | 1 |
| Fabre, M | 1 |
| Gori, L | 1 |
| Pacifico, L | 1 |
| Resti, M | 1 |
| Choulot, JJ | 1 |
| Jacquemin, E | 1 |
| Bernard, O | 2 |
| Charneux, J | 1 |
| Herbrecht, R | 3 |
| Wilhelm, M | 1 |
| Morschhauser, F | 1 |
| Hess, G | 1 |
| Cernohous, P | 1 |
| Veals, SA | 1 |
| Singer, JW | 1 |
| Lu, Z | 1 |
| Yang, G | 1 |
| Ba, J | 1 |
| Dou, J | 1 |
| Mu, Y | 1 |
| Lu, J | 1 |
| Avni-Zauberman, N | 1 |
| Tripathy, D | 1 |
| Rosen, N | 1 |
| Ben Simon, GJ | 1 |
| Park, Y | 1 |
| Choi, YJ | 1 |
| Park, SJ | 1 |
| Lee, SR | 1 |
| Sung, HJ | 2 |
| Park, KH | 2 |
| Jung, KY | 2 |
| Kim, BS | 2 |
| Zhou, J | 1 |
| Jiang, XY | 1 |
| Manfredi, R | 1 |
| Frulloni, L | 1 |
| Mantovani, W | 1 |
| Bonatti, M | 1 |
| Graziani, R | 1 |
| Pozzi Mucelli, R | 1 |
| Vitolo, U | 1 |
| Conconi, A | 1 |
| Gomez, H | 1 |
| Martinelli, G | 2 |
| Merli, F | 1 |
| Novero, D | 1 |
| Orsucci, L | 1 |
| Pavone, V | 1 |
| Storti, S | 1 |
| Cavalli, F | 1 |
| Sarris, AH | 2 |
| Yang, ZX | 1 |
| Xiong, H | 1 |
| Zhang, YH | 1 |
| Bao, XH | 1 |
| Jiang, YW | 1 |
| Chang, XZ | 1 |
| Qin, J | 1 |
| Lin, Q | 1 |
| Wu, XR | 1 |
| Xue, Y | 1 |
| Ji, H | 1 |
| Hou, G | 1 |
| Sánchez-Escuredo, A | 1 |
| Núñez, R | 1 |
| Ibernón, M | 1 |
| Martínez, E | 1 |
| López, D | 1 |
| Navarro, M | 1 |
| Bonet, J | 2 |
| Ara, J | 1 |
| Romero, R | 1 |
| Watanabe, T | 1 |
| Maeshima, AM | 1 |
| Tanosaki, R | 1 |
| Matsuno, Y | 1 |
| Lupi, I | 1 |
| Manetti, L | 1 |
| Raffaelli, V | 1 |
| Lombardi, M | 1 |
| Cosottini, M | 1 |
| Iannelli, A | 1 |
| Basolo, F | 1 |
| Proietti, A | 1 |
| Bogazzi, F | 1 |
| Caturegli, P | 1 |
| Martino, E | 1 |
| Fahey, CE | 1 |
| Milner, RJ | 1 |
| Barabas, K | 1 |
| Lurie, D | 1 |
| Kow, K | 1 |
| Parfitt, S | 1 |
| Lyles, S | 1 |
| Clemente, M | 1 |
| Sellier-Leclerc, AL | 1 |
| Guérin, V | 1 |
| Lapillonne, H | 1 |
| Ulinski, T | 2 |
| Aoki, T | 1 |
| Nishiyama, T | 1 |
| Imahashi, N | 1 |
| Kitamura, K | 2 |
| Shalapour, S | 1 |
| Hof, J | 1 |
| Kirschner-Schwabe, R | 1 |
| Bastian, L | 1 |
| Prada, J | 1 |
| von Stackelberg, A | 1 |
| Seeger, K | 1 |
| Moore, S | 1 |
| Peggs, K | 1 |
| Thomson, K | 1 |
| Lowry, L | 1 |
| Ljubic, A | 1 |
| Goldstone, AH | 1 |
| Linch, DC | 2 |
| Ardeshna, KM | 2 |
| Rezania, K | 1 |
| Soliven, B | 1 |
| Baron, J | 1 |
| Penumalli, V | 1 |
| van Besien, K | 1 |
| Böll, B | 1 |
| Bredenfeld, H | 1 |
| Görgen, H | 1 |
| Halbsguth, T | 1 |
| Markova, J | 1 |
| Keller, U | 1 |
| Graeven, U | 1 |
| Kremers, S | 1 |
| Geissler, M | 1 |
| Trenn, G | 1 |
| Pan, A | 1 |
| Schlup, M | 1 |
| Lubcke, R | 1 |
| Schultz, M | 1 |
| Hernandez-Da Mota, SE | 1 |
| Arellanes-Garcia, L | 1 |
| Recillas-Gispert, C | 1 |
| Cornejo-Ballesteros, H | 1 |
| Melgoza-del-Angel, C | 1 |
| Teran-Estrada, L | 1 |
| Sanchez-Gonzalez, R | 1 |
| Vanderplas, A | 1 |
| LaCasce, AS | 1 |
| Rodriguez, MA | 3 |
| Crosby, AL | 1 |
| Lepisto, E | 1 |
| Czuczman, MS | 1 |
| Nademanee, A | 1 |
| Niland, J | 1 |
| Gordon, LI | 1 |
| Millenson, M | 1 |
| Abel, GA | 1 |
| Gu, K | 1 |
| Weisenburger, DD | 1 |
| Fu, K | 1 |
| Chan, WC | 1 |
| Greiner, TC | 1 |
| Aoun, P | 1 |
| Smith, LM | 2 |
| Bast, M | 1 |
| Bociek, RG | 1 |
| Bierman, PJ | 1 |
| Armitage, JO | 2 |
| Herdy, GV | 1 |
| Gomes, RS | 1 |
| Silva, AE | 1 |
| Silva, LS | 1 |
| Lopes, VG | 1 |
| Hali, F | 1 |
| Khadir, K | 1 |
| Chiheb, S | 2 |
| Bouayad, K | 1 |
| Mikou, N | 1 |
| Benchikhi, H | 1 |
| Kurtzberg, J | 1 |
| Asselin, B | 1 |
| Bernstein, M | 1 |
| Buchanan, GR | 3 |
| Pollock, BH | 3 |
| Camitta, BM | 2 |
| Chinen, Y | 1 |
| Nakao, M | 1 |
| Sugitani-Yamamoto, M | 1 |
| Kiyota, M | 1 |
| Horiike, S | 1 |
| Kuroda, J | 1 |
| Taniwaki, M | 1 |
| Stiefelhagen, P | 1 |
| Palacios Abufón, A | 1 |
| Acebo Mariñas, E | 1 |
| Gardeazabal García, J | 1 |
| García-Ruiz, JC | 1 |
| Jiang, M | 1 |
| Jiang, Y | 1 |
| Liu, W | 1 |
| Ji, X | 1 |
| Li, P | 1 |
| Zhao, S | 1 |
| Wang, F | 1 |
| Zou, L | 1 |
| Khaled, A | 1 |
| Taazayet, SB | 1 |
| Ben Alaya, N | 1 |
| Souissi, A | 1 |
| Zeglaoui, F | 1 |
| Kaffel, N | 1 |
| Kharfi, M | 1 |
| Zermani, R | 1 |
| Fazaa, B | 1 |
| Savino, A | 1 |
| Salvatore, R | 1 |
| Cafarotti, A | 1 |
| Cecamore, C | 1 |
| De Sanctis, S | 1 |
| Angelucci, D | 1 |
| Mohn, A | 1 |
| Chiarelli, F | 1 |
| Pelliccia, P | 1 |
| Cleper, R | 1 |
| Krause, I | 1 |
| Blumenthal, D | 1 |
| Misago, N | 1 |
| Narisawa, Y | 1 |
| D'Agati, VD | 1 |
| Kaskel, FJ | 1 |
| Falk, RJ | 1 |
| Cianchini, G | 1 |
| Lupi, F | 1 |
| Masini, C | 1 |
| Corona, R | 1 |
| Puddu, P | 1 |
| De Pità, O | 1 |
| Maschi, C | 1 |
| Tieulié, N | 1 |
| Gastaud, P | 1 |
| Baillif, S | 1 |
| Hiroshima, Y | 1 |
| Shiono, Y | 1 |
| Suzuki, I | 1 |
| Kouno, K | 1 |
| Kato, Y | 1 |
| Kato, T | 1 |
| Schmidt, J | 1 |
| Bacani, AK | 1 |
| Matteson, EL | 1 |
| Offidani, M | 1 |
| Polloni, C | 1 |
| Cavallo, F | 3 |
| Liberati, AM | 2 |
| Ballanti, S | 1 |
| Pulini, S | 1 |
| Catarini, M | 1 |
| Alesiani, F | 1 |
| Corvatta, L | 1 |
| Gentili, S | 1 |
| Caraffa, P | 1 |
| Leoni, P | 2 |
| Matsukura, S | 1 |
| Knowles, SR | 1 |
| Walsh, S | 1 |
| Shear, NH | 1 |
| Dufour, JF | 1 |
| Le Gallou, T | 1 |
| Cordier, JF | 4 |
| Pinède, L | 1 |
| Aslangul, E | 1 |
| Pagnoux, C | 2 |
| Marie, I | 1 |
| Decaux, O | 1 |
| Dubois, A | 2 |
| Agard, C | 1 |
| Mahr, A | 2 |
| Comoz, F | 1 |
| Boutemy, J | 1 |
| Broussolle, C | 2 |
| Sève, P | 2 |
| Yamamoto, T | 1 |
| Umegae, S | 1 |
| Matsumoto, K | 1 |
| Kalincik, T | 1 |
| Jain, S | 2 |
| Shah, N | 1 |
| Gregory, S | 1 |
| Glaß, B | 1 |
| van Egmond, ME | 1 |
| Dikkers, FG | 1 |
| Boot, AM | 1 |
| van Lierop, AH | 1 |
| Papapoulos, SE | 1 |
| Brouwer, OF | 1 |
| El-Sharkawi, D | 1 |
| Basu, S | 1 |
| Ocampo, C | 1 |
| D'Sa, S | 1 |
| Hoskin, PJ | 1 |
| Termuhlen, AM | 2 |
| Perkins, SL | 1 |
| Lones, M | 1 |
| Finlay, JL | 1 |
| Weinstein, H | 3 |
| Gross, TG | 1 |
| Abromowitch, M | 2 |
| Chavers, BM | 1 |
| Rheault, MN | 1 |
| Gillingham, KJ | 2 |
| Quartuccio, L | 1 |
| Maset, M | 1 |
| De Maglio, G | 1 |
| Pontarini, E | 1 |
| Fabris, M | 1 |
| Mansutti, E | 1 |
| Mariuzzi, L | 1 |
| Pizzolitto, S | 1 |
| Beltrami, CA | 1 |
| De Vita, S | 1 |
| Tarasenkova, AA | 2 |
| Filatova, LV | 2 |
| Gershanovich, ML | 2 |
| Semiglazova, TIu | 1 |
| He, XH | 1 |
| Li, B | 1 |
| Lu, N | 1 |
| Zou, SM | 1 |
| Li, YX | 3 |
| Song, YW | 3 |
| Zheng, S | 1 |
| Dong, M | 1 |
| Zhou, SY | 1 |
| Yang, JL | 1 |
| Liu, P | 1 |
| Zhang, CG | 1 |
| Qin, Y | 1 |
| Feng, FY | 1 |
| Shi, YK | 1 |
| Maurer, MJ | 1 |
| Ziesmer, SC | 1 |
| Slager, SL | 1 |
| Habermann, TM | 2 |
| Link, BK | 1 |
| Witzig, TE | 2 |
| Macon, WR | 1 |
| Cerhan, JR | 1 |
| Novak, AJ | 1 |
| Alpert, DR | 1 |
| Patel, J | 1 |
| Chiang, PK | 1 |
| Gupta, S | 1 |
| Bhatt, VR | 1 |
| Varma, S | 2 |
| Pircher, A | 1 |
| Gassner, EM | 1 |
| Steurer, M | 1 |
| Wolf, D | 1 |
| Semiglazov, TIu | 1 |
| Ishizawa, J | 1 |
| Mori, T | 1 |
| Tsukada, Y | 1 |
| Matsuki, E | 1 |
| Yokoyama, K | 1 |
| Shimizu, T | 1 |
| Sugita, K | 1 |
| Iwata, S | 1 |
| Okamoto, S | 1 |
| Ruiz-Moreno, JL | 1 |
| Peña-Santos, G | 1 |
| Mian, M | 1 |
| Farsad, M | 1 |
| Pescosta, N | 2 |
| Casini, M | 1 |
| Cavattoni, IM | 1 |
| Deola, S | 1 |
| Guirguis, HR | 1 |
| Cheung, MC | 1 |
| Mahrous, M | 1 |
| Piliotis, E | 1 |
| Berinstein, N | 1 |
| Imrie, KR | 1 |
| Tsuji, RK | 1 |
| Bittencourt, AG | 1 |
| Arai, MH | 1 |
| Santiago Gebrim, EM | 1 |
| Liu, XK | 1 |
| Ren, J | 1 |
| Wang, XH | 1 |
| Li, XS | 1 |
| Zhang, HP | 1 |
| Zeng, K | 1 |
| Sagnelli, E | 1 |
| Pisaturo, M | 1 |
| Sagnelli, C | 1 |
| Coppola, N | 1 |
| Hart, PA | 1 |
| Topazian, MD | 1 |
| Clain, JE | 1 |
| Gleeson, FC | 1 |
| Klebig, RR | 1 |
| Levy, MJ | 1 |
| Pearson, RK | 1 |
| Petersen, BT | 1 |
| Smyrk, TC | 1 |
| Sugumar, A | 1 |
| Takahashi, N | 1 |
| Vege, SS | 1 |
| Chari, ST | 1 |
| Jian, X | 1 |
| Liu, H | 3 |
| Vidal, L | 1 |
| Gafter-Gvili, A | 1 |
| Gurion, R | 1 |
| Raanani, P | 2 |
| Dreyling, M | 3 |
| Pajares, V | 1 |
| Torrego, A | 1 |
| Granell, M | 2 |
| Szafranska, J | 1 |
| Mozos, A | 1 |
| Puzo, C | 1 |
| Anton-Harisi, M | 1 |
| Douna, V | 1 |
| Baka, M | 1 |
| Servitzoglou, M | 1 |
| Kosmidis, HV | 1 |
| Georgouli, H | 1 |
| Anastasiou, T | 1 |
| Miltényi, Z | 1 |
| Magyari, F | 1 |
| Váróczy, L | 1 |
| Péter, N | 1 |
| Scotti, S | 1 |
| Russo, S | 1 |
| Bravo Mancheño, B | 1 |
| Perin, F | 1 |
| Guez Vázquez Del Rey, Mdel M | 1 |
| García Sánchez, A | 1 |
| Alcázar Romero, PP | 1 |
| Alaama, T | 1 |
| Basharat, P | 1 |
| Nicolle, MW | 1 |
| Carr, R | 2 |
| Cataland, SR | 1 |
| Yoon, JH | 1 |
| Park, JD | 1 |
| Pönisch, W | 1 |
| Bourgeois, M | 1 |
| Moll, B | 1 |
| Heyn, S | 1 |
| Jäkel, N | 1 |
| Wagner, I | 1 |
| Rohrberg, R | 1 |
| Schmalfeld, M | 1 |
| Aßmann, M | 1 |
| Edelmann, T | 1 |
| Mohren, M | 1 |
| Hoffmann, FA | 1 |
| Becker, C | 1 |
| Schwarzer, A | 1 |
| Schönfelder, U | 1 |
| Zehrfeld, T | 1 |
| Hensel, G | 1 |
| Löschcke, K | 1 |
| Krahl, R | 1 |
| Ali, HA | 1 |
| Niederwieser, D | 1 |
| Zhang, XM | 1 |
| Wang, WH | 2 |
| Jin, J | 2 |
| Liu, YP | 2 |
| Ren, H | 1 |
| Fang, H | 1 |
| Zhou, LQ | 2 |
| Chen, B | 1 |
| Qi, SN | 1 |
| Liu, QF | 1 |
| Lu, NN | 1 |
| Liu, XF | 2 |
| Yu, ZH | 2 |
| Munyentwali, H | 1 |
| Bouachi, K | 1 |
| Audard, V | 1 |
| Remy, P | 1 |
| Lang, P | 1 |
| Mojaat, R | 1 |
| Ronco, PM | 1 |
| Plaisier, EM | 1 |
| Dahan, KY | 1 |
| Peroni, DL | 1 |
| Stanley, S | 1 |
| Kollias-Baker, C | 1 |
| Robinson, NE | 1 |
| Werner, P | 1 |
| Kiechl, S | 1 |
| Thaler, C | 1 |
| Willeit, J | 1 |
| Poewe, W | 1 |
| Baldissera, I | 1 |
| Zhou, H | 1 |
| Zhong, H | 2 |
| Fu, T | 1 |
| Liu, Q | 1 |
| Min, H | 1 |
| Du, H | 1 |
| Hu, T | 1 |
| Andersen, NS | 1 |
| Donovan, JW | 1 |
| Zuckerman, A | 1 |
| Pedersen, L | 1 |
| Geisler, C | 1 |
| Gribben, JG | 1 |
| Lauten, M | 2 |
| Matthias, T | 1 |
| Stanulla, M | 2 |
| Beger, C | 1 |
| Welte, K | 3 |
| Oinonen, R | 1 |
| Itälä, M | 1 |
| Lehtinen, T | 1 |
| Franssila, K | 1 |
| Wiklund, T | 1 |
| Elonen, E | 1 |
| Tkaczyk, M | 1 |
| Baj, Z | 1 |
| Robak, T | 3 |
| Boński, JZ | 1 |
| Kasznicki, M | 2 |
| Góra-Tybor, J | 1 |
| Hellmann, A | 1 |
| Konopka, L | 1 |
| Dwilewicz-Trojaczek, J | 1 |
| Wołowiec, D | 1 |
| Gupta, N | 1 |
| Kavuru, S | 1 |
| Patel, D | 1 |
| Janson, D | 1 |
| Driscoll, N | 1 |
| Rai, KR | 1 |
| Mantadakis, E | 1 |
| Smith, AK | 1 |
| Hynan, L | 1 |
| Winick, NJ | 1 |
| Kamen, BA | 1 |
| Levy, RM | 1 |
| Junkins-Hopkins, JM | 1 |
| Turchi, JJ | 1 |
| James, WD | 1 |
| Abraham, D | 1 |
| Saltoun, CA | 1 |
| Gajdos, P | 3 |
| Toyka, K | 1 |
| Linassier, C | 1 |
| Desablens, B | 3 |
| Lefrancq, T | 1 |
| Le Prise, PY | 1 |
| Harousseau, JL | 3 |
| Jacob, C | 1 |
| Gandhour, C | 1 |
| Haillot, O | 1 |
| Lucas, V | 1 |
| Leloup, R | 1 |
| Escoffre, M | 1 |
| Colombat, P | 3 |
| Tabuteau, S | 1 |
| Purvin, V | 1 |
| Ranson, N | 1 |
| Kawasaki, A | 1 |
| Hoffmann, J | 1 |
| Zeitz, M | 1 |
| Kratz, CP | 1 |
| Niehues, T | 1 |
| Lyding, S | 1 |
| Heusch, A | 1 |
| Janssen, G | 1 |
| Göbel, U | 2 |
| Kim, YB | 1 |
| Chang, SK | 1 |
| Yang, WI | 1 |
| Hahn, JS | 1 |
| Koom, WS | 1 |
| Shim, SJ | 1 |
| Park, W | 1 |
| Lee, KK | 1 |
| Kim, GE | 1 |
| Song, A | 1 |
| Johnson, TE | 1 |
| Dubovy, SR | 1 |
| Toledano, S | 1 |
| Joseph, DP | 1 |
| Brantley, MA | 1 |
| Grand, MG | 1 |
| Harzallah, K | 1 |
| Badid, C | 1 |
| Fouque, D | 1 |
| Lefrancois, N | 1 |
| Touraine, JL | 1 |
| Laville, M | 1 |
| Czaja, AJ | 10 |
| Carpenter, HA | 1 |
| Pettengell, R | 1 |
| Linch, D | 1 |
| Corbacioglu, S | 1 |
| Eber, S | 1 |
| Gungor, T | 1 |
| Hummerjohann, J | 1 |
| Jover, JA | 2 |
| Hernández-Garcia, C | 2 |
| Morado, IC | 2 |
| Vargas, E | 2 |
| Bañares, A | 2 |
| Fernandez-Gutierrez, B | 2 |
| Tona, F | 1 |
| Bellotto, F | 1 |
| Laveder, F | 1 |
| Meneghin, A | 1 |
| Sinagra, G | 1 |
| Marcolongo, R | 1 |
| Huang, HQ | 1 |
| Jiang, WQ | 1 |
| Zhou, ZM | 1 |
| Xia, ZJ | 1 |
| Lin, XB | 1 |
| Li, YH | 1 |
| Xu, RH | 1 |
| Xu, GC | 1 |
| Liu, DG | 1 |
| He, YJ | 2 |
| Guan, ZZ | 1 |
| Osorio, G | 1 |
| Caglevic, C | 1 |
| Talar-Williams, C | 2 |
| Barron, KS | 1 |
| Sneller, MC | 2 |
| Fatourechi, V | 2 |
| Aniszewski, JP | 1 |
| Fatourechi, GZ | 1 |
| Atkinson, EJ | 1 |
| Jacobsen, SJ | 1 |
| Kuchel, J | 1 |
| Femiano, F | 1 |
| Gombos, F | 1 |
| Scully, C | 1 |
| Oh, SJ | 2 |
| Alapati, A | 1 |
| Claussen, GC | 1 |
| Vernino, S | 1 |
| Gulati, S | 2 |
| Godbole, M | 1 |
| Singh, U | 1 |
| Gulati, K | 1 |
| Srivastava, A | 1 |
| Dieckmann, K | 1 |
| Pötter, R | 1 |
| Hofmann, J | 1 |
| Heinzl, H | 1 |
| Wagner, W | 1 |
| Schellong, G | 3 |
| Alliot, C | 1 |
| Brihi, E | 1 |
| Akoum, R | 1 |
| Saade, M | 1 |
| Chahine, G | 1 |
| Kiemeneij, IM | 1 |
| de Leeuw, FE | 1 |
| Ramos, LM | 1 |
| van Gijn, J | 1 |
| PausJenssen, ES | 1 |
| Cockcroft, DW | 1 |
| Schiller, P | 1 |
| Josting, A | 1 |
| Herrmann, R | 1 |
| Koch, P | 2 |
| Sieber, M | 2 |
| Boissevain, F | 1 |
| De Wit, M | 1 |
| Mezger, J | 1 |
| Duhmke, E | 1 |
| Willich, N | 1 |
| Muller, RP | 1 |
| Schmidt, BF | 1 |
| Renner, H | 1 |
| Muller-Hermelink, HK | 1 |
| Pfistner, B | 1 |
| Hasenclever, D | 2 |
| Loffler, M | 1 |
| Diehl, V | 2 |
| Shums, Z | 1 |
| Binder, WL | 1 |
| Lewis, SJ | 1 |
| Nelson, VJ | 1 |
| Norman, GL | 1 |
| Brunner, HI | 1 |
| Jones, OY | 1 |
| Lovell, DJ | 1 |
| Johnson, AM | 1 |
| Alexander, P | 1 |
| Klein-Gitelman, MS | 1 |
| TRAISSAC, FJ | 1 |
| MOULINIER, J | 1 |
| DUPUY, P | 1 |
| BROCARD, H | 1 |
| CHOFFEL, C | 1 |
| GUIBE, C | 1 |
| HEMPEL-JORGENSEN, P | 1 |
| EFFERSOE, P | 1 |
| KJERULF, K | 1 |
| GAVRILA, I | 1 |
| JOSAN, R | 1 |
| MARINA, M | 1 |
| BERDILA, L | 1 |
| CUCU, A | 1 |
| PIRVU, C | 1 |
| SACREZ, R | 1 |
| PAIRA, M | 1 |
| Blazek, B | 1 |
| Ptoszková, H | 1 |
| Mihál, V | 1 |
| Pospísilová, D | 1 |
| Hrstková, H | 1 |
| Dembická, D | 1 |
| Kopecná, L | 1 |
| Slavík, Z | 1 |
| Hak, J | 1 |
| Procházková, D | 1 |
| Zahálka, F | 1 |
| Cerná, Z | 1 |
| Jabali, Y | 1 |
| Timr, P | 1 |
| Vávra, V | 1 |
| Mydlil, J | 1 |
| Hrusák, O | 1 |
| Trka, J | 1 |
| Proven, A | 1 |
| Gabriel, SE | 1 |
| Orces, C | 1 |
| O'Fallon, WM | 2 |
| Stefoni, V | 1 |
| Alinari, L | 1 |
| Vianelli, N | 1 |
| Baccarani, M | 3 |
| Brière, J | 3 |
| Morel, P | 2 |
| Bouabdallah, R | 2 |
| Raffoux, E | 1 |
| Sebban, C | 2 |
| Lepage, E | 4 |
| Brice, P | 2 |
| Scarfone, RJ | 2 |
| Friedlaender, E | 1 |
| Tsang, RW | 1 |
| Pintilie, M | 1 |
| Sun, A | 1 |
| Wells, W | 1 |
| Schnopp, C | 1 |
| Mempel, M | 1 |
| Brockow, K | 1 |
| Ring, J | 1 |
| Abeck, D | 1 |
| Mandigers, CM | 1 |
| Verdonck, LF | 1 |
| Meijerink, JP | 1 |
| Dekker, AW | 2 |
| Schattenberg, AV | 1 |
| Raemaekers, JM | 1 |
| Füessl, HS | 1 |
| Pless, ML | 1 |
| Malik, SI | 1 |
| Shao, ZH | 1 |
| Cui, ZZ | 1 |
| Wu, YH | 1 |
| Qin, TJ | 1 |
| Fu, R | 1 |
| He, GS | 1 |
| Bai, J | 1 |
| Cao, YR | 1 |
| Yang, CL | 1 |
| Yang, TY | 1 |
| Khandelwal, M | 1 |
| McCormick, BB | 1 |
| Lajoie, G | 1 |
| Sweet, J | 1 |
| Cole, E | 1 |
| Cattran, DC | 2 |
| Neuberg, D | 1 |
| Silver, B | 3 |
| Stevenson, MA | 1 |
| Fisher, DC | 1 |
| Kolyvanos Naumann, U | 2 |
| Käser, L | 2 |
| Vetter, W | 3 |
| Sarmadi, M | 1 |
| Ship, JA | 1 |
| du Buf-Vereijken, PW | 2 |
| Branten, AJ | 1 |
| Contreras, G | 1 |
| Pardo, V | 1 |
| Leclercq, B | 1 |
| Lenz, O | 1 |
| Tozman, E | 1 |
| O'Nan, P | 1 |
| Roth, D | 1 |
| Zhao, M | 1 |
| Chen, X | 2 |
| Lu, F | 1 |
| Kaplan, M | 1 |
| Mutlu, EA | 1 |
| Jakate, S | 1 |
| Bruninga, K | 1 |
| Losurdo, J | 2 |
| Keshavarzian, A | 1 |
| de Carsalade, GY | 1 |
| Achirafi, A | 1 |
| Flageul, B | 1 |
| Chun, CS | 1 |
| Kohnen, EM | 1 |
| Pansdorf, Y | 1 |
| Zubcov, A | 1 |
| Rea, TH | 1 |
| Barese, CN | 1 |
| Podestá, M | 1 |
| Litvak, E | 1 |
| Villa, M | 1 |
| Rivas, EM | 1 |
| Vassilakopoulos, TP | 1 |
| Angelopoulou, MK | 1 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 1 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 1 |
| George, JN | 1 |
| Farhey, Y | 1 |
| Hess, E | 1 |
| Janik, JE | 1 |
| Morris, JC | 1 |
| Pittaluga, S | 1 |
| McDonald, K | 1 |
| Raffeld, M | 1 |
| Jaffe, ES | 3 |
| Grant, N | 1 |
| Gutierrez, M | 1 |
| Waldmann, TA | 1 |
| Wilson, WH | 2 |
| Takács, I | 1 |
| Eros, N | 1 |
| Bene, I | 1 |
| Bozsó, F | 1 |
| Tordai, L | 1 |
| Károlyi, Z | 1 |
| Radványi, G | 1 |
| Matolcsy, A | 1 |
| Biyikli, NK | 1 |
| Emre, S | 1 |
| Sirin, A | 1 |
| Bilge, I | 1 |
| Olea, T | 1 |
| Jiménez, C | 1 |
| Escuín, F | 1 |
| García de Miguel, A | 1 |
| Ros, S | 1 |
| Sanz, A | 1 |
| Valentín, M | 1 |
| Bueno, B | 1 |
| Gutiérrez, E | 1 |
| Martínez, A | 1 |
| González, E | 1 |
| Espejo, B | 2 |
| Torres, A | 2 |
| García Camín, RM | 1 |
| Cabezas, A | 1 |
| Calero, F | 1 |
| Ballarín, JA | 1 |
| Muñoz Díaz, AB | 1 |
| Aguilar, P | 1 |
| García Donaire, JA | 1 |
| Manzanera, MI | 1 |
| Valentín, MO | 1 |
| Gutiérrez Martínez, E | 1 |
| Praga, M | 1 |
| Brasington, RD | 1 |
| Lenschow, DJ | 1 |
| Liang, P | 1 |
| Webner, D | 1 |
| Drezner, JA | 1 |
| Kadir, IS | 1 |
| Barker, TA | 1 |
| Clarke, B | 1 |
| Denley, H | 1 |
| Grötte, GJ | 1 |
| Marciano, BE | 1 |
| Rosenzweig, SD | 1 |
| Kleiner, DE | 1 |
| Anderson, VL | 1 |
| Darnell, DN | 1 |
| Anaya-O'Brien, S | 1 |
| Hilligoss, DM | 1 |
| Malech, HL | 1 |
| Gallin, JI | 1 |
| Holland, SM | 1 |
| Calista, D | 1 |
| Morri, M | 1 |
| Borst, F | 1 |
| Keuning, JJ | 1 |
| van Hulsteijn, H | 1 |
| Sinnige, H | 1 |
| Vreugdenhil, G | 1 |
| Bertz, H | 1 |
| Zeiser, R | 1 |
| Lange, W | 2 |
| Fetscher, S | 2 |
| Waller, CF | 1 |
| Finke, J | 2 |
| Santoe, MF | 1 |
| Van Houten, AA | 1 |
| Muller, AF | 1 |
| Berghout, A | 1 |
| Mok, CC | 1 |
| Ying, KY | 1 |
| Tang, S | 1 |
| Leung, CY | 1 |
| Ng, WL | 1 |
| Wong, RW | 1 |
| Lau, CS | 1 |
| Dai, MS | 1 |
| Chao, TY | 2 |
| Kao, WY | 2 |
| Shyu, RY | 1 |
| Liu, TM | 1 |
| Salvagno, L | 2 |
| Sorarù, M | 2 |
| Mazzarotto, R | 1 |
| Boso, C | 1 |
| Gaion, F | 1 |
| Chiarion-Sileni, V | 1 |
| De Franchis, G | 1 |
| Favaretto, AG | 1 |
| Crivellari, G | 1 |
| Banna, GL | 1 |
| Sotti, G | 1 |
| Monfardini, S | 1 |
| Chalhoub, B | 1 |
| Suzan, F | 1 |
| Aloulou, S | 1 |
| Cainap, C | 2 |
| Fermé, C | 2 |
| Carde, P | 3 |
| Ribrag, V | 3 |
| Marbello, L | 1 |
| Anghilieri, M | 1 |
| Nosari, A | 1 |
| Minola, E | 1 |
| Cairoli, R | 2 |
| Ricci, F | 1 |
| Dolev, J | 1 |
| Reyter, I | 1 |
| Maurer, T | 1 |
| Acquatella, G | 1 |
| Insausti, CL | 1 |
| García, R | 1 |
| Gómez, R | 1 |
| Hernández, M | 1 |
| Carneiro, M | 1 |
| Santos, S | 1 |
| Nouel, A | 1 |
| Falco, P | 2 |
| Bertola, A | 1 |
| Heim, MH | 1 |
| Nishioka, T | 1 |
| Tsuchiya, K | 1 |
| Nishioka, S | 1 |
| Kitahara, T | 1 |
| Ohmori, K | 1 |
| Homma, A | 1 |
| Aoyma, H | 1 |
| Shindoh, M | 1 |
| Shirato, H | 1 |
| Gardner, RV | 1 |
| Velez, MC | 1 |
| Ode, DL | 1 |
| Correa, H | 1 |
| Dursun, D | 1 |
| Akova, YA | 1 |
| Bilezikçi, B | 1 |
| Lenz, G | 1 |
| Unterhalt, M | 1 |
| Hiddemann, W | 4 |
| Sarmiento, E | 1 |
| Fernàndez-Yáñez, J | 1 |
| Muñoz, P | 1 |
| Palomo, J | 1 |
| Rodríguez-Molina, JJ | 1 |
| Bermejo, J | 1 |
| Catalan, P | 1 |
| Bouza, E | 1 |
| Fernández-Cruz, E | 1 |
| Carbone, J | 1 |
| Arya, LS | 1 |
| Dinand, V | 1 |
| Bakhshi, S | 1 |
| Thavaraj, V | 1 |
| Singh, R | 1 |
| Dawar, R | 1 |
| Soni, N | 1 |
| Harrington, JW | 1 |
| Weiss, R | 1 |
| Chander, P | 1 |
| Vyas, S | 1 |
| Zell, JA | 1 |
| Yoon, EJ | 1 |
| Ignatius Ou, SH | 1 |
| Hoefs, JC | 1 |
| Chang, JC | 1 |
| Janić, D | 1 |
| Dokmanović, L | 1 |
| Jovanović, N | 1 |
| Skorić, D | 1 |
| Lazić, J | 1 |
| Johnston, LJ | 1 |
| Brown, J | 2 |
| Shizuru, JA | 1 |
| Stockerl-Goldstein, KE | 2 |
| Stuart, MJ | 1 |
| Blume, KG | 4 |
| Negrin, RS | 4 |
| Chao, NJ | 4 |
| Vignes, S | 1 |
| Stoyanova, M | 1 |
| Vasseur, E | 1 |
| Haicault de la Regontais, G | 1 |
| Hanslik, T | 2 |
| Kennedy, ED | 1 |
| Urbach, DR | 1 |
| Krahn, MD | 1 |
| Steinhart, AH | 3 |
| Cohen, Z | 1 |
| McLeod, RS | 1 |
| Ben Ghorbel, I | 1 |
| Ibn Elhadj, Z | 1 |
| Khanfir, M | 1 |
| Moryl-Bujakowska, A | 3 |
| Depowska, T | 2 |
| Klekawka, T | 2 |
| Stanuch, H | 2 |
| Sopyło, B | 3 |
| Kołakowska-Mrozowska, B | 3 |
| Krenke, K | 2 |
| Chybicka, A | 3 |
| Raś, M | 2 |
| Sońta-Jakimczyk, D | 3 |
| Moszant, A | 2 |
| Kaczmarek-Kanold, M | 3 |
| Kowalczyk, J | 3 |
| Odój, T | 2 |
| Balcerska, A | 2 |
| Drozyńska, E | 2 |
| Stolarska, M | 2 |
| Mathis, AS | 1 |
| Shah, NK | 1 |
| Mulgaonkar, S | 1 |
| Dalle, JH | 1 |
| Moghrabi, A | 1 |
| Rousseau, P | 1 |
| Leclerc, JM | 2 |
| Barrette, S | 1 |
| Bernstein, ML | 1 |
| Champagne, J | 2 |
| David, M | 4 |
| Demers, J | 1 |
| Duval, M | 1 |
| Hume, H | 1 |
| Meyer, P | 1 |
| Champagne, MA | 1 |
| Abouzahir, A | 1 |
| Chaurin, P | 1 |
| Coutant, G | 1 |
| Garcin, JM | 1 |
| Wessels, G | 1 |
| Bernard Hesseling, P | 1 |
| Madani, A | 1 |
| Benhmiddoune, L | 1 |
| Zafad, S | 1 |
| Harif, M | 1 |
| Quessar, A | 1 |
| Benchekroun, S | 1 |
| Monteiro, ML | 1 |
| Borges, WI | 1 |
| do Val Ferreira Ramos, C | 1 |
| Lucato, LT | 1 |
| Leite, CC | 1 |
| Navaneethan, SD | 1 |
| Venkatesh, S | 1 |
| Shrivastava, R | 1 |
| Mehta, J | 1 |
| Israel, R | 1 |
| Siracusano, L | 2 |
| Magagnoli, M | 3 |
| Castagna, L | 1 |
| Rahal, D | 1 |
| Santoro, A | 6 |
| Kiderman, A | 1 |
| Yaphe, J | 1 |
| Bregman, J | 1 |
| Zemel, T | 1 |
| Furst, AL | 1 |
| Masuda, M | 1 |
| Hotta, T | 1 |
| Miyazaki, T | 1 |
| Miura, AB | 1 |
| Mizoguchi, H | 1 |
| Shibata, A | 1 |
| Saito, H | 1 |
| Matsuda, T | 1 |
| Masaoka, T | 1 |
| Harada, M | 1 |
| Niho, Y | 1 |
| Takaku, F | 1 |
| Long, SS | 1 |
| Henderson, RD | 1 |
| Sandroni, P | 1 |
| Wijdicks, EF | 1 |
| Hoecht, S | 1 |
| Hinkelbein, W | 1 |
| Adli, M | 1 |
| Sevinc, A | 1 |
| Kalender, ME | 1 |
| Bernard, M | 1 |
| Rachieru, P | 1 |
| LeMevel, A | 1 |
| Branger, B | 1 |
| Le Maignan, C | 1 |
| Ghandour, C | 1 |
| Delwail, V | 1 |
| Milpied, N | 3 |
| Cassasus, P | 1 |
| Celigny, PS | 1 |
| Guyotat, D | 1 |
| Cheng, SP | 1 |
| Liu, JL | 1 |
| El Cheikh, J | 1 |
| de Colella, JM | 1 |
| Vacher-Copponat, H | 1 |
| Moal, V | 1 |
| Costello, RT | 1 |
| Briemberg, H | 1 |
| Doorduijn, J | 1 |
| Buijt, I | 1 |
| Holt, B | 1 |
| Steijaert, M | 1 |
| Uyl-de Groot, C | 1 |
| Sonneveld, P | 1 |
| Armour, KS | 1 |
| Scolyer, RA | 1 |
| Barnetson, RS | 1 |
| Thomas, DW | 1 |
| Owen, RG | 1 |
| Johnson, SA | 1 |
| Wolf, MM | 1 |
| Rule, SA | 1 |
| Müller-Beissenhirtz, H | 1 |
| Kasper, C | 1 |
| Nückel, H | 1 |
| Dührsen, U | 1 |
| Andrade, J | 1 |
| Taylor, PA | 1 |
| Love, JM | 1 |
| Levin, A | 1 |
| Arista, S | 1 |
| Sailler, L | 2 |
| Astudillo, L | 1 |
| Larson, DR | 1 |
| Plevak, MF | 1 |
| Grande, JP | 1 |
| Lanyi, B | 2 |
| Dienes, HP | 3 |
| Kruis, W | 2 |
| Hamidah, A | 1 |
| Thambidorai, CR | 1 |
| Jamal, R | 1 |
| Campbell, B | 1 |
| Milner, A | 1 |
| Di Iulio, J | 1 |
| Ryan, G | 1 |
| Chakravarti, A | 1 |
| Leslie, WT | 1 |
| Venugopal, P | 1 |
| Imazio, M | 2 |
| Bobbio, M | 1 |
| Cecchi, E | 2 |
| Demarie, D | 1 |
| Pomari, F | 1 |
| Moratti, M | 1 |
| Ghisio, A | 1 |
| Belli, R | 1 |
| Trinchero, R | 2 |
| Buriot, D | 1 |
| Scheinmann, P | 1 |
| Meyer, B | 1 |
| Vialatte, J | 1 |
| Nathanson, S | 1 |
| Cochat, P | 1 |
| André, JL | 1 |
| Guyot, C | 1 |
| Loirat, C | 1 |
| Nivet, H | 1 |
| Chen, CI | 1 |
| Nanji, S | 1 |
| Prabhu, A | 1 |
| Beheshti, R | 1 |
| Yi, QL | 1 |
| Sutton, D | 1 |
| Stewart, AK | 1 |
| Sasaki, H | 1 |
| Washio, M | 1 |
| Ohara, N | 1 |
| Maruo, T | 1 |
| Rodriguez, V | 1 |
| Anderson, PM | 1 |
| Trotz, BA | 1 |
| Arndt, CA | 2 |
| Allen, JA | 1 |
| Khan, SP | 2 |
| Park, BB | 1 |
| Park, KW | 1 |
| Kang, JH | 1 |
| Lee, SH | 1 |
| Park, JO | 1 |
| Jung, CW | 1 |
| Park, YS | 1 |
| Im, YH | 1 |
| Kang, WK | 1 |
| Lee, MH | 1 |
| Veneri, D | 1 |
| Ambrosetti, A | 1 |
| Franchini, M | 1 |
| Mosna, F | 1 |
| Poli, G | 1 |
| Pizzolo, G | 1 |
| Oprea, C | 1 |
| Azoulay, R | 1 |
| Assaf, E | 1 |
| Koscielny, S | 1 |
| Lapusan, S | 1 |
| Vanel, D | 1 |
| Bosq, J | 1 |
| Di Franco, A | 1 |
| Bacci, E | 1 |
| Bartoli, ML | 1 |
| Cianchetti, S | 1 |
| Dente, FL | 1 |
| Taccola, M | 1 |
| Vagaggini, B | 1 |
| Zingoni, M | 1 |
| Paggiaro, PL | 1 |
| Yager, JE | 1 |
| Hernandez, AF | 1 |
| Steenbergen, C | 1 |
| Persing, B | 1 |
| Russell, SD | 1 |
| Milano, C | 1 |
| Felker, GM | 1 |
| Bartlett, NL | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| Gill, SI | 1 |
| Gibbs, SD | 1 |
| Hicks, RJ | 1 |
| Plancarte, F | 1 |
| Arenillas, L | 1 |
| Giné, E | 1 |
| Muntañola, A | 1 |
| Ferrer, A | 1 |
| Villamor, N | 1 |
| Colomo, L | 1 |
| Balaguer, O | 1 |
| Campo, E | 1 |
| Rives, S | 1 |
| Alcorta, I | 1 |
| Toll, T | 1 |
| Tuset, E | 1 |
| Estella, J | 1 |
| Cross, NC | 1 |
| Papadhimitriou, SI | 1 |
| Polychronopoulou, S | 1 |
| Tsakiridou, AA | 1 |
| Androutsos, G | 1 |
| Paterakis, GS | 1 |
| Athanassiadou, F | 1 |
| van Alfen, N | 1 |
| van Engelen, BG | 1 |
| Fayad, F | 1 |
| Lioté, F | 1 |
| Berenbaum, F | 1 |
| Orcel, P | 1 |
| Bardin, T | 1 |
| Di Renzo, N | 1 |
| Brugiatelli, M | 1 |
| Montanini, A | 1 |
| Vigliotti, ML | 1 |
| Cervetti, G | 1 |
| Luminari, S | 1 |
| Spedini, P | 1 |
| Giglio, G | 1 |
| Noer, MS | 1 |
| Stewart, DA | 1 |
| Bahlis, N | 1 |
| Valentine, K | 1 |
| Savoie, L | 1 |
| Morris, DG | 1 |
| Jones, A | 1 |
| Brown, C | 1 |
| Russell, JA | 1 |
| Mounier, N | 1 |
| Casasnovas, O | 1 |
| Divine, M | 2 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Bordessoule, D | 3 |
| Voillat, L | 1 |
| Reman, O | 1 |
| Blanc, M | 2 |
| Gisselbrecht, C | 3 |
| Rayón, JM | 2 |
| Berenguer, J | 2 |
| Lladó, L | 1 |
| Xiol, X | 1 |
| Figueras, J | 1 |
| Ramos, E | 1 |
| Memba, R | 1 |
| Serrano, T | 1 |
| Torras, J | 1 |
| Garcia-Gil, A | 1 |
| Gonzalez-Pinto, I | 1 |
| Castellote, J | 1 |
| Baliellas, C | 1 |
| Fabregat, J | 1 |
| Rafecas, A | 1 |
| Yamauchi, PS | 1 |
| Turner, L | 1 |
| Lowe, NJ | 1 |
| Gindi, V | 1 |
| Jackson, JM | 1 |
| Srivastava, T | 1 |
| Garola, RE | 1 |
| Kestila, M | 1 |
| Tryggvason, K | 1 |
| Ruotsalainen, V | 1 |
| Sharma, M | 1 |
| Savin, VJ | 1 |
| Jalanko, H | 1 |
| Warady, BA | 1 |
| Marshall, GA | 1 |
| Doyle, JJ | 1 |
| Brodeh, J | 1 |
| Scope, A | 1 |
| Azizi, E | 1 |
| Gomard-Mennesson, E | 1 |
| Koenig, M | 1 |
| Woods, A | 1 |
| Magy, N | 1 |
| Rousset, H | 1 |
| Salles, G | 2 |
| McPherson, CM | 1 |
| Kim, AW | 1 |
| DeMonte, F | 1 |
| Wasilewska, AM | 1 |
| Zoch-Zwierz, WM | 1 |
| Pietruczuk, M | 1 |
| Kieffer, P | 1 |
| Dukic, R | 1 |
| Hueber, M | 1 |
| Kieffer, C | 1 |
| Bouhala, M | 1 |
| Riegel, P | 1 |
| Wilhelm, JM | 1 |
| Vianna, RN | 1 |
| Ozdal, PC | 1 |
| Deschênes, J | 1 |
| Burnier, MN | 1 |
| Yamaguchi, M | 1 |
| Kotani, T | 1 |
| Nakamura, Y | 1 |
| Ueda, M | 1 |
| Han, JZ | 1 |
| Xiang, XJ | 1 |
| Rus, C | 1 |
| Zeldis, JB | 1 |
| Rodeghiero, F | 1 |
| Betticher, DC | 1 |
| Radford, JA | 1 |
| Kaufmann, M | 1 |
| Dyer, MJ | 1 |
| Kaiser, U | 1 |
| Aulitzky, WE | 1 |
| Beck, J | 1 |
| von Rohr, A | 1 |
| Kovascovics, T | 1 |
| Cogliatti, SB | 1 |
| Cina, S | 1 |
| Maibach, R | 1 |
| Cerny, T | 1 |
| Mazzucco, S | 1 |
| Ferrari, S | 1 |
| Mezzina, C | 1 |
| Tomelleri, G | 1 |
| Bertolasi, L | 1 |
| Rizzuto, N | 1 |
| Geier, P | 1 |
| Jurencák, R | 1 |
| Zapletalová, J | 1 |
| Daniel, E | 1 |
| Gangaputra, S | 1 |
| Kempen, JH | 1 |
| Seo, HY | 1 |
| Seol, HR | 1 |
| Kim, IS | 1 |
| Kim, CY | 1 |
| Holt, EW | 1 |
| Tan, J | 1 |
| Hosgood, HD | 1 |
| Banerjee, S | 2 |
| Rahhal, R | 1 |
| Bishop, WP | 1 |
| Pérez Martínez, A | 1 |
| Alonso Ojembarrena, A | 1 |
| Ramírez Orellana, M | 1 |
| García Castro, J | 1 |
| González-Vicent, M | 1 |
| Contra Gómez, T | 1 |
| Madero López, L | 1 |
| Díaz Pérez, MA | 1 |
| Greco, M | 1 |
| Valsecchi, M | 1 |
| Niccodemi, C | 1 |
| Presas, J | 1 |
| Corrado, C | 1 |
| Winkel, M | 1 |
| Mubashir, E | 1 |
| Ahmed, MM | 1 |
| Hayat, S | 1 |
| Latif, S | 1 |
| Heldmann, M | 1 |
| Berney, SM | 1 |
| Jayabose, S | 1 |
| Levendoglu-Tugal, O | 1 |
| Ozkaynak, MF | 1 |
| Sandoval, C | 1 |
| Carmona, A | 1 |
| Alonso, JD | 1 |
| de las Heras, M | 1 |
| Navarrete, A | 1 |
| Kurzen, C | 1 |
| Kunz, I | 1 |
| Nigg, C | 1 |
| Majhail, NS | 1 |
| Weisdorf, DJ | 1 |
| Defor, TE | 1 |
| Miller, JS | 1 |
| McGlave, PB | 2 |
| Slungaard, A | 1 |
| Ramsay, NK | 1 |
| Orchard, PJ | 1 |
| MacMillan, ML | 1 |
| Burns, LJ | 1 |
| Cummins, DL | 1 |
| Tzu, J | 1 |
| Owens, N | 1 |
| Meyerle, JH | 1 |
| Famularo, G | 1 |
| Nicotra, GC | 1 |
| Minisola, G | 1 |
| De Simone, C | 1 |
| Wasilewska, A | 1 |
| Zoch-Zwierz, W | 1 |
| Tobolczyk, J | 1 |
| Tenderenda, E | 1 |
| Vahid, B | 1 |
| Marik, PE | 1 |
| Hu, GH | 1 |
| Dang, XQ | 1 |
| Wang, JH | 1 |
| Ambrosini, MT | 1 |
| Benevolo, G | 1 |
| Pregno, P | 1 |
| Callea, V | 1 |
| Cangialosi, C | 1 |
| Caravita, T | 1 |
| Musto, P | 1 |
| Avonto, I | 1 |
| Magni, M | 1 |
| Pagliano, G | 1 |
| De Marco, F | 1 |
| Drandi, D | 1 |
| Ricca, I | 1 |
| Astolfi, M | 1 |
| Matteucci, P | 1 |
| Guidetti, A | 1 |
| Mantoan, B | 1 |
| Bodoni, CL | 1 |
| Zanni, M | 1 |
| Gianni, AM | 1 |
| Tarella, C | 1 |
| Menees, S | 1 |
| Higgins, P | 1 |
| Korsnes, S | 1 |
| Elta, G | 1 |
| Marcus, R | 2 |
| Field, JJ | 1 |
| Blinder, MA | 1 |
| Raderer, M | 1 |
| Wohrer, S | 1 |
| Streubel, B | 1 |
| Drach, J | 1 |
| Jager, U | 1 |
| Turetschek, K | 1 |
| Troch, M | 1 |
| Puspok, A | 1 |
| Zielinski, CC | 1 |
| Chott, A | 1 |
| Sugimoto, T | 1 |
| Matano, S | 1 |
| Nishijima, H | 1 |
| Kakuta, K | 1 |
| Inamura, K | 1 |
| Okamura, T | 1 |
| Munemoto, S | 1 |
| Satoh, S | 1 |
| Suvannasankha, A | 1 |
| Fausel, C | 1 |
| Juliar, BE | 1 |
| Yiannoutsos, CT | 1 |
| Fisher, WB | 1 |
| Ansari, RH | 1 |
| Wood, LL | 1 |
| Smith, GG | 1 |
| Cripe, LD | 1 |
| Abonour, R | 1 |
| Lee, DA | 1 |
| Tatevian, N | 1 |
| Herring, RA | 1 |
| Ramirez-Ortiz, MA | 1 |
| Vasquez-Resendis, A | 1 |
| Weigert, O | 1 |
| Pastore, A | 1 |
| Rieken, M | 1 |
| Lang, N | 1 |
| Ergas, D | 1 |
| Toledo, S | 1 |
| Sthoeger, D | 1 |
| Sthoeger, ZM | 1 |
| Ramírez V, P | 1 |
| Ocqueteau T, M | 1 |
| Alvarez Z, M | 1 |
| Bertín C-M, P | 1 |
| Lira V, P | 1 |
| Bustos C, M | 1 |
| Besa de C, P | 1 |
| Baldeschi, L | 1 |
| Lupetti, A | 1 |
| Vu, P | 1 |
| Wakelkamp, IM | 1 |
| Prummel, MF | 1 |
| Wiersinga, WM | 1 |
| Walsh, KJ | 1 |
| Al-Quran, SZ | 1 |
| Braylan, RC | 1 |
| Lynch, JW | 2 |
| Santos, RP | 1 |
| Awa, E | 1 |
| Anbar, RD | 1 |
| Yoshimi, A | 1 |
| Baumann, I | 1 |
| Führer, M | 1 |
| Bergsträsser, E | 1 |
| Sykora, KW | 1 |
| Klingebiel, T | 2 |
| Gross-Wieltsch, U | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Fischer, A | 1 |
| Nöllke, P | 1 |
| Wittenberg, S | 1 |
| Kedhar, SR | 1 |
| Dunn, JP | 1 |
| Hirunwiwatkul, P | 1 |
| Trobe, JD | 2 |
| Olszewska, M | 2 |
| Kolacinska-Strasz, Z | 1 |
| Sulej, J | 1 |
| Labecka, H | 1 |
| Cwikla, J | 1 |
| Natorska, U | 1 |
| Blaszczyk, M | 1 |
| Italiano, A | 1 |
| Peyrade, F | 1 |
| Soler, C | 1 |
| Cardot, N | 1 |
| Thyss, A | 1 |
| Trappe, R | 1 |
| Riess, H | 1 |
| Babel, N | 1 |
| Hummel, M | 1 |
| Lehmkuhl, H | 1 |
| Jonas, S | 1 |
| Anagnostopoulos, I | 1 |
| Papp-Vary, M | 1 |
| Reinke, P | 1 |
| Hetzer, R | 1 |
| Dörken, B | 1 |
| Oertel, S | 1 |
| Hogan, AC | 1 |
| McAvoy, CE | 1 |
| Dick, AD | 1 |
| Lee, RW | 1 |
| Ravaglia, S | 1 |
| Bogdanov, EI | 1 |
| Pichiecchio, A | 1 |
| Bergamaschi, R | 1 |
| Moglia, A | 1 |
| Mikhaylov, IM | 1 |
| Bertoli, AM | 1 |
| Font, YM | 1 |
| Nadal, A | 1 |
| Vilá, LM | 1 |
| Manzini, C | 1 |
| Paolazzi, G | 1 |
| Trotta, A | 1 |
| Manganelli, P | 1 |
| Cimmino, M | 1 |
| Gerli, R | 1 |
| Cantini, F | 1 |
| Klersy, C | 1 |
| Fernández Fernández, FJ | 1 |
| de la Fuente Aguado, J | 1 |
| Puerta Louro, R | 1 |
| Fernández Villaverde, A | 1 |
| Soto Ríos, C | 1 |
| Peterson, BA | 4 |
| Johnson, J | 1 |
| Shipp, MA | 1 |
| Barcos, M | 3 |
| Gockerman, JP | 1 |
| Canellos, GP | 6 |
| Strecker, T | 1 |
| Zimmermann, I | 1 |
| Wiest, GH | 1 |
| Burkhardt Soares, S | 2 |
| Fehr, A | 2 |
| Brandt, AS | 2 |
| Roth, S | 2 |
| Callejas-Rubio, JL | 1 |
| Rios-Fernández, R | 1 |
| Tomás-Jiménez, C | 1 |
| Ortego-Centeno, N | 1 |
| Imafuku, S | 1 |
| Yoshimura, D | 1 |
| Moroi, Y | 1 |
| Urabe, K | 1 |
| Furue, M | 1 |
| Reale, LD | 1 |
| Besa, EC | 2 |
| Green, WH | 1 |
| Yosipovitch, G | 1 |
| Pichardo, RO | 1 |
| Kumari, S | 1 |
| Mahi, S | 1 |
| Sharma, SC | 1 |
| Radhika, S | 1 |
| Girszyn, N | 1 |
| Leport, J | 1 |
| Arnaud, L | 1 |
| Kahn, JE | 1 |
| Piette, AM | 1 |
| Bletry, O | 2 |
| Gemici, C | 1 |
| Salepci, T | 1 |
| Iacob, S | 1 |
| Cicinnati, VR | 1 |
| Hilgard, P | 1 |
| Iacob, RA | 1 |
| Gheorghe, LS | 1 |
| Popescu, I | 1 |
| Frilling, A | 1 |
| Malago, M | 1 |
| Gerken, G | 1 |
| Broelsch, CE | 1 |
| Beckebaum, S | 1 |
| Appenzeller, S | 1 |
| Cendes, F | 1 |
| Costallat, LT | 1 |
| Advani, R | 1 |
| Maeda, L | 1 |
| Lavori, P | 1 |
| Hoppe, R | 1 |
| Breslin, S | 1 |
| Rosenberg, SA | 6 |
| Horning, SJ | 3 |
| Correndo, L | 1 |
| D'Oulx, EA | 1 |
| Doronzo, B | 1 |
| Meyer, GS | 1 |
| Hales, CA | 1 |
| Amrein, PC | 1 |
| Kradin, RL | 1 |
| Hall, GW | 1 |
| Katzilakis, N | 1 |
| Pinkerton, CR | 2 |
| Nicolin, G | 1 |
| Ashley, S | 1 |
| Wallace, WH | 1 |
| Zaraa, I | 1 |
| Mokni, M | 2 |
| Hsairi, M | 1 |
| Boubaker, S | 1 |
| Sellami, M | 1 |
| Zitouni, M | 1 |
| Makni, S | 1 |
| Dhahri, AB | 1 |
| Netzer, P | 1 |
| Gschossmann, JM | 1 |
| Straumann, A | 1 |
| Sendensky, A | 1 |
| Weimann, R | 1 |
| Schoepfer, AM | 1 |
| Wong, E | 1 |
| Blitz, S | 1 |
| Diner, B | 1 |
| Mackey, D | 1 |
| Ross, S | 1 |
| Senthilselvan, A | 1 |
| Taskinen, M | 2 |
| Karjalainen-Lindsberg, ML | 2 |
| Nyman, H | 1 |
| Eerola, LM | 1 |
| Leppä, S | 2 |
| Siracusano, LV | 1 |
| Spina, M | 1 |
| Isa, L | 1 |
| Morenghi, E | 1 |
| Tirelli, U | 1 |
| Mekeel, K | 1 |
| Mulligan, D | 1 |
| Reddy, KS | 1 |
| Moss, A | 1 |
| Harold, K | 1 |
| Fuster, F | 1 |
| Medina, L | 1 |
| Vallansot, R | 1 |
| Davutoglu, M | 1 |
| Ece, A | 1 |
| Bilici, M | 1 |
| Dagli, A | 1 |
| Pérez-Díaz, H | 1 |
| Casado, JL | 1 |
| Uclés-Sánchez, A | 1 |
| Saiz, A | 1 |
| Bleid, D | 1 |
| Garaventa, A | 1 |
| Coccia, C | 1 |
| Gambini, C | 1 |
| Perfumo, F | 2 |
| Miceli-Richard, C | 1 |
| Mejjad, O | 1 |
| Lafforgue, P | 1 |
| Marcelli, C | 1 |
| Solau-Gervais, E | 1 |
| Steinfeld, S | 1 |
| Villoutreix, C | 1 |
| Trèves, R | 1 |
| Pavlakis, M | 1 |
| Layden, BT | 1 |
| Joseph, M | 1 |
| Tallman, MS | 1 |
| Platanias, LC | 1 |
| López Carmona, D | 1 |
| Pérez de Pedro, I | 1 |
| de Ramón, E | 1 |
| Camps García, MT | 1 |
| Martinez, V | 1 |
| Vinzio, S | 1 |
| Delaunay, C | 1 |
| Sadoun, A | 1 |
| Provencio, M | 1 |
| Fayad, LE | 1 |
| Schaefer, ET | 1 |
| Fitzgerald, JF | 1 |
| Molleston, JP | 1 |
| Croffie, JM | 1 |
| Pfefferkorn, MD | 1 |
| Corkins, MR | 1 |
| Lim, JD | 1 |
| Steiner, SJ | 1 |
| Gupta, SK | 1 |
| Furman, R | 1 |
| Niesvizky, R | 1 |
| George, P | 1 |
| Leonard, J | 1 |
| Kaufmann, T | 1 |
| Gu, LJ | 1 |
| Xue, HL | 1 |
| Tang, JY | 1 |
| Zhao, HJ | 1 |
| Ye, H | 1 |
| Pan, C | 1 |
| Leroy, S | 1 |
| Dubrel, M | 1 |
| Danon, S | 1 |
| Bensman, A | 1 |
| Kukuk, S | 1 |
| Ali, U | 1 |
| Kanitkar, M | 1 |
| Phadke, KD | 1 |
| Senguttuvan, P | 1 |
| Shah, M | 1 |
| Chan, CC | 1 |
| Shen, D | 1 |
| Masini, L | 1 |
| Ilariucci, F | 1 |
| Masetti, M | 1 |
| Asioli, S | 1 |
| Sartori, A | 1 |
| Cappuccini, L | 1 |
| Tasic, V | 1 |
| Angjeleska, M | 1 |
| Ristoska-Bojkovska, N | 1 |
| Petrusevska, G | 1 |
| Gucev, Z | 1 |
| Greenberg, RA | 1 |
| Kerby, G | 1 |
| Roosevelt, GE | 1 |
| Leon, P | 1 |
| Shi, MZ | 1 |
| Singleton, JW | 4 |
| Sale, S | 1 |
| Patterson, R | 13 |
| Bender, SW | 1 |
| Posselt, HG | 1 |
| Waag, KL | 1 |
| Auer, IO | 1 |
| DiFilippo, NM | 1 |
| Sutcliffe, SB | 1 |
| Economopoulos, T | 1 |
| Wrigley, PF | 2 |
| Stansfeld, AG | 1 |
| Malpas, JS | 2 |
| Hauser, SL | 1 |
| Fosburg, M | 1 |
| Kevy, S | 1 |
| Weiner, HL | 1 |
| Bonnet, JD | 1 |
| Alexanian, R | 3 |
| Salmon, SE | 2 |
| Haut, A | 1 |
| Dixon, DO | 1 |
| Todd, M | 1 |
| Cadman, E | 2 |
| Spiro, P | 1 |
| Bertino, J | 2 |
| Farber, L | 2 |
| Waldron, J | 1 |
| Fischer, D | 2 |
| Obrecht, JP | 1 |
| Jiang, BK | 1 |
| Zhao, Z | 1 |
| Shimm, DS | 1 |
| Logue, GL | 1 |
| Rosse, WF | 1 |
| O'Donnell, PP | 1 |
| Pula, TP | 1 |
| Sellman, M | 1 |
| Camenga, DL | 1 |
| Hansen, N | 1 |
| Stapleton, FB | 2 |
| Roy, S | 2 |
| Arant, BS | 1 |
| Yaffe, BH | 1 |
| Korelitz, BI | 3 |
| Leisti, S | 2 |
| Cuoghi, D | 1 |
| Vangelista, A | 1 |
| Baraldi, A | 1 |
| Cheli, E | 1 |
| Garay, G | 2 |
| Milone, J | 1 |
| Dibar, E | 1 |
| Pavlovsky, S | 4 |
| Kvicala, R | 3 |
| Sackmann Muriel, F | 2 |
| Montres Varela, D | 1 |
| Eppinger-Helft, M | 3 |
| Kotulová, D | 1 |
| Stefanovic, J | 1 |
| Kaplan, D | 1 |
| Cooper, MR | 2 |
| Pajak, TF | 3 |
| Gottlieb, AJ | 1 |
| Glicksman, AS | 1 |
| Nissen, N | 1 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Holland, JF | 2 |
| Paryani, SB | 1 |
| Cox, RS | 1 |
| Colby, TV | 1 |
| Kaplan, HS | 4 |
| Stoffer, SS | 1 |
| Dixon, RS | 1 |
| Lubbe, WF | 1 |
| Butler, WS | 1 |
| Palmer, SJ | 1 |
| Liggins, GC | 1 |
| Yonker, RA | 1 |
| Katz, P | 1 |
| Gómez Campderá, FJ | 1 |
| López Gómez, JM | 1 |
| Cervera, A | 1 |
| Gómez Campderá, J | 1 |
| Canals, MJ | 1 |
| Morales, JL | 1 |
| Luque, A | 1 |
| Hudson, JA | 1 |
| Kelley, T | 1 |
| Burke, KD | 1 |
| Swaby, ED | 1 |
| Shah, DJ | 1 |
| Williams, WW | 1 |
| Eichberg, JW | 1 |
| De Villez, RL | 1 |
| Abuelo, JG | 1 |
| Esparza, AR | 1 |
| Garella, S | 1 |
| Manthey, KF | 1 |
| Heidemann, H | 1 |
| Hengst, W | 1 |
| Kovryzhkina, TA | 1 |
| Bayle-Weisgerber, C | 1 |
| Lemercier, N | 1 |
| Teillet, F | 1 |
| Asselain, B | 1 |
| Gout, M | 1 |
| Schweisguth, O | 1 |
| Cadman, EC | 1 |
| Glick, JH | 2 |
| Cross, J | 1 |
| Horton, J | 2 |
| Taylor, SG | 1 |
| Tsyplenkov, VG | 1 |
| Sviridova, AV | 1 |
| Khardori, R | 1 |
| Weaver, ME | 1 |
| Soler, NG | 1 |
| Muriel, FS | 1 |
| Bustelo, P | 1 |
| Giuntoli, JM | 1 |
| Divito, J | 1 |
| Picón, A | 1 |
| Amato, KR | 1 |
| Sallan, SE | 3 |
| Lipton, JM | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| Callegaro, D | 1 |
| Zambon, AA | 1 |
| de Assis, JL | 1 |
| Manns, M | 1 |
| Meyer zum Büschenfelde, KH | 1 |
| Dormeyer, HH | 1 |
| Burke, BR | 1 |
| Bear, RA | 2 |
| Ambriz-Fernández, R | 1 |
| Sinco-Angeles, A | 1 |
| Avilés-Miranda, A | 1 |
| Chávez-Vela, J | 1 |
| Pizzuto-Chávez, J | 1 |
| Fuller, LM | 4 |
| Hagemeister, FB | 5 |
| Denz, H | 1 |
| Lechleitner, M | 1 |
| Peschel, C | 1 |
| Peer, L | 1 |
| Huber, H | 1 |
| Kolygin, BA | 3 |
| Kharatishvili, ZV | 1 |
| Wagener, DJ | 1 |
| Burgers, JM | 3 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 1 |
| Somers, R | 2 |
| Kroese, WF | 1 |
| Mazza, P | 1 |
| Lauria, F | 2 |
| Sciascia, R | 2 |
| Emiliani, E | 2 |
| Fiacchini, M | 2 |
| Frezza, G | 1 |
| Dominici, G | 1 |
| Cantore, M | 1 |
| Faedi, M | 1 |
| Lever, WF | 3 |
| Schaumburg-Lever, G | 2 |
| Olsen, KD | 1 |
| Jakobovits, J | 1 |
| Schuster, MM | 1 |
| Witte, AS | 1 |
| Cornblath, DR | 1 |
| Parry, GJ | 1 |
| Lisak, RP | 1 |
| Schatz, NJ | 1 |
| Bloomfield, CD | 2 |
| Morris, DD | 1 |
| Whitlock, RH | 1 |
| Lordier, A | 1 |
| Pousse, H | 1 |
| Valleteau de Moulliac, J | 1 |
| Lagardère, B | 1 |
| Carmel, R | 1 |
| Schoeneman, MJ | 2 |
| Bloom, AF | 1 |
| Prosnitz, L | 1 |
| Vera, R | 1 |
| Lawrence, R | 1 |
| Freedman, MH | 1 |
| Guldsten, H | 1 |
| Bladé, J | 1 |
| Feliú, E | 1 |
| Rozman, C | 1 |
| Estapé, J | 1 |
| Millá, A | 1 |
| Panzo, GJ | 1 |
| Tomsak, RL | 1 |
| Weinstein, GS | 1 |
| Dresner, SC | 1 |
| Slamovits, TL | 1 |
| Kennerdell, JS | 1 |
| Reaman, GH | 2 |
| Echelberger, C | 1 |
| Poplack, DG | 4 |
| Creutzig, U | 1 |
| Kimball, JC | 1 |
| Herson, J | 2 |
| Sullivan, MP | 2 |
| Langermann, HJ | 1 |
| Brämswig, J | 1 |
| Breu, H | 1 |
| Riehm, H | 3 |
| Hitchcock-Bryan, S | 1 |
| Amadori, S | 5 |
| Spiriti, MA | 1 |
| Meloni, G | 4 |
| Pacilli, L | 1 |
| Papa, G | 3 |
| Wesley, R | 1 |
| Rivera, G | 2 |
| Bowman, WP | 2 |
| Murphy, SB | 2 |
| Dahl, GV | 1 |
| Aur, RJ | 3 |
| Kalwinsky, DK | 1 |
| Wood, A | 2 |
| Stagner, S | 1 |
| Avery, TL | 1 |
| Feldges, AJ | 1 |
| Imbach, P | 1 |
| Plüss, HJ | 1 |
| Sartorius, J | 1 |
| Wagner, HP | 1 |
| Wyss, M | 1 |
| James, MP | 1 |
| Herdson, PB | 1 |
| Gavin, JB | 1 |
| Tomonaga, M | 1 |
| Meakin, JW | 1 |
| Allt, WE | 1 |
| Beale, FA | 1 |
| Bush, RS | 1 |
| Clark, RM | 1 |
| Fitzpatrick, PJ | 1 |
| Hawkins, NV | 1 |
| Jenkin, RD | 1 |
| Pringle, JF | 1 |
| Reid, JG | 1 |
| Rider, WD | 1 |
| Hayward, JL | 1 |
| Bulbrook, RD | 1 |
| Kleinknecht, C | 1 |
| Broyer, M | 3 |
| Jarde, O | 1 |
| Guillot, M | 1 |
| McEnery, PT | 1 |
| Strife, CF | 2 |
| Allen, WR | 1 |
| Travis, LB | 1 |
| Cavallo, T | 1 |
| Brouhard, BH | 1 |
| Cunningham, RJ | 1 |
| Greenberger, PA | 3 |
| Radin, RC | 1 |
| Roberts, M | 3 |
| Cupps, TR | 1 |
| Springer, RM | 1 |
| Fauci, AS | 3 |
| Nemoto, T | 1 |
| Simon, R | 1 |
| Dao, TL | 1 |
| Rosner, D | 1 |
| Cunningham, T | 1 |
| Sponzo, R | 1 |
| Snyderman, M | 1 |
| Sherry, DD | 1 |
| Patterson, MW | 1 |
| Petty, RE | 1 |
| Vilska, J | 2 |
| Rapola, J | 2 |
| Hallman, N | 2 |
| Elidrissy, AT | 1 |
| Nash, MA | 1 |
| Bakare, MA | 1 |
| D'Agati, V | 1 |
| Pirani, CL | 1 |
| Davis, JH | 1 |
| Peters, DK | 1 |
| Rees, AJ | 1 |
| Lockwood, CM | 1 |
| Pusey, CD | 1 |
| Tapia, JE | 1 |
| Hauser, GA | 1 |
| Riedler, GF | 1 |
| Dalakas, MC | 1 |
| Engel, WK | 1 |
| Adler, S | 1 |
| Bruns, FJ | 1 |
| Fraley, DS | 1 |
| Segel, DP | 1 |
| Bechtel, MA | 1 |
| Callen, JP | 2 |
| Ammon, HV | 1 |
| Summerskill, WH | 3 |
| Moore, DH | 1 |
| Shackelford, PG | 1 |
| Robson, AM | 1 |
| Rose, GM | 1 |
| Engle, JE | 1 |
| Schoolwerth, AC | 1 |
| Stein, R | 1 |
| Kwee, YN | 1 |
| Greenbaum, J | 1 |
| Dolovich, J | 1 |
| Kaplan, HG | 1 |
| Doolittle, CH | 1 |
| Blumberg, S | 1 |
| Giansiracusa, DF | 1 |
| Docken, WP | 1 |
| Kantrowitz, FG | 1 |
| Ludwig, J | 1 |
| Baggenstoss, AH | 1 |
| Wolf, A | 1 |
| Drewinko, B | 1 |
| Boyer, H | 1 |
| Barlogie, B | 1 |
| Rubinow, SI | 1 |
| Honkoop, P | 1 |
| de Man, RA | 1 |
| Heijtink, RA | 1 |
| Schalm, SW | 1 |
| Ksiazek, J | 2 |
| Wyszyńska, T | 1 |
| Dinçol, D | 2 |
| Içli, F | 2 |
| Karaoğuz, H | 1 |
| Cay, F | 1 |
| Arican, A | 1 |
| Demirkazik, A | 1 |
| Akbulut, H | 1 |
| Smith, MR | 1 |
| Khanuja, PS | 1 |
| al-Katib, A | 1 |
| Bishop, CR | 1 |
| Andersen, J | 1 |
| Hussein, ME | 1 |
| Karanes, C | 1 |
| Aster, RH | 1 |
| Brusamolino, E | 2 |
| Orlandi, E | 2 |
| Canevari, A | 1 |
| Castelli, G | 1 |
| Pagnucco, G | 2 |
| Astori, C | 2 |
| Lazzarino, M | 2 |
| Gilchrist, GS | 2 |
| Smithson, WA | 1 |
| Chen, MG | 2 |
| Schomberg, PJ | 1 |
| Matsumoto, JM | 1 |
| Mjaaland, I | 1 |
| Ganser, D | 1 |
| Freitag, EM | 1 |
| Bohndorf, W | 1 |
| Krasin, MJ | 1 |
| Velasquez, WS | 2 |
| Allen, PK | 1 |
| McLaughlin, P | 2 |
| Swan, F | 2 |
| Palmer, JL | 1 |
| Friedman, WH | 1 |
| Katsantonis, GP | 1 |
| Bumpous, JM | 1 |
| de Asis, ML | 1 |
| Bernstein, LJ | 1 |
| Schliozberg, J | 1 |
| Loiselle, JM | 1 |
| Wiley, JF | 1 |
| Decker, JM | 1 |
| Henretig, FM | 1 |
| Joffe, MD | 1 |
| Hammer, MS | 1 |
| Larsen, MB | 1 |
| Stack, CV | 1 |
| Korula, J | 1 |
| Bendandi, M | 3 |
| Tura, S | 4 |
| Messina, C | 1 |
| Mori, PG | 1 |
| Miniero, R | 1 |
| Colella, R | 1 |
| Chan, GL | 1 |
| Weinstein, SS | 1 |
| Vijayanagar, RR | 1 |
| Maytal, J | 1 |
| Grossman, R | 1 |
| Yusuf, FH | 1 |
| Shende, AC | 1 |
| Karayalycin, G | 1 |
| Lanzkowsky, P | 2 |
| Schaul, N | 1 |
| Eviatar, L | 1 |
| Petroni, GR | 1 |
| Duggan, DB | 1 |
| Späth, M | 1 |
| Schollmeyer, P | 1 |
| Chryssomallis, F | 1 |
| Dimitriades, A | 1 |
| Chaidemenos, GC | 1 |
| Panagiotides, D | 1 |
| Karakatsanis, G | 1 |
| Kura, Y | 1 |
| Sawada, U | 1 |
| Satoh, Y | 1 |
| Irie, T | 1 |
| Tsuboi, I | 1 |
| Horie, T | 1 |
| Trüeb, RM | 1 |
| Becker-Wegerich, P | 1 |
| Hafner, J | 1 |
| Wüthrich, B | 1 |
| Burg, G | 1 |
| Woodle, ES | 2 |
| So, S | 1 |
| Jendrisak, MD | 1 |
| Perdrizet, GA | 1 |
| White, HM | 1 |
| Marsh, JW | 1 |
| Uematsu, M | 1 |
| Tarbell, NJ | 2 |
| Coleman, CN | 1 |
| Rosenthal, DS | 2 |
| Canellos, G | 1 |
| Mauch, P | 2 |
| Bader, SB | 1 |
| Bryant, G | 1 |
| Bates, S | 1 |
| Fojo, A | 1 |
| Wittes, RE | 1 |
| Kohler, DR | 1 |
| Herdt, J | 1 |
| Cheson, BD | 1 |
| Niitsu, N | 1 |
| Hara, A | 1 |
| Umeda, M | 1 |
| Shirai, T | 1 |
| Bianco, A | 1 |
| Chiarion Sileni, V | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 1 |
| Carré, P | 1 |
| Rouquette, I | 1 |
| Durand, D | 1 |
| Didier, A | 1 |
| Dahan, M | 2 |
| Fournial, G | 1 |
| Léophonte, P | 1 |
| Wong, MK | 1 |
| Bjarnason, GA | 1 |
| Hrushesky, WJ | 1 |
| Webster, P | 1 |
| Morava-Protzner, I | 1 |
| Towers, M | 1 |
| Kerr, GS | 2 |
| Hallahan, CW | 2 |
| Rodríguez, VM | 1 |
| Barriales, V | 1 |
| Morís, C | 1 |
| Lambert, JL | 1 |
| Barriales, R | 1 |
| Trabanco, IM | 1 |
| Touroutoglou, N | 1 |
| Hess, M | 1 |
| Pugh, W | 2 |
| Tubergen, DG | 2 |
| Krailo, MD | 2 |
| Meadows, AT | 2 |
| Rosenstock, J | 1 |
| Kadin, M | 1 |
| Morse, M | 2 |
| King, D | 1 |
| Steinherz, PG | 5 |
| Kersey, JH | 3 |
| Ye, RG | 1 |
| Ren, GH | 1 |
| Li, HQ | 1 |
| Wolin, MJ | 1 |
| Kent, AD | 1 |
| Hymes, LC | 2 |
| Beressi, N | 1 |
| Cohen, R | 1 |
| Beressi, JP | 1 |
| Dumas, JL | 2 |
| Legrand, M | 1 |
| Iba-Zizen, MT | 1 |
| Modigliani, E | 1 |
| Frequin, ST | 1 |
| Lamers, KJ | 1 |
| Barkhof, F | 1 |
| Borm, GF | 1 |
| Hommes, OR | 1 |
| Airoldi, M | 1 |
| Fantasia, R | 1 |
| Cotti, D | 1 |
| Castiglioni, G | 1 |
| Pelucco, L | 1 |
| Chrysomallis, F | 1 |
| Ioannides, D | 1 |
| Teknetzis, A | 1 |
| Panagiotidou, D | 1 |
| Minas, A | 1 |
| Atar, S | 1 |
| Oberman, AS | 1 |
| Ben-Izhak, O | 1 |
| Flatau, E | 1 |
| Crozier, S | 1 |
| Verstichel, P | 1 |
| Masson, C | 1 |
| Nys, PM | 1 |
| Masson, M | 1 |
| Le Guennec, P | 1 |
| Dromer, C | 1 |
| Sixou, L | 1 |
| Marc, V | 1 |
| Coustals, P | 1 |
| Fournié, B | 2 |
| Zochodne, DW | 1 |
| Brunet, DG | 1 |
| Carrión, JR | 1 |
| García Arroyo, FR | 1 |
| Salinas, P | 1 |
| Kher, V | 1 |
| Elhence, R | 1 |
| Kumar, P | 1 |
| Sharma, RK | 1 |
| Gupta, A | 1 |
| Gordon, M | 1 |
| Luqmani, RA | 1 |
| Adu, D | 1 |
| Greaves, I | 1 |
| Richards, N | 1 |
| Michael, J | 1 |
| Emery, P | 1 |
| Bacon, PA | 1 |
| Drymalski, W | 1 |
| Hosen, RS | 1 |
| Smook, S | 1 |
| Vlachoyiannopoulos, PG | 1 |
| Tsiakou, E | 1 |
| Chalevelakis, G | 1 |
| Raptis, SA | 1 |
| Moutsopoulos, HM | 1 |
| Greenberger, NJ | 1 |
| Miner, PB | 2 |
| Khan, GA | 1 |
| Glicklich, DG | 1 |
| Iskaros, BF | 1 |
| Posner, L | 1 |
| Liedtke, W | 1 |
| Quabeck, K | 1 |
| Beelen, DW | 1 |
| Straeten, V | 1 |
| Schaefer, UW | 1 |
| Lederman, DA | 1 |
| Wilcox, CM | 1 |
| Schwartz, DA | 2 |
| Stasi, R | 1 |
| Stipa, E | 1 |
| Masi, M | 1 |
| Oliva, F | 1 |
| Sciarra, A | 1 |
| Perrotti, A | 1 |
| Olivieri, M | 1 |
| Zaccari, G | 1 |
| Gandolfo, GM | 1 |
| Gans, M | 1 |
| Palcoux, JB | 1 |
| Goumy, P | 1 |
| Zuckerman, MJ | 1 |
| al-Samman, M | 1 |
| Boman, DA | 1 |
| Saito, S | 1 |
| Hayashi, K | 1 |
| Ohnoshi, T | 1 |
| Kawashima, K | 1 |
| Matsutomo, S | 1 |
| Tagawa, S | 1 |
| Yoshino, T | 1 |
| Nishiuchi, R | 1 |
| Kimura, I | 1 |
| Yagyu, K | 1 |
| Takeshita, M | 1 |
| Otsuka, T | 1 |
| Kubota, H | 1 |
| Furuse, A | 1 |
| van Breda Vriesman, PJ | 1 |
| Baxter, JD | 1 |
| DiNubile, MJ | 1 |
| Maluf, PT | 1 |
| Odone Filho, V | 1 |
| Cristofani, LM | 1 |
| Britto, JL | 1 |
| Almeida, MT | 1 |
| Pontes, E | 1 |
| Maksoud, JG | 1 |
| Manissadjian, A | 1 |
| Chiu, EK | 1 |
| Chan, LC | 1 |
| Liang, R | 1 |
| Lie, A | 1 |
| Kwong, YL | 1 |
| Todd, D | 1 |
| Chan, TK | 1 |
| Liozon, F | 4 |
| Vidal, E | 4 |
| Boutros-Toni, F | 1 |
| Gaches, F | 1 |
| Loustaud-Ratti, V | 1 |
| Berdah, JF | 1 |
| Hoppen, T | 1 |
| Keller, KM | 1 |
| Stolte, M | 1 |
| Rister, M | 1 |
| Boatman, BW | 1 |
| Taylor, RC | 1 |
| Klein, LE | 1 |
| Cohen, BA | 2 |
| Wilson, WB | 1 |
| Delmez, JA | 1 |
| Safdar, SH | 1 |
| Kissane, JM | 1 |
| Lapidoth, M | 1 |
| Ben-Amitai, D | 1 |
| Katzenelson, V | 2 |
| Lustig, S | 1 |
| Sandbank, M | 3 |
| Adler, Y | 1 |
| Aharon, A | 1 |
| Zandman-Goddard, G | 1 |
| Heitger, A | 1 |
| Gatterer-Menz, I | 1 |
| Touton, B | 1 |
| Lecerf, V | 1 |
| Crickx, B | 1 |
| Picard, C | 2 |
| Michaud, V | 1 |
| L'Anthoën-Arditi, MH | 1 |
| Belaïch, S | 1 |
| Cleary, PA | 2 |
| Kaufman, DI | 2 |
| Kupersmith, MJ | 2 |
| Paty, DW | 1 |
| Brown, CH | 1 |
| Chemtob, A | 1 |
| Malka, D | 1 |
| Lévy, P | 1 |
| Lévy, H | 1 |
| Ponsot, P | 1 |
| Bernades, P | 1 |
| Glabiński, A | 1 |
| Tawsek, NS | 1 |
| Bartosz, G | 1 |
| Ochocka, M | 1 |
| Kulus, M | 1 |
| Armata, J | 4 |
| Bogusławska-Jaworska, J | 2 |
| Jackowska, T | 1 |
| Jakowicka, M | 1 |
| Michalewska, D | 1 |
| Yu, LC | 1 |
| Kuvibidila, S | 1 |
| Ducos, R | 1 |
| Warrier, RP | 1 |
| Cherlow, JM | 2 |
| Sather, HN | 4 |
| Gaynon, PS | 2 |
| Grossman, NJ | 2 |
| Johnstone, HS | 2 |
| Breneman, JC | 2 |
| Trigg, ME | 2 |
| Hammond, GD | 2 |
| Fogazzi, GB | 1 |
| Banfi, G | 1 |
| Allegri, L | 1 |
| Bignardi, L | 1 |
| Haak, HL | 1 |
| Gerrits, WB | 1 |
| Wijermans, PW | 1 |
| Kerkhofs, H | 1 |
| Rivard, GE | 1 |
| Infante-Rivard, C | 1 |
| Dresse, MF | 1 |
| Lavignac, C | 1 |
| Emilie, D | 1 |
| Crevon, MC | 1 |
| Catanzano, G | 1 |
| Galanaud, P | 1 |
| Fish, RH | 1 |
| Hoskins, JC | 1 |
| Kline, LB | 1 |
| Bader-Meunier, B | 1 |
| Jullien, M | 1 |
| Rey, C | 1 |
| Dommergues, JP | 1 |
| Ayabe, T | 1 |
| Maekawa, I | 1 |
| Ashida, T | 1 |
| Taruishi, M | 1 |
| Shibata, Y | 1 |
| Namiki, M | 1 |
| Engelhard, D | 1 |
| Eldor, A | 1 |
| Polacheck, I | 1 |
| Hardan, I | 2 |
| Ben-Yehuda, D | 1 |
| Amselem, S | 1 |
| Salkin, IF | 1 |
| Lopez-Berestein, G | 1 |
| Sacks, T | 1 |
| Rachmilewitz, EA | 1 |
| Mughal, T | 1 |
| Morleda, J | 1 |
| Goldman, J | 1 |
| Sawyer, MD | 1 |
| Mayoral, JL | 1 |
| Kramer, MA | 1 |
| Dunn, DL | 1 |
| Ike, RW | 1 |
| Blaivas, M | 1 |
| Massey, JM | 1 |
| Sanders, DB | 1 |
| Dhaliwal, HS | 1 |
| Rohatiner, AZ | 1 |
| Gregory, W | 1 |
| Richards, MA | 1 |
| Whelan, JS | 1 |
| Gallagher, CJ | 1 |
| Matthews, J | 1 |
| Ganesan, TS | 1 |
| Barnett, MJ | 1 |
| Schmidt, GM | 2 |
| Niland, JC | 2 |
| Amylon, MD | 2 |
| Dagis, AC | 2 |
| Long, GD | 3 |
| Nademanee, AP | 2 |
| O'Donnell, MR | 2 |
| Parker, PM | 2 |
| Chadelat, K | 1 |
| Baculard, A | 1 |
| Grimfeld, A | 1 |
| Tournier, G | 1 |
| Boule, M | 1 |
| Boccon-Gibod, L | 1 |
| Clement, A | 1 |
| Danziger, RN | 1 |
| Goren, AT | 1 |
| Becker, J | 1 |
| Greene, JM | 1 |
| Douglas, SD | 1 |
| Wang, KK | 1 |
| Shiels, MT | 2 |
| Katzmann, JA | 1 |
| Goodkin, DE | 1 |
| Rudick, RA | 1 |
| Kinkel, R | 1 |
| Ransohoff, RM | 1 |
| Goodin, DS | 1 |
| Enriquez, R | 1 |
| Gonzalez, C | 1 |
| Cabezuelo, JB | 1 |
| Lacueva, J | 1 |
| Ruiz, JA | 1 |
| Tovar, JV | 1 |
| Niembro, E | 1 |
| Tondini, C | 2 |
| Zanini, M | 2 |
| Lombardi, F | 1 |
| Bengala, C | 1 |
| Rocca, A | 1 |
| Giardini, R | 2 |
| Buzzoni, R | 1 |
| Valagussa, P | 6 |
| Bonadonna, G | 6 |
| Mullen, RS | 1 |
| Romans-Clarkson, SE | 1 |
| Ehrich, JH | 1 |
| Brodehl, J | 5 |
| Wiegand, L | 1 |
| Zwillich, CW | 1 |
| Lyttle, BD | 1 |
| Hollestelle, AM | 1 |
| Bartley, GB | 1 |
| Garrity, JA | 1 |
| Bergstralh, EJ | 1 |
| Ebersold, MJ | 1 |
| Gorman, CA | 1 |
| Smith, ME | 1 |
| Stone, LA | 1 |
| Albert, PS | 1 |
| Frank, JA | 1 |
| Martin, R | 1 |
| Armstrong, M | 1 |
| Maloni, H | 1 |
| McFarlin, DE | 1 |
| McFarland, HF | 1 |
| Golden, HE | 1 |
| Lam, S | 1 |
| Tessler, HH | 2 |
| Leznoff, A | 1 |
| Mochon, M | 1 |
| Kaiser, B | 1 |
| Palmer, JA | 1 |
| Polinsky, M | 1 |
| Flynn, JT | 1 |
| Caputo, GC | 1 |
| Baluarte, HJ | 1 |
| Falga Tirado, C | 1 |
| Valero Rovira, S | 1 |
| Cucurull Canosa, E | 1 |
| Pérez Pemán, P | 1 |
| Ordi Ros, J | 1 |
| Puścińska, E | 1 |
| Zych, D | 1 |
| Pawlicka, L | 2 |
| Zieliński, J | 1 |
| Bayless, TM | 1 |
| Hofkin, GA | 1 |
| Ting, CD | 1 |
| Sugerman, HJ | 1 |
| Kellum, JM | 1 |
| Reines, HD | 1 |
| DeMaria, EJ | 1 |
| Newsome, HH | 1 |
| Lowry, JW | 1 |
| Pautier, P | 1 |
| Dupriez, B | 1 |
| Lederlin, P | 2 |
| Mineur, P | 1 |
| Audhuy, B | 1 |
| Reyes, F | 2 |
| Falini, B | 1 |
| Sabattini, E | 1 |
| Gherlinzoni, F | 2 |
| Martelli, MF | 1 |
| Pileri, SA | 1 |
| Oh, H | 1 |
| Nakamura, H | 1 |
| Yokota, A | 1 |
| Asai, T | 1 |
| Saito, Y | 1 |
| Kryński, J | 1 |
| Bocchi, EA | 1 |
| Bellotti, G | 1 |
| Mocelin, AO | 1 |
| Uip, D | 1 |
| Bacal, F | 1 |
| Higuchi, ML | 1 |
| Amato-Neto, V | 1 |
| Fiorelli, A | 1 |
| Stolf, NA | 1 |
| Jatene, AD | 1 |
| Pileggi, F | 1 |
| Han, DJ | 2 |
| Yoon, HS | 1 |
| Lee, HM | 1 |
| Marcen, R | 1 |
| Mampaso, F | 1 |
| Teruel, JL | 2 |
| Rivera, ME | 1 |
| Orofino, L | 1 |
| Navarro-Antolin, J | 1 |
| Ortuño, J | 2 |
| Abdallah, JM | 1 |
| Lombardi, DP | 1 |
| Kirsch, IR | 1 |
| McDiarmid, SV | 1 |
| Grignetti, M | 1 |
| Carraro, M | 1 |
| Faccini, L | 1 |
| Smith, MC | 1 |
| Austen, JL | 1 |
| Carey, JT | 1 |
| Emancipator, SN | 1 |
| Herbener, T | 1 |
| Gripshover, B | 1 |
| Mbanefo, C | 1 |
| Phinney, M | 1 |
| Rahman, M | 1 |
| Salata, RA | 1 |
| Weigel, K | 1 |
| Kalayjian, RC | 1 |
| Tsuruchi, N | 1 |
| Okamura, J | 1 |
| Schlemper, RJ | 1 |
| Uchigata, Y | 1 |
| Frölich, M | 1 |
| Vingerhoeds, AC | 1 |
| Meinders, AE | 1 |
| Teitel, AD | 1 |
| van der Veen, MJ | 1 |
| Dinant, HJ | 1 |
| van Booma-Frankfort, C | 1 |
| van Albada-Kuipers, GA | 1 |
| Bijlsma, JW | 1 |
| Guillaume, JC | 1 |
| Donnard, JC | 1 |
| Schnebelen, MP | 1 |
| Tortel, MC | 1 |
| Michel, C | 1 |
| Daly, KA | 1 |
| Giebink, GS | 2 |
| Lindgren, B | 1 |
| Margolis, RH | 1 |
| Westover, D | 1 |
| Hunter, LL | 1 |
| Le, CT | 2 |
| Buran, D | 1 |
| Bachman, KH | 1 |
| Sewell, DL | 1 |
| Strausbaugh, LJ | 1 |
| Mannino, D | 1 |
| Geiss, R | 1 |
| Hodous, T | 1 |
| Lapp, NL | 1 |
| George, J | 1 |
| Present, DH | 1 |
| Pou, R | 1 |
| Bodian, C | 1 |
| Rubin, PH | 1 |
| Kitamura, Y | 1 |
| Okano, Y | 1 |
| Denham, JW | 1 |
| Denham, E | 1 |
| Dear, KB | 1 |
| Hudson, GV | 1 |
| Nishikawa, K | 1 |
| Azuma, E | 1 |
| Nishihara, H | 1 |
| Hanada, M | 1 |
| Nagai, M | 1 |
| Hiratake, S | 1 |
| Komada, Y | 1 |
| Sakurai, M | 1 |
| Yuen, AR | 1 |
| Bruce, DS | 1 |
| Josephson, M | 1 |
| Newell, KA | 2 |
| Piper, JB | 1 |
| Millis, JM | 1 |
| Cronin, D | 1 |
| Whitman, G | 1 |
| Ruebe, M | 1 |
| Thistlethwaite, JR | 2 |
| Raez, LE | 1 |
| Temple, JD | 1 |
| Saldana, M | 1 |
| Faedda, R | 1 |
| Pirisi, M | 1 |
| Satta, A | 1 |
| Tanda, F | 1 |
| Bartoli, E | 1 |
| Zamora, RL | 1 |
| del Priore, LV | 1 |
| Storch, GA | 1 |
| Gelb, LD | 1 |
| Sharp, J | 1 |
| Aranow, C | 1 |
| Emy, J | 1 |
| Barland, P | 1 |
| Aziz, Z | 1 |
| Zahid, M | 1 |
| Mahmood, R | 1 |
| Maqbool, S | 1 |
| Vazquez, MC | 1 |
| Sabbatiello, R | 1 |
| Schiavelli, R | 1 |
| Maiolo, E | 1 |
| Jacob, N | 1 |
| Pattin, M | 1 |
| Rearte, A | 1 |
| Popińska, K | 1 |
| Lyszkowska, M | 1 |
| Ksiazyk, J | 1 |
| Kierkuś, J | 1 |
| Socha, J | 1 |
| Norero, C | 1 |
| Delucchi, A | 1 |
| Lagos, E | 1 |
| Rosati, P | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| Lübbert, M | 1 |
| Kanz, L | 1 |
| Behringer, D | 1 |
| Mertelsmann, R | 1 |
| Izuno, I | 1 |
| Takei, K | 1 |
| Shikama, N | 1 |
| Sasaki, S | 1 |
| Gomi, K | 1 |
| Sone, S | 1 |
| Ross, HJ | 1 |
| Gullestad, L | 1 |
| Pak, J | 1 |
| Slauson, S | 1 |
| Valantine, HA | 1 |
| Hunt, SA | 1 |
| Mombaerts, I | 1 |
| Koornneef, L | 1 |
| Gottlieb, JE | 1 |
| Israel, HL | 1 |
| Steiner, RM | 1 |
| Triolo, J | 1 |
| Patrick, H | 1 |
| López de Maturana, D | 1 |
| Benedetto, A | 1 |
| Amaro, P | 1 |
| Moreno, F | 1 |
| Barai, U | 1 |
| Teoh, N | 1 |
| Lee, AY | 1 |
| Klimo, P | 1 |
| O'Reilly, SE | 1 |
| Tarshish, P | 1 |
| Tobin, JN | 1 |
| Bernstein, J | 2 |
| Edelmann, CM | 2 |
| Rühl, U | 1 |
| Nisters-Backes, H | 1 |
| Tesch, H | 1 |
| Franklin, J | 1 |
| Geilen, W | 1 |
| Bartels, H | 1 |
| Cartoni, C | 2 |
| Dölken, G | 1 |
| Enzian, J | 1 |
| Fuchs, R | 1 |
| Gassmann, W | 1 |
| Gerhartz, H | 1 |
| Hagen-Aukamp, U | 1 |
| Hiller, E | 1 |
| Hinkelbein, H | 1 |
| Hinterberger, W | 1 |
| Kirchner, H | 1 |
| Krüger, B | 1 |
| Schwarze, EW | 1 |
| Zeng, FC | 1 |
| Hong, F | 1 |
| Yang, YQ | 1 |
| Spiekermann, K | 1 |
| Wörmann, B | 1 |
| Rumpf, KW | 1 |
| Merla, E | 1 |
| Giona, F | 3 |
| Annino, L | 2 |
| Rondelli, R | 3 |
| Arcese, W | 3 |
| Moleti, ML | 3 |
| Resegotti, L | 1 |
| Tabilio, A | 1 |
| Ladogana, S | 1 |
| Fioritoni, G | 1 |
| Camera, A | 1 |
| Liso, V | 1 |
| Sharma, OP | 1 |
| Arora, A | 1 |
| Alonso, EM | 1 |
| Kelly, SM | 1 |
| Rubin, CM | 1 |
| Whitington, PF | 1 |
| Reiter, A | 2 |
| Dördelmann, M | 1 |
| Masera, G | 1 |
| Hasday, JD | 1 |
| Mergner, WJ | 1 |
| Collins, MT | 1 |
| Lee, W | 1 |
| Zimmermann, B | 1 |
| Lally, EV | 1 |
| Cantarovich, M | 1 |
| Latter, DA | 1 |
| Loertscher, R | 1 |
| Klig, JE | 1 |
| Hodge, D | 1 |
| Rutherford, MW | 1 |
| Watts, BV | 1 |
| Grady, TA | 1 |
| Ghandour, FZ | 1 |
| Knauss, TC | 1 |
| Mulligan, DC | 1 |
| Schulak, JA | 1 |
| Hricik, DE | 1 |
| Wyser, CP | 1 |
| van Schalkwyk, EM | 1 |
| Alheit, B | 1 |
| Bardin, PG | 1 |
| Joubert, JR | 1 |
| Simmons, Z | 1 |
| Wald, JJ | 1 |
| Albers, JW | 2 |
| Ceci, A | 1 |
| Pillon, M | 1 |
| Madon, E | 1 |
| Comis, M | 1 |
| Pession, A | 1 |
| Lhote, F | 2 |
| Jarrousse, B | 2 |
| Royer, I | 1 |
| Lesavre, P | 1 |
| Jacquot, C | 1 |
| Bindi, P | 1 |
| Bielefeld, P | 1 |
| Desson, JF | 1 |
| Détrée, F | 1 |
| Hoen, B | 1 |
| Jacomy, D | 1 |
| Seigneuric, C | 1 |
| Lauque, D | 1 |
| Stern, M | 1 |
| Longy-Boursier, M | 1 |
| Lozada-Nur, F | 1 |
| Miranda, C | 1 |
| Hoskins, PJ | 1 |
| Le, N | 1 |
| O'Reilly, S | 1 |
| Stanford, AR | 1 |
| Mezebish, DS | 1 |
| Cobb, MW | 1 |
| Uckun, FM | 1 |
| Bleyer, WA | 3 |
| Rojas-Poceros, G | 1 |
| Ramírez Peredo, J | 1 |
| Hernández Andrade, E | 1 |
| Bustos López, HH | 1 |
| Meleniewska-Maciszewska, A | 1 |
| Korzeniewska-Koseła, M | 1 |
| Wesołowski, S | 1 |
| Kuś, J | 1 |
| Zołnowska, B | 1 |
| Słodkowska, J | 2 |
| Stelmaszczyk, W | 1 |
| Vuori, ML | 1 |
| Reich, JM | 1 |
| Schuckman, H | 1 |
| DeJulius, DP | 1 |
| Blanda, M | 1 |
| Gerson, LW | 1 |
| DeJulius, AJ | 1 |
| Rajaratnam, M | 1 |
| Viviani, S | 3 |
| Camerini, E | 1 |
| Bonfante, V | 2 |
| Fornier, M | 1 |
| Devizzi, L | 1 |
| Verderio, P | 1 |
| Herrada, J | 1 |
| Rice, L | 1 |
| Manning, J | 1 |
| Bosch, X | 1 |
| Callanan, D | 1 |
| Fish, GE | 1 |
| Anand, R | 2 |
| Baughman, RP | 1 |
| Lower, EE | 1 |
| Rizzato, G | 1 |
| Montemurro, L | 1 |
| Colombo, P | 1 |
| Córdoba, J | 1 |
| Carrasco, D | 1 |
| Olaso, V | 1 |
| San-Juan, F | 1 |
| Gobernado, M | 1 |
| Río, J | 1 |
| Nos, C | 1 |
| Marzo, ME | 1 |
| Tintoré, M | 1 |
| Montalban, X | 1 |
| Ghobrial, RM | 1 |
| Colquhoun, S | 1 |
| Rosen, H | 1 |
| Hollis, P | 1 |
| Ponthieux, S | 1 |
| Pakrasi, A | 1 |
| Farmer, DG | 1 |
| Markman, JF | 1 |
| Markowitz, J | 1 |
| Drazan, K | 1 |
| Yersiz, H | 1 |
| Singer, J | 1 |
| Stribling, R | 1 |
| Arnout, W | 1 |
| Holt, CD | 1 |
| Goss, J | 1 |
| Imagawa, D | 1 |
| Seu, P | 1 |
| Goldstein, LI | 1 |
| Shackleton, CR | 1 |
| Busuttil, RW | 1 |
| Mwanda, OW | 1 |
| Othieno-Abinya, N | 1 |
| Sabeel, A | 1 |
| Qunibi, W | 1 |
| Chorzelski, TP | 1 |
| Jarzabek-Chorzelska, M | 1 |
| Jablonska, S | 1 |
| Parameswaran, K | 1 |
| Pizzichini, MM | 1 |
| Li, D | 1 |
| Pizzichini, E | 1 |
| Jeffery, PK | 1 |
| Hargreave, FE | 2 |
| Khan, OA | 1 |
| Hebel, JR | 1 |
| Jibaly, RM | 1 |
| Moallem, H | 1 |
| Fikrig, SM | 1 |
| Rabinowitz, SS | 1 |
| Whittaker, PE | 1 |
| Fitzsimons, MG | 1 |
| Zee, B | 1 |
| Cole, B | 1 |
| Li, T | 1 |
| Browman, G | 1 |
| James, K | 1 |
| Johnston, D | 1 |
| Sugano, D | 1 |
| Pater, J | 1 |
| Sentongo, TA | 1 |
| Piccoli, DA | 1 |
| Chapelon Abric, C | 1 |
| Ginsburg, C | 1 |
| Biousse, V | 1 |
| de Gennes, C | 1 |
| Darbois, Y | 1 |
| Janse Marec, J | 1 |
| Godeau, P | 2 |
| Mandler, RN | 1 |
| Ahmed, W | 1 |
| Dencoff, JE | 1 |
| Dejaco, C | 1 |
| Gasché, C | 1 |
| Reinisch, W | 1 |
| Moser, G | 1 |
| Novacek, G | 1 |
| Tillinger, W | 1 |
| Vogelsang, H | 1 |
| Gangl, A | 1 |
| Balis, FM | 1 |
| Holcenberg, JS | 1 |
| Ge, J | 1 |
| Murphy, RF | 1 |
| Ames, MM | 1 |
| Waskerwitz, MJ | 1 |
| Zimm, S | 1 |
| Dengler, R | 1 |
| Plewan, A | 1 |
| Münstermann, U | 1 |
| Eger, G | 1 |
| Emmerich, B | 1 |
| Crestani, B | 1 |
| Valeyre, D | 2 |
| Roden, S | 1 |
| Wallaert, B | 1 |
| Dalphin, JC | 1 |
| Guslandi, M | 2 |
| Tittobello, A | 1 |
| Płodziszewska, M | 1 |
| Orłowski, T | 1 |
| Rowińska-Zakrzewska, E | 1 |
| Papadimitriou, JC | 1 |
| Wiland, A | 1 |
| Drachenberg, CB | 1 |
| Klassen, DK | 1 |
| Bartlett, ST | 1 |
| Prados, E | 1 |
| Cuervas-Mons, V | 1 |
| de la Mata, M | 1 |
| Fraga, E | 1 |
| Rimola, A | 1 |
| Clemente, G | 1 |
| Vicente, E | 1 |
| Casanovas, T | 1 |
| Fabrega, E | 1 |
| Kaplan, SS | 1 |
| Rybka, WB | 1 |
| Blom, J | 1 |
| Shekhter-Levin, S | 1 |
| González-Treviño, O | 1 |
| Rosas-Guzmán, J | 1 |
| O'Neill, BP | 1 |
| Wang, CH | 1 |
| O'Fallon, JR | 1 |
| Colgan, JD | 1 |
| Earle, JD | 1 |
| Krigel, RL | 1 |
| Brown, LD | 1 |
| McGinnis, WL | 1 |
| Fernández de la Puebla Giménez, RA | 1 |
| García Alegría, J | 1 |
| Lechuga Varona, MT | 1 |
| Blanco Molina, MA | 1 |
| Reichardt, VL | 1 |
| Okada, CY | 1 |
| Liso, A | 1 |
| Benike, CJ | 1 |
| Engleman, EG | 1 |
| Levy, R | 1 |
| Apak, RA | 1 |
| Köse, G | 1 |
| Anlar, B | 2 |
| Turanli, G | 1 |
| Topaloğlu, H | 1 |
| Ozdirim, E | 1 |
| Baraldi, E | 1 |
| Dario, C | 1 |
| Ongaro, R | 1 |
| Scollo, M | 1 |
| Azzolin, NM | 1 |
| Panza, N | 1 |
| Paganini, N | 1 |
| Zacchello, F | 1 |
| Dries, V | 1 |
| Błoński, JZ | 1 |
| Urbańska-Ryś, H | 1 |
| Błasińska-Morawiec, M | 1 |
| Skotnicki, AB | 1 |
| Shteyngarts, AR | 1 |
| Warner, MR | 1 |
| Camisa, C | 1 |
| Ito, M | 1 |
| Ohira, H | 1 |
| Miyata, M | 1 |
| Sato, Y | 2 |
| Kaise, S | 1 |
| Nishimaki, T | 1 |
| Sakuma, H | 1 |
| Nihei, Y | 1 |
| Iwatsuki, K | 1 |
| Kasukawa, R | 1 |
| Kamath, SS | 1 |
| Marcus, RB | 1 |
| Mendenhall, NP | 1 |
| Bota, GW | 1 |
| Fabris, L | 1 |
| Therrien, SA | 1 |
| Milner, RA | 1 |
| Jacono, J | 1 |
| van Vonderen, MG | 1 |
| ter Maaten, JC | 1 |
| van der Valk, P | 1 |
| Hoorntje, SJ | 1 |
| Gans, RO | 1 |
| Bornstein, JD | 1 |
| Byrd, DE | 1 |
| Trotter, JF | 1 |
| Reinhardt, W | 1 |
| Sauter, V | 1 |
| Jockenhövel, F | 1 |
| Kummer, G | 1 |
| Uppenkamp, M | 1 |
| Witzke, O | 1 |
| Philipp, T | 1 |
| Reinwein, D | 1 |
| Mann, K | 1 |
| García-Porrúa, C | 1 |
| Vázquez-Caruncho, M | 1 |
| Dababneh, A | 1 |
| Hajeer, A | 1 |
| Ollier, WE | 1 |
| Davila, R | 1 |
| Keeffe, EB | 1 |
| Thuy, GN | 1 |
| Cuguilliere, A | 1 |
| Arteaga, C | 1 |
| Miltgen, J | 1 |
| Bonnet, D | 1 |
| Rayder, R | 1 |
| Brewer, W | 1 |
| Hamilton, R | 1 |
| Sebes, J | 1 |
| Carbone, L | 1 |
| Brodell, RT | 2 |
| Williams, L | 2 |
| Sweetenham, J | 1 |
| Hieke, K | 1 |
| Kerrigan, M | 1 |
| Howard, P | 1 |
| Smartt, PF | 1 |
| McIntyre, AM | 1 |
| Townshend, S | 1 |
| Suki, WN | 1 |
| Trimarchi, H | 1 |
| Frommer, JP | 1 |
| Tutor-Ureta, O | 1 |
| Díaz, MA | 1 |
| Algara, P | 1 |
| Madero, L | 1 |
| Martínez, P | 1 |
| Ferri, M | 1 |
| Ross, C | 1 |
| Harvey, JT | 1 |
| Pisarek, J | 1 |
| Janik-Moszant, A | 1 |
| Rokicka-Milewska, R | 1 |
| Kołecki, P | 1 |
| Skomra, S | 1 |
| Newecka-Samól, T | 1 |
| Hamrick, M | 1 |
| Chambliss, ML | 1 |
| Aguayo, A | 1 |
| Cortes, J | 1 |
| Thomas, D | 1 |
| Keating, M | 1 |
| Kantarjian, H | 1 |
| Vaiman, E | 1 |
| Odeh, M | 1 |
| Attias, D | 1 |
| Ben-Arie, Y | 1 |
| Oliven, A | 1 |
| Yao, NA | 1 |
| Chagnon, A | 1 |
| Paris, JF | 1 |
| Kologo, K | 1 |
| Marlier, S | 1 |
| Carli, P | 1 |
| Ross, M | 1 |
| Smith, EP | 1 |
| Snyder, DS | 1 |
| Stein, AS | 1 |
| Wong, RM | 1 |
| Forman, SJ | 1 |
| Visser, R | 1 |
| Zweegman, S | 1 |
| Ossenkoppele, GJ | 1 |
| Huijgens, PC | 1 |
| Rampinelli, I | 1 |
| Fouillard, L | 1 |
| Laporte, J | 1 |
| Douay, L | 1 |
| Lesage, S | 1 |
| Najman, A | 1 |
| Gourmelon, P | 1 |
| Gorin, NC | 1 |
| Braun, MC | 1 |
| West, CD | 2 |
| Hari, P | 1 |
| Srivastava, RN | 4 |
| De Souza, S | 1 |
| Aslanides, IM | 1 |
| Altomare, F | 1 |
| Tisone, G | 1 |
| Laria, G | 1 |
| Orlando, G | 1 |
| Pisani, F | 1 |
| Palmieri, GP | 1 |
| Bellanova, G | 1 |
| Torri, E | 1 |
| Buonomo, O | 1 |
| Angelico, M | 1 |
| Casciani, CU | 1 |
| Ahmed, I | 1 |
| Cronk, JS | 1 |
| Crutchfield, CE | 1 |
| Dahl, MV | 1 |
| Guzman, EJ | 1 |
| Smith, AJ | 1 |
| Tietjen, PA | 1 |
| Judson, MA | 1 |
| Chapelon-Abric, C | 1 |
| Belin, C | 1 |
| Tandjaoui-Lambiotte, H | 1 |
| Brauner, M | 1 |
| Goldlust, D | 1 |
| Laghzaoui Boukaidi, M | 1 |
| Ghazli, M | 1 |
| Bennani, O | 1 |
| Hermas, S | 1 |
| Soummani, A | 1 |
| Bouhya, S | 1 |
| Aderdour, M | 1 |
| Brugières, L | 1 |
| Quartier, P | 1 |
| Le Deley, MC | 1 |
| Pacquement, H | 2 |
| Bergeron, C | 2 |
| Landmann, J | 1 |
| Patte, C | 3 |
| Terrier-Lacombe, MJ | 3 |
| Delsol, G | 1 |
| Hartmann, O | 1 |
| Lien, YH | 1 |
| Scott, K | 1 |
| Boix, E | 1 |
| Rivera, F | 1 |
| Gil, CM | 1 |
| Pérez-Contreras, J | 1 |
| Olivares, J | 1 |
| Constantinescu, AR | 1 |
| Shah, HB | 1 |
| Foote, EF | 1 |
| Weiss, LS | 1 |
| Rivera, GK | 1 |
| Boyett, JM | 2 |
| Chauvenet, AR | 1 |
| Wagner, H | 1 |
| Maybee, DA | 1 |
| Crist, WM | 3 |
| Pinkel, D | 1 |
| Gobbi, PG | 1 |
| Ghirardelli, ML | 1 |
| Avanzini, P | 1 |
| Baldini, L | 1 |
| Quarta, G | 1 |
| Broglia, C | 1 |
| Loni, C | 1 |
| Silingardi, V | 2 |
| Ascari, E | 2 |
| Hayabuchi, N | 1 |
| Shibamoto, Y | 1 |
| Onizuka, Y | 1 |
| Mikou, O | 1 |
| Zouhair, K | 1 |
| Jarmouni, RI | 1 |
| Nejjam, F | 1 |
| El Ouazzani, T | 1 |
| Amraoui, A | 1 |
| Lakhdar, H | 1 |
| Feagan, BG | 1 |
| Fedorak, RN | 1 |
| Irvine, EJ | 1 |
| Wild, G | 1 |
| Sutherland, L | 1 |
| Greenberg, GR | 1 |
| Koval, J | 1 |
| Wong, CJ | 1 |
| Hopkins, M | 1 |
| Hanauer, SB | 1 |
| McDonald, JW | 1 |
| Miljić, P | 1 |
| Milosević-Jovicić, N | 1 |
| Antunović, P | 1 |
| Bosković, D | 1 |
| Basara, N | 1 |
| Rolović, Z | 1 |
| Perez, RA | 1 |
| Silver, D | 1 |
| Banerjee, B | 1 |
| Knight, JF | 1 |
| Renner, S | 1 |
| Weisz, J | 1 |
| Krajewski, S | 1 |
| Krajewska, M | 1 |
| Reed, JC | 1 |
| Lichtenstein, A | 1 |
| Lazor, R | 1 |
| Vandevenne, A | 1 |
| Pelletier, A | 1 |
| Leclerc, P | 1 |
| Court-Fortune, I | 1 |
| Mattoo, TK | 1 |
| Mahmoud, MA | 1 |
| Altrogge, H | 1 |
| Ludwig, K | 1 |
| Timmermann, K | 1 |
| Müller-Wiefel, DE | 3 |
| Walewski, J | 1 |
| Krzyzanowska, JB | 1 |
| Kraszewska, E | 1 |
| Lampka, E | 1 |
| Romejko-Jarosińska, J | 1 |
| Miśkiewicz, Z | 1 |
| Meder, J | 1 |
| Tonnelier, JM | 1 |
| Ansart, S | 1 |
| Tilly-Gentric, A | 1 |
| Pennec, YL | 1 |
| Oksenhendler, E | 1 |
| Gerard, L | 1 |
| Dubreuil, ML | 1 |
| Levy, Y | 1 |
| Matheron, S | 1 |
| Cazals-Hatem, D | 1 |
| Clauvel, JP | 1 |
| Lopez-Picazo, JM | 1 |
| Gonzalez Manzano, R | 1 |
| Ordoñez Tres, JM | 1 |
| Jimenez, MM | 1 |
| Calvo, JP | 1 |
| Brugarolas, A | 1 |
| Takigawa, N | 1 |
| Segawa, Y | 1 |
| Saeki, T | 1 |
| Kataoka, M | 1 |
| Ida, M | 1 |
| Kishino, D | 1 |
| Fujiwara, K | 1 |
| Ohsumi, S | 1 |
| Eguchi, K | 1 |
| Takashima, S | 1 |
| Roblot, P | 1 |
| Paire, D | 1 |
| Loustaud, V | 2 |
| Jauberteau, MO | 1 |
| Clark, WF | 1 |
| Lichtman, SM | 1 |
| Niedzwiecki, D | 1 |
| Carlisle, TL | 1 |
| Johnson, JL | 1 |
| Avigdor, A | 1 |
| Grotto, I | 1 |
| Ben-Bassat, I | 1 |
| Jang, YJ | 1 |
| Seok, HJ | 1 |
| Morin, AF | 1 |
| Lane, JE | 1 |
| Parish, DC | 1 |
| Cornillet, P | 1 |
| Deconinck, E | 2 |
| Tourani, JM | 1 |
| Gardembas, M | 2 |
| Delain, M | 1 |
| Abgrall, JF | 1 |
| Kootz, C | 1 |
| Tauro, S | 1 |
| Dobie, D | 1 |
| Richardson, G | 1 |
| Hastings, M | 1 |
| Mahendra, P | 2 |
| El Alaoui Faris, M | 1 |
| Rabhi, M | 1 |
| Kissani, N | 1 |
| Benabdeljalil, M | 1 |
| Aidi, S | 1 |
| Amarti, A | 1 |
| Belaïdi, H | 1 |
| Benomar, A | 1 |
| Chkili, T | 1 |
| Kim, SC | 1 |
| Kang, CH | 1 |
| Kim, SK | 1 |
| Jang, HJ | 1 |
| Kim, TH | 1 |
| Jung, JG | 1 |
| Belmont, HM | 1 |
| Sanislo, SR | 1 |
| Lowder, CY | 1 |
| Kaiser, PK | 1 |
| Gutman, FA | 1 |
| Zegarra, H | 1 |
| Dodds, EM | 1 |
| Dailey, JP | 1 |
| Meisler, DM | 1 |
| Cunningham, ET | 1 |
| Garcia-Valenzuela, E | 1 |
| Carnahan, M | 1 |
| Ryan, JJ | 1 |
| Oldstein, DA | 1 |
| Fisher, RI | 1 |
| Al-Mayouf, SM | 1 |
| Ghonaium, A | 1 |
| Bahabri, S | 1 |
| Brown, BW | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Anderer, G | 1 |
| Brechlin, AM | 1 |
| Muti, P | 1 |
| Solary, E | 1 |
| Mannone, L | 1 |
| Moreau, D | 1 |
| Caillot, D | 1 |
| Casasnovas, RO | 1 |
| Guy, H | 1 |
| Grandjean, M | 1 |
| Wolf, JE | 1 |
| André, F | 1 |
| Fenaux, P | 2 |
| Canal, P | 1 |
| Chauffert, B | 1 |
| Wotawa, A | 1 |
| Bayssas, M | 1 |
| Genne, P | 1 |
| Weyman, RL | 1 |
| Voigt, M | 1 |
| Riahi, I | 1 |
| Haouet, S | 1 |
| Cherif, F | 1 |
| El Euch, D | 1 |
| Azaiz, MI | 1 |
| Zitouna, MM | 1 |
| Ben Osman-Dhahri, A | 1 |
| Appel, GB | 1 |
| Hebert, LA | 1 |
| Hunsicker, LG | 1 |
| Pohl, MA | 1 |
| Hoy, WE | 1 |
| Maxwell, DR | 1 |
| Kunis, CL | 1 |
| Atra, A | 1 |
| Gerrard, M | 1 |
| Hobson, R | 1 |
| Imeson, JD | 1 |
| Hann, IM | 1 |
| Verity, DH | 1 |
| Graham, EM | 1 |
| van der Walt, JD | 1 |
| Stanford, MR | 1 |
| McMillan, R | 1 |
| Auperin, A | 1 |
| Michon, J | 1 |
| Behrendt, H | 2 |
| Frappaz, D | 1 |
| Lutz, P | 1 |
| Coze, C | 1 |
| Raphaël, M | 1 |
| Forni, A | 1 |
| Faggian, G | 1 |
| Luciani, GB | 1 |
| Lamascese, N | 1 |
| Mazzucco, A | 1 |
| Lamasciese, N | 1 |
| Błoński , JZ | 1 |
| Rutgeerts, PJ | 1 |
| Foltz, V | 1 |
| Koeger, AC | 1 |
| de Sauverzac, C | 1 |
| de Person, JF | 1 |
| Bourgeois, P | 1 |
| Fautrel, B | 1 |
| Wiernik, PH | 2 |
| Leong, T | 1 |
| Oken, MM | 1 |
| Neiman, RS | 1 |
| Bennett, JM | 1 |
| Schuster, S | 1 |
| Hwang, IP | 1 |
| Jordan, DR | 1 |
| Acharya, V | 1 |
| Li, CY | 1 |
| Tefferi, A | 2 |
| Phyliky, RL | 1 |
| Qureshi, F | 1 |
| Zaritsky, A | 1 |
| Poirier, MP | 1 |
| Pardi, DS | 1 |
| Murray, JA | 1 |
| Ahmed, AR | 2 |
| Colón, JE | 1 |
| Beşbaş, N | 1 |
| Apak, A | 1 |
| Kansu, T | 1 |
| Eisen, D | 1 |
| Lynch, DP | 1 |
| Kang, DW | 1 |
| Kim, DE | 1 |
| Yoon, BW | 1 |
| Seo, JW | 1 |
| Roh, JK | 1 |
| Lévy, V | 1 |
| Maloisel, F | 1 |
| Fermand, JP | 1 |
| Remenieras, L | 1 |
| Porcher, R | 1 |
| Marit, G | 1 |
| Guilhot, F | 1 |
| Philippe, G | 1 |
| Stamatoullas, A | 1 |
| Guibon, O | 1 |
| Alsaran, K | 1 |
| Grisaru, S | 1 |
| Stephens, D | 1 |
| Arbus, G | 1 |
| Bibeau, F | 1 |
| El Weshi, A | 1 |
| Frayfer, J | 1 |
| Fadel, C | 1 |
| Cebotaru, C | 1 |
| Rose, EA | 1 |
| Schwartz, K | 1 |
| Maung, K | 1 |
| D'Orazio, AI | 1 |
| Tosi, C | 1 |
| Städler, C | 1 |
| Merenda, C | 1 |
| Bernasconi, E | 1 |
| Sposto, R | 1 |
| Chilcote, RR | 1 |
| Kjeldsberg, C | 1 |
| Kadin, ME | 1 |
| Siegel, SE | 2 |
| Kumar, S | 1 |
| Gastineau, DA | 1 |
| Inwards, DJ | 1 |
| Litzow, MR | 1 |
| Chen, YC | 1 |
| Ho, CL | 1 |
| Hwang, JM | 1 |
| Sheu, LF | 1 |
| Eidlitz-Markus, T | 1 |
| Gilai, A | 1 |
| Mimouni, M | 1 |
| Shuper, A | 1 |
| Al-Khalidi, JA | 1 |
| Empson, M | 1 |
| Lassere, M | 1 |
| Scott, JR | 1 |
| Kang, EM | 1 |
| de Witte, M | 1 |
| Malech, H | 1 |
| Morgan, RA | 1 |
| Phang, S | 1 |
| Carter, C | 1 |
| Leitman, SF | 1 |
| Childs, R | 1 |
| Barrett, AJ | 1 |
| Little, R | 1 |
| Tisdale, JF | 1 |
| Wei, L | 1 |
| Ye, R | 1 |
| Murohashi, I | 1 |
| Kashimura, T | 1 |
| Tominaga, K | 1 |
| Wakao, D | 1 |
| Akiba, M | 1 |
| Kishimoto, K | 1 |
| Yoshida, K | 1 |
| Yagasaki, F | 1 |
| Itoh, Y | 1 |
| Sakata, T | 1 |
| Kawai, N | 1 |
| Itoh, K | 1 |
| Matsuda, A | 1 |
| Hirashima, K | 1 |
| Bessho, M | 1 |
| Debray, M | 1 |
| Avansi, MA | 1 |
| Pabion, B | 1 |
| Lortholary, O | 1 |
| Patriarca, F | 1 |
| Zaja, F | 1 |
| Silvestri, F | 1 |
| Sperotto, A | 1 |
| Scalise, A | 1 |
| Gigli, G | 1 |
| Fanin, R | 1 |
| Van Den Neste, E | 1 |
| Gaulard, P | 1 |
| Broide, E | 1 |
| Stein, M | 1 |
| Bujanover, Y | 1 |
| Weizman, Z | 1 |
| Dinari, G | 1 |
| Pacht, A | 1 |
| Branski, D | 1 |
| Zahavi, I | 1 |
| Roujeau, JC | 3 |
| Dreno, B | 1 |
| Vaillant, L | 1 |
| Plantin, P | 1 |
| Young, P | 1 |
| Arnal, C | 1 |
| Léone, J | 1 |
| Taillan, B | 1 |
| Roudot-Thoraval, F | 1 |
| Papo, T | 1 |
| Schaeffer, A | 1 |
| Bierling, P | 1 |
| Gargantini, L | 1 |
| Colombo, AA | 1 |
| Calatroni, S | 1 |
| Iacona, I | 1 |
| Regazzi, MB | 1 |
| Shao, Z | 1 |
| Jing, L | 1 |
| DiCaudo, DJ | 1 |
| Connolly, SM | 1 |
| Laver, JH | 1 |
| Mahmoud, H | 1 |
| Pick, TE | 1 |
| Hutchison, RE | 1 |
| Weinstein, HJ | 1 |
| Schwenn, M | 1 |
| Ochoa, S | 1 |
| Shuster, JJ | 3 |
| Lian, EC | 1 |
| Villar, MJ | 1 |
| Noy, LI | 1 |
| Ruiz-Dayao, Z | 1 |
| Ndiaye, O | 1 |
| Sylla, A | 1 |
| Ndiaye, FS | 1 |
| Diagne, I | 1 |
| Diallo-Chauvin, M | 1 |
| Diouf, S | 1 |
| Sallm, G | 1 |
| Kuakuvi, K | 1 |
| Harris, E | 1 |
| Paneesha, S | 1 |
| Jackson, N | 1 |
| Jones, L | 1 |
| Furlong, T | 1 |
| Leisenring, W | 1 |
| Anasetti, C | 1 |
| Doney, K | 1 |
| Kiem, HP | 1 |
| Nash, RA | 1 |
| Sanders, JE | 1 |
| Witherspoon, R | 1 |
| Thompson, D | 1 |
| Bökenkamp, A | 1 |
| van Wijk, JA | 1 |
| Lentze, MJ | 1 |
| Stoffel-Wagner, B | 1 |
| Rote, NS | 1 |
| Langman, MJ | 1 |
| Dronfield, MW | 1 |
| Gryboski, JD | 1 |
| Spiro, HM | 1 |
| Winship, DH | 1 |
| Summers, RW | 2 |
| Best, WR | 2 |
| Becktel, JM | 2 |
| Lenk, LF | 1 |
| Kern, F | 2 |
| Switz, DM | 1 |
| Sessions, JT | 1 |
| Goldberg, HI | 1 |
| Caruthers, SB | 1 |
| Nelson, JA | 1 |
| Peto, R | 1 |
| Galton, DA | 1 |
| Kallen, RJ | 1 |
| Lee, SK | 1 |
| Alberts, DS | 1 |
| Durie, BG | 1 |
| Hamilton, JD | 1 |
| Chambers, RA | 1 |
| Wynn-Williams, A | 1 |
| Perheentupa, J | 1 |
| Porzig, KJ | 1 |
| Portlock, CS | 2 |
| Robertson, A | 1 |
| Stoll, BA | 1 |
| Anteunis, A | 1 |
| Audebert, AA | 1 |
| Krulik, M | 2 |
| Debray, J | 1 |
| Robineaux, R | 1 |
| Glatstein, EJ | 1 |
| Lange, B | 1 |
| Littman, P | 1 |
| Schnaufer, L | 1 |
| Evans, A | 1 |
| Mintz, U | 1 |
| Miller, JB | 1 |
| Golomb, HM | 1 |
| Kinzie, J | 1 |
| Sweet, DL | 1 |
| Lester, EP | 1 |
| Variakojis, D | 1 |
| Roth, NO | 1 |
| Blough, RR | 1 |
| Ferguson, DJ | 1 |
| Ultmann, JE | 1 |
| Lovschall, S | 1 |
| O'Day, DM | 1 |
| Jones, BR | 1 |
| Poirier, R | 1 |
| Pilley, S | 1 |
| Chisholm, I | 1 |
| Steele, A | 1 |
| Rice, NS | 1 |
| Britz, M | 1 |
| Sibulkin, D | 1 |
| Derrida, JP | 1 |
| Herreman, G | 1 |
| Blyth, WA | 1 |
| Hill, TJ | 1 |
| Field, HJ | 1 |
| Harbour, DA | 1 |
| Freour, P | 1 |
| Tessier, JF | 1 |
| Bernadou, M | 1 |
| Gachie, JP | 1 |
| Lhermitte, P | 1 |
| Friedman, HM | 1 |
| Grossman, RA | 1 |
| Plotkin, SA | 1 |
| Perloff, LJ | 1 |
| Barker, CF | 1 |
| Farmer, RG | 1 |
| Bodalski, J | 1 |
| Scharf, J | 1 |
| Nahir, M | 1 |
| Chan, DM | 1 |
| Traggis, D | 1 |
| Jaffe, N | 2 |
| Kung, FH | 1 |
| Nythan, WL | 1 |
| Cuttner, J | 1 |
| Falkson, G | 2 |
| Del Duca, V | 1 |
| Nawabi, IU | 1 |
| Koch, K | 2 |
| Pluess, H | 1 |
| Freeman, A | 1 |
| Burgert, EO | 1 |
| Leone, LA | 1 |
| Ruymann, F | 1 |
| Patterson, RB | 1 |
| Degnan, T | 1 |
| Hakami, N | 1 |
| Holland, J | 1 |
| Stewart, SJ | 1 |
| Shepherd, DA | 1 |
| Steuber, CP | 1 |
| Starling, KA | 2 |
| Falletta, JM | 2 |
| Donadio, JV | 2 |
| Holley, KE | 2 |
| Ferguson, RH | 1 |
| Ilstrup, DM | 1 |
| Weinerman, BH | 1 |
| Levitt, M | 1 |
| Babick, T | 1 |
| Maize, JC | 1 |
| Provost, TT | 1 |
| Williams, GW | 1 |
| Steinberg, AD | 1 |
| Reinertsen, JL | 1 |
| Klassen, LW | 1 |
| Decker, JL | 1 |
| Dolin, R | 1 |
| Smith, RC | 1 |
| Rhodes, J | 1 |
| Heatley, RV | 1 |
| Hughes, LE | 1 |
| Crosby, DL | 1 |
| Rees, BI | 1 |
| Jones, H | 1 |
| Evans, KT | 1 |
| Lawrie, BW | 1 |
| Senn, HJ | 3 |
| Jungi, WF | 1 |
| Amgwerd, R | 1 |
| Sprenger, F | 1 |
| Hochuli, E | 1 |
| Engelhart, G | 1 |
| Heinz, C | 1 |
| Wick, A | 1 |
| Enderlin, F | 1 |
| Simeon, B | 1 |
| Lanz, R | 1 |
| Bigler, R | 1 |
| Dyment, PG | 1 |
| Humphrey, GB | 1 |
| Pullen, J | 1 |
| Vats, T | 1 |
| Mayr, AC | 1 |
| Botnick, LE | 1 |
| Goodman, R | 1 |
| Filler, R | 1 |
| Cassady, JR | 1 |
| Levi, JA | 1 |
| Madoc-Jones, H | 1 |
| Gamble, JF | 1 |
| Butler, JJ | 1 |
| Fernandez, CH | 1 |
| Gehan, EA | 1 |
| Mintzer, R | 1 |
| Rosenberg, M | 1 |
| Hall, RC | 1 |
| Popkin, MK | 1 |
| Stickney, SK | 1 |
| Gardner, ER | 1 |
| Smith, PG | 1 |
| Wald, N | 1 |
| Spitzer, A | 3 |
| Madowitz, JS | 1 |
| Schweiger, MJ | 1 |
| Jenkin, D | 2 |
| Freedman, M | 2 |
| McClure, P | 1 |
| Peters, V | 1 |
| Saunders, F | 2 |
| Sonley, M | 1 |
| Ghory, AC | 1 |
| Vázquez Tadei, G | 1 |
| Fernández, J | 1 |
| Martin Malo, A | 1 |
| Campdera, FG | 1 |
| Sanz Guajardo, D | 1 |
| Traver, JA | 1 |
| Botella, J | 1 |
| Bellows, JG | 1 |
| Stout, R | 1 |
| Todd, ID | 1 |
| de Belleville-Séjourné, AM | 1 |
| Chevalier, J | 1 |
| Colvez, A | 1 |
| Durand, M | 1 |
| Paillot, B | 1 |
| Grupe, WE | 3 |
| Svarch, E | 1 |
| Almagro, D | 1 |
| Lagarde, M | 1 |
| Esposito, L | 1 |
| Ferrara, M | 1 |
| Guerriero, A | 1 |
| Ponte, G | 1 |
| Jones, WB | 1 |
| Rhamy, RK | 1 |
| Faber, RB | 1 |
| Flexner, JM | 1 |
| Molin, JA | 1 |
| Bienenstock, H | 1 |
| Lanyi, VF | 1 |
| Haim, S | 1 |
| Friedman-Birnbaum, R | 1 |
| Pryor, ND | 1 |
| Fennell, RS | 1 |
| Richard, GA | 1 |
| Pearson, DL | 1 |
| Rosenow, EC | 1 |
| Cebrian-Bonesana, A | 1 |
| Schvartzman, E | 1 |
| Roca-Garcia, C | 1 |
| Pependieck, C | 1 |
| Sackmann-Muriel, S | 1 |
| Ojeda, FG | 1 |
| Lein, JM | 1 |
| Penchansky, L | 1 |
| Imbeau, SA | 1 |
| Nichols, D | 1 |
| Flaherty, D | 1 |
| Dickie, H | 1 |
| Reed, C | 1 |
| Babini, L | 1 |
| Franchini, A | 1 |
| Olweny, CL | 2 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Magrath, I | 2 |
| Ziegler, JL | 2 |
| Young, RC | 4 |
| Chabner, BA | 2 |
| Hubbard, SM | 2 |
| DeVita, VT | 5 |
| Theodor, E | 1 |
| Niv, Y | 1 |
| Lytton, B | 2 |
| Finkelstein, FO | 1 |
| Schiff, M | 1 |
| Black, HR | 1 |
| Lawson, RK | 1 |
| Murphy, JB | 1 |
| Talwalkar, YB | 1 |
| Rai, GS | 1 |
| Wilkinson, R | 1 |
| Elliott, RW | 1 |
| Uldall, PR | 1 |
| Taylor, RM | 1 |
| Rance, CP | 1 |
| Arbus, GS | 1 |
| Balfe, JW | 1 |
| Wright, RC | 1 |
| Franco, RS | 1 |
| Denton, D | 1 |
| Blaney, DJ | 1 |
| Axelsson, C | 1 |
| Jarnum, S | 1 |
| DeRemee, RA | 1 |
| Panoff, A | 1 |
| Milanoff, G | 1 |
| Finelli, PF | 1 |
| Yockey, CC | 1 |
| Herbert, AJ | 1 |
| Bartel, J | 1 |
| Briedigkeit, W | 1 |
| Makker, SP | 3 |
| Ingelfinger, JR | 1 |
| Ehrenreich, T | 1 |
| Porush, JG | 1 |
| Churg, J | 1 |
| Garfinkel, L | 1 |
| Glabman, S | 1 |
| Goldstein, MH | 1 |
| Grishman, E | 1 |
| Yunis, SL | 1 |
| Shaps, RS | 1 |
| Stoopler, M | 1 |
| Contamin, F | 1 |
| Singer, B | 1 |
| Mignot, B | 1 |
| Ecoffet, M | 1 |
| Kazatchkine, M | 1 |
| Nicholas, KC | 1 |
| Bays, RA | 1 |
| Lyon, ED | 1 |
| Johns, CJ | 3 |
| Macgregor, MI | 2 |
| Zachary, JB | 3 |
| Ball, WC | 2 |
| Kay, LW | 1 |
| Pedersen, FK | 1 |
| Petersen, EA | 1 |
| Velosa, JA | 1 |
| Rosenberg, JL | 1 |
| Levin, B | 1 |
| Wall, AJ | 1 |
| Kirsner, JB | 1 |
| Valchár, J | 1 |
| Lusins, JO | 1 |
| Szilagyi, PA | 1 |
| Lewis, RA | 1 |
| Weisberg, LA | 1 |
| Coleman, WS | 1 |
| Lischner, HW | 1 |
| Grover, WD | 1 |
| Trainin, EB | 1 |
| Boichis, H | 2 |
| Greifer, I | 2 |
| Fedoreev, GA | 1 |
| Aspnes, GT | 1 |
| Pearson, HA | 1 |
| Spencer, RP | 1 |
| Pickett, LK | 1 |
| Kansky, A | 1 |
| Schlaegel, TF | 1 |
| Reddemann, H | 1 |
| Ballke, H | 1 |
| Vuia, O | 1 |
| Kuijten, RH | 1 |
| Donckerwolcke, RA | 1 |
| Tiddens, HA | 1 |
| Glikson, M | 1 |
| Galun, E | 1 |
| Oren, R | 1 |
| Tur-Kaspa, R | 1 |
| Shouval, D | 1 |
| de Freitas, D | 1 |
| Sato, EH | 1 |
| Kelly, LD | 1 |
| Pavan-Langston, D | 1 |
| Le Thi Huong, D | 1 |
| Bussel, A | 1 |
| Leon, A | 1 |
| Goldstein, F | 1 |
| Oberlin, O | 1 |
| Raquin, MA | 1 |
| Chompret, A | 1 |
| Habrand, JL | 1 |
| Bey, P | 1 |
| Bertrand, Y | 1 |
| Rubie, H | 1 |
| Ródenas, JM | 1 |
| Ortego, N | 1 |
| Herranz, MT | 1 |
| Tercedor, J | 1 |
| Pinar, A | 1 |
| Quero, JH | 1 |
| Peter, SA | 1 |
| Comer, M | 1 |
| Harvey, AR | 1 |
| Miller, LC | 1 |
| Sisson, BA | 1 |
| Tucker, LB | 1 |
| DeNardo, BA | 1 |
| Schaller, JG | 1 |
| Lampert, F | 1 |
| Harbott, J | 1 |
| Niemeyer, CM | 1 |
| Müller-Weihrich, S | 1 |
| Ritter, J | 1 |
| Neuhaus, TJ | 1 |
| Burger, HR | 1 |
| Klingler, M | 1 |
| Fanconi, A | 1 |
| Leumann, EP | 1 |
| Reyes-Terán, G | 1 |
| Ramírez-Amador, V | 1 |
| De la Rosa, E | 1 |
| González-Guevara, M | 1 |
| Ponce de León, S | 1 |
| Fischer, BM | 1 |
| Schadmand, S | 1 |
| Gerharz, CD | 1 |
| Steppling, H | 1 |
| Ferlinz, R | 1 |
| Sotnikov, VM | 2 |
| Pan'shin, GA | 2 |
| Pivnik, AV | 1 |
| Grigor'eva, MA | 1 |
| Olsen, EA | 1 |
| Carson, SC | 1 |
| Turney, EA | 1 |
| Salmaggi, A | 1 |
| Venegoni, E | 1 |
| Eoli, M | 1 |
| Lamperti, E | 1 |
| Dufour, A | 1 |
| Ciusani, E | 1 |
| Milanese, C | 1 |
| Nespolo, A | 1 |
| Novi, C | 1 |
| Barras, MH | 1 |
| Guignard, JP | 1 |
| Silverman, S | 1 |
| Gallo, J | 1 |
| Stites, DP | 1 |
| Sica, S | 1 |
| Di Mario, A | 1 |
| Pagano, L | 1 |
| Etuk, B | 1 |
| Salutari, P | 1 |
| Leone, G | 1 |
| Juchet, H | 1 |
| Arlet, P | 1 |
| Ollier, S | 1 |
| Montané de la Roque, P | 1 |
| Le Tallec, Y | 1 |
| Prosnitz, LR | 1 |
| Monpoint, S | 1 |
| Donadio, D | 1 |
| Guilhou, JJ | 1 |
| Attal, M | 1 |
| Huguet, F | 1 |
| Schlaifer, D | 1 |
| Payen, C | 1 |
| Laroche, M | 1 |
| Mazieres, B | 1 |
| Pris, J | 1 |
| Laurent, G | 1 |
| Watson, HS | 1 |
| Singh, EO | 1 |
| Hermans, MR | 1 |
| Coffield, KS | 1 |
| Keegan, GT | 1 |
| Lauzurica, R | 1 |
| Vaquero, M | 1 |
| Torguet, P | 1 |
| Serra, A | 1 |
| Borrás, M | 1 |
| Caralps, A | 1 |
| Schaison, G | 1 |
| Sommelet, D | 1 |
| Bancillon, A | 1 |
| Leblanc, T | 1 |
| Hamm, H | 1 |
| Niedermeyer, J | 1 |
| Krause, J | 1 |
| Fabel, H | 1 |
| Pullen, DJ | 1 |
| Borowitz, MJ | 1 |
| Wharam, M | 1 |
| Foreman, E | 1 |
| Vietti, TJ | 2 |
| Takagi, T | 1 |
| Sakai, C | 1 |
| Oguro, M | 1 |
| Colucciello, M | 1 |
| Goyal, A | 1 |
| Achiron, A | 1 |
| Djaldetti, R | 1 |
| Ziv, I | 1 |
| Vasudev, AS | 1 |
| Sunderam, KR | 1 |
| Ruiz Morales, MJ | 1 |
| Gómez Huelgas, R | 1 |
| Sanz Moreno, J | 1 |
| de la Torre Solís, C | 1 |
| Ronchetto, F | 1 |
| Detjen, PF | 1 |
| Noskin, GA | 1 |
| Phair, JP | 1 |
| Loyd, SO | 1 |
| Rosenstein, DI | 1 |
| Chiodo, GT | 1 |
| Bartley, MH | 1 |
| Negretti, E | 2 |
| Lerman, P | 1 |
| Lerman-Sagie, T | 1 |
| Kivity, S | 1 |
| Zucali, R | 1 |
| Henry-Amar, M | 2 |
| Tarayre, M | 1 |
| Thomas, J | 2 |
| Monconduit, M | 1 |
| de Pauw, BE | 1 |
| Breed, WP | 1 |
| Freund, M | 1 |
| Diedrich, H | 1 |
| Ganser, A | 1 |
| Gramatzki, M | 1 |
| Heil, G | 1 |
| Heyll, A | 1 |
| Henke, M | 1 |
| Haas, R | 1 |
| Kuse, R | 1 |
| Kaeser, HE | 1 |
| Anderson, MM | 1 |
| Keltner, JL | 1 |
| Shults, WT | 1 |
| Buckley, EG | 1 |
| Corbett, JJ | 1 |
| Miller, NR | 1 |
| Jindal, K | 1 |
| West, M | 1 |
| Bear, R | 1 |
| Goldstein, M | 1 |
| Leavitt, RY | 1 |
| Lebovics, RS | 1 |
| Travis, WD | 1 |
| Rottem, M | 1 |
| Biti, GP | 1 |
| Cimino, G | 2 |
| Magrini, SM | 1 |
| Anselmo, AP | 2 |
| Enrici, RM | 1 |
| Bellesi, GP | 1 |
| Bosi, A | 1 |
| Giannarelli, D | 1 |
| Kulczyński, B | 1 |
| Soboczyński, R | 1 |
| Manasterski, J | 1 |
| Weksler, BB | 1 |
| Lehany, AM | 1 |
| Otero Gilz, A | 1 |
| Esteban, J | 1 |
| Martínez Salgado, J | 1 |
| Mariña, G | 1 |
| Rodríguez Guede, G | 1 |
| Korobov, KV | 1 |
| Novikov, ID | 1 |
| Demina, EA | 1 |
| Kondrat'eva, NF | 1 |
| Pirogova, NA | 1 |
| Prange, E | 1 |
| Haferlach, T | 1 |
| Griesser, H | 1 |
| Sonnen, R | 1 |
| Schlegelberger, B | 1 |
| Claus, S | 1 |
| Löffler, H | 2 |
| Campolmi, P | 1 |
| Bonan, P | 1 |
| Lotti, T | 1 |
| Palleschi, GM | 1 |
| Fabbri, P | 1 |
| Panconesi, E | 1 |
| Dopfer, R | 1 |
| Bender-Götze, C | 1 |
| Ebell, W | 1 |
| Ehninger, G | 1 |
| Friedrich, W | 1 |
| Peters, C | 1 |
| Rudzka, E | 1 |
| Holowiecki, J | 1 |
| Kachel, L | 1 |
| Lawniczek, T | 1 |
| Pajak, J | 1 |
| Habib, R | 1 |
| Frustaci, A | 1 |
| Caldarulo, M | 1 |
| Buffon, A | 1 |
| Bellocci, F | 1 |
| Fenici, R | 1 |
| Melina, D | 1 |
| Hooper, PL | 1 |
| Kaplan, HJ | 1 |
| Lane, PH | 1 |
| Schnaper, HW | 1 |
| Vernier, RL | 1 |
| Bunchman, TE | 1 |
| Gulanikar, AC | 1 |
| Kotylak, G | 1 |
| Bitter-Suermann, H | 1 |
| Hettich, R | 1 |
| Bochner, BS | 1 |
| Friedman, B | 1 |
| Krishnaswami, G | 1 |
| Schleimer, RP | 1 |
| Lichtenstein, LM | 1 |
| Kroegel, C | 1 |
| Steurer, J | 1 |
| Furrer, J | 1 |
| Rhyner, K | 1 |
| Siegenthaler, W | 2 |
| Feldman, EL | 1 |
| Bromberg, MB | 1 |
| Pestronk, A | 1 |
| Dubbeld, P | 1 |
| van der Heul, C | 1 |
| Hillen, HF | 1 |
| Fitzgerald, JM | 1 |
| Biddle, WL | 1 |
| Adler, DJ | 1 |
| Wong, S | 2 |
| Dykewicz, MS | 5 |
| Ro, J | 1 |
| Sahin, A | 1 |
| Ro, JY | 1 |
| Fritsche, H | 1 |
| Hortobagyi, G | 1 |
| Blick, M | 1 |
| Farid, Z | 1 |
| Mansour, N | 1 |
| Kamal, M | 1 |
| Kamal, K | 1 |
| Safwat, Y | 1 |
| Woody, JN | 1 |
| Philip, T | 1 |
| Rodary, C | 1 |
| Zucker, JM | 1 |
| Gentet, JC | 1 |
| Lamagnère, JP | 1 |
| Otten, J | 1 |
| Dufillot, D | 1 |
| Pein, F | 1 |
| Longo, DL | 1 |
| Russo, A | 1 |
| Duffey, PL | 1 |
| Glatstein, E | 1 |
| Hill, JB | 1 |
| Murata, GH | 2 |
| Gorby, MS | 2 |
| Chick, TW | 2 |
| Halperin, AK | 2 |
| Chapman, KR | 1 |
| Verbeek, PR | 1 |
| White, JG | 1 |
| Rebuck, AS | 1 |
| Shornick, JK | 1 |
| Formica, N | 1 |
| Parke, AL | 1 |
| Piamphongsant, T | 1 |
| Ophaswongse, S | 1 |
| Tenorio, G | 1 |
| Whitaker, JN | 1 |
| Marazuela, M | 1 |
| Yebra, M | 1 |
| Girón, JA | 1 |
| Menéndez, JL | 1 |
| Vargas, JA | 1 |
| España, P | 1 |
| Garcia-Font, M | 1 |
| Durántez, A | 1 |
| Levine, EG | 1 |
| Raczynski, JM | 1 |
| Carpenter, JT | 1 |
| Redman, JR | 1 |
| North, L | 1 |
| Dixon, D | 1 |
| Silvermintz, K | 1 |
| Laurent-Puig, P | 1 |
| Prost, C | 1 |
| Espagne, E | 1 |
| Wechsler, J | 1 |
| Revuz, J | 2 |
| Nickerson, HJ | 1 |
| Coccia, PF | 1 |
| Finklestein, JZ | 1 |
| Miller, DR | 2 |
| Littman, PS | 1 |
| Lukens, JN | 1 |
| Yanofsky, RA | 1 |
| Ghim, T | 1 |
| Wharam, MD | 1 |
| Johnson, W | 1 |
| Jones, B | 1 |
| Freeman, AI | 1 |
| Jacquillat, C | 1 |
| Weil, M | 1 |
| Pochedly, C | 1 |
| Sinks, L | 1 |
| Chevalier, L | 1 |
| Maurer, HM | 1 |
| Euler, HH | 1 |
| Schröder, JO | 1 |
| Gutschmidt, HJ | 1 |
| Harten, P | 1 |
| Stueber, F | 1 |
| Zeuner, RA | 1 |
| Psilas, K | 1 |
| Petroutsos, G | 1 |
| Aspiotis, M | 1 |
| Mendeleev, IM | 1 |
| Oleĭnik, VA | 1 |
| Miasnikov, AA | 1 |
| Polezhaev, IuN | 1 |
| Leone, MR | 1 |
| Barry, JM | 1 |
| Alexander, SR | 1 |
| Melvin, T | 1 |
| Striegel, J | 1 |
| Reller, K | 1 |
| Henell, KR | 1 |
| Kimball, J | 1 |
| Funnell, MB | 1 |
| Goldstein, G | 1 |
| Markin, RS | 1 |
| Wood, RP | 1 |
| Shaw, BW | 1 |
| Brichacek, B | 1 |
| Purtilo, DT | 1 |
| Gao, J | 1 |
| Wang, Y | 1 |
| Miró, J | 1 |
| Amado, JA | 1 |
| Pesquera, C | 1 |
| López-Cordovilla, JJ | 1 |
| Berciano, J | 1 |
| Falkson, HC | 1 |
| Gray, R | 1 |
| Wolberg, WH | 1 |
| Gillchrist, KW | 1 |
| Harris, JE | 1 |
| Tormey, DC | 1 |
| de Andrea, ML | 1 |
| de Camargo, B | 1 |
| Melaragno, R | 1 |
| Zamir, R | 1 |
| Mellibovsky, J | 1 |
| Idises, C | 1 |
| Laurent-Poig, P | 1 |
| Delchier, JC | 1 |
| Bozzette, SA | 1 |
| Sattler, FR | 1 |
| Chiu, J | 3 |
| Wu, AW | 1 |
| Gluckstein, D | 1 |
| Kemper, C | 1 |
| Bartok, A | 1 |
| Niosi, J | 1 |
| Abramson, I | 1 |
| Coffman, J | 1 |
| Pedersen, RS | 1 |
| Aunsholt, NA | 1 |
| Venot, J | 1 |
| Weinbreck, P | 1 |
| Belasco, JB | 1 |
| Luery, N | 1 |
| Scher, C | 1 |
| Rapoport, M | 1 |
| Kornberg, A | 1 |
| Yona, R | 1 |
| Kaufman, S | 1 |
| Chanson, P | 1 |
| Timsit, J | 1 |
| Kujas, M | 1 |
| Violante, A | 1 |
| Guillausseau, PJ | 1 |
| Derome, PJ | 1 |
| Warnet, A | 1 |
| Lubetzki, J | 1 |
| Gómez García, S | 1 |
| Conde Redondo, F | 1 |
| Filippeschi, C | 1 |
| Battini, ML | 1 |
| Tiradritti, L | 1 |
| Mastrolorenzo, A | 1 |
| Staderini, C | 1 |
| Rapaccini, AL | 1 |
| Zuccati, G | 1 |
| Avvisati, G | 1 |
| Tribalto, M | 1 |
| Harris, KE | 1 |
| Wilkel, CS | 1 |
| McDonald, CJ | 1 |
| Roach, M | 1 |
| Brophy, N | 1 |
| Cox, R | 1 |
| Varghese, A | 1 |
| Vlot, AJ | 1 |
| Hené, RJ | 1 |
| Sixma, JJ | 1 |
| Devriese, PP | 1 |
| Schumacher, T | 1 |
| Scheide, A | 1 |
| de Jongh, RH | 1 |
| Houtkooper, JM | 1 |
| Beatty, P | 1 |
| Ash, R | 1 |
| Hows, JM | 1 |
| Wingen, AM | 2 |
| Schärer, K | 2 |
| Rakela, J | 1 |
| Hay, JE | 1 |
| Moore, SB | 1 |
| Doyle, J | 1 |
| Berry, M | 1 |
| Blanchette, V | 1 |
| Chan, H | 1 |
| Doherty, M | 1 |
| Greenberg, M | 1 |
| Panzarella, T | 1 |
| Baker, JP | 1 |
| Brzezinski, A | 1 |
| Prokipchuk, EJ | 1 |
| Unal, M | 1 |
| Witz, F | 1 |
| Troussard, X | 1 |
| Gratecos, N | 1 |
| Michallet, M | 1 |
| Auzanneau, G | 1 |
| Batalden, PB | 1 |
| Lassman, FM | 1 |
| Buran, DJ | 1 |
| Seltz, AE | 1 |
| Nunnink, JC | 1 |
| Krusinski, PA | 1 |
| Yates, JW | 1 |
| Rusthoven, JJ | 1 |
| Tubiana, M | 1 |
| Hayat, M | 1 |
| Van der Schueren, E | 1 |
| Noordijk, EM | 1 |
| Tanguy, A | 1 |
| Meerwaldt, JH | 1 |
| Eifel, PJ | 1 |
| McClure, S | 1 |
| Frassoldati, A | 1 |
| Barbieri, F | 1 |
| Palomba, G | 1 |
| Mauri, C | 1 |
| Boxer, MB | 1 |
| Dirks, E | 1 |
| Goebell, H | 1 |
| Schaarschmidt, K | 1 |
| Förster, S | 1 |
| Quebe-Fehling, E | 1 |
| Eigler, FW | 1 |
| Dölle, W | 1 |
| Hartmann, F | 1 |
| Bates, SE | 1 |
| Raphaelson, MI | 1 |
| Price, RA | 1 |
| McKeever, P | 1 |
| Cohen, S | 1 |
| Ito, R | 1 |
| Saito, T | 1 |
| Suto, Y | 1 |
| Tateoka, N | 1 |
| Onodera, N | 1 |
| Ikeda, Y | 1 |
| Ito, E | 1 |
| Miyano, T | 1 |
| Tachibana, N | 1 |
| Janka, GE | 1 |
| Wiggins, CA | 3 |
| Stone, GW | 1 |
| Rutherford, BD | 1 |
| McConahay, DR | 1 |
| Johnson, WL | 1 |
| Giorgi, LV | 1 |
| Ligon, RW | 1 |
| Hartzler, GO | 1 |
| Meier, B | 1 |
| Diaz-Llopis, M | 1 |
| Menezo, JL | 1 |
| Warshaw, BL | 1 |
| Lloyd, AR | 1 |
| Breit, SN | 1 |
| Rozenberg, MC | 1 |
| Case, JD | 1 |
| Smith, SZ | 1 |
| Padilla, R | 1 |
| Brem, AS | 1 |
| Bailey, RR | 1 |
| Tapio, CM | 1 |
| Wienbeck, M | 1 |
| Purrmann, J | 1 |
| Miller, B | 1 |
| Krull, F | 1 |
| Hellmann, DB | 1 |
| Hardy, K | 1 |
| Lindenfeld, S | 1 |
| Ring, E | 1 |
| Lockshin, MD | 1 |
| Druzin, ML | 1 |
| Qamar, T | 1 |
| Druker, BJ | 1 |
| Bernengo, MG | 1 |
| Meregalli, M | 1 |
| Jemma, C | 1 |
| Lisa, F | 1 |
| Katzen, DR | 1 |
| Leiferman, KM | 1 |
| Weller, PF | 1 |
| Leung, DY | 1 |
| Schwarz, F | 1 |
| Eichhorn, J | 1 |
| Schuler, G | 1 |
| Manthey, J | 1 |
| Kübler, W | 1 |
| Gouet, D | 1 |
| Maréchaud, R | 1 |
| Le Berre, D | 1 |
| Alcalay, M | 1 |
| Becq-Giraudon, B | 1 |
| Boissonnot, L | 1 |
| Bontoux, D | 1 |
| Gil, R | 1 |
| Lefevre, JP | 1 |
| Risse, JF | 1 |
| Lynch, JP | 1 |
| Flint, A | 1 |
| Miller, DM | 1 |
| Fantone, JC | 1 |
| Rinaldo, CR | 1 |
| DeBiasio, RL | 1 |
| Hamoudi, WH | 1 |
| Rabin, B | 1 |
| Liebert, M | 1 |
| Hakala, TR | 1 |
| Millette, TJ | 1 |
| Subramony, SH | 1 |
| Wee, AS | 1 |
| Harisdangkul, V | 1 |
| Klasa, RJ | 1 |
| Abboud, RT | 1 |
| Ballon, HS | 1 |
| Grossman, L | 1 |
| Hyams, JS | 1 |
| Treem, WR | 1 |
| Schwartz, AN | 1 |
| Desche, P | 1 |
| Juliard, JM | 1 |
| Charlier, P | 1 |
| Langlois, J | 1 |
| Gourgon, R | 1 |
| Keating, MJ | 1 |
| Estey, E | 1 |
| Walters, R | 1 |
| Smith, T | 1 |
| McCredie, KB | 1 |
| Freireich, EJ | 2 |
| Elzouki, AY | 1 |
| Jaiswal, OP | 1 |
| Jones, DP | 1 |
| Wyatt, RJ | 1 |
| Mongeau, JG | 1 |
| Robitaille, PO | 1 |
| Roy, F | 1 |
| Mondino, BJ | 1 |
| Phinney, RB | 1 |
| Seidenbaum, M | 1 |
| Holdrinet, RS | 1 |
| Namdar, Z | 1 |
| Haanen, C | 1 |
| Friedlander, RJ | 1 |
| Assan, R | 1 |
| Feutren, G | 1 |
| Sirmai, J | 1 |
| Smith, AY | 1 |
| Van Buren, CT | 1 |
| Lewis, RM | 1 |
| Kerman, RH | 1 |
| Welsh, M | 1 |
| Kahan, BD | 1 |
| Smith, KC | 1 |
| Pittelkow, MR | 1 |
| Su, WP | 1 |
| Obrador, D | 1 |
| Carrió, I | 1 |
| Abadal, ML | 1 |
| Cladellas, M | 1 |
| Ballester, M | 1 |
| Pons-Lladó, G | 1 |
| Binia, M | 1 |
| Bordes, R | 1 |
| Gordillo-Paniagua, G | 1 |
| Mora-Muñoz, A | 1 |
| Herrera-Garnica, J | 1 |
| Gordillo-de Anda, R | 1 |
| Muñoz-Arizpe, R | 1 |
| Harvey, JA | 1 |
| Pak, CY | 1 |
| Hoyoux, C | 1 |
| Chantraine, JM | 1 |
| Geubelle, F | 1 |
| Shohet, I | 1 |
| Meyerovitch, J | 1 |
| Aladjem, M | 1 |
| Esquivel, N | 1 |
| Grünberg, J | 1 |
| Wertman, E | 1 |
| Argov, Z | 1 |
| Abrmasky, O | 1 |
| Schonfeld, SA | 1 |
| Scott, PP | 1 |
| Höpfner, J | 1 |
| Ganser, G | 1 |
| Schmidt, H | 1 |
| Clemens, S | 1 |
| Gaynon, P | 1 |
| Reaman, G | 1 |
| Bleyer, A | 1 |
| Finklestein, J | 1 |
| Evans, RG | 1 |
| Meyers, P | 1 |
| Steinherz, LJ | 1 |
| Sather, H | 1 |
| Landsberg, K | 1 |
| Dias-Tosta, E | 1 |
| Brasil, JP | 1 |
| Figueiredo, MA | 1 |
| Leys, D | 1 |
| Parent, M | 1 |
| Petit, H | 1 |
| Cohen Tervaert, D | 1 |
| Cruysberg, JR | 1 |
| Deutman, AF | 1 |
| Manschot, WA | 1 |
| Ryoo, MC | 1 |
| Kagan, AR | 1 |
| Wollin, M | 1 |
| Nussbaum, H | 1 |
| Chan, PY | 1 |
| Hintz, BL | 1 |
| Rao, AR | 1 |
| McMahon, J | 1 |
| Hernández, MA | 1 |
| Lara, JI | 1 |
| Peces, R | 1 |
| Riera, JR | 1 |
| López Larrea, C | 1 |
| Alvarez, J | 1 |
| Lipton, RB | 1 |
| Rosenbaum, D | 1 |
| Mehler, MF | 1 |
| Scherpbier, HJ | 1 |
| Oosterhuis, HJ | 1 |
| Feurle, GE | 1 |
| Ivanick, MJ | 1 |
| Donohue, JF | 1 |
| Kanaev, SV | 1 |
| Malinin, AP | 1 |
| Chikrizov, SI | 1 |
| Lovell, HB | 1 |
| Lindsley, CB | 1 |
| Beaver, SJ | 1 |
| Zittoun, R | 1 |
| Audebert, A | 1 |
| Hoerni, B | 1 |
| Bernadou, A | 1 |
| Rojouan, J | 1 |
| Eghbali, H | 1 |
| Merle-Béral, H | 1 |
| Parlier, Y | 1 |
| Diebold, J | 1 |
| Scherer, E | 1 |
| Müller, RD | 1 |
| Gingrich, RD | 1 |
| Burns, CP | 1 |
| Aunan, SB | 1 |
| Edwards, RW | 1 |
| Dick, FR | 1 |
| Maguire, LC | 1 |
| Leimert, JT | 1 |
| Ochs, J | 1 |
| Moake, JL | 1 |
| Rudy, CK | 1 |
| Troll, JH | 1 |
| Schafer, AI | 1 |
| Weinstein, MJ | 1 |
| Colannino, NM | 1 |
| Hong, SL | 1 |
| Demetris, AJ | 1 |
| Lasky, S | 1 |
| Van Thiel, DH | 1 |
| Starzl, TE | 1 |
| Dekker, A | 1 |
| Bohn, T | 2 |
| Hunstein, W | 2 |
| Imbasciati, E | 1 |
| Gusmano, R | 1 |
| Zucchelli, P | 1 |
| Pozzi, C | 1 |
| Grassi, C | 1 |
| Della Volpe, M | 1 |
| Petrone, P | 1 |
| Picca, M | 1 |
| Riggs, BS | 1 |
| Harchelroad, FP | 1 |
| Poole, C | 1 |
| Agarwal, RK | 1 |
| Moudgil, A | 1 |
| Bhuyan, UN | 1 |
| Homberg, JC | 1 |
| Hadchouel, M | 1 |
| Alvarez, F | 1 |
| Hadchouel, P | 1 |
| Odièvre, M | 1 |
| Alagille, D | 1 |
| Girino, M | 1 |
| Riccardi, A | 1 |
| Danova, M | 1 |
| Montecucco, CM | 1 |
| Ucci, G | 1 |
| Janda, J | 1 |
| Zábrodský, V | 1 |
| Spatenka, J | 1 |
| Tůma, S | 1 |
| Cade, R | 1 |
| Mars, D | 1 |
| Privette, M | 1 |
| Thompson, R | 1 |
| Croker, B | 1 |
| Peterson, J | 1 |
| Campbell, K | 1 |
| Naveh, Y | 1 |
| Alon, U | 1 |
| Kaftori, JK | 1 |
| Berant, M | 1 |
| Hall, S | 1 |
| McCormick, JL | 1 |
| Greipp, PR | 1 |
| Michet, CJ | 1 |
| McKenna, CH | 1 |
| Shapiro, CM | 1 |
| Vander Laan, BF | 1 |
| Jao, W | 1 |
| Sloan, DE | 1 |
| Mangla, A | 1 |
| Fisher, J | 1 |
| Libby, DM | 1 |
| Saddekni, S | 1 |
| Cogan, E | 1 |
| Fastrez, R | 1 |
| Domingo, P | 1 |
| Llistosella, E | 1 |
| Pérez, M | 1 |
| Sambeat, MA | 1 |
| de Moragas, JM | 1 |
| Guglielmi, C | 1 |
| Ruco, LP | 1 |
| Biagini, C | 1 |
| McIntyre, OR | 1 |
| Cornwell, GG | 1 |
| Leone, L | 1 |
| Ayoub, WT | 1 |
| Franklin, CM | 1 |
| Torretti, D | 1 |
| Jenkins, RB | 1 |
| Grahne, B | 1 |
| Siirala, U | 1 |
| Meurman, L | 1 |
| Kunnas, K | 1 |
| Schein, PS | 1 |
| Silverman, EM | 1 |
| Reed, RE | 1 |
| MacKechnie, HL | 1 |
| Squires, AH | 1 |
| Platts, M | 1 |
| Pruzanski, W | 1 |
| Levo, Y | 2 |
| Pick, AI | 2 |
| Nir, MA | 1 |
| Weiss, C | 2 |
| Feuerman, EJ | 1 |
| Korman, MG | 1 |
| Hofmann, AF | 1 |
| Simone, JV | 3 |
| McDonald, J | 1 |
| Murphy, AV | 1 |
| Arneil, GC | 1 |
| McLaren, JH | 1 |
| Papac, RJ | 1 |
| Amiel, JL | 1 |
| Mathé, G | 1 |
| Mbidde, EK | 1 |
| Nkwocha, J | 1 |
| Glass, JL | 1 |
| Wisch, N | 1 |
| Arvanitakis, C | 1 |
| Manier, JW | 1 |
| Vrubel, F | 1 |
| Martínek, K | 1 |
| Vítek, J | 1 |
| Olbing, H | 2 |
| Beevers, DG | 1 |
| Harpur, JE | 1 |
| Turk, KA | 1 |
| Essig, LJ | 1 |
| Timms, ES | 1 |
| Hancock, DE | 1 |
| Sharp, GC | 1 |
| Goldenberg, DL | 1 |
| Brandt, KD | 1 |
| Cathcart, ES | 1 |
| Cohen, AS | 1 |
| Warnock, ML | 1 |
| Fennessy, J | 1 |
| Rippon, J | 1 |
| Lebenthal, E | 1 |
| Laron, Z | 1 |
| Aygen, M | 1 |
| Gaifman, M | 1 |
| Pertzelan, A | 1 |
| Miller, GC | 1 |
| Witham, AC | 1 |
| Kjaer, M | 1 |
| Degeorges, M | 1 |
| Passa, P | 1 |
| Varin, G | 1 |
| Siegel, NJ | 1 |
| Goldberg, B | 1 |
| Krassner, LS | 1 |
| Hayslett, JP | 1 |
| Resnick, J | 1 |
| Schanberger, JE | 1 |
| Barham, JE | 1 |
| Ruffin, JM | 1 |
| Orenstein, JM | 1 |
| Castadot, MJ | 1 |
| Wilens, SL | 1 |
| Underwood, GE | 1 |
| Weed, SD | 1 |
| Betts, RF | 1 |
| Douglas, RG | 1 |
| Pabico, RC | 1 |
| Talley, TE | 1 |
| Yakub, YN | 1 |
| Freeman, RB | 1 |
| Casassa, PM | 1 |
| Guala, A | 1 |
| Piglia, P | 1 |
| Hurley, RM | 1 |
| Steinberg, RH | 1 |
| Patriquin, H | 1 |
| Drummond, KN | 3 |
| Newman, MJ | 1 |
| Nelson, N | 1 |
| Byland, W | 1 |
| Nagel, G | 1 |
| Mayekar, G | 1 |
| Choudhry, VP | 1 |
| Ghai, OP | 1 |
| Nethercott, J | 1 |
| Lester, RS | 1 |
| Reuschel, I | 1 |
| Reinelt, D | 1 |
| Gruber, G | 1 |
| Raichs, A | 1 |
| Giralt, M | 1 |
| Aztarain, E | 1 |
| Kjeldsberg, CR | 1 |
| Ward, HP | 1 |
| Nyberg-Hansen, R | 1 |
| Hustu, HO | 2 |
| Verzosa, MS | 2 |
| Wyszkowski, J | 1 |
| O'Gorman Hughes, DW | 1 |
| Brunning, RD | 1 |
| Kennedy, BJ | 1 |
| Blatt, PM | 1 |
| Rothstein, G | 1 |
| Miller, HL | 1 |
| Cathey, WJ | 1 |
| Seigler, HF | 1 |
| Gunnells, JC | 1 |
| Robinson, RR | 1 |
| Ward, FE | 1 |
| Amos, DB | 1 |
| Rowlands, DT | 1 |
| Burkholder, PM | 1 |
| Klein, WJ | 1 |
| Stickel, DL | 1 |
| Raij, L | 1 |
| Hoyer, JR | 1 |
| Michael, AF | 1 |
| Williams, R | 1 |
| Smith, MG | 1 |
| Mahon, FB | 1 |
| Malek, GH | 1 |
| Uehling, DT | 1 |
| Greig, WR | 1 |
| Snyder, GG | 1 |
| McCarthy, RE | 1 |
| Toomey, JM | 1 |
| Rothfield, NF | 1 |
| Schmidt, CG | 1 |
| Mukherji, B | 1 |
| Yagoda, A | 1 |
| Lee, BJ | 1 |
| Krakoff, IH | 1 |
| Land, VJ | 1 |
| Sutow, WW | 1 |
| Fernbach, DJ | 1 |
| Lane, DM | 1 |
| Williams, TE | 1 |
| Schachter, EN | 1 |
| Karpick, RJ | 1 |
| Wiggelinkhuizen, J | 1 |
| McDonald, R | 1 |
| Kaschula, RO | 1 |
| Heymann, W | 2 |
| Nicolaescu, V | 1 |
| Leahu, S | 1 |
| Teculescu, D | 1 |
| Racoveanu, C | 1 |
| Nordentoft, AM | 1 |
| Jensen, KB | 1 |
| McLaine, PN | 1 |
| Panush, RS | 1 |
| Wilkinson, LS | 1 |
| Fagin, RR | 1 |
| McElwain, TJ | 1 |
| Hunter, A | 1 |
| Crowther, D | 1 |
| Peckham, MJ | 1 |
| Smithers, DW | 1 |
| Fairley, GH | 1 |
| Cazenave, JP | 1 |
| Gagnon, JA | 1 |
| Girouard, E | 1 |
| Bastarache, A | 1 |
| McGuire, EJ | 1 |
| Cornog, JL | 1 |
| Tofte, T | 1 |
| Bennett, BP | 1 |
| Johnson, RE | 1 |
| Orha, I | 1 |
| Mărcuş, S | 1 |
| Dumitru, C | 1 |
| Andaloro, VA | 1 |
| Babott, D | 1 |
| Sood, VD | 1 |
| Pasricha, JS | 1 |
| Janeczko, J | 1 |
| Osuch, T | 1 |
| Karel, I | 1 |
| Votocková, J | 1 |
| Peleska, M | 1 |
| Logan, WS | 1 |
| Tindall, JP | 1 |
| Elson, ML | 1 |
| Sugar, HS | 1 |
| Nebe, H | 1 |
| Sönnichsen, N | 1 |
| Moore, MR | 1 |
| Bull, JM | 1 |
| Jones, SE | 1 |
| Becker, K | 1 |
| Sawkar, LA | 1 |
| Easom, HF | 1 |
| Lindahl, F | 1 |
| Hart, JS | 1 |
| Trujillo, JM | 1 |
| George, SL | 1 |
| Frei, E | 1 |
| Whang-Peng, J | 1 |
| Carbone, PP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| COrticosteroids in acUte uRticAria in emerGency dEpartment[NCT03545464] | Phase 3 | 240 participants (Anticipated) | Interventional | 2019-09-21 | Recruiting | ||
| Intravenous Methotrexate 1g/m2 as Central Nervous System Prophylaxis for High Risk Diffuse Large B Cell Lymphoma: a Prospective, Phase III, Randomized, Controlled Study[NCT05054426] | Phase 3 | 488 participants (Anticipated) | Interventional | 2021-10-08 | Recruiting | ||
| Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus[NCT00784589] | Phase 3 | 90 participants (Anticipated) | Interventional | 2009-07-31 | Completed | ||
| Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis[NCT02955147] | Phase 1/Phase 2 | 13 participants (Actual) | Interventional | 2016-12-01 | Terminated (stopped due to Inefficacy) | ||
| A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine[NCT02994927] | Phase 3 | 331 participants (Actual) | Interventional | 2017-03-15 | Completed | ||
| Improving Outcomes Assessment in Chronic GVHD[NCT00637689] | 601 participants (Actual) | Observational | 2007-09-30 | Active, not recruiting | |||
| Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus: A Prospective, Random Control, Open-label, Single Center Clinical Trial[NCT05916781] | Phase 4 | 220 participants (Anticipated) | Interventional | 2023-07-01 | Recruiting | ||
| Evaluation of Efficacy of Pharmacotherapy Treatment of COVID- 19 Infection Using Oral Levamisole and Formoterol+Budesonide Inhaler and Comparison of This Treatment Protocol With Standard National Treatment of the Disease[NCT04331470] | Phase 2/Phase 3 | 30 participants (Anticipated) | Interventional | 2020-04-04 | Recruiting | ||
| ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia[NCT00430118] | Phase 3 | 4,559 participants (Actual) | Interventional | 2000-07-31 | Completed | ||
| AIEOP LLA 2000 Multicenter Study for the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia[NCT00613457] | Phase 3 | 2,039 participants (Actual) | Interventional | 2000-09-30 | Completed | ||
| Study of Rituximab Monotherapy VS Steroid Therapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial[NCT05734794] | Phase 3 | 80 participants (Anticipated) | Interventional | 2023-02-09 | Recruiting | ||
| Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.[NCT01910038] | Phase 2 | 20 participants (Actual) | Interventional | 2013-11-08 | Completed | ||
| A Phase II, Randomised Study of CHOP-R in Combination With Acalabrutinib Compared to CHOP-R in Patients With Newly Diagnosed Richter's Syndrome and a Platform for Initial Investigations Into Activity of Novel Treatments in Relapsed/Refractory and Newly Di[NCT03899337] | Phase 2 | 105 participants (Anticipated) | Interventional | 2019-07-23 | Recruiting | ||
| Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis[NCT00276757] | 376 participants (Anticipated) | Interventional | 2001-04-30 | Completed | |||
| A Prospective Institutional Study for the Treatment of Children With Newly Diagnosed Langerhans Cell Histiocytosis Using a Cytarabine Contained Protocol[NCT04773366] | Phase 3 | 200 participants (Anticipated) | Interventional | 2018-07-01 | Recruiting | ||
| The Efficacy of Oral Prednisone in Treating Langerhans Cell Histiocytosis of Bone in Childhood and Adolescence: A Multi-center, Open-label, Randomized-controlled, Phase II Study[NCT06078969] | Phase 2 | 118 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
| A Prospective Study to Evaluate the Efficacy and Safety of Cyclophosphamide in the Treatment of Idiopathic Retroperitoneal Fibrosis[NCT04762810] | Phase 4 | 40 participants (Anticipated) | Interventional | 2020-01-03 | Recruiting | ||
| Rituximab in Patients With Low Dose Steroid-dependent Idiopathic Nephrotic Syndrome[NCT04494438] | Phase 3 | 30 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor-dependent Idiopathic Nephrotic Syndrome: an Open-label, Randomized, Controlled, Superiority Trial.[NCT02394119] | Phase 2 | 140 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| Use of IL-2 for Pediatric, Multi Drug Resistant, Idiopathic Nephrotic Syndrome[NCT02455908] | Phase 1/Phase 2 | 5 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| Randomized Phase 3 Study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma. An AMN Study[NCT03143049] | Phase 3 | 120 participants (Anticipated) | Interventional | 2017-09-13 | Recruiting | ||
| A Phase I/II, Multi-center, Open Label Study of Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma Relapsed and/or Refractory to Lenalidomide[NCT01166113] | Phase 1/Phase 2 | 67 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| Salvage Therapy for Patients With Inadequate Response to Standard of Care Therapy in Granulomatosis With Polyangiitis[NCT04871191] | Phase 2 | 42 participants (Anticipated) | Interventional | 2023-03-31 | Not yet recruiting | ||
| A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis[NCT00468208] | Phase 1/Phase 2 | 20 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Prednisone in Chronic Rhinosinusitis Without Nasal Polyps. A Double-blind, Randomized, Placebo-controlled Trial[NCT02367118] | Phase 3 | 90 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| SinoNasal Microbiota Transfer (SNMT) to Treat Chronic Rhinosinusitis: A Randomized, Double-blind, Placebo-controlled Trial[NCT05454072] | 80 participants (Anticipated) | Interventional | 2022-06-15 | Recruiting | |||
| A Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (Bortezomib) in Combination With Rituximab, Cyclophosphamide, and Prednisone With or Without Doxorubicin Followed by Rituximab Maintenance in Patients With Relapsed Follicular Lymphoma.[NCT00715208] | Phase 2 | 55 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis (ITN021AI)[NCT00104299] | Phase 2/Phase 3 | 197 participants (Actual) | Interventional | 2005-01-31 | Completed | ||
| MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma[NCT00838591] | Phase 2 | 176 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Biomarkers in Giant Cells Arteritis[NCT02844023] | 100 participants (Actual) | Interventional | 2015-01-31 | Terminated (stopped due to recruitment failure) | |||
| CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)[NCT00309881] | Phase 2 | 75 participants (Anticipated) | Interventional | 2003-04-30 | Completed | ||
| A Multicenter Prospective Randomized Study of Dexamethasone Combined With Decitabine Versus Dexamethasone in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP)[NCT03252457] | Phase 3 | 200 participants (Anticipated) | Interventional | 2018-09-01 | Not yet recruiting | ||
| Phase II of Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Patients With Relapsed or Refractory Follicular Lymphoma[NCT00366275] | Phase 2 | 64 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study[NCT03399175] | 40 participants (Anticipated) | Interventional | 2015-03-23 | Recruiting | |||
| Ofatumumab in Children With Steroid- and Calcineurin-inhibitor-resistant Nephrotic Syndrome: a Double-blind Randomized, Controlled, Superiority Trial[NCT02394106] | Phase 2 | 13 participants (Actual) | Interventional | 2015-07-31 | Terminated | ||
| A Phase II Study of Imatinib Mesylate in Children and Adults With Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease[NCT00702689] | Phase 2 | 20 participants (Actual) | Interventional | 2008-12-15 | Completed | ||
| A Multinational Prospective Study on the Duration of Steroid Therapy in Steroid Sensitive Nephrotic Syndrome[NCT03878914] | Phase 4 | 34 participants (Actual) | Interventional | 2019-08-06 | Terminated (stopped due to The study was terminated at all but one site because of the pandemic) | ||
| A Phase II Study of Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma[NCT01068392] | Phase 2 | 42 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma[NCT01241006] | Phase 4 | 376 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course[NCT04204876] | 40 participants (Anticipated) | Observational | 2020-05-28 | Recruiting | |||
| Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized Aggressive Histologies of Non-Hodgkin's Lymphoma[NCT00005089] | Phase 2 | 71 participants (Actual) | Interventional | 2000-04-30 | Completed | ||
| INSIGHT (Insight Into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics)[NCT01605266] | 1,000 participants (Anticipated) | Observational | 2011-01-31 | Recruiting | |||
| Multimodal Analysis and Electroretinogram in VKH From Acute Onset - a Prospective Study[NCT03811366] | 12 participants (Actual) | Interventional | 2011-06-01 | Completed | |||
| A Phase II, Prospective, Single-center Study of Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement[NCT04432714] | Phase 1/Phase 2 | 81 participants (Anticipated) | Interventional | 2020-06-09 | Recruiting | ||
| Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia[NCT01429610] | Phase 2 | 78 participants (Actual) | Interventional | 2011-11-30 | Active, not recruiting | ||
| Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study[NCT01628315] | 159 participants (Actual) | Observational | 2009-03-31 | Completed | |||
| Phase IV Study of Oral Prednisone Taper vs. Placebo Following Intravenous Steroids for the Treatment of Acute Relapses in Multiple Sclerosis Within the Ticino Cohort[NCT01411514] | Phase 4 | 27 participants (Actual) | Interventional | 2011-08-31 | Terminated (stopped due to Difficulties to recruit patients) | ||
| A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study[NCT05142254] | Phase 2 | 64 participants (Actual) | Interventional | 2022-04-01 | Active, not recruiting | ||
| A Pilot Study of Mycophenolate Mofetil (MMF) in Patients With p-ANCA Microscopic Polyangiitis and Mild to Moderate Renal Dysfunction.[NCT00405860] | Phase 1 | 18 participants (Actual) | Interventional | 2002-12-31 | Completed | ||
| Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma[NCT00151281] | Phase 2 | 25 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for[NCT05218603] | 100 participants (Anticipated) | Observational | 2021-11-30 | Recruiting | |||
| Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) in Remission Induction and Maintenance Treatment of Relapsed Follicular Non-Hodgkin's Lymphoma: A Phase III Randomized Clinical Trial - Intergroup Collaborative Study[NCT00004179] | Phase 3 | 475 participants (Actual) | Interventional | 1999-05-31 | Completed | ||
| A Phase II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituximab, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)[NCT00295932] | Phase 1/Phase 2 | 79 participants (Actual) | Interventional | 2005-12-13 | Completed | ||
| ALL-REZ BFM 2002: Protocol for the Treatment of Children With Relapsed Acute Lymphoblastic Leukemia[NCT00114348] | Phase 4 | 338 participants (Actual) | Interventional | 2003-08-31 | Completed | ||
| PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma[NCT00147875] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2004-03-31 | Completed | ||
| A Phase Ib/II Trial of Combined SGN-35 (BrentuximabVedotin) Therapy With Cyclophosphamide, Procarbazine, Prednisone, Etoposide and Mitoxantrone (BrEPEM) for Older Patients With Untreated Hodgkin Lymphoma (HL)[NCT03576378] | Phase 1/Phase 2 | 41 participants (Actual) | Interventional | 2018-08-08 | Active, not recruiting | ||
| Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis[NCT03126201] | 86 participants (Actual) | Observational | 2016-12-31 | Completed | |||
| Clinical Trial to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis[NCT05430412] | 15 participants (Anticipated) | Interventional | 2022-01-11 | Recruiting | |||
| Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma[NCT00004228] | Phase 3 | 393 participants (Actual) | Interventional | 2000-06-30 | Completed | ||
| Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)[NCT02258217] | 30 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| Interest of Plasma Exchange in Patients With Anti-interferon Type 1 Autoantibodies With Severe COVID-19 -[NCT05182515] | Phase 3 | 50 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis[NCT01837433] | Phase 4 | 40 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
| A Randomized, Controled, Open Label Trial: Comparison Between Two Standardized Corticosteroids Tapering, Respectively Short (North American) and Long (European), in Giant Cell Arteritis[NCT04012905] | Phase 3 | 150 participants (Anticipated) | Interventional | 2020-11-05 | Not yet recruiting | ||
| Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study.[NCT03244709] | Phase 4 | 15 participants (Anticipated) | Interventional | 2015-01-01 | Recruiting | ||
| A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL).[NCT00195871] | Phase 2 | 155 participants (Actual) | Interventional | 2004-02-29 | Active, not recruiting | ||
| A Randomized, Multicenter Study to Assess the Efficacy on Diseases Activity of Enteric-coated Mycophenolate Sodium Versus Continuation of Azathioprine in Patients With Systemic Lupus Erythematosus on Azathioprine Maintenance Therapy.[NCT00504244] | Phase 3 | 12 participants (Actual) | Interventional | 2007-07-31 | Terminated (stopped due to Insufficient recruitment) | ||
| Five-Year Single-Blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis: Oral Cyclophosphamide Versus High Dose Intravenous Cyclophosphamide Versus Intermediate Dose Intrav[NCT00336414] | Phase 3 | 0 participants (Actual) | Interventional | 2006-06-30 | Withdrawn (stopped due to the study is withdrawn due to low and unexpected enrollment rate) | ||
| CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid[NCT03492255] | 49 participants (Actual) | Interventional | 2018-04-12 | Terminated (stopped due to Significative difference between percentage of renal response (primary outcome) between the two study arms.) | |||
| VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu's Arteritis):Development as Clinical Trial Outcome Measures[NCT00744952] | 26 participants (Actual) | Observational | 2008-08-31 | Completed | |||
| Natural History of Intestinal Inflammation in Patients With Primary Immune Dysregulations[NCT03278912] | 0 participants (Actual) | Observational | 2023-09-08 | Withdrawn (stopped due to Funding completed.) | |||
| Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis[NCT01671423] | 42 participants (Actual) | Interventional | 2012-08-31 | Completed | |||
| Outcomes of Low-dose Colchicine in Patients With Myocardial Infarction: A Randomized Controlled Trial[NCT04218786] | Phase 2 | 0 participants (Actual) | Interventional | 2025-12-31 | Withdrawn (stopped due to Due to the pandemic, there were logistical issues in continuing the study.) | ||
| Viral Infection of Lymphoid Cells Occuring at the First Manifestation of Idiopathic Nephrotic Syndrome[NCT00577525] | 401 participants (Actual) | Observational | 2007-12-31 | Completed | |||
| Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study[NCT02066454] | Phase 3 | 105 participants (Anticipated) | Interventional | 2014-04-30 | Recruiting | ||
| Standard Chemotherapy (CHOP Regimen) Versus Sequential High-Dose Chemotherapy With Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas and Poor Prognostic Factors: A Randomized Phase III Study (MISTRAL)[NCT00003215] | Phase 3 | 400 participants (Anticipated) | Interventional | 1997-04-30 | Completed | ||
| Is the Melanocortin System Involved in Inflammatory Resolution[NCT05681676] | 9 participants (Actual) | Observational | 2012-03-01 | Completed | |||
| A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794] | Phase 3 | 94 participants (Anticipated) | Interventional | 2019-03-01 | Recruiting | ||
| A Prospective Cross-over Study Comparing the Effect of Sirolimus Versus Mycophenolate on Viral Load in Liver Transplant Recipients With Recurrent Chronic HCV Infection[NCT01134952] | Phase 4 | 11 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener's Granulomatosis and SHURG-STRAUSS Syndrome) During and After Corticosteroids and Immunosuppressant Therapies a Multicenter Prospective Trial[NCT00307658] | Phase 3 | 40 participants | Interventional | 2001-03-31 | Terminated | ||
| Randomized Controlled Trial Comparing Fluticasone Plus Omeprazole With Fluticasone Alone for Eosinophilic Esophagitis[NCT03781596] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-10-02 | Recruiting | ||
| A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children[NCT01458418] | 4 participants (Actual) | Interventional | 2011-12-31 | Terminated (stopped due to Inability to complete enrollment due to difficulty in finding subjects) | |||
| Single Dose Dexamethasone is as Effective as Two Doses in Mild to Moderate Pediatric Asthma Exacerbations in the Emergency Department[NCT02192827] | Phase 3 | 318 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| Oral Dexamethasone Versus Oral Prednisone in Children Hospitalized With Asthma: A Randomized Control Study[NCT02780479] | Phase 4 | 6 participants (Actual) | Interventional | 2017-03-20 | Terminated (stopped due to insufficient number of participants met the enrollment criteria.) | ||
| Comparison of Single Dose Versus Two Doses of Oral Dexamethasone in the Management of Acute Asthma Exacerbations in the Pediatric Emergency Department.[NCT00942201] | 125 participants (Actual) | Interventional | 2008-08-31 | Completed | |||
| A Pilot Study of Neurocysticercosis Treatment[NCT00283699] | Phase 3 | 178 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
| The Efficacy of High-Dose Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)[NCT00001287] | Phase 2 | 60 participants | Interventional | 1990-12-31 | Completed | ||
| Budesonide Inhalation Suspension for Acute Asthma in Children[NCT00393367] | Phase 4 | 179 participants (Actual) | Interventional | 2006-12-31 | Completed | ||
| A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas[NCT00001430] | Phase 2 | 49 participants | Interventional | 1995-02-28 | Completed | ||
| A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides[NCT00001473] | 100 participants | Observational | 1995-03-31 | Completed | |||
| An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis[NCT00001256] | Phase 2 | 100 participants | Interventional | 1990-03-31 | Completed | ||
| Multicentric Double Blind Versus Placebo Randomised Study Evaluating the Corticosteroid Sparing Effect of Hydrocyschloroquine in Non Complicated Giant Cell Arteritis.[NCT00430807] | Phase 3 | 75 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| [NCT00000147] | 0 participants | Interventional | 1988-07-31 | Active, not recruiting | |||
| Phase I Dose Escalation of T-cell Receptor α/β Depleted Donor Lymphocyte Infusions Following CD34+- Selected Allogeneic Stem Cell Transplantation From Related & Unrelated Donors in Patients With Lymphoid, Myeloid or Plasma Cell Malignancies[NCT05350163] | Phase 1 | 11 participants (Actual) | Interventional | 2022-04-05 | Active, not recruiting | ||
| Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus[NCT00237653] | Phase 3 | 40 participants (Anticipated) | Interventional | 2004-02-29 | Terminated (stopped due to difficulty to include patients) | ||
| Effect of Prophylactic Prosthesis Placement With Versus Without Omega-3 at the Umbilical Trocar Level on Surgical Site Infection and Herniation After Laparoscopic Cholecystectomy in Patients With Risk Factors.[NCT04345809] | 95 participants (Actual) | Observational | 2016-01-31 | Completed | |||
| Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome: a Randomized, Multicenter, Open-label, Parallel-arm Study[NCT04048161] | Phase 4 | 270 participants (Actual) | Interventional | 2019-11-12 | Completed | ||
| Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome[NCT06125405] | Phase 3 | 20 participants (Anticipated) | Interventional | 2023-11-24 | Recruiting | ||
| [NCT00000146] | Phase 3 | 0 participants | Interventional | 1988-07-31 | Active, not recruiting | ||
| Dalfampridine After Optic Neuritis to Improve Visual Function in Multiple Sclerosis[NCT01337986] | Phase 2/Phase 3 | 53 participants (Actual) | Interventional | 2011-05-31 | Completed | ||
| A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia (T-ALL[NCT05289687] | Phase 2 | 20 participants (Anticipated) | Interventional | 2023-05-25 | Recruiting | ||
| Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation[NCT00151580] | Phase 3 | 200 participants (Actual) | Interventional | 2002-02-28 | Completed | ||
| A Trial of Prednisone and Acetaminophen Versus Acetaminophen Alone in Minimizing Flu-like Symptoms From Pegylated Interferon Beta-1a[NCT03424733] | Phase 4 | 50 participants (Anticipated) | Interventional | 2017-09-25 | Recruiting | ||
| A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL[NCT02046694] | Early Phase 1 | 34 participants (Actual) | Interventional | 2014-01-06 | Completed | ||
| A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone as Post Autologous Transplant Consolidation in Patients With High-risk Multiple Myeloma[NCT02906332] | Phase 2 | 12 participants (Actual) | Interventional | 2016-12-12 | Terminated (stopped due to FDA Hold Due to Updated Risks) | ||
| [NCT00222053] | Phase 3 | 800 participants (Actual) | Interventional | 2000-04-30 | Completed | ||
| Relevance of Maintenance Therapy Using Lenalidomide (Revimid®) After Autologous Stem Cell Transplantation Patients Under the Age Of 65. (Open, Randomised, Multi-centric Trial Versus Placebo).[NCT00430365] | Phase 3 | 614 participants (Anticipated) | Interventional | 2006-06-30 | Completed | ||
| A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcad[NCT00443235] | Phase 3 | 260 participants (Anticipated) | Interventional | 2005-03-31 | Completed | ||
| A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With VBMCP-VBAD/Velcade Versus Thalidomide / Dexamethasone Versus Velcade / Thalidomide / Dexamethasone Followed by High Dose Intensive Therapy With Autolo[NCT00461747] | Phase 3 | 390 participants (Anticipated) | Interventional | 2006-03-31 | Completed | ||
| A Prospective, Pilot Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections[NCT01090557] | 60 participants (Anticipated) | Observational | 2007-10-31 | Completed | |||
| A Prospective Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections[NCT01098227] | 0 participants (Actual) | Observational | 2010-01-31 | Withdrawn (stopped due to The equipment to be used for the study was inoperable and not repairable.) | |||
| Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?[NCT01239199] | 86 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Initiating Inhaled Corticosteroid Therapy at Discharge From the Pediatric Emergency Department to Prevent Asthma Relapse: A Randomized Control Trial[NCT03369847] | Phase 4 | 43 participants (Actual) | Interventional | 2017-09-10 | Completed | ||
| Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy[NCT02852694] | Phase 4 | 312 participants (Anticipated) | Interventional | 2017-02-28 | Recruiting | ||
| Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System[NCT02235857] | 35 participants (Anticipated) | Interventional | 2015-05-03 | Recruiting | |||
| Predictors of Clinical Response to Montelukast in Children With Functional Dyspepsia[NCT02360696] | 18 participants (Actual) | Observational | 2014-08-31 | Completed | |||
| Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies or Patients With Autoinflammatory/Immunodysregulatory Conditions: Busulfan-Based Conditioning With Campath- 1H or h-ATG, Radiation, and Sirolimus[NCT00426517] | Early Phase 1 | 48 participants (Actual) | Interventional | 2007-01-19 | Completed | ||
| Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma[NCT00135499] | Phase 3 | 138 participants (Actual) | Interventional | 2001-10-16 | Terminated (stopped due to Recruitment too low) | ||
| A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma[NCT03151044] | Phase 3 | 408 participants (Anticipated) | Interventional | 2016-07-31 | Recruiting | ||
| Randomized Study of ICE Plus RITUXIMAB Versus DHAP Plus Rituximab in Previously Treated Patients With Diffuse Large B-cell Lymphoma, Followed by Randomized Maintenance With Rituximab[NCT00137995] | Phase 3 | 481 participants (Actual) | Interventional | 2003-06-30 | Completed | ||
| Phase Ib Dose Finding Study of ABT-199 (A-1195425.0) Plus Ibrutinib (PCI-32765) and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell NHL (DLBCL)[NCT03136497] | Phase 1 | 10 participants (Actual) | Interventional | 2017-09-05 | Active, not recruiting | ||
| Gemcitabine-oxaliplatin Plus Rituximab (R-GEMOX) in Refractory/Relapsed Patients With CD 20 Positive Diffuse Large B-cell Lymphoma, Non Eligible for High-dose Chemotherapy Followed by Autotransplantation[NCT00169195] | Phase 2 | 49 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma[NCT00169468] | Phase 2 | 48 participants (Actual) | Interventional | 2005-01-31 | Completed | ||
| Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis[NCT00261118] | Phase 2/Phase 3 | 24 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258] | Phase 4 | 50 participants (Anticipated) | Interventional | 2006-10-31 | Completed | ||
| Phase III,Randomized Controlled Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma[NCT02767674] | Phase 3 | 258 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | ||
| Candidate Gene Polymorphisms and Response to Rituximab-CHOP in Patients With Diffuse Large Cell Lymphoma[NCT00590941] | 52 participants (Actual) | Interventional | 2005-02-28 | Completed | |||
| Phase II Trial Investigating Tailoring First-Line Therapy For Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Mid-Treatment Positron Emission Tomography (PET) Scan Results[NCT00324467] | Phase 2 | 150 participants (Actual) | Interventional | 2006-08-31 | Active, not recruiting | ||
| A Phase 2a Study of the Addition of Temozolomide to a Standard Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed and Refractory Central Nervous System (CNS) Lymphoma[NCT01235793] | Phase 2 | 11 participants (Actual) | Interventional | 2010-10-14 | Terminated (stopped due to The clinical trial was terminated due to poor enrollment) | ||
| Phase II Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy[NCT01626352] | Phase 2 | 22 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Rituximab, Cyclophosphamide, Vincristine, and Prednisone in Combination With Doxorubicin (R-CHOP) Versus in Combination With Pegylated-liposomal Doxorubicin (R-CDOP) as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma: a Random[NCT02428751] | Phase 3 | 216 participants (Anticipated) | Interventional | 2015-09-30 | Recruiting | ||
| Phase I/II Study of MLN4924 Alone Followed by Dose-Adjusted EPOCH-Rituximab + MLN4924 With Gene Expression Profiling and Mutational Analysis in Relapsed/Refractory de Novo Diffuse Large B-Cell Lymphoma[NCT01415765] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2011-07-15 | Withdrawn | ||
| Cyclophosphamide and Hydroxychloroquine for the Treatment of Severe Thrombocytopenia in Systemic Lupus Erythematosus[NCT02444728] | Phase 3 | 50 participants (Actual) | Interventional | 2015-07-31 | Terminated (stopped due to Because of insufficient enrollement) | ||
| Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate[NCT00323960] | Phase 3 | 139 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease[NCT01981889] | Phase 4 | 53 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| (PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
| Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
| Observational Prospective Multicentered Study Evaluating Initial Clinical Presentation of Inflammatory Optic Neuritis (ON) Associated or Not With Autoantibodies Anti- Myelin-oligodendrocyte-glycoprotein (MOG-Ab)[NCT03345537] | 103 participants (Actual) | Observational | 2018-02-12 | Completed | |||
| An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies[NCT00072592] | Phase 1 | 10 participants | Interventional | 2003-10-31 | Completed | ||
| Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis[NCT02626845] | Phase 4 | 3 participants (Actual) | Interventional | 2015-12-31 | Terminated (stopped due to Slow recruitment) | ||
| Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis[NCT00001761] | Phase 1 | 15 participants | Interventional | 1998-02-28 | Completed | ||
| Treatment of Wegener's Granulomatosis With Cyclophosphamide[NCT00001155] | Phase 2 | 200 participants | Interventional | 1976-02-29 | Completed | ||
| Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.[NCT00751517] | Phase 2 | 0 participants | Interventional | Active, not recruiting | |||
| A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides[NCT00004567] | Phase 2 | 75 participants | Interventional | 2000-02-29 | Completed | ||
| Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis[NCT00001901] | Phase 2 | 60 participants | Interventional | 1999-02-28 | Completed | ||
| Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149] | Phase 4 | 300 participants | Interventional | 2000-05-31 | Recruiting | ||
| Oral Corticosteroids Therapy and Interstitial Fibrosis in Patients With Pneumocystis Jirovecii Pneumonia (PCP) and pO2 of >70 at Presentation.[NCT00636935] | Phase 4 | 0 participants (Actual) | Interventional | 2008-02-29 | Withdrawn (stopped due to No patient completed protocol) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02955147)
Timeframe: 52 weeks
| Intervention | mg of prednisone (Mean) |
|---|---|
| Ustekinumab Plus Prednisone | 2289 |
(NCT02955147)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Ustekinumab Plus Prednisone | 12 |
Disease relapse was defined as the recurrence of signs or symptoms of GCA (e.g., cranial or PMR) that required treatment intensification, regardless of the ESR and CRP levels. (NCT02955147)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Ustekinumab Plus Prednisone | 7 |
The primary study endpoint, prednisone-free remission, was defined as: 1) absence of relapse from the time that remission was achieved through week 52; 2) normalization of ESR (<40 mm/hour) and CRP (<10 mg/L); and, 3) adherence to the protocol prednisone taper. (NCT02955147)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Ustekinumab Plus Prednisone | 3 |
"BVAS=Birmingham Vasculitis Activity Score;~A relapse was defined as occurrence of at least one major item in the BVAS, or three or more minor items in the BVAS, or one or two minor items in the BVAS recorded at two consecutive visits, after:~having achieved remission at Week 26 (BVAS=0 and no glucocorticoids for ANCA-associated vasculitis within 4 weeks) or~having achieved BVAS=0 at any time during the treatment period~The BVAS form is divided into 9 organ-based systems, with each section including symptoms/signs that are typical of that particular organ involvement in systemic vasculitis. The clinician only scores features believed to be due to active vasculitis. Completion of the form provides a numerical score, which ranges from 0 (best health) to 63 (worst health)." (NCT02994927)
Timeframe: From day 1 throughout the study period (day 421/week 60)
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone Group | 33 |
| Avacopan Group | 16 |
"Clinical significance was assessed by the individual reading of the ECGs~ECG=Electrocardiogram" (NCT02994927)
Timeframe: From day 1 throughout the study period (day 421/week 60)
| Intervention | Participants (Count of Participants) |
|---|---|
| Prednisone Group | 8 |
| Avacopan Group | 12 |
"AC=Adjudication Committee; BVAS=Birmingham Vasculitis Activity Score;~The BVAS form is divided into 9 organ-based systems, with each section including symptoms/signs that are typical of that particular organ involvement in systemic vasculitis. The clinician only scores features believed to be due to active vasculitis. Completion of the form provides a numerical score, which ranges from 0 (best health) to 63 (worst health)." (NCT02994927)
Timeframe: Week 4
| Intervention | percentage of participants (Number) |
|---|---|
| Prednisone Group | 68.9 |
| Avacopan Group | 62.7 |
"Disease remission at Week 26 was defined as:~Achieving a BVAS of 0 as determined by the Adjudication Committee;~No administration of glucocorticoids given for ANCA-associated vasculitis within 4 weeks prior to Week 26;~No BVAS >0 during the 4 weeks prior to Week 26 (if collected for an unscheduled assessment)." (NCT02994927)
Timeframe: Week 26
| Intervention | percentage of participants (Number) |
|---|---|
| Prednisone Group | 70.1 |
| Avacopan Group | 72.3 |
"Sustained remission at Week 52 was defined as:~Disease remission at Week 26 as defined above;~Disease remission at Week 52 defined as a BVAS of 0 at Week 52 as determined by the Adjudication Committee and no administration of glucocorticoids for treatment of ANCA-associated vasculitis within 4 weeks prior to Week 52;~No disease relapse between Week 26 and Week 52 as determined by the Adjudication Committee." (NCT02994927)
Timeframe: Week 52
| Intervention | percentage of participants (Number) |
|---|---|
| Prednisone Group | 54.9 |
| Avacopan Group | 65.7 |
"The median time to relapse was not estimable because of small number of relapsed subjects.~A relapse was defined as occurrence of at least one major item in the BVAS, or three or more minor items in the BVAS, or one or two minor items in the BVAS recorded at two consecutive visits, after:~having achieved remission at Week 26 (BVAS=0 and no glucocorticoids for ANCA-associated vasculitis within 4 weeks) or~having achieved BVAS=0 at any time during the treatment period~The Birmingham Vasculitis Activity Score (BVAS) form is divided into 9 organ-based systems, with each section including symptoms/signs that are typical of that particular organ involvement in systemic vasculitis. The clinician only scores features believed to be due to active vasculitis. Completion of the form provides a numerical score, which ranges from 0 (best health) to 63 (worst health)." (NCT02994927)
Timeframe: Week 52
| Intervention | percentage of participants (Number) |
|---|---|
| Prednisone Group | 21.0 |
| Avacopan Group | 10.1 |
"The median time to relapse was not estimable because of small number of relapsed subjects.~A relapse was defined as occurrence of at least one major item in the BVAS, or three or more minor items in the BVAS, or one or two minor items in the BVAS recorded at two consecutive visits, after:~having achieved remission at Week 26 (BVAS=0 and no glucocorticoids for ANCA-associated vasculitis within 4 weeks) or~having achieved BVAS=0 at any time during the treatment period~ANCA=anti-neutrophil cytoplasmic autoantibody; BVAS=Birmingham Vasculitis Activity Score; The BVAS form is divided into 9 organ-based systems, with each section including symptoms/signs that are typical of that particular organ involvement in systemic vasculitis. The clinician only scores features believed to be due to active vasculitis. Completion of the form provides a numerical score, which ranges from 0 (best health) to 63 (worst health)." (NCT02994927)
Timeframe: Week 52
| Intervention | percentage of participants (Number) |
|---|---|
| Prednisone Group | 12.2 |
| Avacopan Group | 7.5 |
"WBC=White Blood Cell~TEAE=Treatment-Emergent Adverse Event" (NCT02994927)
Timeframe: From day 1 throughout the study period (day 421/week 60)
| Intervention | Participants (Count of Participants) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Any Treatment-Emergent Infection | Any Serious Treatment-Emergent Infection | Any Severe Treatment-Emergent Infection | Any Treatment-Emergent Infection Leading to Study Withdrawal | Any Treatment-Emergent Life-threatening Infection | Any Treatment-Emergent Infection Leading to Death | Any TEAE Associated with Hepatic Abnormalities | Any TEAE Associated with Low WBC Counts | Any TEAE Associated with hypersensitivity | |
| Avacopan Group | 113 | 22 | 12 | 4 | 1 | 1 | 22 | 31 | 68 |
| Prednisone Group | 124 | 25 | 10 | 5 | 2 | 2 | 19 | 39 | 70 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | 10^3 cells/μL (Mean) | |||||
|---|---|---|---|---|---|---|
| Leukocytes (Week 26) | Leukocytes (Week 52) | Neutrophils (Week 26) | Neutrophils (Week 52) | Lymphocytes (Week 26) | Lymphocytes (Week 52) | |
| Avacopan Group | -5.94 | -5.62 | -5.24 | -4.95 | -0.84 | -0.82 |
| Prednisone Group | -5.69 | -5.54 | -5.10 | -4.89 | -0.62 | -0.67 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | 10^9 cells/L (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Eosinophils (Week 26) | Eosinophils (Week 52) | Basophils (Week 26) | Basophils (Week 52) | Monocytes (Week 26) | Monocytes (Week 52) | Platelets (Week 26) | Platelets (Week 52) | |
| Avacopan Group | 0.07 | 0.07 | -0.00 | -0.01 | -0.04 | -0.01 | -77.1 | -73.8 |
| Prednisone Group | 0.07 | 0.05 | -0.01 | -0.01 | 0.01 | 0.01 | -73.9 | -75.5 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | 10^12 cells/L (Mean) | |
|---|---|---|
| Erythrocytes (Week 26) | Erythrocytes (Week 52) | |
| Avacopan Group | 0.252 | 0.279 |
| Prednisone Group | 0.226 | 0.244 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | g/dL (Mean) | |
|---|---|---|
| Hemoglobin (Week 26) | Hemoglobin (Week 52) | |
| Avacopan Group | 1.10 | 1.27 |
| Prednisone Group | 1.07 | 1.20 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | percentage of red blood cells (Mean) | |
|---|---|---|
| Hematocrit (Week 26) | Hematocrit (Week 52) | |
| Avacopan Group | 2.7 | 3.2 |
| Prednisone Group | 2.6 | 3.0 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | U/L (Mean) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lactate Dehydrogenase (Week 26) | Lactate Dehydrogenase (Week 52) | Alkaline Phosphatase (Week 26) | Alkaline Phosphatase (Week 52) | Creatine Kinase (Week 26) | Creatine Kinase (Week 52) | Alanine Aminotransferase (Week 26) | Alanine Aminotransferase (Week 52) | Aspartate Aminotransferase (Week 26) | Aspartate Aminotransferase (Week 52) | |
| Avacopan Group | -6.1 | -10.7 | -3.9 | -4.0 | 76.8 | 76.3 | -6.1 | -7.2 | 2.5 | 2.0 |
| Prednisone Group | 2.3 | -8.6 | -0.6 | 0.8 | 47.6 | 57.6 | -6.8 | -8.2 | 1.9 | 0.5 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | mg/dL (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creatinine (Week 26) | Creatinine (Week 52) | Urea Nitrogen (Week 26) | Urea Nitrogen (Week 52) | Protein (Week 26) | Protein (Week 52) | Cholesterol (Week 26) | Cholesterol (Week 52) | LDL Cholesterol (Week 26) | LDL Cholesterol (Week 52) | Bilirubin (Week 26) | Bilirubin (Week 52) | |
| Avacopan Group | -0.195 | -0.244 | -11.0 | -11.9 | 220 | 250 | 7.4 | 9.3 | 12.0 | 11.9 | 0.078 | 0.057 |
| Prednisone Group | -0.105 | -0.200 | -9.4 | -7.8 | 50 | 160 | 19.0 | 13.8 | 22.7 | 21.7 | 0.065 | 0.053 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | mmHg (Mean) | |||
|---|---|---|---|---|
| Systolic Blood Pressure (Week 26) | Systolic Blood Pressure (Week 52) | Diastolic Blood Pressure (Week 26) | Diastolic Blood Pressure (Week 52) | |
| Avacopan Group | -2.6 | -1.0 | 0.5 | 1.4 |
| Prednisone Group | -2.5 | -2.4 | 2.7 | 1.4 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | beats/min (Mean) | |
|---|---|---|
| Pulse Rate (Week 26) | Pulse Rate (Week 52) | |
| Avacopan Group | 0.9 | -0.3 |
| Prednisone Group | 2.2 | -1.3 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | degree Celsius (Mean) | |
|---|---|---|
| Temperature (Week 26) | Temperature (Week 52) | |
| Avacopan Group | -0.11 | -0.11 |
| Prednisone Group | -0.03 | 0.04 |
(NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | kilogram(s) (Mean) | |
|---|---|---|
| Weight (Week 26) | Weight (Week 52) | |
| Avacopan Group | 1.93 | 2.59 |
| Prednisone Group | 3.33 | 3.27 |
BMI=Body Mass Index (NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | kilogram(s)/ square meter (Mean) | |
|---|---|---|
| BMI (Week 26) | BMI (Week 52) | |
| Avacopan Group | 0.67 | 0.94 |
| Prednisone Group | 1.13 | 1.12 |
"SF-36v2: Measure of health- related quality of life (Medical Outcomes Survey Short Form-36 version 2)~EQ-5D-5L: EuroQuality of Life-5 Domains-5 Levels~The SF-36v2 component scores and the EQ-5D-5L VAS score range from 0 (worst health) to 100 (best health). The EQ-5D-5L Index Score ranges from 0 (worst health) to 1 (best health)." (NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | Change from baseline (Least Squares Mean) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SF-36v2: Physical Component Score (Week 26) | SF-36v2: Physical Component Score (Week 52) | SF-36v2: Physical Functioning (Week 26) | SF-36v2: Physical Functioning (Week 52) | SF-36v2: Role Physical (Week 26) | SF-36v2: Role Physical (Week 52) | SF-36v2: Bodily Pain (Week 26) | SF-36v2: Bodily Pain (Week 52) | SF-36v2: General Health Perception (Week 26) | SF-36v2: General Health Perception (Week 52) | SF-36v2: Mental Component Score (Week 26) | SF-36v2: Mental Component Score (Week 52) | SF-36v2: Mental Health (Week 26) | SF-36v2: Mental Health (Week 52) | SF-36v2: Role Emotional (Week 26) | SF-36v2: Role Emotional (Week 52) | SF-36v2: Social Functioning (Week 26) | SF-36v2: Social Functioning (Week 52) | SF-36v2: Vitality (Week 26) | SF-36v2: Vitality (Week 52) | EQ-5D-5L VAS Score (Week 26) | EQ-5D-5L VAS Score (Week 52) | EQ-5D-5L Index Score (Week 26) | EQ-5D-5L Index Score (Week 52) | |
| Avacopan Group | 4.445 | 4.980 | 7.31 | 9.55 | 16.78 | 17.12 | 14.75 | 16.12 | 3.12 | 5.84 | 4.849 | 6.394 | 8.29 | 10.89 | 7.32 | 9.38 | 14.50 | 18.06 | 12.03 | 14.36 | 9.1 | 13.0 | 0.0229 | 0.0474 |
| Prednisone Group | 1.344 | 2.626 | 1.88 | 4.82 | 7.52 | 12.27 | 9.82 | 11.87 | -2.89 | -0.17 | 3.271 | 4.694 | 6.84 | 9.66 | 1.40 | 4.14 | 11.09 | 13.56 | 6.42 | 10.48 | 5.5 | 7.1 | -0.0010 | -0.0038 |
VDI=Vasculitis Damage Index; The VDI is comprised of 64 items of damage, grouped into 11 organ-based systems or categorizations. Damage is defined as the presence of non-healing scars and does not give any indication of current disease activity. Damage is also defined as having been present or currently present for at least 3 months. Completion of the form provides a numerical score, which ranges from 0 (best health) to 64 (worst health). (NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | score on a scale (Least Squares Mean) | |
|---|---|---|
| Week 26 | Week 52 | |
| Avacopan Group | 1.06 | 1.17 |
| Prednisone Group | 0.97 | 1.15 |
"GTI-CWS=Glucocorticoid Toxicity Index Cumulative Worsening Score;~GTI-AIS=Glucocorticoid Toxicity Index Aggregate Improvement Score;~The Glucocorticoid Toxicity Index (GTI) was developed to score glucocorticoid toxicity. The GTI includes: the Cumulative Worsening Score (CWS) that captures cumulative toxicity, both permanent and transient, over the course of time (serves as a cumulative record of toxicity); and the Aggregate Improvement Score that captures both improvement and worsening of toxicity over time (serves as a record of both improving and worsening toxicity). Both scores range from 0 (best health) to 100 (worst health)." (NCT02994927)
Timeframe: Baseline, Week 13 and 26
| Intervention | Glucocorticoid Toxicity Index (Least Squares Mean) | |||
|---|---|---|---|---|
| GTI-CWS (Week 13) | GTI-CWS (Week 26) | GTI-AIS (Week 13) | GTI-AIS (Week 26) | |
| Avacopan Group | 25.7 | 39.7 | 9.9 | 11.2 |
| Prednisone Group | 36.6 | 56.6 | 23.2 | 23.4 |
"BVAS=Birmingham Vasculitis Activity Score~UACR=Urinary albumin:creatinine ratio" (NCT02994927)
Timeframe: Baseline, Week 4, 26 and 52
| Intervention | Percentage change (Least Squares Mean) | ||
|---|---|---|---|
| Week 4 | Week 26 | Week 52 | |
| Avacopan Group | -40 | -63 | -74 |
| Prednisone Group | 0 | -70 | -77 |
"Change from baseline in kidney function, as measured by eGFR (based on the MDRD equation), was measured in subjects with renal disease based on the BVAS renal component.~eGFR=estimated glomerular filtration rate~BVAS=Birmingham Vasculitis Activity Score~MDRD=Modification of Diet in Renal Disease" (NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | Change in eGFR (mL/min/1.73 m^2) (Least Squares Mean) | |
|---|---|---|
| Week 26 | Week 52 | |
| Avacopan Group | 5.8 | 7.3 |
| Prednisone Group | 2.9 | 4.1 |
"BVAS=Birmingham Vasculitis Activity Score~MCP-1=monocyte chemoattractant protein-1" (NCT02994927)
Timeframe: Baseline, Week 26 and 52
| Intervention | Percentage change (Least Squares Mean) | |
|---|---|---|
| Week 26 | Week 52 | |
| Avacopan Group | -67 | -73 |
| Prednisone Group | -64 | -71 |
AE=Adverse Event (NCT02994927)
Timeframe: From day 1 throughout the study period (day 421/week 60)
| Intervention | Participants (Count of Participants) | ||||||
|---|---|---|---|---|---|---|---|
| Relationship of avacopan/placebo to an AE | Relationship of glucocorticoid use to an AE | Relationship of cyclophosphamide IV use to an AE | Relationship of oral cyclophosphamide use to an AE | Relationship of rituximab use to an AE | Relationship of azathioprine use to an AE | Relationship of mycophenolate use to an AE | |
| Avacopan Group | 100 | 107 | 31 | 8 | 50 | 28 | 6 |
| Prednisone Group | 103 | 131 | 30 | 4 | 61 | 35 | 9 |
"AEs=Adverse events~SAEs=Serious adverse events~TEAE=Treatment-emergent adverse event" (NCT02994927)
Timeframe: From day 1 throughout the study period (day 421/week 60)
| Intervention | Number (Number) | ||||
|---|---|---|---|---|---|
| Number of subjects with at least one TEAE | Number of TEAEs | Number of subjects with SAEs | Number of SAEs | Subjects with TEAE leading to discontinuation | |
| Avacopan Group | 164 | 1779 | 70 | 116 | 27 |
| Prednisone Group | 161 | 2139 | 74 | 166 | 28 |
"Disease improvement was measured by a reduction in the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG).~The BVAS/WG is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63." (NCT00468208)
Timeframe: Measured monthly until common closing or early termination, up to 3 years and 4 months.
| Intervention | participants (Number) |
|---|---|
| Open-label Abatacept | 18 |
"Disease relapse was measured by a rise in the Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) of greater than or equal to 1 after achieving remission.~The BVAS/WG is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63." (NCT00468208)
Timeframe: Measured monthly until common closing or early termination, up to 3 years and 4 months.
| Intervention | participants (Number) |
|---|---|
| Open-label Abatacept | 3 |
"Disease remission was measured by a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) of 0.~The BVAS/WG is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63." (NCT00468208)
Timeframe: Measured monthly until common closing or early termination,up to 3 years and 4 months.
| Intervention | participants (Number) |
|---|---|
| Open-label Abatacept | 16 |
The number of subjects that reached the common closing date. (NCT00468208)
Timeframe: Number assessed at the time of common closing, up to 3 years and 4 months.
| Intervention | participants (Number) |
|---|---|
| Open-label Abatacept | 14 |
"This study examined the safety profile of this agent when used in Wegener's granulomatosis. Information was gathered on all adverse events with specific events being identified in the protocol for analysis that included the following:~Infection~Infusion reactions~Cytopenias~Transaminase elevation~Skin reactions~GI side effects~Malignancy~All adverse events were reportable for this study." (NCT00468208)
Timeframe: Measured continuously from the screening visit through to the 6 month post-treatment study visit, up to 3 years and 4 months.
| Intervention | participants (Number) | |||||
|---|---|---|---|---|---|---|
| Serious adverse events | Non-serious adverse events | Infection | Infusion related (systemic) | Infusion related( intravenous site reaction) | Cytopenia | |
| Open-label Abatacept | 7 | 16 | 14 | 1 | 1 | 4 |
"Time (in months) from the first documentation of a response (CR or partial response [PR]) to the date of first documentation of progressive disease or relapse from complete response.~CR is defined as disappearance of all evidence of disease assessed by CT or PET; PR is defined as regression of measurable disease and no new sites assessed by CT or PET according to the revised International Working Group (IWG) Criteria." (NCT00715208)
Timeframe: 2 years
| Intervention | Months (Median) |
|---|---|
| VELCADE R-CP | 21.9 |
"OR = Complete Response (CR) + Partial Response (PR)according to the revised International Working Group (IWG) Criteria.~CR is the disappearance of all evidence of disease assessed by CT and PET. PR is the regression of measurable disease and no new sites assessed by CT and PET." (NCT00715208)
Timeframe: 30 weeks
| Intervention | participants (Number) |
|---|---|
| VELCADE R-CAP | 6 |
| VELCADE R-CP | 37 |
(NCT00715208)
Timeframe: From completion of informed consent through 30 days after the last dose of study drug
| Intervention | participants (Number) |
|---|---|
| VELCADE R-CAP | 2 |
| VELCADE R-CP | 12 |
Disappearance of all evidence of disease assessed by computed tomography (CT) and PET (position-emission tomography) according to the revised International Working Group (IWG) Criteria. (NCT00715208)
Timeframe: 30 weeks
| Intervention | participants (Number) |
|---|---|
| VELCADE R-CAP | 1 |
| VELCADE R-CP | 13 |
PFS was defined as the time from the first dose to the date of progressive disease (PD)/relapse or death, whichever comes first. For a participant who had not progressed/relapsed or died, PFS was censored at the last response assessment that was stable disease (failure to attain complete response/partial response or PD or better). (NCT00715208)
Timeframe: Assessed at at the end of Cycle 2, at end of treatment visit, and every 12± 1 weeks for the first year (4 visits) until PD
| Intervention | percentage of participants (Number) |
|---|---|
| VELCADE R-CAP | 67 |
| VELCADE R-CP | 63 |
A Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) score of 0 with prednisone taper successfully completed at six months. The BVAS/WG is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease. (NCT00104299)
Timeframe: 6 months post-randomization
| Intervention | Participants (Number) |
|---|---|
| Rituximab | 63 |
| Control Group | 52 |
"The 2-sided 95% CI of the percentage of participants who have a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG)[1] of 0 and have successfully completed the glucocorticoid taper by 6 months post-randomization and the 2-sided 95% CI of the difference between two arms for assessing the superiority of rituximab to control~[1] The BVAS/WG is a disease activity index designed to document new or worsening clinically active vasculitis consisting of items divided into 9 organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease" (NCT00104299)
Timeframe: 6 months post-randomization
| Intervention | participants (Number) |
|---|---|
| Rituximab | 62 |
| Control Group | 51 |
Number of subjects according to originally received treatment that experienced a serious adverse event through 18 months post-randomization or prior to being censored from analyses due to crossover, switching to open-label treatment, or best medical judgment for censor. Events are categorized by coded system organ classes (SOC). Within each SOC, a participant was counted once if the participant reported one or more events coded to that SOC. (NCT00104299)
Timeframe: Randomization to censor at Crossover, Open-label or Best Medical Judgment (up to 18 months post-randomization)
| Intervention | participants (Number) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Participants with at least one SAE | Blood and Lymphatic System Disorders | Cardiac Disorders | Eye Disorders | Gastrointestinal Disorders | General Disorders and Administration Site | Immune System Disorders | Infections and Infestations | Injury, Poisoning, and Procedural Complications | Investigations | Metabolism and Nutrition Disorders | Musculoskeletal and Connective Tissue Disorders | Neoplasms Benign, Malignant, and Unspecified | Nervous System Disorders | Pregnancy, Puerperium, and Perinatal Conditions | Psychiatric Disorders | Renal and Urinary Disorders | Respiratory, Thoracic, and Mediastinal Disorders | Vascular Disorders | |
| Control Group | 37 | 5 | 2 | 1 | 1 | 3 | 2 | 12 | 0 | 0 | 2 | 3 | 2 | 0 | 0 | 1 | 3 | 8 | 7 |
| Rituximab | 42 | 4 | 2 | 1 | 4 | 5 | 2 | 12 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 4 | 8 | 1 |
The adverse event rate for the following events considered related to vasculitis: Death; Grade 2 or higher leukopenia or thrombocytopenia; Grade 3 or higher infections; Hemorrhagic cystitis (grade 2 or lower needs confirmation by cytoscopy); Malignancy; Venous thromboembolic event (deep venous thrombosis or pulmonary embolism); Hospitalization resulting either from the disease or from a complication due to study treatment; Infusion reactions (within 24 hours of infusion) that result in the cessation of further infusions (including cytokine release allergic reaction); Cerebrovascular accident (NCT00104299)
Timeframe: Through common close-out (defined as 18 months after the last participant is enrolled in the trial)
| Intervention | participants (Number) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Death | Grade 2 or Higher Leukopenia | Grade 2 or Higher Thrombocytopenia | Grade 3 or Higher Infections | Hemorrhagic Cystitis (Grade 2 or Lower) | Malignancy | Venous Thromboembolic Event | Hospitalization Resulting from the Disease | Cerebrovascular Accident (CVA) | Infusion Reactions Leading to Infusion Disc. | |
| Control Group | 2 | 23 | 1 | 16 | 1 | 2 | 8 | 7 | 1 | 0 |
| Rituximab | 2 | 7 | 4 | 18 | 2 | 5 | 6 | 16 | 1 | 1 |
"Duration of complete remission is defined as a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG)[1] of 0 and a completing taper of Prednisone to the first flare, BVAS/WG score of greater than 0, or an increase in Prednisone dosing.~[1] The BVAS/WG is a disease activity index designed to document new or worsening clinically active vasculitis consisting of items divided into 9 organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease" (NCT00104299)
Timeframe: 18 months post-randomization
| Intervention | Days (Number) | ||
|---|---|---|---|
| 25% Quartile (95%CI) | 50% Quartile (95%CI) | 75% Quartile (95%CI) | |
| Control Group | 230 | NA | NA |
| Rituximab | 243 | NA | NA |
Duration of remission is defined as a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG)[1] of 0 and a completing taper of glucocorticoid by 6 months post-randomization to the first flare, BVAS/WG score of greater than 0, or an increase in Prednisone dosing. (NCT00104299)
Timeframe: 18 months post-randomization
| Intervention | Days (Number) | ||
|---|---|---|---|
| 25% Quartile (95%CI) | 50% Quartile (95%CI) | 75% Quartile (95%CI) | |
| Control Group | 168 | NA | NA |
| Rituximab | 246 | NA | NA |
"Time to complete remission is defined as the number of days from baseline visit (Visit 1) to a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG)[1] of 0 and completing taper of glucocorticoid by 6 months post-randomization.~[1] The BVAS/WG is a disease activity index designed to document new or worsening clinically active vasculitis consisting of items divided into 9 organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease" (NCT00104299)
Timeframe: 18 months post-randomization
| Intervention | Days (Number) | ||
|---|---|---|---|
| 25% Quartile (95%CI) | 50% Quartile (95%CI) | 75% Quartile (95%CI) | |
| Control Group | 177 | 183 | 266 |
| Rituximab | 176 | 180 | 189 |
"Time to complete remission is defined as the number of days from baseline visit (Visit 1) to a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG)[1] of 0.~[1] The BVAS/WG is a disease activity index designed to document new or worsening clinically active vasculitis consisting of items divided into 9 organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease" (NCT00104299)
Timeframe: 18 months post-randomization
| Intervention | Days (Number) | ||
|---|---|---|---|
| 25% Quartile (95%CI) | 50% Quartile (95%CI) | 75% Quartile (95%CI) | |
| Control Group | 29 | 43 | 112 |
| Rituximab | 30 | 57 | 119 |
"PFS is calculated according to the Kaplan-Meier estimator. The observation time of each subject is defined as the time from entry into the study until lymphoma progression or death as a result of any cause whichever occurs first.~The 5-year PFS is the estimated cumulative probability of surviving at least 5 years without progression." (NCT00366275)
Timeframe: every 3 months for the first year after autotransplant and every 6 months after the first year of follow up
| Intervention | percent chance of PFS at 5 years (Number) |
|---|---|
| Immunochemotherapy, in Vivo Purging and Autotransplant | 59 |
One or more joints were assessed for ROM deficit by a physiatrist with expertise in graft versus host disease and joint ROM. (NCT00702689)
Timeframe: 6 months
| Intervention | Percent change (Mean) |
|---|---|
| Imatinib Mesylate in Patients With cGVHD | 24.2 |
Here is the number of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria for Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00702689)
Timeframe: Date treatment consent signed to date off study, approximately, 41 months, 27 days
| Intervention | Participants (Number) |
|---|---|
| Imatinib Mesylate in Patients With cGVHD | 20 |
Change in immunosuppression was defined by an increase or decrease in steroid use form baseline. (NCT00702689)
Timeframe: 6 months
| Intervention | participants (Number) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ↓ Pred 20 mg everyday (qd )to 5 mg every other day | ↓ MPred 16 mg every other day(qod) to 4 mg qod | ↓ Pred:24mg every day(qd) to 20mg qd | No change | ↓ Tacro 2mg every am 1.5mg every pm to .5mg bid | Pred↓ 25mg qd to 15mg qd;Tacro↓ 2mg bid to 1mg bid | Pred↓ 2.5mg qd to 2.5mg every other day | ↓ Siro:2mg qd to 1 mg qd | Pred wean then ↑ 10 12.5mg bid;Tacro↑1.0 to 1.5bid | MMF↓ 1g/bid to discontinued | |
| Imatinib Mesylate in Patients With cGVHD | 1 | 1 | 1 | 5 | 1 | 1 | 1 | 1 | 1 | 1 |
Lung function was graded by the National Institutes of Health Chronic Graft Versus Host Disease organ response criteria. The Lung function score = forced expiratory volume 1 (FEV1) score + carbon monoxide diffusing capacity (DLCO) score, with a possible range of 2 (better outcome)-12 (worst outcome). The percent predicted FEV1 and DLCO (adjusted for hematocrit but not alveolar volume) should be converted to a numeric score as follows: >80% =1; 70-79% = 2; 60-69% = 3; 50-59% = 4; 40-49% = 5; <40% = 6. (NCT00702689)
Timeframe: Baseline and 6 Months
| Intervention | units on a scale (Number) | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient #2 at Baseline | Patient #2 at 6 Months | Patient #3 at Baseline | Patient #3 at 6 Months | Patient #7 at Baseline | Patient #7 at 6 Months | Patient #8 at Baseline | Patient #8 at 6 Months | Patient #10 at Baseline | Patient #10 at 6 Months | Patient #12 at Baseline | Patient #12 at 6 Months | Patient #13 at Baseline | Patient #13 at 6 Months | Patient #14 at Baseline | Patient #14 at 6 Months | Patient # 15 at Baseline | Patient #15 at 6 Months | Patient #16 at Baseline | Patient #16 at 6 Months | Patient #17 at Baseline | Patient #17 at 6 months | Patient #18 at Baseline | Patient #18 at 6 Months | Patient #19 at Baseline | Patient #19 at 6 Months | Patient #20 at Baseline | Patient #20 at 6 Months | |
| Imatinib Mesylate in Patients With cGVHD | 2 | 2 | 9 | NA | 3 | 8 | 5 | 6 | 3 | 3 | 4 | 5 | 4 | 4 | 5 | 5 | 7 | 6 | 3 | 2 | 5 | 6 | 8 | 8 | 9 | 9 | 2 | 2 |
A change in ROM is 25% or greater from baseline. A partial response required improvement in 25% or more in ROM. Progression required 25% or greater loss of ROM.Patients with negative values in the Table are those who lost ROM. Percent improvement in ROM for 1-3 target joints. For patients with >1 target joint, the average ROM improvement was calculated. The average percentage change in ROM deficit from baseline to 6 months was obtained based on the number of degrees of ROM change (6 months)/total ROM deficit (baseline) at each joint. (NCT00702689)
Timeframe: 6 months
| Intervention | Percent change from baseline (Number) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pt 2 6mo response% change in deficit from baseline | Pt 7 6mo response% change in deficit from baseline | Pt 8 6mo response% change in deficit from baseline | Pt10 6mo response% change in deficit from baseline | Pt12 6mo response% change in deficit from baseline | Pt13 6mo response% change in deficit from baseline | Pt14 6mo response% change in deficit from baseline | Pt15 6mo response% change in deficit from baseline | Pt16 6mo response% change in deficit from baseline | Pt17 6mo response% change in deficit from baseline | Pt18 6mo response% change in deficit from baseline | Pt19 6mo response% change in deficit from baseline | Pt20 6mo response% change in deficit from baseline | |
| Imatinib Mesylate in Patients With cGVHD | 94 | 35 | 16 | 21 | 16 | 61 | 27 | 22 | 3 | -25 | -2 | 31 | 15 |
Progressive disease is defined as joint ROM: decrease of >25% in composite ROM score on 2 consecutive evaluations at least 2 weeks apart, but not greater than 4 weeks apart or steroid pulse: >1 steroid pulse per 3 month period if administered for sclerotic-type chronic graft versus host disease (ScGVHD). Response is joint ROM: increase of >25% in composite ROM score. Maximal response is a response with no further improvement over 2 sequential 3-month evaluations. Stable disease does not meet the criteria for progression, response, or maximal response. (NCT00702689)
Timeframe: 6 months
| Intervention | participants (Number) | ||
|---|---|---|---|
| Partial Response | Stable Disease | Progressive Disease | |
| Imatinib Mesylate in Patients With cGVHD | 5 | 7 | 2 |
The provider global rating is a physician impression of severity of cGVHD symptoms from a scale of zero (no symptoms) to 10 (most severe GVHD symptoms possible). (NCT00702689)
Timeframe: Baseline and 6 months
| Intervention | Provider Global Rating Score (Number) | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient #2 at Baseline | Patient #2 at 6 Months | Patient #3 at Baseline | Patient #3 at 6 Months | Patient #7 at Baseline | Patient #7 at 6 Months | Patient #8 at Baseline | Patient #8 at 6 Months | Patient #10 at Baseline | Patient #10 at 6 Months | Patient #12 at Baseline | Patient #12 at 6 Months | Patient #13 at Baseline | Patient #13 at 6 Months | Patient #14 at Baseline | Patient #14 at 6 Months | Patient # 15 at Baseline | Patient #15 at 6 Months | Patient #16 at Baseline | Patient #16 at 6 Months | Patient #17 at Baseline | Patient #17 at 6 months | Patient #18 at Baseline | Patient #18 at 6 Months | Patient #19 at Baseline | Patient #19 at 6 Months | Patient #20 at Baseline | Patient #20 at 6 Months | |
| Imatinib Mesylate in Patients With cGVHD | 5 | 4 | 3 | NA | 6 | 8 | 6 | 7 | 5 | 4 | 6 | 7 | 6 | 4 | 7 | 6 | 7 | 6 | 5 | 4 | 6 | 8 | 8 | 8 | 8 | 5 | 8 | 8 |
Total skin score was graded by the National Institutes of Health Consensus Criteria. Skin score was calculated by dividing the total score by seven domains (skin, eye, oral, joint, gastrointestinal, hepatic, pulmonary) in men and 8 domains in women (previous domains noted plus gynecologic). Total skin score is a percentage of body surface area (BSA) involvement (range 0-100%). It was calculated from the sum of moveable body surface BSA and non-moveable BSA. Higher numbers = greater body surface area affected. (NCT00702689)
Timeframe: Baseline and 6 Months
| Intervention | units on a scale (Number) | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient # 2 - Baseline | Patient # 2 - 6 months | Patient # 3 - Baseline | Patient # 3 - 6 months | Patient # 7 - Baseline | Patient # 7 - 6 months | Patient # 8 - Baseline | Patient # 8 - 6 months | Patient # 10 - Baseline | Patient # 10 - 6 months | Patient # 12 - Baseline | Patient # 12 - 6 months | Patient # 13 - Baseline | Patient # 13 - 6 months | Patient # 14 - Baseline | Patient # 14 - 6 months | Patient # 15 - Baseline | Patient # 15 - 6 months | Patient # 16 - Baseline | Patient # 16 - 6 months | Patient # 17 - Baseline | Patient # 17 - 6 months | Patient # 18 - Baseline | Patient # 18 - 6 months | Patient # 19 - Baseline | Patient # 19 - 6 months | Patient # 20 - Baseline | Patient # 20 - 6 months | |
| Imatinib Mesylate in Patients With cGVHD | 66.6 | 54 | 43.38 | NA | 66.24 | 55.53 | 53.1 | 55.26 | 10.8 | 6.12 | 21.24 | 30.06 | 79.2 | 62.28 | 39.96 | 40.5 | 71.46 | 61.83 | 9.54 | 8.1 | 84.96 | 85.11 | 26.64 | 24.3 | 21.15 | 37.8 | 23.4 | 25.2 |
Stromal angiogenesis was assessed using blood vascular and perivascular markers, including VEGFR-1, VEGFR-2, CD34, and a-SMA, as well as lymphatic vascular markers ofVEGFR-3, podoplanin, and Lyve-1. (NCT00151281)
Timeframe: 38 months
| Intervention | pg/mL (Median) |
|---|---|
| RT-PEPC Drug Therapy | 109.5 |
measured by overall Response Rate (ORR), which includes Complete response and partial response. (NCT00151281)
Timeframe: 38 months
| Intervention | percentage of patients (Number) |
|---|---|
| Study Treatment Arm | 73 |
Toxicities were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. (NCT00151281)
Timeframe: 38 months
| Intervention | Participants (Count of Participants) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 3 or 4 neutropenia | Anemia | Thrombocytopenia | Fatigue | Constipation | Cough | Nausea | Neuropathy | Dyspnea | Rash | |
| RT-PEPC Drug Therapy | 14 | 1 | 4 | 22 | 14 | 14 | 13 | 13 | 11 | 10 |
"QoL assessments were obtained with version 3 of the Functional Assessment of Cancer Therapy-General (FACT-G) instrument. The FACT-G is comprised of four subscales: physical well-being (7-items, score range 0-28), social/family well-being (7-items, score range 0-28), emotional well-being (6-items, score range 0-24), and functional well-being (7-items, score range 0-28). Users of the FACT-G are able to generate an overall score and four subscale scores with ranges and distributions that are sample-specific. All questions in the FACT-G use a 5-point rating scale (0 = Not at all to 4 = Very much) A higher number indicates a better Quality of Life, and has a possible range of 0-108 points.~ANOVA was used to compare the difference in the means of total score among the different time points (baseline, every 2M until 6M, and every 6M until PD). The mean of the total FACT-G scores at baseline and mean of total score at all timepoints (using ANOVA) are reported below." (NCT00151281)
Timeframe: baseline, every 2 months until Month 6, and every 6 months until disease progression
| Intervention | FACT-G score (Mean) | |
|---|---|---|
| Mean FACT-G Score at baseline | Mean Total FACT-G Score between all time points | |
| RT-PEPC Drug Therapy | 83.3 | 89.4 |
Toxicity assessed using NCI-CTC v. 3.0 (NCT00295932)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) |
|---|---|
| 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide | 4 |
| 1.6 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamide | 6 |
| 1.6 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide | 3 |
| 1.8 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphamide | 4 |
| Dose Level 1- 1.0 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid | 2 |
| Dose Level 2 - 1.3 mg/m2 Bortezomib; 750 mg/m2 Cyclophosphamid | 18 |
| Dose Level 3 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham | 3 |
| Dose Level 4 - 1.5 mg/m2 Bortezomib; 1000 mg/m2 Cyclophosphami | 4 |
| Dose Level 5 - 1.3 mg/m2 Bortezomib; 1000 mg/m2 Cyclophospham | 10 |
| Weekly Bortezomib Dosing Schedule | 12 |
| Twice-weekly Bortezomib Dosing Schedule | 13 |
Maximum tolerated dose of Bortezomib in combination with Rituximab, Cyclophosphamide and Prednisone in Phase I participants (NCT00295932)
Timeframe: 2 years
| Intervention | mg/m^2 of Bortezomib (Number) | |
|---|---|---|
| Weekly Bortezomib | Twice-Weekly Bortezomib | |
| Arm I | 1.8 | 1.5 |
Assessed by time to treatment failure, occurrence of second malignant neoplasm, or death from any cause. Statistical analysis will be to estimate the difference in the proportion of patients treated with each therapy who are long-term event-free survivors due either to the difference between the backbone therapy regimens (CCG BFM vs NHL/BFM-95), or due to the intensification. (NCT00004228)
Timeframe: 5 years
| Intervention | percentage of particpants (Number) |
|---|---|
| A0 (Localized Disease Stg I/II) Modified CCG BFM | 88 |
| A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens | 82 |
| A2 (Disseminated, No CNS - CCG Mod BFM w/ Intens | 80 |
| B2 (CNS+) NHL/BFM-95 w/Intens Delayed Radiation Therapy | 63 |
| B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/Intens | 82 |
| B1 (Disseminated CNS-) NHL/BFM-95 w/Out Intens | 84 |
| B1 (NHL/BFM-95 w/Out Intens) Additional Enrollment | 90 |
Overall survival will be computed by measuring the rate of deaths during induction due primarily to treatment toxicity and cumulative incidence of toxic deaths in induction or deaths in remission overall and separately for treatment groups defined by the two design factors. (NCT00004228)
Timeframe: 5 years
| Intervention | percentage of participants (Number) |
|---|---|
| A0 (Localized Disease Stg I/II) Modified CCG BFM | 96 |
| A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens | 84 |
| A2 (Disseminated, No CNS - CCG Mod BFM w/Intens | 88 |
| B2 (CNS+) NHL/BFM-95 w/Intens Delayed Radiation Therapy | 81 |
| B2 (Disseminated,CNS- (< Amend 7B)) NHL/BFM-95 w/Intens | 85 |
| B1 (Disseminated CNS-) NHL/BFM-95 w/Out Intens | 85 |
| B1 (NHL/BFM-95 w/Out Intens) Additional Enrollment | 92 |
"Patients completed the ARMS survey after treatment for the new relapse.The ARMS questionnaire (assessing relapses in multiple sclerosis) was developed by a panel of expert MS nurses. Part one consists of 7 questions designed to assess relapse symptoms, impact on activities of daily living, and response to past treatment for MS relapses. Part two consists of 7 questions to evaluate treatment response in terms of relief from symptoms, functioning and tolerability.~The TCS score was calculated only for the time point after treatment of relapse. It was a sum of questions 4 (symptom improvement), 5 (ADL), and 6 (return to previous state of health (RSH)) were evaluated. Scores range from 0 to 30 units, with higher scores representing greater improvement/better functioning." (NCT02258217)
Timeframe: Follow-up visit
| Intervention | score on a scale (Mean) |
|---|---|
| Single Arm | 14.3 |
"Patient history of prior corticosteroid tolerability for the treatment of MS relapses. This will be determined based on patient completion of the ARMS survey at the baseline visit. Also, history of patients from the survey after treatment for the new relapse will be collected.~The ARMS questionnaire (assessing relapses in multiple sclerosis) was developed by a panel of expert MS nurses. Part one consists of 7 questions designed to assess relapse symptoms, impact on activities of daily living, and response to past treatment for MS relapses. Part two consists of 7 questions to evaluate treatment response in terms of relief from symptoms, functioning and tolerability.~ADL scores were calculated from Part 1 (new relapse), question 3 and Part 2 (after treatment of relapse), question 5 both specifically refer to ADL;~Scale: ADL (Activities of Daily Living) Minimum value: 0 Maximum value: 9 Higher scores indicated better functioning/ improvement." (NCT02258217)
Timeframe: baseline visit & follow-up after treatment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| ADL (new relapse) | ADL (after treatment of relapse) | |
| Single Arm | 3.1 | 4.9 |
"Patient history of prior corticosteroid tolerability for the treatment of MS relapses. This will be determined based on patient completion of the ARMS survey at the baseline visit. Also, patients completed the survey after treatment for the new relapse.~The ARMS questionnaire (assessing relapses in multiple sclerosis) was developed by a panel of expert MS nurses. Part one consists of 7 questions designed to assess relapse symptoms, impact on activities of daily living, and response to past treatment for MS relapses. Part two consists of 7 questions to evaluate treatment response in terms of relief from symptoms, functioning and tolerability.~PCS was computed based on the sum of the ADL and RSH questions. The PCS was computed separately for Part 1 (new relapse) and Part 2 (after relapse treatment) and summarized descriptively; Higher scores indicating better functioning/greater improvement. The PCS scores were on a scale of 0 to 20 units." (NCT02258217)
Timeframe: baseline visit & follow-up after treatment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| PCS (New relapse) | PCS (after treatment of relapse) | |
| Single Arm | 7.7 | 9.2 |
"Patient history of prior corticosteroid tolerability for the treatment of MS relapses. This will be determined based on patient completion of the ARMS survey at the baseline visit. Also, patients completed the survey after treatment for the new relapse. The ARMS questionnaire (assessing relapses in multiple sclerosis) was developed by a panel of expert MS nurses. Part one consists of 7 questions designed to assess relapse symptoms, impact on activities of daily living, and response to past treatment for MS relapses. Part two consists of 7 questions to evaluate treatment response in terms of relief from symptoms, functioning and tolerability.~Part 1 (new relapse) & Part 2 (after treatment of new relapse), question 6 were used to calculate RSH;~Scale: RSH (Return to previous health) Minimum value: -1 Maximum value: 10 Higher scores indicating a more complete return to previous state of health." (NCT02258217)
Timeframe: baseline visit & follow-up after treatment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| RSH (new relapse) | RSH (after treatment of new relapse) | |
| Single Arm | 4.6 | 4.4 |
"This scaling score is obtained by performing a neurologic exam with specific attention to eight different neurologic functional systems: visual, pyramidal, cerebellar, bowel and bladder, cerebral, brainstem, sensory and other (10). The score is rated from zero (normal neurologic examination) to ten (death due to MS). This is the standard neurologic disability scale used in clinical trials for the evaluation of disability in patients with MS.~These scores were compared between pre and post phase using paired t-tests." (NCT02258217)
Timeframe: baseline and at follow-up
| Intervention | score on a scale (Median) | |
|---|---|---|
| EDSS score (new relapse) | EDSS score (after treatment of new relapse) | |
| Single Arm | 3.5 | 3.0 |
"Patients who reported a history of poor corticosteroid tolerability will be placed on Acthar and GASE scale will be given to assess tolerability to Acthar.~We listed the number of times a symptom was reported and was attributable to the ACTHAR treatment" (NCT02258217)
Timeframe: 1 week
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Headache | Dry Mouth | Dizziness | Tachycardia, palpitation or arrhythmia | Breathing problems | Abdominal pain | Nausea | Diarrhea | Reduced Appetite | Increased appetite | Difficulties with urination | Skin rash or itching | Tendency to develop bruises | Sweating | Hot flashes | Fatigue, loss of energy | Insomnia, sleeping problems | Nightmares or abnormal dreams | Back pain | Agitation | Irritability | Depressed Mood | Anxiety, fearfulness | Further symptoms | |
| Single Arm | 3 | 1 | 2 | 1 | 1 | 4 | 4 | 4 | 1 | 4 | 2 | 1 | 1 | 1 | 1 | 2 | 8 | 2 | 1 | 6 | 6 | 3 | 1 | 8 |
"The MSIS-29 is a self-reported questionnaire in which MS patients answer a series of 29 questions designed to capture the impact of multiple sclerosis on their life over the past 2 weeks (11). Twenty of the 29 questions assess the physical impact of MS and 9 questions assess the psychological impact of MS.~The psychological impact of MS was compared between pre and post phase using paired t-tests.~The psychological impact of MS was compared between pre and post phase using paired t-tests.~The score was on a scale of 9 to 45 points for MSIS psychological score.~Higher score indicate worse outcome." (NCT02258217)
Timeframe: baseline visit & follow-up after treatment
| Intervention | score on a scale (Mean) | |
|---|---|---|
| MSIS psychological(new relapse) | MSIS psychological(after treatment of new relapse) | |
| Single Arm | 29.4 | 26.3 |
"The MSIS-29 is a self-reported questionnaire in which MS patients answer a series of 29 questions designed to capture the impact of multiple sclerosis on their life over the past 2 weeks (11). Twenty of the 29 questions assess the physical impact of MS.~The physical impact of MS was compared between pre and post phase using paired t-tests. Each question is answered with points ranging from 1 to 5. Higher score indicates worse outcome. The total MSIS physical score ranges from 20 to 100 points with lower points indicating better impact." (NCT02258217)
Timeframe: baseline visit & follow-up after treatment
| Intervention | score on a scale (Median) | |
|---|---|---|
| MSIS physical (new relapse) | MSIS physical (after treatment of new relapse) | |
| Single Arm | 58.5 | 56 |
"The Self-Administered Gerocognitive Exam (SAGE) is designed to detect early signs of cognitive, memory or thinking impairments. It evaluates your thinking abilities and helps physicians to know how well your brain is working.~It consists of 12 questions which are scored at different scales. The final SAGE score is calculated as a sum of these 12 questions and it ranges from 0 to 22.~Higher score indicates better outcome." (NCT02258217)
Timeframe: baseline and follow-up
| Intervention | score on a scale (Median) | |
|---|---|---|
| SAGE (new relapse) | SAGE (after treatment of new relapse) | |
| Single Arm | 21 | 21 |
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | B cells per microliter (Median) |
|---|---|
| Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | Elisa Units (Median) |
|---|---|
| Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
| Intervention | Days (Median) |
|---|---|
| Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
| Intervention | participants (Number) |
|---|---|
| Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
| Intervention | participants (Number) | ||
|---|---|---|---|
| Treatment emergent adverse events | Infusion reactions | Disease Progression | |
| Treated | 0 | 0 | 1 |
Number of times the subject needed to use pain medication between day 1 and the 48 hour follow-up (NCT01671423)
Timeframe: Assessed once during the 48 hour follow-up
| Intervention | medications taken (Median) |
|---|---|
| Prednisone | 7 |
| Placebo | 2 |
The level of pain as measured by a Visual Analog Scale(VAS) measured once at day 1 and once during the 48th hour follow-up visit. Minimum value 0, maximum value 100mm, higher scores corresponds to more pain/worse outcomes. (NCT01671423)
Timeframe: Assessed once at day 1 and then once during the 48 hour follow-up
| Intervention | score on a scale (Mean) | |
|---|---|---|
| VAS at Day 1 | VAS at 48 hrs | |
| Placebo | 56.45 | 25.91 |
| Prednisone | 79.64 | 39.71 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 9 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 13.8 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -6.0 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 1.2 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -2.7 |
Percent change in HCV load determined 3 months after switch from MMF to SRL. (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 15 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -8.5 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 23 |
Percent change determined 3 months after switch from MMF to SRL (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | 23 |
Percent change in HCV load determined 3 months after switch from SRL to MMF (NCT01134952)
Timeframe: 3 month
| Intervention | percent change (Mean) |
|---|---|
| MMF SRL Switch | -47 |
(NCT01134952)
Timeframe: 3 month
| Intervention | ng/ml (Mean) |
|---|---|
| MMF SRL Switch | 7.2 |
Eosinophils/high powered field(hpf) in the mid esophagus will be measured after 12 weeks of therapy. (NCT01458418)
Timeframe: 12 weeks
| Intervention | Eosinophils/HPF (Mean) |
|---|---|
| Subjects Whose Arm is Unknown Due to Not Being Unblinded | 8 |
The investigators will determine if each patient had any unscheduled visits to the emergency room, urgent care or primary care physician. (NCT02192827)
Timeframe: 5 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Single Dose Dexamethasone | 14 |
| Two Dose Dexamethasone | 12 |
Will determine number of days to symptom resolution, including missed school days. (NCT02192827)
Timeframe: 5 days
| Intervention | Days (Mean) |
|---|---|
| Single Dose Dexamethasone | 2.4 |
| Two Dose Dexamethasone | 2.5 |
The investigators will determine during phone follow up if patient experienced any side effects related to the Dexamethasone, including vomiting, mood swings, behavior changes, appetite changes, sweating or headache. (NCT02192827)
Timeframe: 5 days
| Intervention | Participants (Count of Participants) | ||||||
|---|---|---|---|---|---|---|---|
| No side effects | Decreased Appetite | Difficulty Sleeping | Mood swings/Agitation | Headache | Other | Multiple | |
| Single Dose Dexamethasone | 71 | 4 | 9 | 7 | 3 | 5 | 17 |
| Two Dose Dexamethasone | 83 | 7 | 0 | 3 | 1 | 4 | 18 |
Mean of heart rate in beats per minute before treatment minus mean of heart rate 2 hours after treatment with either budesonide/albuterol or saline/albuterol (NCT00393367)
Timeframe: From the initial heart rate to heart rate 2 hours after intervention with budesonide/albuterol or saline/albuterol comparator
| Intervention | Beats per minute (Mean) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 12 |
| Placebo (Normal Saline) | 13 |
The scale used is the Asthma Score published by Qureshi et al. The Asthma Score ranges from a low of 5 to maximum of 15 points. One to 3 points are given for each of 5 categories: age-based respiratory rate, oxygen saturation, wheeze, retractions, and dyspnea. For category detalails, please see the Qureshi reference. Scores of 5-7 are considered mild, 8-11 moderate, and 12-15 severe. Asthma Scores are recorded prior to any intervention and at 2 hours after budesonide inhalation suspension/albuterol intervention or saline placebo/albuterol comparator. (NCT00393367)
Timeframe: Initial asthma score minus score 2 hours after budesonide/albuterol intervention or saline placebo/albuterol comparator
| Intervention | Units on a scale (Mean) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | -2.9 |
| Placebo (Normal Saline) | -3.0 |
Mean respiratory rate in breaths per minute before treatment minus respiratory rate 2 hours after treatment with either budesonide/albuterol or saline/albuterol comparator. (NCT00393367)
Timeframe: Initial rate, minus rate taken 2 hours after budesonide/albuterol intervention or saline/albuterol comparator
| Intervention | Breaths per minute (Mean) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | -6 |
| Placebo (Normal Saline) | -6 |
The scale used is the Asthma Score published by Qureshi et al. The Asthma Score ranges from a low of 5 to maximum of 15 points. One to 3 points are given for each of 5 categories: age-based respiratory rate, oxygen saturation, wheeze, retractions, and dyspnea. For category detalails, please see the Qureshi reference. Scores of 5-7 are considered mild, 8-11 moderate, and 12-15 severe. Asthma Scores are recorded prior to any intervention and at 2 hours after budesonide inhalation suspension/albuterol intervention or saline placebo/albuterol comparator. (NCT00393367)
Timeframe: Initial asthma score minus score 2 hours after budesonide/albuterol intervention or saline placebo/albuterol comparator
| Intervention | Units on a scale (Median) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | -3 |
| Placebo (Normal Saline) | -3 |
The number of patients requiring hospital admission 4 hours after budesonide/albuterol intervention or saline/albuterol comparator. All hospitalization decisions are made at the discretion of the attending physician. (NCT00393367)
Timeframe: within 4 hours after the budesonide/albuterol intervention or saline/albuterol placebo
| Intervention | Participants (Number) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 56 |
| Placebo (Saline) | 55 |
Of the patients who presented in the severe asthma category (Asthma Severity score of 12-15), those who moved to the mild category (Asthma Severity score 5-7) 2 hours after the budesonide/albuterol intervention or saline/albuterol comparator. (NCT00393367)
Timeframe: From the initial score to 2 hours after intervention with budesonide/albuterol or saline/albuterol comparator
| Intervention | Participants (Number) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 8 |
| Placebo (Normal Saline) | 10 |
Of the patients who presented in the severe asthma category (Asthma Severity score of 12-15), those who moved to the moderate category (Asthma Severity score 8-11) 2 hours after the budesonide/albuterol intervention or saline/albuterol comparator. (NCT00393367)
Timeframe: From the initial score to 2 hours after intervention with budesonide/albuterol or saline/albuterol comparator
| Intervention | Participants (Number) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 22 |
| Placebo (Normal Saline) | 11 |
Of the patients who presented in the severe asthma category (Asthma Severity score of 12-15), those who remained in this category 2 hours after the budesonide/albuterol intervention or saline/albuterol comparator. (NCT00393367)
Timeframe: From the initial score to 2 hours after intervention with budesonide/albuterol or saline/albuterol comparator
| Intervention | Participants (Number) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 4 |
| Placebo (Normal Saline) | 4 |
Mean oxygen saturation (non-invasive pulse-oximetry, % hemoglobin saturation) 2 hours after treatment with either budesonide/albuterol or saline/albuterol comparator minus mean oxygen saturation before treatment. (NCT00393367)
Timeframe: 2 hours after treatment with either budesonide/albuterol or saline/albuterol comparator
| Intervention | Percent Hemoglobin Saturation (Mean) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 1.0 |
| Placebo (Normal Saline) | 1.0 |
Participants admitted to the hospital within 5 days of the ED visit (NCT00393367)
Timeframe: within 5 days of ED visit
| Intervention | Participants (Number) |
|---|---|
| Budesonide Inhalation Suspension (BIS) | 2 |
| Placebo (Normal Saline) | 2 |
(NCT00393367)
Timeframe: within 30 days of the ED visit
| Intervention | Participants (Number) | |||||
|---|---|---|---|---|---|---|
| Rhinorrhea | Headache | Diarrhea | Sore throat | Cough | Hyperglycemia | |
| Budesonide Inhalation Suspension (BIS) | 6 | 5 | 3 | 4 | 2 | 2 |
| Placebo (Normal Saline) | 11 | 9 | 7 | 3 | 3 | 0 |
Serious Adverse Events (NCT00393367)
Timeframe: 0-5 days
| Intervention | participants (Number) | |
|---|---|---|
| Return within 5 days with hosptial admission | Increased level of care | |
| Budesonide Inhalation Suspension (BIS) | 2 | 1 |
| Placebo (Saline) | 2 | 0 |
Intent to treat analysis of treatment effect in primary endpoint EDTRS 5% Contrast Sensitivity. Change in the number of letters able to read while on Dalfampridine and Placebo relative to their baseline scores. (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | letters (Mean) |
|---|---|
| Dalfampridine | 3 |
| Placebo | 2.5 |
Dalfampridine will change color vision Total Error Scores from baseline on the Farnsworth Munsell 100 Hue Sort Test. Farnsworth Munsell 100 Hue Test requires placing 100 color palettes in the correct order based upon color hue. Scores are determined by the frequency and severity of any displacement in the correct order. One error equates to one misplaced hue, by one step or position. An error score greater than 500 indicates virtually no color discrimination. An error score of 0 indicates no errors in ordering the hues. A Total Error Score of 0 to 128 could be seen in a normal population. (NCT01337986)
Timeframe: Visit 1 (Week 0 - baseline), Visit 2 (Week 3 - postintervention 1) and Visit 3 (Week 8 - post intervention 2)
| Intervention | FM100 Total Error Score (Mean) |
|---|---|
| Dalfampridine | -13.0 |
| Placebo | -10.6 |
Dalfampridine treatment will result in change in quality of life. The National Eye Institute Visual Function Questionnaire consists of 25 questions characterizing visual function at home and in the community. Score ranges from 100 (best) to 0 (worst). (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | NEI VFQ percentage (Median) |
|---|---|
| Dalfampridine | 0 |
| Placebo | 0 |
Intent to treat analysis of treatment effect in primary endpoint EDTRS 5% Contrast Sensitivity. Improvement from baseline scores. (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | 5% Contrast LogMAR Score (Mean) |
|---|---|
| Dalfampridine | 0.06 |
| Placebo | 0.05 |
Difference in Pelli- Robson Score at Visits 2 and 3 Relative to Visit 1 on Dalfampridine vs Placebo. Pelli-Robson is scored based upon the numbers read on the chart converted to LogMAR units. The scale is 0.00 (worst) to 2.35 (best). (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | units on a scale (Mean) |
|---|---|
| Dalfampridine | 0.07 |
| Placebo | 0.06 |
Per Protocol Analysis to assess difference in number of letters on the EDTRS 5% Contrast Sensitivity (LogMAR) Chart scores at visits 2 and 3 Relative to Visit 1 (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | letters (Mean) |
|---|---|
| Group B: Dalfampridine | 2 |
| Group B: Placebo | 2 |
| Group A: Placebo | 4 |
| Group A: Dalfampridine | 3 |
Per Protocol Analysis to assess differences in EDTRS 5% Contrast Sensitivity (LogMAR) Scores at visits 2 and 3 Relative to Visit 1 on patients taking Dalfampridine vs Placebo. (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | LogMAR Score (Mean) |
|---|---|
| Group B: Dalfampridine | -0.04 |
| Group B: Placebo | -0.06 |
| Group A: Placebo | -0.08 |
| Group A: Dalfampridine | -0.06 |
(NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | Percentages of eyes that improved (Number) |
|---|---|
| Dalfampridine | 9.7 |
| Placebo | 11.1 |
| Both | 11.1 |
| None | 68.1 |
Percentage of eyes that improved by one-line (5 letters) on the 5% contrast sensitivity chart (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | Percent of Eyes (Number) |
|---|---|
| Dalfampridine | 11.1 |
| Placebo | 15.3 |
| Both | 37.5 |
| Neither | 36.1 |
Visual evoked potential 60min P100 latency on dalfampridine vs. placebo. (NCT01337986)
Timeframe: Visit 1 (Week 0), Visit 2 (Week 3) and Visit 3 (Week 8)
| Intervention | milliseconds (Mean) |
|---|---|
| Dalfampridine | 121.6 |
| Placebo | 120.2 |
"The Visual Field Index (VFI) is a global index that assigns a number between 1% to 100% based on an aggregate percentage of visual function, with 100% being a perfect age-adjusted visual field.~Probability of falling in the best quartile for visual field (VFI) measures (Q1), relative to the three next quartiles for worse VFIs (Q2-4), while on Dalfampridine vs Placebo. Due to the clustered observations at different times in a cross-over design, the visual field data is not suited to a normal theory model and should not be expressed as a continuous variable. Thus, a categorical model that uses a multinomial distribution for measurement of 4 categories was selected for proper statistical modeling, with results expressed as odds ratios." (NCT01337986)
Timeframe: Visit 1 (Week 0 - baseline), Visit 2 (Week 3 - post intervention 1) and Visit 3 (Week 8 - post intervention 2)
| Intervention | Visual Field Index % of normal vision (Mean) | ||
|---|---|---|---|
| Baseline (Visit 1) | Post Intervention 1 (Visit 2) | Post Intervention 2 (Visit 3) | |
| Dalfampridine Then Placebo | 77.53 | 78.50 | 79.71 |
| Placebo Then Dalfampridine | 85.38 | 86.65 | 86.00 |
Assessed by the investigator per International Myeloma Working Group criteria(IMWG) uniform response criteria. Result reflects number of participants whose best overall response qualified as sCR, CR, or VGPR in 2 year follow up period. (NCT02906332)
Timeframe: Every 3 weeks (day 1 of every 21-day treatment cycle +/- 7 days) through 12 weeks.
| Intervention | Participants (Count of Participants) |
|---|---|
| Pembrolizumab + Lenalidomide | 11 |
Safety will be assessed by quantifying the toxicities and grades experienced by subjects who have received pembrolizumab (MK-3475), lenalidomide and dexamethasone, including serious adverse events (SAEs). Result reflects count of participants who experienced an SAE. (NCT02906332)
Timeframe: Up to 3 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Pembrolizumab + Lenalidomide | 1 |
Assessed at 12 months; Subjects without documented PD or death will be censored at the last disease assessment date. Those who died without documented PD will be censored at the time of death. Result reflects count of participants who had progressed at 12 months. (NCT02906332)
Timeframe: Time from Day 0 (transplant) and date of enrollment to study completion (through 12 weeks) by investigator assessment.
| Intervention | Participants (Count of Participants) |
|---|---|
| Pembrolizumab + Lenalidomide | 10 |
PFS will be assessed from the date of ASCT, with day 0 defined as date of stem cell infusion (if tandem transplant the 2nd of 2 transplants will be used) until the date of progression, defined as the date at which the patient starts the next line of therapy or the date of death. (NCT02906332)
Timeframe: Up to 3 years
| Intervention | months (Median) |
|---|---|
| Pembrolizumab + Lenalidomide | 27.6 |
Recovery is defined as an absolute neutrophil count (ANC) of ≥ 0.5 x 109 /L (500/mm3 ) for three consecutive laboratory values obtained on different days. Date of ANC recovery is the date of the first of three consecutive laboratory values where the ANC is ≥ 0.5 x 109 /L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 19.42 |
| Matched Unrelated Donor Stem Cell Transplant | 77.44 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 25.5 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Rapidity of immune reconstitution based on number of days to CD3 count greater than 100 u/L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 355 |
| Matched Unrelated Donor Stem Cell Transplant | 284 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 16 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Platelet recovery is defined as platelet value ≥ 20 × 109/L for three consecutive days and no platelet transfusions administered for previous seven consecutive days. The date of platelet recovery is the date of the first of three consecutive laboratory values ≥ 20 × 109/L. (NCT00426517)
Timeframe: 1 year
| Intervention | Days (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 31 |
| Matched Unrelated Donor Stem Cell Transplant | 31.9 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 32.6 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Participants who achieved engraftment without development of graft versus host disease (GVHD). (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 6 |
| Matched Unrelated Donor Stem Cell Transplant | 30 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Number of events of Cytomegalovirus disease based on clinical sequelae that requires treatment (not reactivation) (NCT00426517)
Timeframe: 1 year
| Intervention | Number of events (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 0 |
| Matched Unrelated Donor Stem Cell Transplant | 0 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 0 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | 0 |
Average number of red blood cell (RBC) transfusion per subject (NCT00426517)
Timeframe: 1 year
| Intervention | transfusions per person (Mean) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 1.71 |
| Matched Unrelated Donor Stem Cell Transplant | 7.08 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 4 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Number of participants with myeloid chimerism of greater than 10% of donor cells at 1 year post transplant (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 7 |
| Matched Unrelated Donor Stem Cell Transplant | 30 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | NA |
Engraftment of allogeneic or matched unrelated (including cord blood) hematopoietic progenitor cells using moderate-dose busulfan and Campath-1H with or without whole body irradiation so as to attain phenotypic correction of congenital immunodeficiencies. (NCT00426517)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Matched Related Donor Stem Cell Transplant | 7 |
| Matched Unrelated Donor Stem Cell Transplant | 31 |
| Matched Unrelated Donor Stem Cell Transplant (MUD-non CGD) | 3 |
| Matched Unrelated Donor Transplant (MUD-CGD) Cord Blood | 0 |
Safety will be assessed using a dose escalation design for temozolomide's use to determine the target dose and also to evaluate any and all acute treatment related toxicities. During the course of patient follow up and therapy, toxicities will be evaluated, particularly as the investigators will be determining the target dose of temozolomide. One of the major criteria for dose limiting toxicity for the study will be any Grade 3 or 4 nonhematologic toxicity from a list of commonly expected toxicities associated with autologous transplantation and temozolomide. (NCT01235793)
Timeframe: One Year
| Intervention | dose in mg/m^2 (Number) |
|---|---|
| DRBEAT Regimen | 773.25 |
"Efficacy of the DRBEAT Regimen will be assessed by analysis of~one-year progression-free survival (PFS), defined as the time interval from maximal response from therapy to tumor regrowth, progression*, or death, (*Progression is defined as meeting the response criteria listed in Table 4: Response Criteria for Primary Central Nervous System Lymphoma according to Abrey LE, Batchelor TT, Ferreri AJM et al.)~and~Overall survival, defined as the time interval between the date of transplant and the date of death from any cause." (NCT01235793)
Timeframe: (1) One Year (2) Until date of death from any cause, assessed up to 2 years
| Intervention | Days (Median) | |
|---|---|---|
| Progression Free Survival | Overall Survival | |
| DRBEAT Regimen | 132 | 564 |
Defined as the time from date of first documented confirmed response to date of disease progression or relapse from complete response as defined by the International Working Group (IMW)-revised response criteria for malignant lymphoma (Cheson 2007). This criteria categorizes the response of a patient's tumor to treatment as Complete Response (CR): the disappearance of all disease evidence; Partial Response (PR): regression of measurable disease and no new sites; Stable Disease (SD): less than a PR but not progressive disease (PD); Relapsed Disease or PD: Any new lesion or increase by ≥ 50% of previously involved sites from nadir. Patients who are alive and free from disease progression will be censored at the date of last tumor assessment. Patients who begin further anticancer therapy prior to disease progression will be censored at the date of last tumor assessment prior to the start date of the anticancer therapy. (NCT01626352)
Timeframe: After cycles 3 and 6 of each 21-day cycle and every 3 months thereafter until disease progression or relapse from complete response for up to 38 months
| Intervention | months (Median) |
|---|---|
| Bendamustine/Ofatumumab | 5.6 |
Disease response assessments will be performed using the International Working Group (IMW)-revised response criteria for malignant lymphoma (Cheson 2007). Complete response requires a disappearance of all evidence of disease. (NCT01626352)
Timeframe: 18 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Bendamustine/Ofatumumab | 7 |
A treatment-related adverse event was any untoward medical occurrence in a participant which was considered to have a relationship with the study drug (suspected to be possibly or probably related to the study drug per the Investigator's assessment). Adverse events were evaluated using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0. (NCT01626352)
Timeframe: after cycles 3 and 6 of each 21-day cycle, and up to 30 days after last dose, projected 24 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Bendamustine/Ofatumumab | 16 |
Overall response is the number of patients with observed complete or partial response (CR or PR) as assessed using the International Working Group (IMW) revised response criteria for malignant lymphoma (Cheson 2007). Complete response requires disappearance of all evidence of disease. Partial response requires regression of measurable disease and no new sites. (NCT01626352)
Timeframe: after cycles 3 and 6 of each 21-day cycle, and every 3 months thereafter, projected 18 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Bendamustine/Ofatumumab | 19 |
Defined as the time from Day 1 of study drug administration to date of death from any cause. (NCT01626352)
Timeframe: every 3 cycles during treatment and every 3 months thereafter until progression or death from any cause, projected 18 months
| Intervention | months (Median) |
|---|---|
| Bendamustine/Ofatumumab | 12.0 |
Defined as the time from first treatment until objective tumor progression, relapse from complete response, or death from any cause. Tumor response is defined by the International Working Group (IMW)-revised response criteria for malignant lymphoma (Cheson 2007). This criteria categorizes the response of a patient's tumor to treatment as Complete Response (CR): the disappearance of all disease evidence; Partial Response (PR): regression of measurable disease and no new sites; Stable Disease (SD): less than a PR but not progressive disease (PD); Relapsed Disease or PD: Any new lesion or increase by ≥ 50% of previously involved sites from nadir. Patients who are alive and free from disease progression will be censored at the date of last tumor assessment. (NCT01626352)
Timeframe: After cycles 3 and 6 of each 21-day cycle, and every 3 months thereafter until progression or relapse from complete response for up to 40 months
| Intervention | months (Median) |
|---|---|
| Bendamustine/Ofatumumab | 8.6 |
Defined as the time from date of first treatment to the date of first documented disease progression or relapse from complete response as defined by the International Working Group (IMW)-revised response criteria for malignant lymphoma (Cheson 2007). This criteria categorizes the response of a patient's tumor to treatment as Complete Response (CR): the disappearance of all disease evidence; Partial Response (PR): regression of measurable disease and no new sites; Stable Disease (SD): less than a PR but not progressive disease (PD); Relapsed Disease or PD: Any new lesion or increase by ≥ 50% of previously involved sites from nadir. (NCT01626352)
Timeframe: After cycles 3 and 6 of each 21-day cycle, and every 3 months thereafter until progression or relapse from complete response for up to 40 months
| Intervention | months (Median) |
|---|---|
| Bendamustine/Ofatumumab | 10.5 |
"The PRINTO Juvenile Dermatomyositis (JDM) core set variables are:~muscle strength by the mean of the Childhood Myositis Assessment Scale (CMAS);~physician's global assessment of disease activity on a 10 cm Visual Analogue Scale (VAS);~global disease activity assessment by the mean of the Disease Activity Index (DAS);~parent's/patient's global assessment of overall well-being on a 10 cm VAS;~functional ability assessment by the mean of the Childhood Health Assessment Questionnaire (CHAQ)~health-related quality of life assessment." (NCT00323960)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Group 1 (MPDN+PDN) | 24 |
| Group 2 (MPDN+PDN+CSA) | 32 |
| Group 3 (MPDN+PDN+MTX) | 33 |
Clinical remission is defined as the status of inactive disease for at least 6 continuous months defined as normal muscle strength (CMAS equal to 52) and physician global assessment of disease activity equal to 0. (NCT00323960)
Timeframe: 60 months
| Intervention | events per 1000 persons-time (Number) |
|---|---|
| Group 1 (MPDN+PDN) | 5.99 |
| Group 2 (MPDN+PDN+CSA) | 4.95 |
| Group 3 (MPDN+PDN+MTX) | 13.39 |
Time to major therapeutic changes is defined as the addition of CSA or MTX or any other disease-modifying antirheumatic drug (DMARS) in any of the 3 groups or discontinuation of assigned therapy for any reason including adverse events. Retention on treatment was used as main measure of effectiveness. (NCT00323960)
Timeframe: 60 months
| Intervention | events per 1000 persons-time (Number) |
|---|---|
| Group 1 (MPDN+PDN) | 30.52 |
| Group 2 (MPDN+PDN+CSA) | 17.52 |
| Group 3 (MPDN+PDN+MTX) | 13.92 |
Prednisone or equivalent glucocorticoid discontinuation is defined as the complete discontinuation of glucocorticoids (NCT00323960)
Timeframe: 60 months
| Intervention | events per 1000 persons-time (Number) |
|---|---|
| Group 1 (MPDN+PDN) | 15.91 |
| Group 2 (MPDN+PDN+CSA) | 27.82 |
| Group 3 (MPDN+PDN+MTX) | 24.42 |
(NCT01453088)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 27 |
| Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 13 |
| Auto Transplant High Dose Melphalan+Bortezomib | 11 |
151 reviews available for prednisone and Recrudescence
| Article | Year |
|---|---|
Dexamethasone versus prednisone/prednisolone in the management of pediatric patients with acute asthmatic exacerbations: a systematic review and meta-analysis.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Child; Dexamethasone; Humans; Prednisolone; Prednisone | 2023 |
Dexamethasone versus prednisone/prednisolone in the management of pediatric patients with acute asthmatic exacerbations: a systematic review and meta-analysis.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Child; Dexamethasone; Humans; Prednisolone; Prednisone | 2023 |
Dexamethasone versus prednisone/prednisolone in the management of pediatric patients with acute asthmatic exacerbations: a systematic review and meta-analysis.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Child; Dexamethasone; Humans; Prednisolone; Prednisone | 2023 |
Dexamethasone versus prednisone/prednisolone in the management of pediatric patients with acute asthmatic exacerbations: a systematic review and meta-analysis.
Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Child; Dexamethasone; Humans; Prednisolone; Prednisone | 2023 |
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2023 |
[Therapeutic Strategies In Children And Adolescents With Langerhans Cell Histiocytosis].
Topics: Adolescent; Child; Histiocytosis, Langerhans-Cell; Humans; Prednisone; Prospective Studies; Recurren | 2023 |
Perspectives on chemotherapy for the management of double-hit lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoie | 2020 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Alkylating Agents; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide | 2020 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Labo | 2020 |
Gastrointestinal: Recurrence of pembrolizumab-induced severe gastritis after tapering steroid therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Drug Tapering; Gastric Mucosa; Gastritis; Humans; Infusions | 2021 |
Predicting the risk of relapse in polymyalgia rheumatica: novel insights.
Topics: Humans; Polymyalgia Rheumatica; Prednisone; Recurrence; Risk Factors | 2021 |
2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Cell Lineage; Combined Modalit | 2021 |
Update on the treatment of steroid-sensitive nephrotic syndrome.
Topics: Child; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic | 2022 |
Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis.
Topics: Child; Glucocorticoids; Humans; Nephrotic Syndrome; Prednisolone; Prednisone; Recurrence | 2021 |
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose Fractionation, Radiation; Dox | 2018 |
Evaluating the effectiveness of systemic corticosteroids to mitigate relapse in children assessed and treated for acute asthma: A network meta-analysis.
Topics: Acute Disease; Adrenal Cortex Hormones; Asthma; Dexamethasone; Glucocorticoids; Humans; Network Meta | 2019 |
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; | 2018 |
RECURRENT BRANCH RETINAL ARTERY OCCLUSION FROM SUSAC SYNDROME: CASE REPORT AND REVIEW OF LITERATURE.
Topics: Administration, Oral; Adrenal Cortex Hormones; Enzyme Inhibitors; Fluorescein Angiography; Humans; I | 2020 |
Idiopathic nephrotic syndrome in children.
Topics: Acute Kidney Injury; Child; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisone; Progno | 2018 |
Multivisceral IgG4-related disease presenting as recurrent massive gastrointestinal bleeding: a case report and literature review.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Diagnostic Errors; Digestive System Diseases; Duodena | 2018 |
Anakinra as rescue therapy for steroid-dependent idiopathic recurrent pericarditis in children: case report and literature review.
Topics: Adolescent; Antirheumatic Agents; Chronic Disease; Drug Therapy, Combination; Glucocorticoids; Human | 2019 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathio | 2019 |
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; H | 2013 |
Diffuse large B-cell non-Hodgkin lymphoma in the very elderly: challenges and solutions.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2013 |
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2014 |
Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.
Topics: Adolescent; Aged; Autoimmune Diseases; Blood Safety; Contraceptives, Oral, Hormonal; Female; Headach | 2015 |
Primary bone marrow lymphoma is a rare neoplasm with poor outcome: case series from single tertiary care centre and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Bone Marrow; Bone Marrow Exam | 2016 |
Treatment for and clinical characteristics of granulomatous mastitis.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Breast; Drug Therapy, Combination; Female; Granulomatous Ma | 2015 |
Corticosteroid therapy for nephrotic syndrome in children.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Drug Administration Schedule; Glucoco | 2015 |
Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
Topics: Anti-Inflammatory Agents; Antithyroid Agents; Bayes Theorem; Combined Modality Therapy; Evidence-Bas | 2015 |
Colchicine in addition to conventional therapy for pericarditis recurrence : An update meta-analysis.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Drug Combinatio | 2016 |
Clinical Management Updates in Mantle Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2016 |
Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions.
Topics: Acyclovir; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protoc | 2016 |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Huma | 2016 |
The Treatment of IgG4-Related Diseases in the Hepatobiliary-Pancreatic System.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Cholangiopancreatography, Endoscopic Retrograde; Chol | 2016 |
Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma.
Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2017 |
Diffuse large B-cell lymphoma: R-CHOP failure-what to do?
Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2016 |
Ophthalmoplegic migraine: a case with recurrent palsy of the abducens nerve.
Topics: Abducens Nerve Diseases; Adult; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Migrain | 2008 |
Minimization of steroids in kidney transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Clinical Trials as Topic; Daclizum | 2009 |
Kimura disease: a case report and review of the Chinese literature.
Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Biopsy; Child; Child, Preschool; Chi | 2009 |
Two differing presentations of chronic bilateral anterior uveitis.
Topics: Aged, 80 and over; Chronic Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Middle | 2009 |
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Glucocorticoids; Humans; Injections, Intravenous; Me | 2009 |
Primary pituitary lymphoma: idiopathic anasarca with relapse in bone marrow only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyc | 2010 |
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody | 2010 |
Intrathecal chemotherapy in lymphomatous meningitis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2011 |
Autoimmune hepatitis.
Topics: Animals; Azathioprine; Budesonide; Diagnosis, Differential; Drug Therapy, Combination; Genetic Predi | 2010 |
[Biologicals in gastroenterology: TNF-blockers].
Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2010 |
Periodic Fever syndromes.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies | 2011 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug | 2011 |
Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; | 2011 |
Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature.
Topics: Adolescent; Adult; Biopsy; Eyelid Diseases; Female; Glucocorticoids; Humans; Injections, Intralesion | 2012 |
Diagnosis and treatment of autoimmune hypophysitis: a short review.
Topics: Adult; Autoimmune Diseases; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Pituitary Dis | 2011 |
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2012 |
Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.
Topics: Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; | 2011 |
Therapies for peripheral T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; | 2011 |
Role of ultrasonography in the diagnosis and follow-up of pediatric eosinophilic gastroenteritis: a case report and review of the literature.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents; Ascites; Diagnosis, Differential; Enteritis; E | 2011 |
Focal segmental glomerulosclerosis.
Topics: Adult; Algorithms; Biopsy; Child; Genetic Predisposition to Disease; Glomerulosclerosis, Focal Segme | 2011 |
Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature.
Topics: Adult; Aged; Constriction, Pathologic; Cystostomy; Follow-Up Studies; Genital Diseases, Male; Glucoc | 2012 |
Autologous or allogeneic transplantation in B- and T-cell lymphomas.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2012 |
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2012 |
Rituximab-based treatment, HCV replication, and hepatic flares.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamusti | 2012 |
[Immunologic changes in diffuse large B-cell lymphomas after rituximab-CHOP treatment: own data and review of the literature].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Glucocorticoids; Humans; Injections, Intravenous; Me | 2012 |
Autologous stem cell transplantation in patients with mantle cell lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modal | 2002 |
Plasma exchange for myasthenia gravis.
Topics: Combined Modality Therapy; Glucocorticoids; Humans; Myasthenia Gravis; Plasma Exchange; Prednisone; | 2002 |
Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report.
Topics: Anemia, Hemolytic, Autoimmune; Atrophy; Autoimmune Diseases; Brain; Chromosome Deletion; Chromosomes | 2003 |
Primary NK/T cell lymphoma of the testis. A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Doxorubici | 2003 |
Cutaneous Wegener's granulomatosis: a variant or atypical localized form?
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biopsy, Needle; Cyclophosphamide; Drug Therapy, Combin | 2003 |
Corticosteroids in acute asthma: past, present, and future.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones | 2003 |
Recurrence of anti-GBM disease 8 years after renal transplantation.
Topics: Anti-Glomerular Basement Membrane Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gra | 2004 |
[Wegener's granulomatosis (morbus Wegener)].
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Diagnosis, D | 2003 |
[Lipoid nephrosis in childhood].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Biopsy; Child; Cyclosporins; | 2003 |
Chronic recurrent multifocal osteomyelitis of the spine and mandible: case report and review of the literature.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Chron | 2004 |
[Waldenstrom macroglobulinemia].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, M | 2004 |
Recurrent eosinophilic cystitis in a child with chronic granulomatous disease.
Topics: Cyclosporine; Cystitis; Eosinophilia; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agen | 2004 |
Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management.
Topics: Adult; Autoimmune Diseases; Combined Modality Therapy; Diagnosis, Differential; Hemorrhage; Humans; | 2004 |
Lichen planus induced by hepatitis B vaccination: a new case and review of the literature.
Topics: Adult; Clobetasol; Glucocorticoids; Hepatitis B Vaccines; Humans; Lichen Planus; Male; Prednisone; R | 2004 |
Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease Progress | 2004 |
[Autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Female; | 2004 |
[Current strategies in the treatment of advanced stage mantle cell lymphoma].
Topics: Age Factors; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Ag | 2004 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
Distinguishing among prolonged, recurrent, and periodic fever syndromes: approach of a pediatric infectious diseases subspecialist.
Topics: Algorithms; Allergy and Immunology; Anti-Inflammatory Agents; Cardiovascular Deconditioning; Child; | 2005 |
Evidence-based management of steroid-sensitive nephrotic syndrome.
Topics: Alkylating Agents; Child; Evidence-Based Medicine; Glucocorticoids; Humans; Nephrotic Syndrome; Pred | 2005 |
10 most commonly asked questions about idiopathic inflammatory myopathies.
Topics: Creatine Kinase; Diagnosis, Differential; Electromyography; Glucocorticoids; Humans; Immunosuppressi | 2005 |
Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.
Topics: Aged; Amyloidosis; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; C | 2005 |
Prolonged remission after splenectomy for refractory Evans syndrome--a case report and literature review.
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Blood Transfusion; Female; Glucocorticoids; Humans; Immun | 2005 |
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A | 2007 |
Wegener granulomatosis: a case report and update.
Topics: Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Drug Administration Schedule; Female; Gluc | 2006 |
The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
Use of rituximab in patients with follicular lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Retroperitoneal fibrosis].
Topics: Combined Modality Therapy; Decompression, Surgical; Diagnosis, Differential; Humans; Immunosuppressi | 2007 |
Rituximab in autoimmune pancytopenia: a case report and review of literature.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2007 |
[Imatinib-induced toxic hepatitis: description of two cases and review of the literature].
Topics: Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal | 2007 |
[High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Forecasting; Hu | 2008 |
Management of steroid sensitive nephrotic syndrome: revised guidelines.
Topics: Adjuvants, Immunologic; Cyclophosphamide; Glucocorticoids; Humans; Levamisole; Mycophenolic Acid; Ne | 2008 |
Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Antilymphocyte Serum; Azathioprine; Cell Separati | 1982 |
[A review on "cryptogenic neuropathy" with special reference to idiopathic chronic polyneuritis (author's transl)].
Topics: Adult; Chronic Disease; Female; Humans; Male; Neuromuscular Diseases; Polyneuropathies; Polyradiculo | 1981 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
[Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients].
Topics: Aged; Aged, 80 and over; Antimalarials; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Pre | 1994 |
Granulomatous gastroenteritis. Case report with comparison to idiopathic isolated granulomatous gastritis.
Topics: Adult; Crohn Disease; Diagnosis, Differential; Female; Gastritis; Gastroenteritis; Granuloma; Humans | 1994 |
[Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Fol | 1994 |
[Clinical course of Horton disease. Apropos of 42 cured patients].
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednison | 1994 |
[Dermatomyositis in childhood with recurrence in adulthood: 2 cases].
Topics: Adult; Age Factors; Alopecia Areata; Atrophy; Child; Child, Preschool; Dermatomyositis; Female; Huma | 1993 |
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; D | 1993 |
[An atypical presentation of a case of Horton's giant-cell arteritis].
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Biopsy; Candidiasis; Drug Hypersensitiv | 1995 |
Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case.
Topics: Autoantibodies; Autoimmune Diseases; Female; Glucocorticoids; Humans; Hypoglycemia; Insulin Antibodi | 1996 |
[A case of the "shrinking lung syndrome" in SLE--improvement with corticosteroid therapy].
Topics: Acute Disease; Anti-Inflammatory Agents; Dyspnea; Female; Humans; Lung Diseases; Lupus Erythematosus | 1996 |
[Chemotherapy of relapsed AML and ALL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Relapse of polymyositis after prolonged remission.
Topics: Antibodies, Antinuclear; Glucocorticoids; Humans; Male; Middle Aged; Polymyositis; Prednisone; Recur | 1997 |
Chemotherapy: the more, the better in malignant lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1997 |
Oral lichen planus: topical and systemic therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Biopsy; Clinical Protoco | 1997 |
Relapse of Hodgkin's disease after 10 years of complete remission: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; | 1998 |
Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Hypersensitivity; Hum | 1998 |
[Dose-effects and chemotherapy dose intensity of aggressive non-Hodgkin's lymphomas in the adult].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Dose-R | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb | 1998 |
[Hepatic inflammatory pseudotumor: apropos a case with a response to steroid treatment].
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Combined Modality Therapy; Female; Granuloma, Plasma Cell; H | 1999 |
Lupus erythematosus associated with erythema multiforme: does Rowell's syndrome exist?
Topics: Adult; Azathioprine; Cathartics; Dermatologic Agents; Diagnosis, Differential; Erythema Multiforme; | 1999 |
Relapsing hepatitis A: a case report and review of the literature.
Topics: Aged; Anti-Inflammatory Agents; Female; Hepatitis A; Humans; Methylprednisolone Hemisuccinate; Predn | 1999 |
Myeloma-associated systemic amyloidosis presenting as chronic paronychia and palmodigital erythematous swelling and induration of the hands.
Topics: Amyloidosis; Antineoplastic Agents, Alkylating; Chronic Disease; Drug Therapy, Combination; Erythema | 2000 |
Clinical aspects of pulmonary sarcoidosis.
Topics: Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema N | 2000 |
Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Glucocorticoids; Humans; | 2000 |
The treatment of primary focal segmental glomerulosclerosis.
Topics: Anti-Inflammatory Agents; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Immunosu | 2000 |
Initial management of proliferative lupus nephritis: to cytotoxic or not to cytotoxic?
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Azathioprine; Clinical Trials as Topic; Cyclophospha | 1999 |
Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature.
Topics: Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Recurrence | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprin | 2001 |
Selecting topical and systemic agents for recurrent aphthous stomatitis.
Topics: Administration, Topical; Aminopyridines; Anti-Inflammatory Agents; Humans; Prednisone; Recurrence; S | 2001 |
Management of patients with multiple myeloma: emphasizing the role of high-dose therapy.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pr | 2001 |
Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
Topics: Age Distribution; Anti-Inflammatory Agents; Azathioprine; Causality; Drug Therapy, Combination; Euro | 2001 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2002 |
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin | 2002 |
The protean manifestations of Crohn's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arthritis; Azathioprine; Child; Colectomy; Colitis, | 1975 |
Chronic hepatitis. To treat or not to treat?
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Humans; Middl | 1978 |
Management of the nephrotic syndrome in children.
Topics: Child; Cyclophosphamide; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; | 1976 |
Relapsing hepatitis A. Review of 14 cases and literature survey.
Topics: Adult; Disease Susceptibility; Female; Hepatitis A; Hepatovirus; Humans; Liver Function Tests; Male; | 1992 |
Delayed onset of varicella keratitis.
Topics: Antibodies, Viral; Chickenpox; Child; Corneal Edema; Female; Herpesvirus 3, Human; Humans; Keratitis | 1992 |
Maintenance treatment for Crohn's disease: has the time arrived?
Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combi | 1992 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
Conventional therapy for idiopathic nephrotic syndrome in children.
Topics: Child; Chlorambucil; Cyclophosphamide; Humans; Nephrosis, Lipoid; Prednisone; Recurrence | 1991 |
The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
Topics: Alkylating Agents; Child; Chlorambucil; Cyclophosphamide; Cyclosporins; Humans; Immunosuppressive Ag | 1991 |
[Treating the nephrotic syndrome in the child].
Topics: Adrenal Cortex Hormones; Child; Cyclosporins; Drug Resistance; Humans; Levamisole; Nephrotic Syndrom | 1990 |
[Therapy of multiple myeloma and its complications].
Topics: Acute Kidney Injury; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow | 1990 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosu | 1989 |
Idiopathic anaphylaxis: a review.
Topics: Anaphylaxis; Diagnosis, Differential; Humans; Prednisone; Recurrence; Time Factors | 1989 |
Prevention of restenosis after coronary angioplasty: a pharmacological approach.
Topics: Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical | 1989 |
Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Basement | 1988 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature.
Topics: Adipose Tissue; Adult; Aged; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Biopsy; Blood Prot | 1987 |
Management of childhood leukemia.
Topics: Alkanesulfonates; Amidines; Bone Marrow Examination; Chickenpox; Child; Child, Preschool; Cyclophosp | 1974 |
Treatment of thyrotoxicosis--the current position. 3. Radioiodine therapy. Special considerations.
Topics: Adult; Age Factors; Carbimazole; Chlorpromazine; Female; Heart Diseases; Humans; Hyperthyroidism; Hy | 1973 |
284 trials available for prednisone and Recrudescence
| Article | Year |
|---|---|
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up | 2022 |
Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence.
Topics: Child; Glucocorticoids; Humans; Nephrotic Syndrome; Prednisone; Prospective Studies; Recurrence; Ris | 2022 |
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Topics: Antibodies, Monoclonal, Humanized; C-Reactive Protein; Drug Tapering; Glucocorticoids; Humans; Inter | 2023 |
Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cell Lineage; Child; Chi | 2019 |
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.
Topics: Acute Disease; Adult; Cetirizine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fol | 2019 |
Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Dose-Response Relati | 2020 |
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamid | 2020 |
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
Topics: Adult; Aged; Autoantibodies; Desmoglein 3; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immuno | 2020 |
Ustekinumab for the Treatment of Giant Cell Arteritis.
Topics: Aged; Anti-Inflammatory Agents; Boston; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glu | 2021 |
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2020 |
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children.
Topics: Anti-Inflammatory Agents; Child; Cross-Over Studies; Epinephrine; Glucocorticoids; Humans; Immunosup | 2021 |
Avacopan for the Treatment of ANCA-Associated Vasculitis.
Topics: Administration, Oral; Aniline Compounds; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; | 2021 |
A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy.
Topics: Humans; Methylprednisolone; Multiple Sclerosis; Pilot Projects; Prednisone; Recurrence; Treatment Ou | 2021 |
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2017 |
Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Disease Progression; Drug Resistan | 2017 |
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Topics: Adult; Aged; Calcineurin Inhibitors; Chronic Disease; Disease Progression; Endpoint Determination; F | 2017 |
Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids.
Topics: Adult; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Im | 2017 |
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Topics: Adjuvants, Immunologic; Age Factors; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Com | 2018 |
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2018 |
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2018 |
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2018 |
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2018 |
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Aortitis; C-Reactive Protein; Drug Administration Schedule; | 2018 |
Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil
Topics: Drug Monitoring; Germany; Humans; Immunosuppressive Agents; Logistic Models; Multicenter Studies as | 2018 |
The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamid | 2019 |
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2019 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Ce | 2013 |
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Drug Therapy, Combination; Female | 2013 |
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2013 |
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2013 |
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2013 |
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2013 |
Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2013 |
A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Therapy, Combination; | 2014 |
Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 2014 |
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2014 |
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; | 2014 |
Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation.
Topics: Acute Disease; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; | 2014 |
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Long-term effect of high-dose dexamethasone with or without low-dose dexamethasone maintenance in untreated immune thrombocytopenia.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dexamethasone; Female; Humans; Male; Middle Aged | 2015 |
Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Topics: Calcineurin Inhibitors; Child; Cyclophosphamide; Drug Resistance; Female; Glucocorticoids; Humans; I | 2015 |
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2015 |
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.
Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemoth | 2015 |
Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 2015 |
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunologic Factors; | 2015 |
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunologic Factors; | 2015 |
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunologic Factors; | 2015 |
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Immunologic Factors; | 2015 |
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Administration Schedule; Fasciitis; Female; Gr | 2015 |
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; | 2015 |
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2015 |
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Resista | 2016 |
The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; Cysts; Drug Therapy, Combinati | 2015 |
A Randomized Controlled Noninferiority Trial of Single Dose of Oral Dexamethasone Versus 5 Days of Oral Prednisone in Acute Adult Asthma.
Topics: Administration, Oral; Adult; Anti-Asthmatic Agents; Asthma; Dexamethasone; Drug Administration Sched | 2016 |
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic C | 2016 |
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2016 |
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
Topics: Adolescent; Antibiotics, Antineoplastic; Asparaginase; Bone Marrow; Child; Child, Preschool; Disease | 2017 |
The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.
Topics: Administration, Oral; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple | 2008 |
Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial.
Topics: Acute Disease; Administration, Oral; Adult; Female; Glucocorticoids; Humans; Injections, Intravenous | 2008 |
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2008 |
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineop | 2008 |
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineop | 2008 |
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineop | 2008 |
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineop | 2008 |
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
Topics: Acute Disease; Adolescent; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protoco | 2009 |
Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
Topics: Adult; Atrophy; Azathioprine; Brain; Cerebral Ventricles; Disease Progression; Drug Therapy, Combina | 2009 |
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Atrophy; Azathioprine; Brain; Disability Evaluation; | 2009 |
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; D | 2009 |
Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Drug A | 2010 |
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2010 |
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2010 |
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; China; Europe; Fema | 2010 |
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Canada; Cyclophosphamide; Disease-Free Su | 2010 |
Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Epidemiologic Methods; Female; Gastrointestinal D | 2010 |
Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children.
Topics: Adolescent; Age Distribution; Age of Onset; Child; Child, Preschool; Epidemiologic Methods; Glucocor | 2010 |
Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Bi | 2011 |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine | 2010 |
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boro | 2011 |
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2011 |
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2011 |
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
Topics: Adolescent; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; C | 2011 |
Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda | 2012 |
Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.
Topics: Adolescent; Adult; Blood Pressure; Chi-Square Distribution; Child; Double-Blind Method; Female; Finl | 2012 |
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose | 2012 |
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Brain; Cohort Stud | 2012 |
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Disease-Free Survival; H | 2012 |
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2012 |
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Disease-Free Surviv | 2013 |
[Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
Topics: Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Prog | 2002 |
Surface markers of platelet function in idiopathic nephrotic syndrome in children.
Topics: Adolescent; Biomarkers; Blood Coagulation Tests; Child; Child, Preschool; Female; Flow Cytometry; Hu | 2002 |
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |
[Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2003 |
Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
Topics: Adolescent; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Antimetabolites, Antineoplastic; An | 2003 |
Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Female; Glycosami | 2003 |
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2003 |
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2003 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
Topics: Adolescent; Adult; Aged; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Adult; Amenorrhea; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combi | 2004 |
Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
Topics: Adolescent; Adult; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocort | 2003 |
[Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
Topics: Adolescent; Adult; Erythema Nodosum; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppr | 2003 |
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Mo | 2004 |
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dis | 2004 |
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progres | 2004 |
Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Topics: Agammaglobulinemia; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovi | 2005 |
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Topics: Adult; Calcineurin Inhibitors; Cause of Death; Chronic Disease; Creatinine; Drug Therapy, Combinatio | 2005 |
Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Re | 2005 |
Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Dose-Response Relationshi | 2005 |
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 2005 |
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2005 |
Study of the effect of leeching on plasma endothelin and soluble interleukin-2 receptor in patients with systemic lupus erythematosus.
Topics: Adult; Dose-Response Relationship, Drug; Endothelins; Female; Glucocorticoids; Humans; Leeching; Lup | 2005 |
Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2005 |
Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; D | 2005 |
Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Aspirin; Colchicine; Female; Humans; Male; Middle Aged; Peric | 2005 |
Sequential, cycling maintenance therapy for post transplant multiple myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pr | 2006 |
Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Androstadienes; Asthma; Dose-Respon | 2006 |
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2006 |
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cyta | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Diabetes Mellitus; Drug Therapy, Com | 2006 |
Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Drug Tolerance; Glucoc | 2006 |
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Su | 2006 |
[Clinical effect of shenbing mistura combined with glucocorticoid on recurrent nephrotic syndrome in children and levels of interleukin-6 and tumor necrosis factor-alpha in blood and urine].
Topics: Adult; Child; Child, Preschool; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up | 2006 |
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Toleran | 2007 |
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 2007 |
Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combin | 2007 |
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 2007 |
Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic be | 2007 |
Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Female; Follow-Up Stu | 2008 |
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.
Topics: Administration, Oral; Adolescent; Androstadienes; Child; Child, Preschool; Esophagitis; Esophagus; F | 2008 |
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.
Topics: Administration, Oral; Adolescent; Androstadienes; Child; Child, Preschool; Esophagitis; Esophagus; F | 2008 |
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.
Topics: Administration, Oral; Adolescent; Androstadienes; Child; Child, Preschool; Esophagitis; Esophagus; F | 2008 |
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.
Topics: Administration, Oral; Adolescent; Androstadienes; Child; Child, Preschool; Esophagitis; Esophagus; F | 2008 |
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo | 2008 |
Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2008 |
High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone.
Topics: Administration, Oral; Adolescent; Antibodies, Bacterial; Child; Child, Preschool; Drug Resistance; F | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department.
Topics: Administration, Oral; Adolescent; Asthma; Chi-Square Distribution; Child; Child, Preschool; Dexameth | 2008 |
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Anti-Inflammatory Agents; Antiparasitic Agents; Brain; | 2008 |
[Current status of drug therapy of chronic inflammatory intestinal diseases].
Topics: Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Cromolyn Sodium; Double-Blind Method; D | 1983 |
A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials | 1984 |
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; | 1983 |
Systemic lupus erythematosus--corticosteroids.
Topics: Adrenal Cortex Hormones; Central Nervous System Diseases; Clinical Trials as Topic; Dermatomyositis; | 1983 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
[The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurin | 1981 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Ova | 1980 |
Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Th | 1982 |
Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children.
Topics: Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fol | 1995 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1995 |
Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; As | 1995 |
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sc | 1995 |
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparag | 1995 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Topics: Administration, Oral; Adolescent; Adult; Autoantibodies; Azathioprine; Cyclophosphamide; Drug Therap | 1995 |
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 1993 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; | 1995 |
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Chi | 1995 |
[Observation of therapy of integrated TCM-WM on repeatedly relapsed primary nephrotic syndrome in adults].
Topics: Adolescent; Adult; Cyclophosphamide; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Nephr | 1995 |
Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Human | 1995 |
Treatment of oral pemphigus vulgaris.
Topics: Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Combinations; Female; Fluorescent Antibody Techniq | 1994 |
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res | 1995 |
Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer.
Topics: Adult; Drug Administration Schedule; Esophageal Diseases; Female; HIV Infections; Humans; Male; Pred | 1994 |
Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow | 1994 |
Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diabetes Insipi | 1994 |
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1993 |
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; C | 1993 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophospha | 1993 |
Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Circadian Rhythm; Drug Administration Schedul | 1993 |
Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants.
Topics: Acyclovir; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Tolerance; Ganciclovir; Graf | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distrib | 1993 |
Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses.
Topics: Administration, Oral; Adult; Autoimmune Diseases; Azathioprine; Drug Administration Schedule; Drug T | 1993 |
Corticosteroids and optic neuritis.
Topics: Administration, Oral; Humans; Magnetic Resonance Imaging; Methylprednisolone; Optic Neuritis; Placeb | 1993 |
Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies; Humans; Nephro | 1993 |
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyta | 1996 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug A | 1996 |
Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Double-Blind Method; Drug | 1995 |
The follicular non-Hodgkin's lymphomas--I. The possibility of cure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclophosph | 1996 |
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Topics: Adult; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy | 1996 |
[Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
Topics: Adolescent; Biopsy; Child; Child, Preschool; Follow-Up Studies; Humans; Infant; Kidney; Nephrotic Sy | 1996 |
Multiple statistics for multiple events, with application to repeated infections in the growth factor studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Thera | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; International Cooperation; Lon | 1997 |
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1997 |
[Clinical study of zhinu-I,-II in treating 61 patients with idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Drugs, Chinese Herbal; Female; | 1996 |
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; | 1997 |
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb | 1997 |
Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Age Factors; Albuterol; Anti-Inflammat | 1997 |
Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Progression; Drug Therapy, Combination; F | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Color Perception; Contrast Sensitivity; Fem | 1997 |
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation | 1997 |
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antirheumatic Agents; Cyclophosphamide; Drug Therapy, | 1997 |
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc | 1998 |
[Bronchiolitis obliterans organizing pneumonia].
Topics: Adult; Aged; Cryptogenic Organizing Pneumonia; Female; Humans; Lung; Male; Middle Aged; Prednisone; | 1997 |
Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Ambulatory Care; Asthma; Double-Blind Method | 1998 |
Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.
Topics: Acetaminophen; Adjuvants, Immunologic; Adult; Analgesics, Non-Narcotic; Dose-Response Relationship, | 1998 |
Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Disability Evaluation; Female; Humans; Immunosu | 1998 |
Outcome of ulcerative colitis after treatment with transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Colitis, Ulcerative; Female; Glucocorticoids; Humans; Male; Nicoti | 1998 |
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpla | 1998 |
Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52.
Topics: Adult; Age Distribution; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 1999 |
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.
Topics: Adjuvants, Immunologic; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Ca | 1999 |
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Anti-Asthmatic A | 1999 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Drug Administration Sched | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of De | 1999 |
Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Topics: Child; Child, Preschool; Follow-Up Studies; Glucocorticoids; Humans; Infant; Nephrotic Syndrome; Pre | 1999 |
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cy | 2000 |
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Topics: Adult; Crohn Disease; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents | 2000 |
Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Nephr | 2000 |
Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.
Topics: Child; Cyclophosphamide; Female; HLA-DR7 Antigen; Humans; Male; Nephrotic Syndrome; Prednisone; Recu | 2000 |
CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea | 2000 |
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2000 |
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Purging; Cispl | 2000 |
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantati | 2001 |
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Comb | 2001 |
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cinchona Alkaloids; Cyclophosphamide; D | 2000 |
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; F | 2001 |
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2001 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Topics: Acute Disease; Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Dexamethasone; Dru | 2001 |
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Proto | 2001 |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chil | 2001 |
[Clinical observation of elderly idiopathic nephrotic syndrome treated with integrated traditional Chinese and Western medicine].
Topics: Aged; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glucocorticoids; Humans; Male; Middl | 2000 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamid | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Topics: Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Clobetasol; Glucocorticoids; | 2002 |
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Danazol; Drug Administration Routes; Dru | 2002 |
[The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome].
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Cyclosporine; Danazol; Drug Therapy, Combina | 2001 |
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Disease-Free Su | 2002 |
Disodium cromoglycate maintenance treatment of ulcerative colitis.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Cromolyn Sodium; Drug Evaluation; Humans; Placebos; P | 1977 |
National Cooperative Crohn's Disease Study: study design and conduct of the study.
Topics: Azathioprine; Clinical Trials as Topic; Crohn Disease; Double-Blind Method; Drug Therapy, Combinatio | 1979 |
National Cooperative Crohn's Disease Study: results of drug treatment.
Topics: Adult; Azathioprine; Clinical Trials as Topic; Crohn Disease; Double-Blind Method; Female; Follow-Up | 1979 |
Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Ev | 1979 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clinical Trials as Topic; Follow-Up Studies; Human | 1979 |
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema | 1979 |
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Ch | 1978 |
Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Cyclophosphamide; Drug Therapy, Combination; Female; Fol | 1978 |
Influenza immunization in systemic lupus eruthematosus. A double-blind trial.
Topics: Adult; Antibodies, Viral; Antibody Formation; Clinical Trials as Topic; Complement C3; DNA; Double-B | 1978 |
Low dose steroids and clinical relapse in Crohn's disease: a controlled trial.
Topics: Adolescent; Adult; Clinical Trials as Topic; Crohn Disease; Double-Blind Method; Female; Humans; Mal | 1978 |
Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; | 1979 |
Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug T | 1979 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1978 |
Chlorambucil treatment of frequently relapsing nephrotic syndrome.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Chlorambucil; Drug Evaluation; Drug Therapy, Combi | 1976 |
A controlled trial of azathioprine in Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Clinical Trials as Topic; Crohn Disease; Female; Humans; Male; Midd | 1975 |
Remission maintenance therapy for multiple myeloma.
Topics: Bone Neoplasms; Carmustine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; | 1975 |
Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
Topics: Adult; Aged; Cause of Death; Churg-Strauss Syndrome; Combined Modality Therapy; Cyclophosphamide; Fe | 1992 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Alopecia Areata; Child; Dermatit | 1992 |
[Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
Topics: Administration, Oral; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Giant Cell | 1992 |
Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Creatinine; Cyclosporine; Drug Administration Sch | 1992 |
Intensive combined therapy for previously untreated aggressive myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality | 1992 |
Intensive combined therapy for previously untreated aggressive myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality | 1992 |
Intensive combined therapy for previously untreated aggressive myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality | 1992 |
Intensive combined therapy for previously untreated aggressive myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality | 1992 |
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham | 1992 |
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys | 1992 |
Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.
Topics: Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; | 1992 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; | 1992 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio | 1991 |
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1991 |
Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma.
Topics: Acute Disease; Administration, Oral; Adult; Asthma; Clinical Protocols; Double-Blind Method; Drug Ad | 1991 |
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Child, Presch | 1991 |
The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
Topics: Alkylating Agents; Child; Chlorambucil; Cyclophosphamide; Cyclosporins; Humans; Immunosuppressive Ag | 1991 |
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1991 |
Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dexame | 1991 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat | 1990 |
A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1990 |
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adult; Female; Humans; Male; Multivaria | 1990 |
A controlled trial comparing three treatments for chronic otitis media with effusion.
Topics: Analysis of Variance; Child; Child, Preschool; Chronic Disease; Follow-Up Studies; Hearing Loss; Hum | 1990 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Clinical relapse of Crohn's disease under standardized conservative treatment and after excisional surgery.
Topics: Adult; Colectomy; Crohn Disease; Female; Follow-Up Studies; Humans; Intestine, Small; Life Tables; M | 1989 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosu | 1989 |
A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty.
Topics: Angiography; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Follow- | 1989 |
Prevention of restenosis after coronary angioplasty: a pharmacological approach.
Topics: Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical | 1989 |
Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Female; | 1988 |
Cyclosporine trials in diabetes: updated results of the French experience.
Topics: Autoimmune Diseases; Azathioprine; C-Peptide; Clinical Trials as Topic; Cyclosporins; Diabetes Melli | 1988 |
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio | 1986 |
[The use of corticosteroids in Guillain-Barré syndrome: study of 51 cases].
Topics: Clinical Trials as Topic; Dexamethasone; Female; Humans; Length of Stay; Male; Polyradiculoneuropath | 1986 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
Topics: Administration, Oral; Adult; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hum | 1985 |
Response rate and survival in myeloma patients receiving prednisone alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Female; Humans; Male; Melphalan; Middle | 1985 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
Topics: Adolescent; Age Factors; Alopecia; Child; Child, Preschool; Cyclophosphamide; Cystitis; Drug Evaluat | 1974 |
Comparison of two methods of preventing central nervous system leukemia.
Topics: Adolescent; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Cobalt | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
Toxicity of L-asparginase in children with advanced leukemia.
Topics: Acute Disease; Antineoplastic Agents; Asparaginase; Central Nervous System Diseases; Chemical and Dr | 1972 |
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
Topics: Adolescent; Alopecia; Child; Cyclophosphamide; Cystitis; Drug Synergism; Female; Humans; Hypercholes | 1973 |
Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Child; Drug Combinations; Female; Follow- | 1972 |
1288 other studies available for prednisone and Recrudescence
| Article | Year |
|---|---|
Good pregnancy outcomes in lupus nephritis patients with complete renal remission.
Topics: Adult; Female; Humans; Lupus Nephritis; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2022 |
Presumed Recurrent MEWDS following Covid-19 Vaccination.
Topics: COVID-19; COVID-19 Vaccines; Female; Fluorescein Angiography; Glucocorticoids; Humans; Middle Aged; | 2021 |
Treatment Outcomes in Birdshot Chorioretinitis: Corticosteroid Sparing, Corticosteroid Discontinuation, Remission, and Relapse.
Topics: Adrenal Cortex Hormones; Birdshot Chorioretinopathy; Humans; Prednisone; Recurrence; Retrospective S | 2022 |
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposid | 2022 |
Childhood acute lymphoblastic leukemia: Four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower-middle-income country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Surviv | 2022 |
Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen.
Topics: Alemtuzumab; Canada; Cytokines; Histamine H2 Antagonists; Humans; Methylprednisolone; Multiple Scler | 2022 |
Prednisone for Steroid-Sensitive Nephrotic Syndrome: Can We Use Lower Doses for the First Presentation in Children?
Topics: Child; Drug Administration Schedule; Glucocorticoids; Humans; Nephrotic Syndrome; Prednisone; Recurr | 2022 |
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies.
Topics: Encephalitis; Humans; Prednisone; Recurrence; Retrospective Studies; Rituximab | 2022 |
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Dif
Topics: Canada; Cell- and Tissue-Based Therapy; Clinical Trials as Topic; Cost-Effectiveness Analysis; Cyclo | 2023 |
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
Topics: Aged; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Prednisone; Purpura, Thrombocytopen | 2023 |
How I Treat Steroid-Sensitive Nephrotic Syndrome in Children.
Topics: Child; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Prednisone; Recurren | 2022 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.
Topics: Giant Cell Arteritis; Humans; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome | 2023 |
Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study.
Topics: Aged; Chronic Disease; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Methylprednisolo | 2023 |
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.
Topics: Adult; Child; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; R | 2023 |
Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases.
Topics: Autoantibodies; Child; Humans; Immunoglobulins, Intravenous; Myelin-Oligodendrocyte Glycoprotein; Pr | 2023 |
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
Topics: Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Ce | 2023 |
[Expression of
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Relevance; Disease-Free Survival; Hu | 2023 |
Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure-Reply.
Topics: Birth Rate; Embryo Implantation; Female; Humans; Infant, Newborn; Prednisone; Pregnancy; Pregnancy C | 2023 |
Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure.
Topics: Birth Rate; Embryo Implantation; Female; Humans; Infant, Newborn; Prednisone; Pregnancy; Pregnancy C | 2023 |
Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure.
Topics: Birth Rate; Embryo Implantation; Female; Humans; Infant, Newborn; Prednisone; Pregnancy; Pregnancy C | 2023 |
Prednisone and Live Birth Rate in Patients With Recurrent Implantation Failure.
Topics: Birth Rate; Embryo Implantation; Female; Humans; Infant, Newborn; Prednisone; Pregnancy; Pregnancy C | 2023 |
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
Topics: Asthma; Churg-Strauss Syndrome; Eosinophilia; Granulomatosis with Polyangiitis; Humans; Prednisone; | 2023 |
Prognostic Value of Differential Expression of Polymerase Eta Gene in Nonresponding Patients With Diffuse Large B-cell Lymphoma.
Topics: Disease-Free Survival; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Predniso | 2024 |
Satralizumab as an add-on treatment in refractory pediatric AQP4-antibody-positive neuromyelitis optica spectrum disorder: a case report.
Topics: Antibodies, Monoclonal; Autoantibodies; Child; Female; Humans; Immunoglobulins, Intravenous; Mycophe | 2023 |
[Pure red cell aplasia in children: a clinical analysis of 16 cases].
Topics: Child; Glucocorticoids; Humans; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Retrospective Studie | 2019 |
Autoimmune hemolytic anemia, adverse event to venetoclax.
Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2019 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug | 2019 |
Immunoglobulin G4-related disease of the urinary bladder.
Topics: Adult; Cystitis; Cystoscopy; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Di | 2020 |
Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss.
Topics: Administration, Oral; Adult; Aged; Auditory Threshold; Azathioprine; Chronic Disease; Female; Hearin | 2020 |
[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2019 |
Unexpected neurologic complications following a novel lymphoma treatment 'expected' to give rise to neurologic toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Hu | 2019 |
Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Topics: Adult; Aged; Chromones; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunog | 2020 |
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
Topics: Abnormal Karyotype; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase | 2020 |
Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
Topics: Adrenal Cortex Hormones; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antigens, | 2020 |
Intravenous methotrexate at a dose of 1 g/m
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cerebrospinal Fluid; C | 2020 |
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; H | 2020 |
Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclophosphamide; Female; Humans; Immunosuppressive Agen | 2020 |
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Col | 2020 |
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents | 2020 |
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2020 |
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study.
Topics: Aged; Anti-Inflammatory Agents; Case-Control Studies; Dose-Response Relationship, Drug; Female; Gian | 2020 |
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cycl | 2020 |
Lower Serum miR-145 Predicts Poor Prognosis in Patients with Acute Myeloid Leukemia.
Topics: Adult; Antineoplastic Agents, Hormonal; Area Under Curve; Biomarkers, Pharmacological; Biomarkers, T | 2020 |
Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; | 2020 |
Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus.
Topics: Administration, Oral; Adult; Antibodies, Antinuclear; Asymptomatic Diseases; DNA; Female; Humans; Im | 2020 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Midd | 2021 |
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Do | 2021 |
Do Postoperative Oral Corticosteroids Improve Results After Sialendoscopy for Ductal Stenosis?
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Constrict | 2021 |
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2021 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineopl | 2021 |
Diagnosis, Clinical Features, and Management of Patients With Granulomatous Cheilitis.
Topics: Administration, Oral; Adult; Aged; Cohort Studies; Colonoscopy; Crohn Disease; Diagnosis, Differenti | 2021 |
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Beijing; Female; Glucocorticoids; Humans; Immune Checkpoint Inhibito | 2021 |
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Case-Control Studies; Cy | 2020 |
[Therapeutic de-escalation in systemic lupus erythematosus in remission].
Topics: Dose-Response Relationship, Drug; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mainten | 2020 |
Immunosuppressive therapy in childhood-onset arrhythmogenic inflammatory cardiomyopathy.
Topics: Arrhythmogenic Right Ventricular Dysplasia; Azathioprine; Biomarkers; Child; Echocardiography; Elect | 2021 |
Tough to Swallow: Dysphagia in a Child with an Aberrant Left Subclavian Artery.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Abnormalities; Child; Deglutition Disorders; Dia | 2021 |
Oral Versus Long-Acting Injectable Antipsychotic Treatment for People With Severe Schizophrenia: A 5-Year Follow-up of Effectiveness.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Cytarabine; Female; Fol | 2021 |
Results of the PROPINE randomized controlled trial: determining the ever-elusive target, the optimal plan for relapses of nephrotic syndrome in children.
Topics: Child; Epinephrine; Humans; Nephrotic Syndrome; Prednisone; Recurrence | 2021 |
A Case of Whipple Disease With Cutaneous Manifestations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Erythema Nodosum; Humans; Immune Reconstitution Inf | 2021 |
The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis.
Topics: Adult; Age Factors; Antibodies, Antinuclear; Autoantibodies; Dermatomyositis; Female; Glucocorticoid | 2021 |
SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report.
Topics: Anti-Glomerular Basement Membrane Disease; Child; COVID-19; Cyclophosphamide; Female; Glucocorticoid | 2021 |
A Case of Recurrent Hepatic Abscesses.
Topics: Biopsy; Colonoscopy; Crohn Disease; Drug Tapering; Glucocorticoids; Humans; Liver Abscess; Magnetic | 2021 |
Prednisone reduction for metastatic castration-resistant prostate cancer with recurrent pulmonary tuberculosis: Case report.
Topics: Aged; Glucocorticoids; Humans; Male; Medical Illustration; Mycobacterium; Prednisone; Prostatic Neop | 2021 |
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis.
Topics: Adult; Biopsy; Creatinine; Female; Humans; Immunosuppressive Agents; Kidney; Logistic Models; Lupus | 2022 |
Proteinuria selectivity and prednisone response in children with nephrotic syndrome.
Topics: Child; Cross-Sectional Studies; Humans; Nephrotic Syndrome; Prednisone; Proteinuria; Recurrence | 2020 |
Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Deprescriptions; Female; Glucocorticoids; | 2021 |
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemot | 2021 |
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2021 |
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease | 2021 |
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children.
Topics: Adolescent; Biomarkers; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Inflammation; Methyl | 2021 |
Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study.
Topics: Antibodies, Monoclonal, Humanized; Child; Female; Humans; Immunosuppressive Agents; Male; Nephrotic | 2022 |
Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Crohn Disease; Disease Progressio | 2017 |
Mycobacterium tuberculosis found at both skin lesions and Mantoux testing site in a patient with erythema induratum of Bazin.
Topics: Aged; Antitubercular Agents; Biopsy; Erythema Induratum; Erythema Nodosum; Female; Glucocorticoids; | 2017 |
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2016 |
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2017 |
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2017 |
Loss of CD3 and TCRγδ expression in a relapsed hepatosplenic T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; CD3 Complex; Cyclophosphamide; D | 2018 |
A case of bullous pemphigoid presenting with severe oedema of the hands during recurrence.
Topics: Aged; Anti-Inflammatory Agents; Edema; Hand; Humans; Male; Pemphigoid, Bullous; Prednisone; Recurren | 2017 |
Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
Topics: Adolescent; Adult; Aged; Azathioprine; China; Cyclophosphamide; Drug Therapy, Combination; Female; H | 2017 |
The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Inflammatory | 2017 |
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Bone Marrow; Clofarabine; Cyclophosphamide; Disease- | 2017 |
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
Topics: Adult; C-Reactive Protein; Female; Glomerular Filtration Rate; Glucocorticoids; Humans; IgA Vasculit | 2018 |
The Rare Complication and Diagnostic Challenges of Pulmonary Eosinophilia in Graft versus Host Disease Patients after Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Chronic Disease; Diagn | 2017 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein | 2018 |
[Analysis for the effect of different regimens on ocular myasthenia gravis in children].
Topics: Child; Cholinesterase Inhibitors; Eye Diseases; Glucocorticoids; Humans; Methylprednisolone; Myasthe | 2017 |
The effects of freeze-dried Ganoderma lucidum mycelia on a recurrent oral ulceration rat model.
Topics: Animals; Biological Products; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Fre | 2017 |
Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 2018 |
Validation of an algorithm to detect severe MS relapses in administrative health databases.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents; Databases, Factual; Drug Prescription | 2018 |
Alternating and Relapsing Migratory Orbital Myositis.
Topics: Biopsy; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Follow-Up Studies; For | 2017 |
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2018 |
Recurrence of eosinophilic granulomatosis with polyangitis after orthotopic heart transplant.
Topics: Churg-Strauss Syndrome; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged | 2018 |
Plasma cell leukemia masquerading as a relapse of the Nephrotic syndrome.
Topics: Creatinine; Diagnosis, Differential; Female; Humans; Kidney; Leukemia, Plasma Cell; Middle Aged; Nep | 2018 |
Cough as the sole manifestation of pericardial effusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cough; Echocardiography; | 2018 |
Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Topics: Administration, Oral; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Ato | 2018 |
Corticosteroid Therapy in Combination with Antibiotics for Erysipelas.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Erysipelas; Female; Follow-Up Studies | 2018 |
Case of lamotrigine-induced drug adverse reaction under tocilizumab treatment with clinical and virological features of drug-induced hypersensitivity syndrome.
Topics: Adult; Antibodies, Monoclonal, Humanized; Anticonvulsants; Arthritis, Rheumatoid; Biopsy; C-Reactive | 2018 |
Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi | 2018 |
Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; | 2018 |
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients).
Topics: Aged; Aged, 80 and over; Chromosomes, Human, Pair 5; Czech Republic; Erythropoietin; Female; Genes, | 2018 |
[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 2018 |
Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisp | 2018 |
Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2018 |
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 2018 |
Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
Topics: Adolescent; Age Factors; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Disease-Free Surv | 2018 |
Long-term outcome of primary immune-mediated thrombocytopenia in dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Prednisone; Purpura, Thrombocyt | 2018 |
Relapsed lymphoma mimicking venous ulcer: A case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2018 |
Initial prednisolone dosing for the first relapse of steroid-sensitive nephrotic syndrome in Japanese children.
Topics: Child; Glucocorticoids; Humans; Nephrotic Syndrome; Prednisolone; Prednisone; Recurrence | 2018 |
Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
Topics: Aged; Autoimmune Diseases; China; Female; Follow-Up Studies; Glucocorticoids; Humans; Kaplan-Meier E | 2018 |
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Child; Cycloph | 2018 |
Successful Treatment of Recurrent Inflammatory Pseudotumor With High-dose Prednisone.
Topics: Aged; Glucocorticoids; Granuloma, Plasma Cell; Humans; Prednisone; Recurrence; Treatment Outcome | 2018 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromato | 2018 |
Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report.
Topics: Antiviral Agents; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Male; Middle Aged; Optic N | 2018 |
How dogs are teaching researchers new tricks for treating cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Clinical Trials, Veterinar | 2018 |
How Would You Manage This Patient With Gout?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster | 2018 |
The presence of eosinophil aggregates correlates with increased postoperative prednisone requirement.
Topics: Anti-Inflammatory Agents; Chronic Disease; Eosinophilia; Eosinophils; Female; Humans; Leukocyte Coun | 2019 |
Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
Topics: Academic Medical Centers; Aged; Biopsy, Needle; Case-Control Studies; Dose-Response Relationship, Dr | 2019 |
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age.
Topics: Age Distribution; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoco | 2019 |
Necrotizing Granulomas in a Patient With Psoriasis and Sarcoidosis After Adalimumab-Medication-Induced Reaction or Reactivation of Latent Disease?
Topics: Adalimumab; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Biopsy, Needle; Combined | 2019 |
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immun | 2019 |
Management of Adult Minimal Change Disease.
Topics: Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Ne | 2019 |
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2019 |
Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirh | 2019 |
Carotid intima-media thickness in children with idiopathic nephrotic syndrome: A single center cross-sectional study
.
Topics: Adolescent; Anti-Inflammatory Agents; Arterial Pressure; Atherosclerosis; Body Mass Index; Carotid A | 2019 |
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation
Topics: Aminophylline; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Biological Products | 2019 |
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson and Bonnotte.
Topics: Antibodies, Monoclonal, Humanized; Cross-Sectional Studies; Giant Cell Arteritis; Humans; Infections | 2020 |
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Humans; Infections; Interleukin-6; Predniso | 2020 |
Gingival recessions and ulcerations in association with pruritic papules of the scalp, hands, and trunk in a young adult female.
Topics: Adult; Biopsy; Female; Gingiva; Gingival Recession; Hand; Histiocytosis, Langerhans-Cell; Humans; Pr | 2019 |
Primary pancreatic lymphoma presenting as recurrent idiopathic pancreatitis: a diagnostic dilemma.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Cholangiopancreatogra | 2020 |
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Topics: Adenine; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Pro | 2019 |
[Recurrence of goodpasture syndrome with negative antiglomerular basement antibodies. Report of one case].
Topics: Anti-Bacterial Agents; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Biopsy; Cyclophosp | 2019 |
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2013 |
Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Chemotherapy, Adjuvant | 2013 |
Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2013 |
Recurrent pericarditis in Myhre syndrome.
Topics: Child; Cryptorchidism; Facies; Growth Disorders; Hand Deformities, Congenital; Humans; Hypertrophy; | 2013 |
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2013 |
Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.
Topics: Adolescent; Anti-Inflammatory Agents; B7-1 Antigen; Blotting, Western; Cells, Cultured; Child; Child | 2013 |
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combin | 2013 |
Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; | 2013 |
Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Anticonvulsants; Benzoates; Drug Interactions; Drug R | 2014 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Antibodies, Monoclonal, Murine-Derived; Antigens, CD2 | 2013 |
Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
Topics: Adult; Blood Platelets; Female; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Platelet Coun | 2013 |
IgA monoclonal gammopathy accompanying extranodal B cell lymphomas.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biopsy; China; Drug Therapy, Combination; Female; Glo | 2013 |
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph | 2015 |
HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review.
Topics: Aged; DNA, Viral; Hepatitis B; Humans; Kidney Glomerulus; Male; Nephrotic Syndrome; Prednisone; Recu | 2013 |
Severe exacerbation of Crohn's disease during sunitinib treatment.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Crohn Disease; Disease Progression; Fatal Outcome; G | 2014 |
Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantat | 2014 |
[Levofloxacin-induced autoimmune hepatitis. Description of a case].
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Anti-Asthmatic Agents; Aspartate Aminotransferases; A | 2014 |
[Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoantigens; Desmoglein 1; Desmoglein 3; Di | 2013 |
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2014 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug The | 2014 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug The | 2014 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug The | 2014 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug The | 2014 |
Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Child; Co | 2014 |
Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2014 |
The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2014 |
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
Topics: Bromocriptine; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Hydroxychloroquine; Lupu | 2014 |
Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cohort Studies; Female; Glucocorticoi | 2014 |
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality | 2014 |
Orbitary MALT lymphoma in a patient diagnosed with non-Hodgkin lymphoma.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; H | 2015 |
Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculi | 2014 |
Treatment of giant cellulitis-like Sweet syndrome with dapsone.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Female; Humans; Middle Aged; Prednis | 2014 |
The fate of chronic rhinosinusitis sufferers after maximal medical therapy.
Topics: Administration, Oral; Adult; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans | 2014 |
The fate of chronic rhinosinusitis sufferers after maximal medical therapy.
Topics: Administration, Oral; Adult; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans | 2014 |
The fate of chronic rhinosinusitis sufferers after maximal medical therapy.
Topics: Administration, Oral; Adult; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans | 2014 |
The fate of chronic rhinosinusitis sufferers after maximal medical therapy.
Topics: Administration, Oral; Adult; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans | 2014 |
Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycl | 2014 |
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis.
Topics: Aged; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Multimodal Imaging; Polymyalgia Rheuma | 2014 |
Idiopathic orbital myositis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Child; China; Dexamethasone; Female; Humans; Male; | 2014 |
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Drug Administration Schedule; Drug Monitoring; | 2014 |
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Glucocorticoids; Humans; | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambuc | 2014 |
[Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Topics: Adolescent; Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Child; Ch | 2014 |
Biopsy-proven recurrence of unilateral IgG4-related orbital inflammation after 20 years.
Topics: Administration, Oral; Adult; Azathioprine; Biopsy; Drug Therapy, Combination; Female; Glucocorticoid | 2014 |
High-dose methylprednisolone is effective in treating radiation-induced refractory haemorrhagic cystitis.
Topics: Aluminum Oxide; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Com | 2014 |
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Vi | 2015 |
Pyodermatitis-pyostomatitis vegetans and antibullous pemphigoid antigen 180 autoantibodies: a casual association?
Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Collagen Type XVII; Humans; Male | 2015 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibo | 2014 |
[Peripheral arthritis in polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthralgia; Diagnosis, Differential; Female; Foot | 2014 |
Recurrent right atrial thrombosis due to Behçet disease.
Topics: Anticoagulants; Azathioprine; Behcet Syndrome; Disease Progression; Heart Atria; Heart Diseases; Hum | 2014 |
Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients.
Topics: Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Drug | 2014 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Disease Progression; Female; Histiocy | 2014 |
Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.
Topics: Adult; Biopsy; Cerebral Angiography; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Stud | 2015 |
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug T | 2014 |
Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; A | 2014 |
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
Topics: Adolescent; Adult; Brazil; Child; Chronic Disease; Female; Fibrosis; Fluorescein Angiography; Glucoc | 2015 |
[Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement].
Topics: Autoantibodies; Autoimmune Diseases; Biopsy; Capillaries; Chronic Disease; Complement C1q; Female; H | 2015 |
Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Biliary Tract Diseases; Blood Sedimentation; Case-Contro | 2015 |
A 41-year-old woman with shortness of breath and history of rash and recurrent laryngeal edema.
Topics: Adult; Azathioprine; Complement System Proteins; Disease Progression; Dyspnea; Female; Glucocorticoi | 2015 |
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Recurrent intraluminal eosinophilic tracheal granuloma in a Siberian husky.
Topics: Animals; Dog Diseases; Dogs; Endoscopy; Eosinophilic Granuloma; Glucocorticoids; Male; Prednisone; R | 2015 |
Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cerebral Amyloid Angiopathy; Cohort Studies; Cyclophosph | 2015 |
Steroid-responsive atypical marginal zone hyperplasia of the lip in a child.
Topics: Antibodies, Bacterial; Biomarkers; Biopsy; Child; Diagnosis, Differential; Female; Helicobacter pylo | 2015 |
Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report.
Topics: Drug Therapy, Combination; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Polymyalgia Rheumati | 2015 |
[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxychloroquine; Immunoglobulins | 2015 |
Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2015 |
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumati | 2015 |
Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease.
Topics: Adult; Certolizumab Pegol; Crohn Disease; Female; Humans; Prednisone; Pyoderma Gangrenosum; Recurren | 2016 |
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.
Topics: Aneuploidy; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Combined Chem | 2015 |
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combi | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, A | 2015 |
A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood.
Topics: Adolescent; Adult; Drug Administration Schedule; Female; Humans; Immunologic Factors; Immunosuppress | 2015 |
[Prognostic Value of Prednisone Response in CCLG-ALL 2008].
Topics: Disease-Free Survival; Humans; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblast | 2015 |
Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
Topics: Child; Child, Preschool; Egypt; Female; Follow-Up Studies; Glucocorticoids; Histiocytosis, Langerhan | 2016 |
Therapy: Maintenance of steroid-free remission in nephrotic syndrome.
Topics: Adolescent; Child; Glucocorticoids; Humans; Immunosuppressive Agents; Levamisole; Maintenance Chemot | 2015 |
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezom | 2015 |
The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Topics: Biopsy; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; | 2015 |
Facial lesions heralding the onset and relapse of eosinophilic fasciitis.
Topics: Adult; Arthritis; Biopsy; Chronic Disease; Colchicine; Edema; Eosinophilia; Fascia; Fasciitis; Folic | 2016 |
Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Biop | 2015 |
Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Topics: Adenoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Du | 2016 |
Recurrent Eosinophilic Pneumonia in a Patient with Isolated Immunoglobulin M Deficiency and Celiac Disease.
Topics: Bronchoscopy; Celiac Disease; Chronic Disease; Dysgammaglobulinemia; Glucocorticoids; Humans; Immuno | 2015 |
Head and neck extra nodal NHL (HNENL)--Treatment Outcome and Pattern of failure--A Single Institution Experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; C | 2015 |
Dramatic transient improvement of metastatic BRAF(V600E)-mutated Langerhans cell sarcoma under treatment with dabrafenib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Cyclophosphamide; | 2015 |
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomar | 2017 |
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Ant | 2016 |
A Successful HSCT in a Girl with Novel LRBA Mutation with Refractory Celiac Disease.
Topics: Adaptor Proteins, Signal Transducing; Celiac Disease; Child; Chimerism; Consanguinity; DNA Mutationa | 2016 |
Single-dose oral dexamethasone is effective in preventing relapse after acute asthma exacerbations.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Asthma; Child; Child, Preschool; Dexamet | 2016 |
[Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin | 2015 |
The predictive factors for relapses in children with steroid-sensitive nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Female; Follow-Up Studies; Glomerular Filtration Ra | 2016 |
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke | 2016 |
Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Electronic Health Records; Female | 2016 |
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Histiocytos | 2016 |
The Value of Monitoring the Serum Concentration of Mycophenolate Mofetil in Children with Steroid-Dependent/Frequent Relapsing Nephrotic Syndrome.
Topics: Area Under Curve; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunosuppressive Agents | 2016 |
Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2016 |
Elevation of plasma-soluble HLA-G in childhood nephrotic syndrome is associated with IgE.
Topics: Adolescent; Alleles; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Child; Child, Presc | 2017 |
Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients.
Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Inflammatory Agents; China; Fem | 2016 |
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study.
Topics: Aged; Aged, 80 and over; Biopsy; Disease Progression; Female; Fever; Follow-Up Studies; Giant Cell A | 2016 |
Recurrent Psoriasis After Introduction of Belatacept in 2 Kidney Transplant Recipients.
Topics: Abatacept; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Maintenance Ch | 2016 |
Recurrent episodes of periorbital edema in an elderly woman.
Topics: Aged, 80 and over; Cellulitis; Cheek; Diagnosis, Differential; Edema; Eosinophilia; Eosinophils; Eye | 2016 |
Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor | 2016 |
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Child; Female; Fever; Humans; Inflammation; Lymphadenit | 2017 |
Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Disease-Free Survival | 2016 |
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunologica | 2017 |
[Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Topics: Dermatologic Agents; Dermatomyositis; Dose-Response Relationship, Drug; Drug Therapy, Combination; F | 2016 |
Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases.
Topics: Azathioprine; Child; Female; Glucocorticoids; Humans; IgA Vasculitis; Immunosuppressive Agents; Male | 2016 |
Breast leptomeningeal metastasis recurrence presenting as a manic episode.
Topics: Anti-Inflammatory Agents; Bipolar Disorder; Breast Neoplasms; Female; Humans; Magnetic Resonance Ima | 2017 |
Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclopho | 2016 |
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; | 2016 |
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combine | 2016 |
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2016 |
An 82-Year-Old Man With Diplopia.
Topics: Aged, 80 and over; Azathioprine; Carcinoma, Squamous Cell; Cranial Nerve Neoplasms; Diplopia; Drug T | 2016 |
Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.
Topics: Area Under Curve; Child, Preschool; Female; Glucocorticoids; Humans; Immunologic Factors; Male; Myco | 2016 |
Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.
Topics: Asia, Eastern; Asia, Southeastern; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; | 2016 |
Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.
Topics: Asia, Eastern; Asia, Southeastern; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; | 2016 |
Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.
Topics: Asia, Eastern; Asia, Southeastern; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; | 2016 |
Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.
Topics: Asia, Eastern; Asia, Southeastern; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; | 2016 |
Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bile Duct Diseases; Cholangitis, Sclerosing; Female; Hepatiti | 2016 |
Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplast | 2016 |
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Disease Progression; Drug Therapy, Co | 2017 |
The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Coccidiostats; Drug Administra | 2016 |
The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin's lymp
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, H | 2016 |
Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Fe | 2016 |
CD4
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Combined Chemother | 2016 |
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Ce | 2017 |
Isolated extraocular orbital mass: a rare presentation of sarcoidosis.
Topics: Aged; Azathioprine; Biopsy; Diplopia; Drug Administration Schedule; Drug Therapy, Combination; Eyeli | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progress | 2017 |
A Rare Case of Tubulointerstitial Nephritis and Uveitis Syndrome Treated with a Multi-Specialty Approach.
Topics: Biopsy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female | 2016 |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cyclosporine; Diabetic Nephropathies; Female; Humans; Immun | 2016 |
Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hu | 2017 |
A case of Trousseau syndrome associated with a mucosa-associated lymphoid tissue lymphoma disseminated to the mesenteric adipose tissue.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, B-Cell, Ma | 2017 |
Medical
Topics: Adult; Age Factors; Aged; Analgesics; Analysis of Variance; Chi-Square Distribution; Clostridioides | 2016 |
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve; | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparag | 2017 |
The Use of Rituximab in the Management of Refractory Dermatomyositis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Dermatomyositis; Drug-Related Side Effects and Advers | 2017 |
Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries.
Topics: Child; Disease Progression; Drug Therapy, Combination; Europe; Glucocorticoids; Humans; Immunosuppre | 2017 |
[Granulomatous lobular mastitis: a benign abnormality that mimics malignancy].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Cytodiagnosis; Diagnosis, Different | 2008 |
Recurrent meningitis revealing a Behçet's disease.
Topics: Adult; Anti-Bacterial Agents; Behcet Syndrome; Diagnosis, Differential; Glucocorticoids; Humans; Mal | 2008 |
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic C | 2008 |
Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Drug Evaluation; Drug Therapy, Combination; Etanercept; F | 2008 |
Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Topics: Adult; Anaplastic Lymphoma Kinase; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2009 |
Serpiginous choroiditis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Choroiditis; Cyclosporine; Drug Ther | 2008 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2009 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; | 2008 |
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Cyclophosphamide; Female; Humans; Immunosuppr | 2008 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities | 2008 |
Traumatic hyphema and immune thrombocytopenic purpura: late rebleeds associated with low platelet count.
Topics: Anterior Eye Segment; Child, Preschool; Combined Modality Therapy; Dexamethasone; Eye Injuries; Huma | 2008 |
Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
Topics: Adolescent; Adult; Behcet Syndrome; Child; Drug Therapy, Combination; Female; Fluorescein Angiograph | 2008 |
Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colchicine; Dose-Response Relationship, Dr | 2009 |
[Pubalgia in athlete treated by atorvastatin].
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Anti-Inflammatory Agents, | 2009 |
Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematologic Tests; Hu | 2009 |
Surgical treatment for incessant pericarditis.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Humans; Male; Pericardiectomy; Pericarditis; Predn | 2009 |
Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyc | 2009 |
Graded response to thymectomy in children with myasthenia gravis.
Topics: Adolescent; Adult; Age Distribution; Child; Child, Preschool; Cholinesterase Inhibitors; Cohort Stud | 2009 |
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophospham | 2009 |
Recurrent pericarditis due to natalizumab treatment.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aspirin; Chest Pain; Colchicine; D | 2009 |
Opsoclonus-myoclonus syndrome and HIV-infection.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Autoi | 2009 |
Clinical spectrum of vulva metastatic Crohn's disease.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Colon; Colonoscopy; Crohn Disease; Disease Progression; | 2009 |
[Therapeutic strategies in idiopatic inflammatory myopathies].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Dermatomyos | 2009 |
ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
Topics: Antibodies; Desmoglein 1; Desmoglein 2; Disease Progression; Drug Therapy, Combination; Enzyme-Linke | 2009 |
Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.
Topics: Behcet Syndrome; Drug Therapy, Combination; Fluorescein Angiography; Humans; Immunosuppressive Agent | 2009 |
[Neurological symptoms in patient with focal segmental glomerulosclerosis treated with cyclosporin A--case report].
Topics: Biopsy; Brain Diseases; Child; Cyclosporine; Drug Therapy, Combination; Glomerulosclerosis, Focal Se | 2009 |
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols | 2009 |
Ketoconazole and prednisone to prevent recurrent ischemic priapism.
Topics: Adult; Drug Dosage Calculations; Glucocorticoids; Humans; Ischemia; Ketoconazole; Male; Middle Aged; | 2009 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Ther | 2009 |
Pyoderma gangrenosum; a rare complication of sclerotherapy.
Topics: Adult; Cortisone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Prednisone; Pyoderma G | 2009 |
Central serous chorioretinopathy and idiopathic nonhistaminergic angioedema.
Topics: Adult; Angioedema; Antifibrinolytic Agents; Capillary Permeability; Choroid; Fluorescein Angiography | 2009 |
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Longitudinal Studies; Male; Polymyalgia Rh | 2009 |
Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.
Topics: Atypical Hemolytic Uremic Syndrome; Blood Component Transfusion; Combined Modality Therapy; Compleme | 2010 |
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resis | 2009 |
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther | 2010 |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Female; G | 2009 |
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liv | 2010 |
Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclo | 2010 |
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
Topics: Autoantigens; Dexamethasone; Drug Therapy, Combination; Female; Heart Block; Heart Defects, Congenit | 2010 |
Central nervous system involvement in diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Hormonal; Antipsychotic Agents; Child; Dexa | 2010 |
Kimura's disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up.
Topics: Administration, Oral; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Cyclosporine; Glucocortico | 2013 |
Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2011 |
Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome.
Topics: Adolescent; Age Factors; Age of Onset; Child; Child, Preschool; Cohort Studies; Denmark; Female; Glu | 2010 |
Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combin | 2010 |
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2010 |
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothe | 2011 |
Pyoderma gangrenosum following bilateral deep inferior epigastric perforator flap breast reconstruction.
Topics: Adult; Biopsy; Breast Neoplasms; Diagnosis, Differential; Epigastric Arteries; Female; Glucocorticoi | 2010 |
Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Clinical images: recurrence of sarcoidosis heralded by Bullous reaction within tribal scarification.
Topics: Adult; Anti-Inflammatory Agents; Body Modification, Non-Therapeutic; Female; Humans; Prednisone; Rec | 2010 |
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2010 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2011 |
Fundus autofluorescence and spectral domain optical coherence tomography in recurrent serpiginous choroiditis: case report.
Topics: Adult; Anti-Inflammatory Agents; Choroiditis; Cyclosporine; Female; Fluorescence; Fundus Oculi; Huma | 2011 |
ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Hematopoiet | 2011 |
Clinical effect of additional electroacupuncture on thoracolumbar intervertebral disc herniation in 80 paraplegic dogs.
Topics: Acupuncture Points; Animals; Back Pain; Dogs; Electroacupuncture; Glucocorticoids; Intervertebral Di | 2010 |
Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Aged; Female; France; Health Knowledge, Attitudes, Practice; Humans; Male; | 2011 |
Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study.
Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; China; Cyclophosphamide; Drug Therapy, C | 2011 |
F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain.
Topics: Abdominal Abscess; Abdominal Pain; Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclon | 2011 |
Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit | 2011 |
Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques.
Topics: Adult; Aorta, Abdominal; Constriction, Pathologic; Drug Substitution; Drug Therapy, Combination; Fem | 2012 |
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2011 |
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Com | 2011 |
Sarcoidosis presenting as transient ischemic attack status.
Topics: Adult; Anticoagulants; Biopsy; Central Nervous System Diseases; Diffusion Magnetic Resonance Imaging | 2012 |
PFAPA syndrome in a young adult with a history of tonsillectomy.
Topics: Female; Fever; Follow-Up Studies; Glucocorticoids; Humans; Lymphadenitis; Pharyngitis; Prednisone; R | 2011 |
Treatment of a patient with adnexal lymphoma with Rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2011 |
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combin | 2011 |
Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Bilirubin; Coom | 2011 |
Spontaneous pregnancy in a patient with a relapse of lymphocytic hypophysitis successfully treated with azathioprine and glucocorticoids.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Female; Humans; Inflammation; Pituitary Diseases; Pre | 2011 |
Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agen | 2011 |
[Questions and answers on the dosage of prednisone for patients with steroid-sensitive, dependent/resistant recurrent nephritic syndrome].
Topics: Hormones; Humans; Nephrotic Syndrome; Prednisone; Recurrence | 2011 |
Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Cholangiopancreatography, Magnetic Resonance; Contra | 2011 |
[Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
Topics: Adolescent; Age of Onset; Antibodies; Child; Child, Preschool; Female; Follow-Up Studies; Humans; In | 2011 |
Hormone administration promotes the epithelium healing in patients with recurrent corneal epithelial exfoliation.
Topics: Bandages; Combined Modality Therapy; Corneal Diseases; Epithelium, Corneal; Exfoliation Syndrome; Fi | 2011 |
Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
Topics: Adenocarcinoma; Adult; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Murine-Derive | 2011 |
Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous Syste | 2011 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Drug Resistance, Neopla | 2011 |
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; | 2012 |
Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2012 |
Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Lupus relapse presented as frosted branch retinal angiitis: case report.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervou | 2011 |
Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2012 |
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2012 |
Follow-up of rheumatic carditis treated with steroids.
Topics: Adolescent; Brazil; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Medication Adh | 2012 |
[Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].
Topics: Adolescent; Behcet Syndrome; Child; Dermatologic Agents; Drug Therapy, Combination; Fatal Outcome; F | 2011 |
Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Hyperca | 2011 |
[Low thrombocyte count: when does it become dangerous?].
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Contraindications; Dexamethasone; Diagnosis, Di | 2011 |
[Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Mod | 2012 |
The course and prognosis of pemphigus in 47 Tunisian patients.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Aged, 80 and over; Cohort Studies; Confidence I | 2013 |
Hypothyroidism in children with steroid-resistant nephrotic syndrome.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Drug Resistance; Female; Glomerulosclerosis, Foca | 2012 |
Erythema induratum (nodular vasculitis) associated with Crohn's disease: a rare type of metastatic Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Erythema Induratum; Female; Glucocorticoids; | 2012 |
Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Female; Follow-Up St | 2012 |
Use of hydroxychloroquine in corticodependent and recurrent scleritis.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Hydroxychloroquine; | 2013 |
Rituximab pharmacokinetics in ascites and serum in the treatment of follicular lymphoma with massive ascites.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemot | 2012 |
Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humaniz | 2012 |
Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Dose-Response Relationship, Drug; Drug Administration | 2012 |
Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Femal | 2012 |
Relapsed diffuse large B-cell lymphoma--10 years later.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; | 2011 |
A rare cause of facial nerve palsy in children: hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review.
Topics: Anti-Inflammatory Agents; Bone Density; Child; Child, Preschool; Facial Nerve Diseases; Facial Paral | 2012 |
Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2012 |
Graft loss due to recurrent disease in pediatric kidney transplant recipients on a rapid prednisone discontinuation protocol.
Topics: Adolescent; Child; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney | 2012 |
Role of oral cyclophosphamide in the treatment of giant cell arteritis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cyclophosphamide; Dose-Response Relationship, Drug; D | 2012 |
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2012 |
R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic A | 2012 |
Idiopathic retroperitoneal fibrosis presenting with recurrent bilateral uveitis.
Topics: Anti-Inflammatory Agents; Edema; Female; Humans; Lower Extremity; Middle Aged; Prednisone; Recurrenc | 2011 |
Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone.
Topics: Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; | 2011 |
Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; C | 2012 |
[Relapse in Hodgkin lymphoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2012 |
[Recurrent cellulitis due to Helicobacter cinaedi after chemotherapy for malignant lymphoma].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2012 |
[Bilateral tuberculous mastitis nulliparous patient, initially treated as idiopathic granulomatous mastitis].
Topics: Adult; Antitubercular Agents; Diagnostic Errors; Drug Therapy, Combination; Ethambutol; Female; Gran | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2013 |
Cochleovestibular nerve involvement in multifocal fibrosclerosis.
Topics: Azathioprine; Biopsy; Diagnosis, Differential; Disease Progression; Female; Glucocorticoids; Humans; | 2012 |
Angiolymphoid hyperplasia with eosinophilia and Kimura's disease coexisting in the same patient: evidence for a spectrum of disease.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Betamethasone; Cryotherapy; Drug Combinations; E | 2012 |
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Autoimmune Disea | 2013 |
Recurrent aortic aneurysm due to Behcet's disease: a case report from China.
Topics: Adult; Anticoagulants; Aortic Aneurysm; Aortography; Aspirin; Behcet Syndrome; China; Glucocorticoid | 2013 |
Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobe.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy | 2013 |
Acute megakaryoblastic leukemia with increased hematogones in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy | 2012 |
Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Aorta, Thoracic; Arterial Occlusive Dis | 2012 |
Unusual case of recurrent falls: myasthenia gravis in an elderly patient.
Topics: Accidental Falls; Aged, 80 and over; Antibodies; Blepharoptosis; Cholinesterase Inhibitors; Dysarthr | 2012 |
Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation.
Topics: Antibodies, Monoclonal, Humanized; Cesarean Section; Combined Modality Therapy; Complement Factor H; | 2013 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; | 2012 |
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydroch | 2013 |
Favorable outcome with doxorubicin-based chemotherapy and radiotherapy for adult patients with early stage primary systemic anaplastic large-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2013 |
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antigens, CD20; Fem | 2013 |
Prednisone per os is likely to have limited efficacy in horses.
Topics: Administration, Oral; Airway Obstruction; Animals; Biological Availability; Cross-Over Studies; Dose | 2002 |
A relapsing-remitting type of ocular myasthenia gravis without typical muscle fatiguability.
Topics: Adult; Diagnosis, Differential; Electromyography; Female; Follow-Up Studies; Humans; Male; Middle Ag | 2002 |
[Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
Topics: Adolescent; Adult; Child; Chlorambucil; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Me | 2002 |
Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combi | 2002 |
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Ch | 2002 |
Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclopho | 2002 |
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; | 2002 |
Outcome of posttransplantation hepatitis C virus disease--is it the host, the virus, or how we modify the host and/or the virus?
Topics: Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Hepacivirus; Hepatitis C; Humans; Liver | 2002 |
Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone | 2002 |
Sweet syndrome as the presenting symptom of relapsed hairy cell leukemia.
Topics: Biopsy, Needle; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Le | 2002 |
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Child; Child, Prescho | 2002 |
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Diffe | 2002 |
Idiopathic recurrent neuroretinitis: effects of long-term immunosuppression.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppression | 2003 |
[Chronically active Crohn's disease].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Az | 2003 |
Treatment of recurrent eosinophilic granuloma with systemic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Eosinophilic Granu | 2003 |
Serpiginouslike choroiditis in a patient with cardiac sarcoidosis.
Topics: Cardiomyopathies; Choroiditis; Female; Glucocorticoids; Humans; Middle Aged; Prednisone; Recurrence; | 2003 |
Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosupp | 2003 |
Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Female; Follow-Up Studies; Hepatitis, Autoimmu | 2003 |
Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2003 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; | 2003 |
Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Sch | 2003 |
Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment.
Topics: Adult; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; | 2003 |
Treatment of recurrent focal glomerulosclerosis after renal transplantation: is prednisone essential to maintain a sustained remission?
Topics: Adult; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Kidney Transplantation; | 2003 |
[Relapse of Hodgkin disease after 17 years of complete remission. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Bi | 2003 |
Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies.
Topics: Action Potentials; Adult; Autoantibodies; Cyclophosphamide; Dermatomyositis; Facial Nerve Diseases; | 2003 |
Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium, D | 2003 |
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2003 |
Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Pre | 2003 |
Abdominal irradiation after chemotherapy in non-Hodgkin's lymphoma: review of 32 patients.
Topics: Abdomen; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; | 2003 |
Acute headache as a presenting symptom of tacrolimus encephalopathy.
Topics: Acute Disease; Adult; Brain; Brain Diseases; Cyclosporine; Cystic Fibrosis; Diagnosis, Differential; | 2003 |
A case report of wegener granulomatosis treated only with corticosteroids for 30 years.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Female; Glucocorticoids; Granulomatosis with Polyangii | 2003 |
Frequency and significance of antibodies to chromatin in autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Chromatin; Drug Therapy, Combination; Female; | 2003 |
Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Antirheumatic Agents; Child; Chi | 2003 |
[Extremely severe acute agranulocytic syndrome treated with deltacortisone: apparent cure; recurrence in 9 months].
Topics: Agranulocytosis; Humans; Neoplasms; Prednisone; Recurrence; Syndrome | 1957 |
[Evolutive recurrence of serofibrinous pleurisy after discontinuation of cortisone therapy].
Topics: Cortisone; Neoplasms; Pleurisy; Prednisone; Recurrence | 1957 |
[Lipoid nephrosis; directives for steroid treatment based on a case with six recurrences; variations in blood complement & 17-ketosteroid excretion].
Topics: 17-Ketosteroids; Child; Hormones; Humans; Infant; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; | 1959 |
Cirrhosis of liver. Effect of prednisone on frequency of biochemical relapse.
Topics: Liver Cirrhosis; Prednisone; Recurrence | 1962 |
[RECURRENCES AND CORTICOID THERAPY IN EPIDEMIC HEPATITIS].
Topics: Adrenal Cortex Hormones; Communicable Diseases; Epidemics; Hepatitis; Hepatitis A; Humans; Prednison | 1964 |
[RECURRENCE OF DERMATOMYOSITIS FOLLOWING SEVERAL YEARS OF APPARENT RECOVERY].
Topics: Child; Dermatomyositis; Dexamethasone; Drug Therapy; Humans; Neoplasms; Physiological Phenomena; Pre | 1965 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Topics: Adrenocortical Hyperfunction; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relation | 2003 |
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; | 2003 |
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trial | 2003 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
[Recurring episodes of fever with oral aphthae, lymph node swelling and joint symptoms in a 9-year-old boy. Diagnosis: PFAPA syndrome (Marshall syndrome)].
Topics: Anti-Inflammatory Agents; Arthritis; Child; Diagnosis, Differential; Familial Mediterranean Fever; F | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2003 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul | 2003 |
Relapsing-remitting, corticosteroid-sensitive, varicella zoster virus optic neuritis.
Topics: Adolescent; Anti-Inflammatory Agents; Chronic Disease; Glucocorticoids; Herpesvirus 3, Human; Humans | 2003 |
[An analysis of relapse and risk factors of autoimmune hemolytic anemia and Evans syndrome].
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Autoantibodies; Child; Cyclosporine; Female; | 2003 |
Refractory major aphthous stomatitis managed with systemic immunosuppressants: a case report.
Topics: Adult; Clinical Protocols; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Patient Educat | 2004 |
Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Budesonide; Catheterization; Degl | 2003 |
[Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
Topics: Azathioprine; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2004 |
Reversal reaction occurring 16 years after beginning antibacterial treatment.
Topics: Biopsy, Needle; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Immunohistochemistry; Immu | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
Topics: Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immu | 2004 |
Sequential therapies for proliferative lupus nephritis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid | 2004 |
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Do | 2004 |
Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2004 |
Biochemical bone markers in nephrotic children.
Topics: Biomarkers; Bone and Bones; Child, Preschool; Female; Glucocorticoids; Humans; Male; Nephrotic Syndr | 2004 |
[Calcineurin-inhibitor-free immunosuppression in early renal transplantation].
Topics: Adult; Calcineurin Inhibitors; Comorbidity; Cyclosporine; Drug Therapy, Combination; Fever; Glomerul | 2004 |
[Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis].
Topics: Aged; Autoantibodies; Autoimmune Diseases; Complement C3; Complement C4; Glomerular Mesangium; Glome | 2004 |
[Steroid-responsive nephrotic syndrome in IgA nephropathy].
Topics: Biopsy; Cyclophosphamide; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Glomerulonephr | 2004 |
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Ca | 2004 |
[Relapsing nephrotic syndrome in a diabetic patient with minimal change].
Topics: Chlorambucil; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Drug Thera | 2004 |
Lesser trochanteric bursitis: a rare cause of anterior hip pain.
Topics: Adult; Anti-Inflammatory Agents; Bursitis; Female; Femur; Follow-Up Studies; Hip Joint; Humans; Pain | 2004 |
Recurrent acute rheumatic fever: a forgotten diagnosis?
Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficienc | 2004 |
Gastrointestinal involvement in chronic granulomatous disease.
Topics: Abdominal Pain; Adolescent; Adult; Child; Child, Preschool; Colon; Constipation; Diarrhea; Female; G | 2004 |
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dexamethasone; Dose-Response Relationship, Drug; Fema | 2004 |
[A pregnant woman with autoimmune thyroiditis and recurrent goiter].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Combined Modality Therapy; Cy | 2004 |
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Topics: Adult; Azathioprine; Biopsy; Complement C3; Creatinine; Cyclophosphamide; Female; Humans; Kidney; Ki | 2004 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigen | 2004 |
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Che | 2004 |
Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: a series of 3 cases.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dose-Response Relationship, Drug; Drug Administration | 2004 |
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma.
Topics: Antineoplastic Agents; Combined Modality Therapy; Drug Resistance; Humans; Immunoglobulins, Intraven | 2004 |
Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2004 |
Gamma/delta T-cell lymphoma as a recurrent complication after transplantation.
Topics: Adolescent; Cyclosporine; Disease-Free Survival; Female; Humans; Immunoglobulins; Immunohistochemist | 2004 |
Scleritis associated with sarcoidosis.
Topics: Aged; Anti-Inflammatory Agents; Conjunctiva; Female; Humans; Middle Aged; Prednisone; Recurrence; Sa | 2004 |
Significance of splenomegaly in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2004 |
Recurrent acute interstitial nephritis induced by azithromycin.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Female; Glucocorticoids; Humans; Met | 2004 |
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2005 |
[Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 2004 |
[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Dapsone; Diagnosis, D | 2005 |
Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Colectomy; Combined Modality Therapy; | 2004 |
[Pulmonary arterial aneurysms in Behçet's syndrome. Report of 4 cases].
Topics: Adult; Aneurysm; Anti-Inflammatory Agents; Behcet Syndrome; Colchicine; Cyclophosphamide; Hemoptysis | 2004 |
[Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2004 |
Stress dose steroids in renal transplant patients undergoing lymphocele surgery.
Topics: Adult; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphocele; | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2005 |
[Gleich syndrome. A case report and review of the literature].
Topics: Adult; Angioedema; Anti-Inflammatory Agents; Diagnosis, Differential; Eosinophilia; Female; Humans; | 2005 |
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 2005 |
Bilateral optic neuritis in wegener granulomatosis.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Granulomatosis with Polyangiiti | 2005 |
Recurrent pleural and pericardial effusions due to sarcoidosis.
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Middle Aged; Pericardial Effusion; | 2005 |
Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Topics: Aged; Azathioprine; Biopsy; Coma; Cyclophosphamide; Electromyography; Female; Follow-Up Studies; Hum | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 2005 |
Non-Hodgkin's lymphoma after kidney transplantation: a single institution study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; | 2006 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoi | 2005 |
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2005 |
Successful reintroduction of a different erythropoiesis-stimulating agent after pure red cell aplasia: relapse after successful therapy with prednisone.
Topics: Aged; Antibodies; Darbepoetin alfa; Erythropoietin; Female; Follow-Up Studies; Glucocorticoids; Huma | 2005 |
Relapsing esophageal and gastric ulcers revealing Wegener's granulomatosis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antibody Specificity; Autoantibodies; Blood Sedimentation; C | 2005 |
[Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?].
Topics: Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Biopsy; Bone and Bones; Bone Density; Croh | 2005 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2005 |
[Dermatomyositis in children. Report of 5 cases].
Topics: Adolescent; Child; Dermatomyositis; Electromyography; Enzymes; Female; Follow-Up Studies; Humans; In | 1977 |
Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graf | 2005 |
Acute onset of polymyalgia rheumatica in pregnancy.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Blood Sedimentation; C-Reactive Protein; Cesarean Se | 2005 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2005 |
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Antineoplastic Combi | 2005 |
Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2005 |
Recurrence of cardiac sarcoidosis in a heart transplant recipient.
Topics: Adult; Anti-Inflammatory Agents; Cardiomyopathies; Heart Transplantation; Heart Ventricles; Heart-As | 2005 |
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F1 | 2006 |
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combine | 2006 |
Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Female; Humans; Hypereosinophilic Syndrome; Male; mRNA | 2005 |
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Ch | 2005 |
The clinical spectrum of neuralgic amyotrophy in 246 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age of Onset; Aged; Brachial Plexus; Brachial Plexus Neu | 2006 |
Muscle involvement in sarcoidosis: a retrospective and followup studies.
Topics: Adult; Cardiomyopathies; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studie | 2006 |
Predictors of relapse in steroid-sensitive nephrotic syndrome.
Topics: Child; Child, Preschool; Female; Humans; Indonesia; Male; Nephrotic Syndrome; Prednisone; Recurrence | 2005 |
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Topics: Adult; Aged; Biopsy; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, | 2006 |
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Comorbidity; Etanercept; Female; Humans; Imm | 2006 |
Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.
Topics: Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Capillary Perme | 2006 |
Long-term treatment of Hashimoto's encephalopathy.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antithyroid | 2006 |
The role of IVIg treatment in severe pemphigus vulgaris.
Topics: Adult; Aged; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Pemphigus; Prednisone; | 2006 |
Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Child; Female; Glucocorticoids; Humans; Lupu | 2006 |
Regression of intracranial rosai-dorfman disease following corticosteroid therapy. Case report.
Topics: Brain Diseases; Brain Stem; Craniotomy; Dexamethasone; Diagnosis, Differential; Glucocorticoids; His | 2006 |
Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.
Topics: Adolescent; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; CD3 Compl | 2006 |
[A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of these disease].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Diagnosis, D | 2006 |
Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis.
Topics: Azathioprine; Choroiditis; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Stu | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxor | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
[Clinical significance of survivin and caspase-3 expression in diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Caspase 3; Cyclophosphamide | 2006 |
Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Enoxapari | 2006 |
Something old, something new....
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Gemc | 2006 |
Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Ataxia; Electromyography; Fever; Humans; Immunoglobulins, Intravenous; Imm | 2006 |
Treatment of the first episode of nephrotic syndrome in children.
Topics: Child; Evidence-Based Medicine; Glucocorticoids; Humans; Nephrotic Syndrome; Prednisone; Recurrence; | 2006 |
Recurrent nodular scleritis preceding an adult TINU syndrome.
Topics: Acute Disease; Female; Glucocorticoids; Humans; Indomethacin; Middle Aged; Nephritis, Interstitial; | 2006 |
Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclo | 2006 |
The impact of spirometry on pediatric asthma diagnosis and treatment.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Albuterol; Anti-Inflamm | 2006 |
Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminot | 2006 |
[Twenty years of treating childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham | 2006 |
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cycloph | 2006 |
Recurrent immune thrombocytopenic purpura in children.
Topics: Adolescent; Adult; Cerebral Hemorrhage; Child; Child, Preschool; Combined Modality Therapy; Female; | 2006 |
Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2006 |
[Blue discoloration of hands, numbness of feet, indolent cervical lymph node swelling in a 73-year-old man].
Topics: Aged; Castleman Disease; Diagnosis, Differential; Drug Administration Schedule; Foot; Hand Dermatose | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineopla | 2007 |
Sarcoid relapse with isolated kidney involvement.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anti-Inflammatory Agents; Humans; Kidney Diseases; Male; | 2006 |
High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.
Topics: Adolescent; C-Reactive Protein; Child; Child, Preschool; Cyclosporine; Female; Glucocorticoids; Huma | 2007 |
Recurrent episodes of dermatomyositis-associated pneumonitis masquerading as hypersensitivity pneumonitis.
Topics: Adult; Alveolitis, Extrinsic Allergic; Azathioprine; Biopsy; Dermatomyositis; Diagnosis, Differentia | 2006 |
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2006 |
Does colonoscopy cause increased ulcerative colitis symptoms?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Cross-Over Studies | 2007 |
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Blood C | 2007 |
Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2006 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2007 |
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2008 |
Isolated bilateral posterior scleritis after eye trauma.
Topics: Azathioprine; Child; Conjunctiva; Drug Therapy, Combination; Eye Injuries; Eyelids; Female; Fluoresc | 2007 |
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2007 |
Chronic relapsing lupus pancreatitis.
Topics: Amylases; Glucocorticoids; Humans; Lupus Vulgaris; Male; Middle Aged; Pancreatitis, Chronic; Prednis | 2007 |
[Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2006 |
Reactivation of Graves' orbitopathy after rehabilitative orbital decompression.
Topics: Aged; Decompression, Surgical; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Hu | 2007 |
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortez | 2007 |
Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanism.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2007 |
Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report.
Topics: Administration, Inhalation; Bronchial Spasm; Child, Preschool; Cystic Fibrosis; Dose-Response Relati | 2007 |
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Topics: Antilymphocyte Serum; Blood Transfusion; Child; Combined Modality Therapy; Cyclosporine; Disease Pro | 2007 |
Optic neuropathy complicating multifocal choroiditis and panuveitis.
Topics: Adult; Choroiditis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; | 2007 |
Optic neuropathy associated with periostitis in relapsing polychondritis.
Topics: Aged; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Magnetic Resonanc | 2007 |
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combinat | 2007 |
Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2007 |
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2007 |
Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppr | 2007 |
Pathogenetic role of myelitis for syringomyelia.
Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; | 2007 |
Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents; Blood Sedimentation; C-Reactive Protein; Dose-Respon | 2007 |
Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Double-Blind Method; Drug Therapy, Combination; | 2007 |
[Reactivation of hepatitis B after treatment with CHOP and rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient].
Topics: Adult; Anti-Inflammatory Agents; Cardiomyopathies; Heart Transplantation; Humans; Immunosuppressive | 2007 |
Corticosteroids in preventing severe lupus flares: do all patients have the same risk? Comment on the article by Tseng et al.
Topics: Adrenal Cortex Hormones; Antibodies, Anti-Idiotypic; Antirheumatic Agents; DNA; Dose-Response Relati | 2007 |
Systemic varicella zoster virus reinfection in a case of angioimmunoblastic T-cell lymphoma.
Topics: Acyclovir; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chickenpox; Cyclo | 2007 |
Recurrent, pruritic dermal plaques and bullae. Diagnosis: eosinophilic cellulitis (Wells syndrome).
Topics: Administration, Oral; Aged, 80 and over; Anti-Allergic Agents; Anti-Inflammatory Agents; Blister; Ce | 2007 |
[Crohn's disease affecting only vulvoperineal area].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Biopsy; Crohn Disease; Female; Glucocorticoids; Hu | 2007 |
How can we determine the role of radiotherapy in the treatment of localized aggressive non-Hodgkin's lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 2007 |
Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.
Topics: Cohort Studies; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Hepatitis C; | 2007 |
Acute psychosis in systemic lupus erythematosus.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Dose-Response Relationship, Drug; Female; Follow-Up S | 2008 |
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2007 |
Treatment of refractory recurrent pericarditis.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Fatal Outcome; Female; Huma | 2007 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2007 |
Pemphigus vulgaris and pemphigus foliaceus: similar prognosis?
Topics: Adult; Aged; Autoantibodies; Desmoglein 1; Desmoglein 3; Female; Fluorescent Antibody Technique, Dir | 2007 |
Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Eosinophilia; Esophagitis; Esophagoscopy; Female; Glu | 2007 |
A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2007 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Laparoscopic incisional hernia repair after liver transplantation.
Topics: Aged; Female; Graft Rejection; Hernia, Ventral; Humans; Immunosuppressive Agents; Laparoscopy; Liver | 2007 |
Steroid responsiveness of children with idiopathic nephrotic syndrome in southeastern region of Turkey.
Topics: Child; Child, Preschool; Female; Humans; Infant; Male; Nephrotic Syndrome; Prednisone; Recurrence; R | 2007 |
[Chronic relapsing inflammatory optic neuropathy (CRION) without detection of IgG-NMO antibodies].
Topics: Adult; Chronic Disease; Diagnosis, Differential; Fluorescent Antibody Technique, Indirect; Humans; I | 2007 |
Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.
Topics: Calcineurin Inhibitors; Drug Administration Schedule; Graft Survival; Humans; Immunosuppression Ther | 2007 |
Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin.
Topics: Child; Cyclosporine; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Immunosuppressive Ag | 2009 |
Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheum | 2008 |
Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: con.
Topics: Calcineurin Inhibitors; Drug Administration Schedule; Graft Survival; Humans; Immunosuppression Ther | 2007 |
Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Topics: Adhesives; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyanoacrylates; Cycl | 2007 |
[Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Cy | 2007 |
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Leukocyte Count | 2008 |
[Retroperitoneal fibrosis].
Topics: Aged; Aortic Aneurysm, Abdominal; Autoimmune Diseases; Biopsy; Child; Comorbidity; Diagnosis, Differ | 2008 |
Ocular involvement in nasal natural killer T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eye; Fatal Outcome; F | 2009 |
Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome.
Topics: Adjuvants, Immunologic; Autoantibodies; Child; Child, Preschool; Dose-Response Relationship, Drug; D | 2009 |
[Effect of long-term steroid treatment on the adrenal function in patients with kidney diseases].
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Female; Hum | 1984 |
Medical therapy of inflammatory bowel disease.
Topics: Acute Disease; Adjuvants, Immunologic; Anus Diseases; Azathioprine; Colitis, Ulcerative; Crohn Disea | 1980 |
Recurrent Churg-Strauss vasculitis. With exophthalmos, hearing loss, nasal obstruction, amyloid deposits, hyperimmunoglobulinemia E, and circulating immune complexes.
Topics: Adult; Amyloid; Antigen-Antibody Complex; Asthma; Exophthalmos; Female; Hearing Loss; Humans; Hydroc | 1981 |
[Treatment of Crohn disease in childhood].
Topics: Adolescent; Azathioprine; Child; Child Development; Colectomy; Crohn Disease; Dose-Response Relation | 1982 |
The recurrence of alveolitis in interstitial lung disease.
Topics: Aged; Humans; Male; Prednisone; Pulmonary Fibrosis; Recurrence | 1984 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Doxorubicin; Drug | 1984 |
[Treatment of acute myeloid leukemia].
Topics: Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; | 1984 |
[Treatment of nephrotic syndrome with combined traditional Chinese and western medicine in children--observation of 100 cases].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunosuppressive Ag | 1982 |
[Clinical analysis of 10 refractory cases of idiopathic nephrotic syndrome in children treated with combined traditional Chinese medicine and western medicine].
Topics: Child; Child, Preschool; Cyclophosphamide; Female; Humans; Infant; Male; Medicine, Chinese Tradition | 1984 |
Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause.
Topics: Adult; Blood Platelets; Cytomegalovirus Infections; Humans; Immunoglobulin G; Male; Prednisone; Purp | 1980 |
Recurrent herpes zoster encephalitis. A complication of systemic lupus erythematosus.
Topics: Cerebrospinal Fluid; Encephalitis; Female; Ganglia, Spinal; Herpes Zoster; Herpesvirus 3, Human; Hum | 1981 |
Adrenal responsiveness in children with steroid responsive idiopathic nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Glands; Adrenocorticotropic Hormone; Child; Child | 1982 |
Prognosis for nonoperative management of small-bowel obstruction in Crohn's disease.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Bacterial Agents; Crohn Disease; Fluid Therapy; Follow-Up S | 1983 |
Risk of relapse in steroid-sensitive nephrotic syndrome: effect of stage of post-prednisone adrenocortical suppression.
Topics: Adolescent; Adrenal Cortex; Adrenocorticotropic Hormone; Child; Child, Preschool; Depression, Chemic | 1983 |
Relapse of nephrotic syndrome following remission for 20 years.
Topics: Adrenocorticotropic Hormone; Adult; Child, Preschool; Diagnosis, Differential; Glomerulonephritis; G | 1983 |
Phagocytic capacity of human leukocytes preincubated with Imuran and prednisone.
Topics: Azathioprine; Bacterial Infections; Blood Bactericidal Activity; Candida albicans; Humans; Immune To | 1983 |
The role of radiation therapy in the management of stage III follicular lymphomas.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 1984 |
Graves' ophthalmopathy.
Topics: Adolescent; Adult; Aged; Child; Eyelid Diseases; Female; Graves Disease; Humans; Male; Middle Aged; | 1983 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Necrotizing granulomatous vasculitis with eosinophilic infiltrates limited to the prostate. Case report and review of the literature.
Topics: Aged; Eosinophilic Granuloma; Humans; Male; Necrosis; Postoperative Complications; Prednisone; Prost | 1984 |
[Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood].
Topics: Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Tolerance; Female; Glomerulosclerosis, | 1984 |
Persistent pleural effusion complicating sarcoidosis.
Topics: Adult; Humans; Pleural Effusion; Prednisone; Recurrence; Sarcoidosis | 1984 |
Clinico-pathological study on the nephrotic syndrome in Jamaican children.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Kidney; Male; Nephrotic Syndrom | 1984 |
Alopecia totalis in a chimpanzee.
Topics: Alopecia Areata; Animals; Autoimmune Diseases; Female; Pan troglodytes; Prednisone; Recurrence | 1984 |
Steroid-dependent nephrotic syndrome in lupus nephritis. Response to chlorambucil.
Topics: Adult; Chlorambucil; Female; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Nephrotic Sy | 1984 |
[Climatotherapy in chronic inflammations of the uvea].
Topics: Adolescent; Chronic Disease; Climate; Combined Modality Therapy; Dexamethasone; Female; Humans; Macu | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclo | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Graves' ophthalmopathy. An unusual course.
Topics: Female; Graves Disease; Humans; Middle Aged; Prednisone; Recurrence; Thyroxine; Tomography, X-Ray Co | 1984 |
Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapse.
Topics: Adolescent; Adult; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Humans; Leukemi | 1983 |
Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chil | 1984 |
[Recurrent polyradiculoneuritis: report of 2 cases].
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Female; HLA Antigens; Humans; Immunity; Male; Pol | 1983 |
[Chronic active hepatitis: recurrence after long-term immunosuppressive therapy in spite of normal liver histology].
Topics: Adult; Alkaline Phosphatase; Autoantibodies; Azathioprine; Female; Hepatitis, Chronic; Humans; Immun | 1983 |
Recurrent Goodpasture's syndrome.
Topics: Adolescent; Anti-Glomerular Basement Membrane Disease; Biopsy; Cyclophosphamide; Drug Therapy, Combi | 1983 |
[Idiopathic thrombocytopenic purpura in 225 adult cases. Use of delayed action prednisone in chronic purpura].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Delayed-Action Preparations; Drug Therapy, Co | 1983 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Pemphigus; Predni | 1984 |
Facial nerve paralysis. 1. General evaluation, Bell's palsy.
Topics: Acute Disease; Adult; Child; Electrodiagnosis; Facial Nerve; Facial Paralysis; Humans; Male; Prednis | 1984 |
Metronidazole therapy for Crohn's disease and associated fistulae.
Topics: Adult; Crohn Disease; Female; Follow-Up Studies; Humans; Intestinal Fistula; Male; Metronidazole; Mi | 1984 |
Azathioprine in the treatment of myasthenia gravis.
Topics: Adult; Aged; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Huma | 1984 |
Treatment of multiple myeloma.
Topics: Alkylating Agents; Antineoplastic Agents; Bone Marrow Examination; Drug Therapy, Combination; Humans | 1980 |
Long-term disease-free survival in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Long-Ter | 1981 |
Relapsing idiopathic thrombocytopenia in a horse.
Topics: Animals; Dexamethasone; Horse Diseases; Horses; Male; Platelet Count; Prednisone; Recurrence; Thromb | 1983 |
[Painful Tolosa-Hunt ophthalmoplegia. Apropos of a case report in a child].
Topics: Child; Dexamethasone; Diagnosis, Differential; Humans; Male; Migraine Disorders; Ophthalmoplegia; Pr | 1983 |
An unusual case of autoimmune agranulocytosis with total absence of myeloid precursors: demonstration of diverse sources of R binder for cobalamin in plasma and secretions.
Topics: Adult; Agranulocytosis; Antibodies; Autoimmune Diseases; Bone Marrow; Cyclophosphamide; Female; Gran | 1983 |
Minimal change nephrotic syndrome: treatment with low doses of hydrocortisone.
Topics: Adrenal Glands; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Hydrocortisone; M | 1983 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
'Recurrent' erythroblastopenia of childhood. An IgM-mediated RBC aplasia.
Topics: Anemia, Aplastic; Erythroblasts; Erythropoiesis; Humans; Immunoglobulin G; Immunoglobulin M; Infant; | 1983 |
Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis.
Topics: Adolescent; Adult; Child; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Fluores | 1983 |
Cross-resistance to alkylating agents in multiple myeloma.
Topics: Alkylating Agents; Cyclophosphamide; Drug Administration Schedule; Drug Resistance; Female; Humans; | 1983 |
A retrospective review of 26 cases of dysthyroid optic neuropathy.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Orbit; Prednisone; Radiotherap | 1983 |
Acute and subacute orbital myositis.
Topics: Acute Disease; Adolescent; Adult; Aged; Autoimmune Diseases; Female; Follow-Up Studies; Humans; Male | 1983 |
Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Agranulocytosis; Anaphylaxis; Antineoplastic Agents; Asparaginase; Child; Child, | 1980 |
[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].
Topics: Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Infant; Leukemia, Lymphoid; | 1980 |
Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Drug Administration Schedu | 1980 |
Relapse in childhood acute lymphoblastic leukemia after elective cessation of initial treatment: failure of subsequent treatment with cyclophosphamide, cytosine arabinoside, vincristine and prednisone (COAP).
Topics: Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combinat | 1981 |
Combination chemotherapy for marrow relapse in children and adolescents with acute lymphocytic leukaemia.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; | 1981 |
Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug | 1981 |
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Leuk | 1982 |
[Therapy of juvenile disseminated histiocytosis X. First results of a prospective study at the pediatric section of the Swiss Work Group for Clinical Cancer Research (SAKK)].
Topics: Child; Histiocytosis, Langerhans-Cell; Humans; Mercaptopurine; Prednisone; Recurrence; Remission, Sp | 1980 |
Recurrence of antiglomerular basement membrane glomerulonephritis in sheep renal allografts.
Topics: Animals; Azathioprine; Basement Membrane; Glomerulonephritis; Kidney; Kidney Transplantation; Male; | 1981 |
Treatment of the idiopathic nephrotic syndrome.
Topics: Alkylating Agents; Child; Chlorambucil; Cyclophosphamide; Drug Resistance; Glomerulonephritis; Human | 1981 |
Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Chlorambucil; Complement C3; Complement C4; Cyclophosph | 1982 |
Allergic bronchopulmonary aspergillosis: staging as an aid to management.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspergillosis, Allergic Bronchopulm | 1982 |
Chronic, recurrent small-vessel cutaneous vasculitis. Clinical experience in 13 patients.
Topics: Adolescent; Adult; Biopsy; Chronic Disease; Female; Humans; Male; Middle Aged; Prednisone; Prognosis | 1982 |
The use of indomethacin in the treatment of pericarditis in childhood.
Topics: Adolescent; Aspirin; Child; Female; Humans; Indomethacin; Male; Pericarditis; Prednisone; Radiograph | 1982 |
Long-term outcome of primary nephrotic syndrome.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Kidn | 1982 |
Primary peritonitis and meningitis in nephrotic syndrome in Riyadh.
Topics: Child; Child, Preschool; Female; Humans; Immunoglobulin G; Male; Meningitis, Pneumococcal; Nephrotic | 1982 |
Late development of chronic renal failure in steroid-responsive nephrotic syndrome.
Topics: Adult; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Nephrotic Syndr | 1982 |
Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Kidney; Male; Nephrosis, Lipoid | 1982 |
Multiple relapsing steroid responsive nephrosis treated with chlorambucil.
Topics: Adult; Chlorambucil; Drug Therapy, Combination; Humans; Male; Nephrotic Syndrome; Prednisone; Recurr | 1982 |
Treatment and prognosis in antibasement membrane antibody-mediated nephritis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Basement Membrane; Child; Child, Preschool; C | 1982 |
[Recurring, histologically confirmed Moschcowitz syndrome during pregnancy].
Topics: Adult; Eclampsia; Female; Heparin; Humans; Platelet Count; Prednisone; Pregnancy; Pregnancy Complica | 1981 |
Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment.
Topics: Adolescent; Adult; Chronic Disease; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppre | 1981 |
Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Topics: Adolescent; Child; Child, Preschool; Humans; Nephrotic Syndrome; Prednisone; Recurrence | 1981 |
Rapid progressive glomerulonephritis: relapse after prolonged remission.
Topics: Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Kidney; Male; | 1981 |
Acute febrile neutrophilic dermatosis. Sweet's syndrome.
Topics: Blind Loop Syndrome; Humans; Leukocytosis; Male; Middle Aged; Neutrophils; Prednisone; Recurrence; S | 1981 |
Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission.
Topics: Azathioprine; Biopsy; Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Hepatic Encepha | 1980 |
Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccharide vaccine in a child with nephrotic syndrome.
Topics: Antibodies, Bacterial; Bacterial Vaccines; Child; Humans; Luminescent Measurements; Nephrotic Syndro | 1980 |
Late recurrence of corticosteroid-responsive nephrotic syndrome of childhood.
Topics: Adult; Age Factors; Cortisone; Edema; Female; Humans; Nephrotic Syndrome; Prednisone; Recurrence; Ti | 1980 |
The need for extended treatment of anaphylaxis.
Topics: Adolescent; Adult; Anaphylaxis; Child; Chlorpheniramine; Epinephrine; Female; Humans; Male; Predniso | 1980 |
Hodgkin's disease presenting as steroid-responsive pancytopenia.
Topics: Adult; Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1980 |
Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness.
Topics: Aged; Biopsy; Female; Giant Cell Arteritis; Humans; Prednisone; Recurrence; Temporal Arteries | 1980 |
Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Cirrhosis; Male; M | 1981 |
The growth fraction of human myeloma cells.
Topics: Female; Humans; Kinetics; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recurrence; Th | 1981 |
Hepatitis B reactivation after lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e | 1995 |
Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytar | 1995 |
Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fe | 1994 |
Thrombocytopenia in the HIV-infected patient.
Topics: Adult; Autoimmune Diseases; Danazol; gamma-Globulins; HIV Infections; Humans; Male; Prednisone; Recu | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 1994 |
Staging of chronic hyperplastic rhinosinusitis: treatment strategies.
Topics: Beclomethasone; Cefuroxime; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Ethmoid | 1995 |
Treatment of resistant oral aphthous ulcers in children with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adrenal Cortex Hormones; CD8-Positive T-Ly | 1995 |
Outcome of children with opsoclonus-myoclonus regardless of etiology.
Topics: Adrenocorticotropic Hormone; Child, Preschool; Developmental Disabilities; Epilepsies, Myoclonic; Fe | 1995 |
Tuberculous peritonitis complicating corticosteroid therapy for acute alcoholic hepatitis.
Topics: Acute Disease; Adult; Female; Glucocorticoids; Hepatitis, Alcoholic; Humans; Peritonitis, Tuberculou | 1995 |
Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Topics: Administration, Oral; Azathioprine; Bacterial Infections; Case-Control Studies; Combined Modality Th | 1995 |
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epile | 1995 |
[T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
Topics: Adult; Chlorambucil; Cyclosporins; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Nephr | 1995 |
[Daily oral low-dose etoposide therapy for aged patients with relapsed aggressive lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administra | 1995 |
Relapsing eosinophilic perimyositis.
Topics: Anti-Inflammatory Agents; Dermatomyositis; Eosinophilia; Humans; Male; Middle Aged; Prednisone; Recu | 1995 |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Azathioprine; Bilirubin; Cyclosporine; Drug Therapy, | 1993 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophospha | 1993 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplat | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
Recurrence of sarcoidosis in a human lung allograft.
Topics: Adult; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Prednisone; Re | 1995 |
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
Topics: Aged; Carcinoma, Renal Cell; Cough; Dyspnea; Female; Fever; Floxuridine; Forced Expiratory Volume; H | 1995 |
[Colchicine in the treatment of steroid-dependent recurrent idiopathic pericarditis].
Topics: Acute Disease; Adolescent; Colchicine; Drug Therapy, Combination; Humans; Male; Pericarditis; Predni | 1995 |
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; | 1995 |
Persisting temporal arteritis.
Topics: Aged; Diplopia; Female; Giant Cell Arteritis; Headache; Humans; Ischemia; Optic Nerve; Prednisone; R | 1995 |
Pseudotumoral lymphocytic hypophysitis successfully treated by corticosteroid alone: first case report.
Topics: Adult; Autoimmune Diseases; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1994 |
Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
Topics: Adult; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immuno | 1994 |
[Giant-cell arteritis. Comments on the case histories of 30 patients].
Topics: Aged; Aged, 80 and over; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Midd | 1994 |
Recurrent nephrotic syndrome associated with Kimura's disease in a young non-Oriental male.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Humans; Male; Nephrosis, Lipoid; Prednisone; Rec | 1994 |
[Cortico-dependent Hashimoto encephalitis].
Topics: Adult; Encephalitis; Humans; Male; Prednisone; Recurrence; Thyroiditis, Autoimmune | 1994 |
Upper limb pain in chronic demyelinating polyneuropathy: electrophysiological correlates.
Topics: Arm; Demyelinating Diseases; Electric Stimulation; Female; Humans; Leg; Male; Middle Aged; Neurologi | 1994 |
Treatment of nephrotic syndrome.
Topics: Adolescent; Age of Onset; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Dru | 1994 |
Necrotizing vasculitis--relapse despite cytotoxic therapy.
Topics: Adult; Aged; Arteritis; Azathioprine; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Hu | 1993 |
Response to pooled gamma globulin therapy in a child with polyarteritis nodosa.
Topics: Adolescent; Combined Modality Therapy; Humans; Immunization, Passive; Male; Polyarteritis Nodosa; Pr | 1994 |
Antiphospholipid syndrome: clinical and therapeutic aspects.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Female; Hum | 1994 |
Is maintenance therapy effective in Crohn's disease?
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Meta-Analysis as Topic; Prednisone; Recurre | 1994 |
Relapsing polychondritis occurring de novo in a renal transplant patient.
Topics: Azathioprine; Cyclosporine; Humans; Kidney Transplantation; Male; Middle Aged; Polychondritis, Relap | 1994 |
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Dise | 1994 |
Suppurative stomatitis glandularis.
Topics: Adult; Cephalexin; Cheilitis; Dexamethasone; Diagnosis, Differential; Female; Humans; Prednisone; Re | 1994 |
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Antibodies, Antiphospholipi | 1994 |
"Recurrent" giant cell arteritis.
Topics: Aged; Aged, 80 and over; Follow-Up Studies; Giant Cell Arteritis; Humans; Longitudinal Studies; Male | 1994 |
Side effects of levamisole in children with nephrosis.
Topics: Adolescent; Child; Drug Therapy, Combination; Humans; Levamisole; Male; Nephrotic Syndrome; Predniso | 1994 |
Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
Topics: Animals; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Re | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxo | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophos | 1994 |
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarab | 1994 |
[Clostridium difficile in early childhood ulcerative pancolitis].
Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Mal | 1993 |
Sweet's syndrome in children.
Topics: Child, Preschool; Female; Humans; Prednisone; Recurrence; Sweet Syndrome | 1994 |
How much should we editorialize?
Topics: Acute Disease; Administration, Oral; Humans; Injections, Intravenous; Methylprednisolone; Optic Neur | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study.
Topics: Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Gin | 1994 |
[Relief of recurrent pericarditis by colchicine].
Topics: Adult; Bone Neoplasms; Colchicine; Drug Therapy, Combination; Humans; Male; Osteosarcoma; Pericardit | 1994 |
[Pharyngeal dysphagia and polymyositis].
Topics: Aged; Azathioprine; Deglutition Disorders; Enteral Nutrition; Female; Humans; Pharyngeal Diseases; P | 1993 |
Increased generation of superoxide radicals in the blood of MS patients.
Topics: Adult; Erythrocytes; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Multiple Sclerosis; Pred | 1993 |
Relapses after termination of therapy of acute lymphoblastic leukemia in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 1993 |
Nutritional status of children with leukemia.
Topics: Adolescent; Anthropometry; Blood Proteins; C-Reactive Protein; Child; Child, Preschool; Female; Huma | 1994 |
Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft.
Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Granulomatosis with Polyangiitis; Humans; Kidney; Kid | 1993 |
[Immunohistochemical study of lesions of temporal arteritis in Horton's disease].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Biopsy; Female; Giant Cell Arteritis; Humans; Immun | 1993 |
Toxoplasmosis neuroretinitis.
Topics: Adult; Anti-Bacterial Agents; Child; Female; Humans; Male; Optic Neuritis; Prednisone; Recurrence; R | 1993 |
[Neural sarcoidosis in children. A case report].
Topics: Adolescent; Biopsy; Brain Diseases; Granuloma; Humans; Iridocyclitis; Magnetic Resonance Imaging; Ma | 1993 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxoru | 1993 |
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co | 1993 |
Corticosteroid responsive puffy hands and occult vasculitic neuropathy: RS3PE plus?
Topics: Aged; Antigen-Antibody Reactions; Edema; Humans; Male; Peripheral Nervous System Diseases; Prednison | 1993 |
Single fiber electromyography in myasthenia gravis during pregnancy.
Topics: Adult; Blepharoptosis; Diplopia; Electromyography; Female; Humans; Myasthenia Gravis; Prednisone; Pr | 1993 |
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1993 |
Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment.
Topics: Adolescent; Bronchoalveolar Lavage Fluid; Bronchoscopy; CD4-CD8 Ratio; Child; Female; Follow-Up Stud | 1993 |
Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease.
Topics: Administration, Oral; Ambulatory Care; Child; Clindamycin; Gastric Outlet Obstruction; Granulomatous | 1993 |
Corticosteroids and optic neuritis.
Topics: Administration, Oral; Humans; Methylprednisolone; Optic Neuritis; Prednisone; Recurrence; T-Lymphocy | 1993 |
Relapsing steroid-responsive idiopathic acute interstitial nephritis.
Topics: Acute Kidney Injury; Creatinine; Female; Humans; Middle Aged; Nephritis, Interstitial; Prednisone; R | 1993 |
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1993 |
Behavioural sensitisation and steroid-induced psychosis.
Topics: Adolescent; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Neuropsychological Test | 1993 |
The post-cardiac injury syndrome following blunt chest trauma: case report.
Topics: Heart Diseases; Humans; Male; Middle Aged; Pleurisy; Prednisone; Recurrence; Syndrome; Thoracic Inju | 1993 |
Asthma. Assessment and management in a pediatric hospital.
Topics: Acute Disease; Albuterol; Asthma; Canada; Child; Child, Preschool; Emergency Medicine; Emergency Ser | 1993 |
Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease.
Topics: Adult; Aged; Combined Modality Therapy; Exophthalmos; Female; Graves Disease; Humans; Male; Middle A | 1993 |
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
Topics: Adult; Brain; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; M | 1993 |
Stevens-Johnson syndrome associated with herpes simplex virus.
Topics: Herpes Labialis; Humans; Male; Prednisone; Recurrence; Stevens-Johnson Syndrome; Stomatitis, Herpeti | 1993 |
Quadruple therapy for ocular toxoplasmosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clindamycin; Drug Administration Schedule; Drug Co | 1993 |
Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease.
Topics: Aged; Cyclosporine; Humans; Male; Ophthalmia, Sympathetic; Prednisone; Recurrence | 1993 |
Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
Topics: Acute Disease; Antilymphocyte Serum; Child; Drug Resistance; Evaluation Studies as Topic; Female; Gr | 1993 |
[Recurrent bronchiolitis obliterans organizing pneumonia as first manifestation of polymyositis].
Topics: Anti-Inflammatory Agents; Cryptogenic Organizing Pneumonia; Humans; Male; Middle Aged; Polymyositis; | 1995 |
[Recurrence of pulmonary sarcoidosis].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Disease Progression; Female; Follow-Up Stu | 1995 |
Maintenance therapy for Crohn's disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Clinical Trials as Topic; Crohn Disease; Drug The | 1996 |
Case report: recurrence of chronic ulcerative colitis induced by intercurrent cytomegalic virus infection.
Topics: Adult; Colitis, Ulcerative; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclov | 1995 |
Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh.
Topics: Abdomen; Colectomy; Colitis, Ulcerative; Fascia; Female; Follow-Up Studies; Gastric Bypass; Hernia, | 1996 |
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; | 1996 |
Serum thrombopoietin levels in cyclic thrombocytopenia.
Topics: Female; Humans; Immunosuppressive Agents; Middle Aged; Periodicity; Platelet Count; Prednisone; Recu | 1996 |
[Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Levami | 1995 |
Heart transplantation for chronic Chagas' heart disease.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Cause of Death; Chagas Cardiomyopathy; Child; C | 1996 |
Accelerated acute rejection in renal allograft.
Topics: Acute Disease; Age Factors; Azathioprine; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Surv | 1996 |
Membranous nephropathy: recurrence after kidney transplantation.
Topics: Adult; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Humans; Kidney; | 1996 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
Mycophenolate mofetil in liver transplantation.
Topics: Administration, Oral; Adolescent; Adult; Cyclosporine; Cytomegalovirus Infections; Diarrhea; Female; | 1996 |
Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy.
Topics: Adult; Aged; Creatinine; Female; Follow-Up Studies; Glucocorticoids; HIV Infections; Humans; Kidney | 1996 |
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; | 1996 |
Treatment of pyoderma gangrenosum with methotrexate.
Topics: Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hum | 1996 |
[Lupus nephritis in male adults, an analysis of the clinical and pathological features].
Topics: Adolescent; Adult; Age Factors; Aged; Female; Glucocorticoids; Humans; Kidney; Lupus Nephritis; Male | 1995 |
[Local corticosteroid therapy in a severe form of pemphigoid gestationis].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Female; Fetal Death; Humans; Pemphigoid, B | 1996 |
Recurrent cellulitis and bacteremia caused by Flavobacterium odoratum.
Topics: Anti-Bacterial Agents; Bacteremia; Cellulitis; Flavobacterium; Gram-Negative Bacterial Infections; H | 1996 |
Suspected hypersensitivity pneumonitis after exposure to a biologic forage inoculant.
Topics: Adult; Agrochemicals; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Biological Products; | 1996 |
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 1996 |
Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide.
Topics: Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoimmune Diseases; Child; Cycloph | 1996 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therap | 1996 |
Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Topics: Adult; Biopsy; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Female; Follow-Up S | 1996 |
Multiple recurrent branch retinal artery occlusions associated with varicella zoster virus.
Topics: Acyclovir; Aged; Anti-Inflammatory Agents; Antiviral Agents; DNA, Viral; Female; Fluorescein Angiogr | 1996 |
Reactivation of inactive systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Lupus Eryt | 1996 |
Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 1997 |
Chagas disease and transplantation.
Topics: Adult; Antilymphocyte Serum; Argentina; Azathioprine; Cadaver; Chagas Disease; Child; Cyclosporine; | 1996 |
[Autoimmune enteropathy--difficulties in diagnosis and treatment].
Topics: Autoimmune Diseases; Child, Preschool; Cyclosporine; Diarrhea; Hepatitis C; Humans; Intestinal Disea | 1996 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Ther | 1997 |
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1997 |
Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Topics: Actuarial Analysis; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; He | 1997 |
Current status in the treatment of orbital myositis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Ste | 1997 |
Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy.
Topics: Adult; Black People; Female; Glucocorticoids; Humans; Male; Prednisone; Prognosis; Prospective Studi | 1997 |
[A case of benign cutaneous polyarteritis nodosa].
Topics: Humans; Leg Dermatoses; Male; Middle Aged; Polyarteritis Nodosa; Prednisone; Recurrence; Remission, | 1996 |
Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamid | 1997 |
Combination chemotherapy with CHOP for recurrent thrombotic thrombocytopenic purpura.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans | 1997 |
Coccidioidomycosis and sarcoidosis. Multiple recurrences.
Topics: Antifungal Agents; Coccidioidomycosis; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Recur | 1997 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Foll | 1997 |
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combine | 1997 |
A 69-year-old woman with hemoptysis, bilateral alveolar infiltrates, and microscopic hematuria.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Cyclophosphamide; Diagnosis, Differential; Female; Follow-Up | 1997 |
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Topics: Acute Disease; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Biopsy; C | 1997 |
Tramadol-induced mania.
Topics: Adult; Back Pain; Bipolar Disorder; Female; Humans; Prednisone; Recurrence; Tramadol | 1997 |
Influence of steroid withdrawal on proteinuria in renal allograft recipients.
Topics: Acute Disease; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Chi-Square Distribution | 1997 |
Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Demyelinating Diseases; Female; Follow- | 1997 |
Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1997 |
Nodular fat necrosis associated with lupus-induced pancreatitis.
Topics: Adult; Amylases; Anti-Inflammatory Agents; Erythema; Facial Dermatoses; Fat Necrosis; Female; Humans | 1997 |
[Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; | 1997 |
Recurrent severe hypotony after cataract surgery in an eye with previous trabeculectomy.
Topics: Atropine; Dexamethasone; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans | 1998 |
Corticosteroid therapy and relapse in sarcoidosis.
Topics: Adrenal Cortex Hormones; Black People; Disease Progression; Female; Glucocorticoids; Humans; Male; P | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
The clinical behavior of localized and multicentric Castleman disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Castleman Disease; Combined Modality Therapy; Drug Ther | 1998 |
Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Crohn Disease; Dr | 1998 |
Reactivation of inflammatory lesions in ocular histoplasmosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Chorioretinitis; Eye Infections, Fungal; Female; Fluorescein | 1998 |
Treatment of sarcoidosis with corticosteroids: who is going to relapse and why?
Topics: Glucocorticoids; Humans; Prednisone; Recurrence; Sarcoidosis; Sarcoidosis, Pulmonary; Treatment Outc | 1998 |
The late follow-up of chronic sarcoid patients previously treated with corticosteroids.
Topics: Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Logistic Models; Male; Prednisone; Recurr | 1998 |
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
Topics: Alanine Transaminase; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Genome, Viral; | 1998 |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C; Humans; Immun | 1998 |
Recurrent Kaposi's sarcoma in a renal transplant recipient maintained on minimum doses of immunosuppression.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle A | 1998 |
Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Antimalarials; Chloroquine; Chronic Disease | 1998 |
Serial sputum cell counts in the management of chronic airflow limitation.
Topics: Asthma; Bronchiectasis; Bronchitis; Cell Count; Chronic Disease; Diagnosis, Differential; Female; Gl | 1998 |
Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis.
Topics: Administration, Oral; Adult; Case-Control Studies; Female; Glucocorticoids; Humans; Incidence; Injec | 1998 |
Steroid-resistant idiopathic esophageal ulcer in a child with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Child, Preschool; Drug Resistance; Esophageal Disea | 1998 |
A 24-year-old man with symptoms and signs of polymyalgia rheumatica.
Topics: Adult; Blood Sedimentation; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administ | 1998 |
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma.
Topics: Antineoplastic Agents; Health Status; Humans; Interferon alpha-2; Interferon-alpha; Melphalan; Multi | 1998 |
[Sarcoidosis and pregnancy. A retrospective study of 11 cases].
Topics: Abortion, Induced; Abortion, Spontaneous; Abortion, Therapeutic; Adult; Anti-Inflammatory Agents; Di | 1998 |
[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administr | 1998 |
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother | 1998 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; | 1995 |
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P)
Topics: Aged; Anti-Inflammatory Agents; Breast Neoplasms; Bronchoalveolar Lavage Fluid; Carcinoma; Chemother | 1998 |
[Primary biliary cirrhosis with sarcoid-like infiltrations in the lung].
Topics: Biopsy; Bronchoalveolar Lavage Fluid; Female; Granuloma, Respiratory Tract; Humans; Liver; Liver Cir | 1998 |
Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic grade.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Biopsy, Needle; Drug Therapy, Combination; Graft Reje | 1998 |
Outcome of autoimmune hepatitis after liver transplantation.
Topics: Adult; Aged; Female; Hepatitis, Autoimmune; Humans; Liver Transplantation; Male; Middle Aged; Predni | 1998 |
Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Chromosome Aberra | 1998 |
Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy.
Topics: Adult; Drug Therapy, Combination; Humans; Male; Methimazole; Paralysis; Potassium; Prednisone; Propr | 1999 |
Acute disseminated encephalomyelitis in childhood: report of 10 cases.
Topics: Child; Child, Preschool; Encephalomyelitis, Acute Disseminated; Female; Humans; Infant; Magnetic Res | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.
Topics: Acute Disease; Administration, Oral; Breath Tests; Child, Preschool; Female; Glucocorticoids; Humans | 1999 |
Therapy of prednisone-refractory collagenous colitis with budesonide.
Topics: Aged; Anti-Inflammatory Agents; Budesonide; Colitis; Collagen; Diarrhea; Drug Resistance; Female; Hu | 1999 |
[Treatment of myasthenia: role of corticoids and immunosuppressive agents].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporins; | 1999 |
2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Topics: Adult; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ch | 1999 |
Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cyclosporine; Doxor | 1999 |
The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combine | 1999 |
[Myositis in the presence of slightly elevated creatine kinase values].
Topics: Adult; Azathioprine; Biopsy; Creatine Kinase; Diagnosis, Differential; Humans; Male; Middle Aged; Mu | 1999 |
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexameth | 1999 |
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
Topics: Age Factors; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Follow-Up Studies; Giant | 1999 |
Prednisone withdrawal advocates: beware of recurrent autoimmune hepatitis.
Topics: Drug Administration Schedule; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transpl | 1999 |
[Idiopathic chronic eosinophilic pneumonia].
Topics: Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Chronic Disease; Diagnosis, Differential; Eo | 1998 |
Recurrent fainting, dysesthesia, and impotence.
Topics: Adult; Anti-Inflammatory Agents; Central Nervous System Diseases; Diagnosis, Differential; Erectile | 1999 |
Taking the itch out of poison ivy. Are you prescribing the right medication?
Topics: Adult; Antipruritics; Dermatitis, Toxicodendron; Drug Packaging; Drug Prescriptions; Glucocorticoids | 1999 |
Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.
Topics: Ambulatory Care; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 1999 |
Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeru | 1999 |
[The presence of minimal residual disease during induction therapy is a reliable factor for the prognosis of recurrence in children with standard-risk B-cell precursor acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Cyclophospham | 1999 |
Recurrent orbital angiolymphoid hyperplasia with eosinophilia (Kimura's disease).
Topics: Aged; Angiolymphoid Hyperplasia with Eosinophilia; Glucocorticoids; Humans; Male; Orbital Diseases; | 1999 |
Combined oral and inhaled steroids for acute asthma.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Anti-Inflammator | 1999 |
T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cryptogenic Organizing Pneumonia; Female; Huma | 1999 |
[Corticoid-sensitive recurrent multifocal superficial thrombophlebitis in an 84-year-old man].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Humans; Male; Prednisone; Recurrence; Thrombophle | 1999 |
Combined oral, inhaled steroids prevent relapse in acute asthma.
Topics: Alberta; Asthma; Budesonide; Disease Management; Double-Blind Method; Drug Therapy, Combination; Hum | 1999 |
[Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; | 1999 |
Diffuse large-cell lymphoma of the testis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Pr | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Topics: Child; Complement C3; Creatinine; Disease Progression; Drug Administration Schedule; Female; Glomeru | 1999 |
Acute posterior multifocal placoid pigment epitheliopathy associated with retinal vasculitis, neovascularization and subhyaloid hemorrhage.
Topics: Acute Disease; Adult; Diagnosis, Differential; Female; Fluorescein Angiography; Fundus Oculi; Humans | 1999 |
A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid.
Topics: Acute Disease; Anti-Inflammatory Agents; Asthma; Etretinate; Humans; Keratolytic Agents; Male; Middl | 1999 |
Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; H | 1999 |
Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug | 1999 |
Bronchiolitis obliterans-organizing pneumonia after coronary artery bypass graft surgery.
Topics: Biopsy; Bronchoscopy; Coronary Artery Bypass; Cryptogenic Organizing Pneumonia; Female; Glucocortico | 2000 |
Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.
Topics: Adult; Brain; Brain Diseases; Contrast Media; Demyelinating Diseases; Disease Progression; Female; F | 2000 |
[Granulomatous recurrent mastitis during pregnancy].
Topics: Abortion, Therapeutic; Adult; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Gra | 2000 |
Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow Tra | 2000 |
Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation.
Topics: Aged; Anti-Inflammatory Agents; Cadaver; Cyclophosphamide; Female; Glomerulonephritis, Membranoproli | 2000 |
Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient.
Topics: Anti-HIV Agents; Antihypertensive Agents; Calcium Channel Blockers; Glomerular Mesangium; Glucocorti | 2000 |
Predicting first-year relapses in children with nephrotic syndrome.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Dru | 2000 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho | 2000 |
Primary central nervous system lymphoma in Japan: a nationwide survey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 1999 |
[Vogt-Koyanagi-Harada's disease: 3 cases].
Topics: Adult; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Female; Follow-Up Studies; Humans; | 2000 |
Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chr | 2000 |
Polyarteritis nodosa presenting as massive upper gastrointestinal hemorrhage.
Topics: Abdominal Pain; Adult; Combined Modality Therapy; Electrocoagulation; Endoscopy, Digestive System; G | 2000 |
Expression of BAX in plasma cell dyscrasias.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Biopsy; Blott | 2000 |
Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P).
Topics: Adult; Aged; Alkaline Phosphatase; Cholestasis; Cryptogenic Organizing Pneumonia; Female; gamma-Glut | 2000 |
Juvenile relapsing periarteritis nodosa and streptococcal infection.
Topics: Adolescent; Antibiotic Prophylaxis; Humans; Male; Muscle, Skeletal; Necrosis; Penicillins; Polyarter | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte | 2000 |
Epoch-cyclosporin A induces high response rates in relapsed lymphomas.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; | 2000 |
Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity.
Topics: Adult; Aged; Anti-Inflammatory Agents; Breast Neoplasms; Cryptogenic Organizing Pneumonia; Eosinophi | 2000 |
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Biopsy; Drug Therapy, Combination; Fema | 2000 |
Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Creatinine; C | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
Management of Kikuchi's disease using glucocorticoid.
Topics: Adolescent; Adult; Biopsy; Female; Follow-Up Studies; Glucocorticoids; Histiocytic Necrotizing Lymph | 2000 |
Recurrent pericarditis after thoracic surgery.
Topics: Acute Disease; Adult; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coronary Artery Bypa | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carm | 2000 |
[Relapsing polyneuropathy in the post-partum period].
Topics: Anti-Inflammatory Agents; Chronic Disease; Diagnosis, Differential; Female; Guillain-Barre Syndrome; | 2000 |
Impact of heavy proteinuria (>1 g/d) following renal transplantation.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Biomarkers; Child; Cyclos | 2000 |
Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis.
Topics: Administration, Oral; Adolescent; Adult; Chronic Disease; Female; Fluorescein Angiography; Fundus Oc | 2000 |
Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease.
Topics: Adult; Exudates and Transudates; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Hum | 2000 |
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 2001 |
Hypergammaglobulinaemic purpura associated with IgG subclass imbalance and recurrent infection.
Topics: Child, Preschool; Disease Progression; Humans; Hydroxychloroquine; Immunoglobulin G; Infections; Mal | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Female; Glucocorticoids; Glutathio | 2000 |
[Pyoderma gangrenosum. 15 cases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, | 2001 |
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child | 2001 |
Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eye Neoplasms; | 2000 |
Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.
Topics: Colchicine; Cyclophosphamide; Danazol; Drug Therapy, Combination; Fatal Outcome; Follow-Up Studies; | 2001 |
Acute cardiac ongoing rejection: comparison between different strategies.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Admin | 2001 |
Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2001 |
Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission.
Topics: Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Granulomatosis with P | 2001 |
Lacrimal gland inflammation as the presenting sign of Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dacryocystitis; Drug Therapy, Combina | 2001 |
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2001 |
Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
Topics: Acetates; Adult; Cyclopropanes; Eosinophilia; Gastroenteritis; Glucocorticoids; Humans; Leukotriene | 2001 |
Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Topics: Adult; Aged; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunization, Pa | 2001 |
Optic neuropathy in primary antiphospholipid syndrome in childhood.
Topics: Antiphospholipid Syndrome; Child; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Admini | 2001 |
Delayed diagnosis: recurrent cerebral infarction associated with Churg-Strauss syndrome.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Cerebral Angiography; Cerebral Infarction; Ch | 2001 |
Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Topics: Adjuvants, Immunologic; Child; Child, Preschool; Cyclophosphamide; Drug Costs; Exanthema; Female; Gl | 2001 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2001 |
Is a 2-day course of oral dexamethasone more effective than 5 days of oral prednisone in improving symptoms and preventing relapse in children with acute asthma?
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Inflammatory Agents; Asthma; Child; Child, Pre | 2001 |
6th European Hematology Association Meeting. Frankfurt, Germany. June 21-24, 2001.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2001 |
Recurrent myelitis associated with herpes simplex virus type 2.
Topics: Acyclovir; Aged; Disease Progression; Drug Therapy, Combination; Female; Herpes Genitalis; Herpesvir | 2001 |
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Contraindications; Female; | 2001 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2001 |
Recurrent facial nerve palsy in paediatric patients.
Topics: Adolescent; Blinking; Child; Child, Preschool; Facial Nerve; Facial Paralysis; Female; Humans; Infan | 2001 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Ther | 2002 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2001. Acute febrile respiratory illness in a 57-year-old man with recurrent pulmonary disorders.
Topics: Anti-Inflammatory Agents; Cough; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Fever; H | 2001 |
[Surgical decompression treatment of leprous neuritis at the Bom-Pastor Hospital (Brazilian Amazonia)].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Brazil; Female; Follow-Up Studies; Humans; Leprosy; Lep | 2001 |
Meningeal and cerebral involvement in multiple myeloma patients.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Com | 2001 |
Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Inflammatory Agents; Budesonide; Chi | 2002 |
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine | 2002 |
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fe | 2002 |
Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cyclophosphamide; Drug Therapy, Combination; Fa | 2002 |
[Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Autoimmune Diseases; Blood Transfusion; Chi | 1999 |
Burkitt's lymphoma: single-centre experience with modified BFM protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; C | 2002 |
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Bone Marrow Transplanta | 2002 |
Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations.
Topics: Anti-Inflammatory Agents; beta 2-Microglobulin; Child; Child, Preschool; Cystatin C; Cystatins; Fema | 2002 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Controlled Clinical Trials as T | 2002 |
Prognosis in children with Crohn's disease.
Topics: Adolescent; Adult; Body Height; Body Weight; Child; Child, Preschool; Colitis; Crohn Disease; Female | 1978 |
Crohn's disease of the colon.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; | 1979 |
Radiographic findings of the National Cooperative Crohn's Disease Study.
Topics: Adult; Age Factors; Azathioprine; Colon; Crohn Disease; Duodenum; Female; Humans; Ileum; Intestinal | 1979 |
Letter: Chemoimmunotherapy of adult acute leukaemia.
Topics: Adult; Antineoplastic Agents; BCG Vaccine; Humans; Leukemia, Myeloid, Acute; Prednisone; Recurrence; | 1975 |
A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Topics: alpha-Macroglobulins; Aprotinin; Capillary Permeability; Child; Humans; Kallikreins; Kidney Glomerul | 1975 |
Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
Topics: Alkylating Agents; Blood Cell Count; Carmustine; Cell Count; Doxorubicin; Drug Therapy, Combination; | 1976 |
Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease.
Topics: Administration, Oral; Azathioprine; Celiac Disease; Drug Therapy, Combination; Female; Glutens; Huma | 1976 |
Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Child; Child, Presch | 1977 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Ovarian function and adjuvant chemotherapy for breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphala | 1978 |
Acute eosinophilic leukemia. An ultrastructural study.
Topics: Adult; Bone Marrow; Cytarabine; Daunorubicin; Eosinophils; Humans; Leukemia; Leukemia, Myeloid, Acut | 1978 |
Treatment of advanced Hodgkin's disease in pediatric patients.
Topics: Adolescent; Amenorrhea; Antineoplastic Agents; Bone Marrow; Child; Cyclophosphamide; Female; Hodgkin | 1978 |
[Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
Topics: Aged; Azathioprine; Back Pain; Drug Evaluation; Drug Therapy, Combination; Female; Fractures, Sponta | 1977 |
Proflavine photodynamic viral inactivation in herpes simplex keratitis.
Topics: Acridines; Adult; Anterior Chamber; Betamethasone; Edema; Female; Humans; Idoxuridine; Keratitis, De | 1975 |
Recurrent erythema multiforme and Herpes genitalis (type 2).
Topics: Adolescent; Erythema Multiforme; Herpesviridae Infections; Humans; Male; Mucous Membrane; Penis; Pre | 1975 |
[Recurrent acute pericarditis and corticoid dependence. Apropos of 10 cases].
Topics: Acute Disease; Adolescent; Humans; Male; Niflumic Acid; Pericarditis; Prednisone; Recurrence | 1975 |
Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins.
Topics: Animals; Cortisone; Cyclophosphamide; Female; Herpes Simplex; Mice; Prednisone; Prostaglandins E; Re | 1976 |
[Mediastinopulmonary sarcoidosis; the indications for corticosteroid therapy].
Topics: Adrenal Cortex Hormones; Chronic Disease; Female; Follow-Up Studies; Humans; Long-Term Care; Lung Di | 1976 |
Relapse of pneumonia caused by cytomegalovirus in two recipients of renal transplants.
Topics: Adolescent; Adult; Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Human | 1979 |
[Long-term follow-up study of a case of periarteritis nodosa].
Topics: Adrenocorticotropic Hormone; Child, Preschool; Female; Follow-Up Studies; Humans; Polyarteritis Nodo | 1975 |
Low-dose steroid treatment in polymyalgia rheumatica.
Topics: Humans; Polymyalgia Rheumatica; Prednisone; Recurrence | 1977 |
Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).
Topics: Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Le | 1977 |
Therapeutic considerations in acute lymphocytic leukemia.
Topics: Antineoplastic Agents; Child; Daunorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Le | 1978 |
Dissimilar courses of twins with leukemia.
Topics: Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combinat | 1977 |
Diffuse histiocytic lymphoma. The need for aggressive restaging.
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Di | 1977 |
Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy.
Topics: Adult; Aged; Azathioprine; Basement Membrane; Complement C3; Drug Therapy, Combination; Female; Fluo | 1977 |
Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Femal | 1978 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Allergic bronchopulmonary aspergillosis in pediatric practice.
Topics: Adolescent; Aspergillosis, Allergic Bronchopulmonary; Bronchography; Child; Female; Humans; Immunogl | 1979 |
Presentation of the steroid psychoses.
Topics: Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Male; Middle Aged; Prednisone; Psychoses, Subs | 1979 |
Primary nephrotic syndrome in childhood.
Topics: Biopsy; Child; Child, Preschool; Cytotoxins; Diuretics; Female; Glomerulonephritis; Humans; Infant; | 1979 |
Severe anaphylactoid reaction to radiographic contrast media. Recurrences despites premedication with diphenhydramine and prednisone.
Topics: Anaphylaxis; Contrast Media; Diphenhydramine; Humans; Male; Middle Aged; Prednisone; Premedication; | 1979 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
The management of allergic bronchopulmonary aspergillosis.
Topics: Aspergillosis, Allergic Bronchopulmonary; Beclomethasone; Drug Administration Schedule; Follow-Up St | 1979 |
[Clinical course and recurrences of the nephrotic syndrome due to minimal histologic lesions. Review of 73 cases (author's transl)].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Chlorambucil; Drug Therapy, Combination; Fe | 1979 |
Systemic lupus erythematosus.
Topics: Arthritis; Central Nervous System Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Pre | 1979 |
The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Chlorambucil; Drug Therapy, Comb | 1979 |
[A comparative study of two similar groups of 364 children treated for rheumatic fever according to identical protocols (1955--1961, 1965--1972) (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Penicillin G; Prednisone; Recurrence; Rhe | 1979 |
Relapsing nephrotic syndrome in childhood.
Topics: Adolescent; Azathioprine; Cyclophosphamide; Humans; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1979 |
[Idiopathic thrombocytopenic purpura. A review of 142 cases (author's transl)].
Topics: Child; Child, Preschool; Female; Humans; Infant; Male; Prednisone; Purpura, Thrombocytopenic; Recurr | 1978 |
[Use of corticoid treatment of idiopathic thrombopenic purpura. Data concerning the cases of the Pediatric Clinic of Naples].
Topics: Age Factors; Child; Child, Preschool; Female; Humans; Infant; Male; Prednisone; Purpura, Thrombocyto | 1978 |
Lymphocele. A complication of cancer chemotherapy.
Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Cysts; Drug Therapy, Combination; Female; Humans; Lym | 1978 |
Cricoarytenoid arthritis in a patient with ankylosing spondylitis.
Topics: Arthritis; Female; Humans; Laryngeal Cartilages; Middle Aged; Prednisone; Recurrence; Spondylitis, A | 1977 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemp | 1978 |
Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
Topics: Child; Child, Preschool; Cyclophosphamide; Female; Humans; Infant; Male; Nephrotic Syndrome; Prednis | 1978 |
Chronic eosinophilic pneumonia (Carrington's): a follow-up study.
Topics: Adult; Aged; Chronic Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Pulm | 1978 |
Subacute demyelinating polyneuropathy responding to corticosteroid treatment.
Topics: Adult; Biopsy; Cerebrospinal Fluid Proteins; Child; Demyelinating Diseases; Disability Evaluation; E | 1978 |
Relationships between prednisone therapy, disease activity, and the total serum IgE level in allergic bronchopulmonary aspergillosis.
Topics: Antibodies, Fungal; Aspergillosis; Aspergillus; Female; Humans; Hypersensitivity; Immunoglobulin E; | 1978 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
The clinical course of subacute hepatic necrosis.
Topics: Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Child; Female; Follow-Up Studies; Hepati | 1978 |
Influence of rejection on graft survival after renal transplantation.
Topics: Acute Disease; Agranulocytosis; Cadaver; Dose-Response Relationship, Drug; Graft Rejection; Histocom | 1975 |
Special problems in pediatric renal transplantation.
Topics: Arm; Arteriovenous Shunt, Surgical; Cadaver; Child; Child, Preschool; Graft Rejection; Growth; Human | 1976 |
The effect of recurrent early homograft rejection on subsequent patient and renal graft survival.
Topics: Acute Disease; Azathioprine; Cadaver; Drug Administration Schedule; Graft Rejection; Humans; Kidney | 1976 |
Scleromyxedema.
Topics: Dermabrasion; Humans; Male; Melphalan; Middle Aged; Mucopolysaccharidoses; Myxedema; Paraproteinemia | 1976 |
Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Evaluation Studies as | 1977 |
The present status of treatment of pulmonary sarcoidosis: a house divided.
Topics: Humans; Lung Diseases; Prednisone; Radiography; Recurrence; Sarcoidosis; Time Factors | 1977 |
[On an unusual case of hypoplastic anaemia (author's transl)].
Topics: Anemia, Aplastic; Bone Marrow Examination; Child; Erythrocytes, Abnormal; Female; Humans; Methandros | 1977 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1977 |
Recurrent aseptic meningitis in an elderly man. Unusual prodrome of systemic lupus erythematosus.
Topics: Age Factors; Biopsy; Cerebrospinal Fluid; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; L | 1976 |
[Rheumatic fever - observation to the current clinical picture].
Topics: Aminopyrine; Germany, East; Humans; Prednisone; Recurrence; Rheumatic Fever; Salicylates | 1976 |
Treatment of idiopathic membranous nephropathy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Basement Membrane; Child; Child, Preschool; Female | 1976 |
Systemic sclerosis and regional enteritis occurring simultaneously.
Topics: Colostomy; Contracture; Crohn Disease; Female; Hand Deformities, Acquired; Humans; Middle Aged; Post | 1976 |
[Recurrent polyneuropathy with a 19-year course, associated with a benign IgG monoclonal gammapathy].
Topics: Bone Marrow; Bone Marrow Cells; Cerebrospinal Fluid Proteins; Humans; Hypergammaglobulinemia; Male; | 1976 |
Periadenitis mucosa necrotica recurrens.
Topics: Anesthetics; Cineradiography; Diagnosis, Differential; Erythromycin; Granuloma, Lethal Midline; Gran | 1975 |
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Drug Administration Schedule; Female; Humans; Lung Diseases; Male; M | 1976 |
Corticosteroids in diseases of the oral mucosa.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Epidermolysis Bullosa; E | 1976 |
Varicella followed by glomerulonephritis. Treatment with corticosteroids and azathioprine resulting in recurrence of varicella.
Topics: Azathioprine; Chickenpox; Child, Preschool; Exanthema; Gastrointestinal Hemorrhage; Glomerulonephrit | 1975 |
Focal sclerosing glomerulonephropathy: a clinicopathologic study.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorescent Antibody Technique; Glomerulonephritis; Hematuri | 1975 |
[Wegener's granulomatosis with unusual clinical course (author's transl)].
Topics: Female; Granulomatosis with Polyangiitis; Humans; Middle Aged; Prednisone; Prognosis; Recurrence | 1975 |
Clinical features of chorea associated with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Blood Sedimentation; Chlorpromazine; Chorea; Female; Haloperidol; Humans; Lupus | 1975 |
Acute posterior multifocal placoid pigment epitheliopathy. A recurrence.
Topics: Adolescent; Adult; Child; Epithelium; Female; Fluorescein Angiography; Fundus Oculi; Humans; Injecti | 1975 |
Benign intracranial hypertension.
Topics: Adolescent; Adult; Age Factors; Cerebrospinal Fluid Shunts; Dexamethasone; Female; Follow-Up Studies | 1975 |
Recurrent aseptic meningitis without sequelae.
Topics: Adrenal Cortex Hormones; Cell Count; Cerebrospinal Fluid Proteins; Female; Glucose; Humans; Infant; | 1975 |
Late nonresponsiveness to steroids in children with the nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; Female; Humans; Infant; Ma | 1975 |
Combination chemotherapy of Hodgkin disease in children.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1975 |
Recurrent idiopathic thrombocytopenia purpura with "accessory" splenic tissue.
Topics: Adolescent; Blood Cell Count; Blood Platelets; Female; Humans; Prednisone; Purpura, Thrombocytopenic | 1975 |
[Disseminated granuloma annulare].
Topics: Arm; Buttocks; Chloroquine; Ear, External; Granuloma; Humans; Male; Middle Aged; Prednisone; Recurre | 1975 |
Diagnosis and management of minimal recurrences of macular histoplasmosis.
Topics: Adrenal Cortex Hormones; Histoplasmosis; Humans; Macula Lutea; Prednisone; Recurrence; Retinal Disea | 1975 |
[Acute abdomen in the Wissler-Fanconi syndrome].
Topics: Abdomen, Acute; Child; Child, Preschool; Female; Humans; Hypersensitivity; Male; Prednisone; Recurre | 1975 |
Micronodular encephalitis and acute leukemia treated with immunosuppressives in a child.
Topics: Acute Disease; Cerebellar Nuclei; Child, Preschool; Cyclophosphamide; Encephalitis; Humans; Immunosu | 1975 |
[Therapy of nephrotic syndrome in childhood].
Topics: Adolescent; Age Factors; Azathioprine; Biopsy; Child; Child, Preschool; Cyclophosphamide; Humans; In | 1976 |
Cyclic neutropenia: a cause of recurrent aphthous stomatitis not to be missed.
Topics: Adult; Humans; Male; Neutropenia; Periodicity; Prednisone; Recurrence; Stomatitis, Aphthous | 1992 |
Painful subacute thyroiditis (de Quervain's thyroiditis).
Topics: Adult; Analgesics; Female; Humans; Prednisone; Recurrence; Thyroid Function Tests; Thyroiditis, Suba | 1992 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
Methotrexate treatment of recalcitrant childhood dermatomyositis.
Topics: Adolescent; Calcium; Child; Child, Preschool; Dermatomyositis; Drug Evaluation; Drug Therapy, Combin | 1992 |
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 1992 |
Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Follow-Up S | 1992 |
Major recurrent oral ulcers in AIDS: report of three cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Deglutition Disorders; Humans; Male; Palate, Soft; Predni | 1992 |
[Pulmonary infiltrations with eosinophilia (pulmonary eosinophilia)].
Topics: Adult; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diagnosis, Differential; Eosinophils; Female; Hum | 1992 |
[The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Immunological monitoring in systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; B-Lymphocyte Subsets; Female; Humans; Interleukin-2; Lupus Erythematosus, S | 1992 |
How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
Topics: Child, Preschool; Chlorambucil; Cyclophosphamide; Female; Humans; Nephrotic Syndrome; Prednisolone; | 1992 |
[Therapeutic approach to the nephrotic syndrome in children].
Topics: Adolescent; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cy | 1992 |
Prednisone management of HIV-associated recurrent oral aphthous ulcerations.
Topics: Adult; HIV Infections; Humans; Middle Aged; Prednisone; Recurrence; Stomatitis, Aphthous | 1992 |
[Vitiligo associated with autoimmune thrombocytopenia].
Topics: Adult; Humans; Male; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Vitiligo | 1992 |
Recurrent eosinophilic cystitis: a case responsive to steroids.
Topics: Cystitis; Eosinophilia; Humans; Male; Middle Aged; Prednisone; Recurrence | 1992 |
Recurrence of membranous lupus glomerulonephritis two months after a renal cadaver transplant.
Topics: Adult; Azathioprine; Cyclosporine; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus | 1992 |
[Anti-basement membrane antibody disease of the lungs without clinical kidney involvement].
Topics: Adolescent; Anti-Glomerular Basement Membrane Disease; Antibodies; Basement Membrane; Cyclophosphami | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res | 1992 |
Corticosteroids in the treatment of optic neuritis.
Topics: Humans; Multiple Sclerosis; Optic Neuritis; Prednisone; Recurrence | 1992 |
Corticosteroids in the treatment of optic neuritis.
Topics: Humans; Optic Neuritis; Prednisone; Recurrence | 1992 |
[Temporal arteritis with involvement of the subclavian arteries].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisone; Radiography; Recurrence; Subclavian Artery | 1992 |
Transient monocular blindness in a patient with giant-cell arteritis. Pathogenetic and therapeutic considerations.
Topics: Acute Disease; Aged; Blindness; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Male; Nitro | 1992 |
Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy.
Topics: Acyclovir; Adult; Humans; Male; Prednisone; Recurrence; Stevens-Johnson Syndrome; Stomatitis, Herpet | 1992 |
Treating recurrent aphthous ulcers in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Carboxymethylcellulose Sodium; CD4-CD8 Ratio; CD4-Positiv | 1991 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Effect of early corticosteroid therapy for Landau-Kleffner syndrome.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Aphasia; Child; Child Behavio | 1991 |
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cy | 1992 |
[What is your diagnosis? Tolosa-Hunt syndrome].
Topics: Adult; Humans; Male; Ophthalmoplegia; Prednisone; Recurrence; Remission, Spontaneous | 1992 |
Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephri | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
Wegener granulomatosis: an analysis of 158 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow- | 1992 |
[A case of recurrent inflammation of ear cartilage].
Topics: Ear Cartilage; Humans; Male; Middle Aged; Osteochondritis; Prednisone; Recurrence | 1991 |
Naproxen-induced recurrent aseptic meningitis.
Topics: Adult; Blood Cell Count; Female; Hemodynamics; Humans; Leukocyte Count; Lupus Erythematosus, Systemi | 1991 |
[Chronic juvenile arthritis and minimal change glomerulonephritis (MCGN), the same pathogenic basis?].
Topics: Adult; Arthritis, Juvenile; Female; Glomerulonephritis, Membranoproliferative; Gold; Humans; Nephrot | 1991 |
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Electro | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1991 |
High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Protein Disorder | 1991 |
The role of cyclosporine A in the treatment of pemphigus erythematosus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pemphigus; Predni | 1991 |
Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; C | 1991 |
Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Topics: Child; Cyclosporins; Female; Humans; Kidney; Male; Methylprednisolone; Nephritis, Interstitial; Neph | 1991 |
Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Biopsy; Cardiomyopathies; Cardiomyopathy, Hypert | 1991 |
Triple agent immunosuppression in serpiginous choroiditis.
Topics: Adult; Azathioprine; Choroiditis; Cyclosporins; Drug Synergism; Drug Therapy, Combination; Female; F | 1991 |
Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome.
Topics: Child, Preschool; Graft Rejection; Humans; Kidney Transplantation; Male; Nephrotic Syndrome; Prednis | 1991 |
Does immunosuppression alter the growth of metastatic liver carcinoid after orthotopic liver transplantation?
Topics: Aneuploidy; Carcinoid Tumor; Cyclosporins; Diploidy; DNA, Neoplasm; Female; Humans; Immunosuppressio | 1991 |
[Prednisone lessens incidence of recurrence after severe asthma attack].
Topics: Administration, Oral; Asthma; Humans; Prednisone; Recurrence | 1991 |
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor.
Topics: Angioedema; Eosinophilia-Myalgia Syndrome; Eosinophils; Flow Cytometry; Granulocyte-Macrophage Colon | 1991 |
[Histiocytosis X. Clinical aspects and course in 5 patients].
Topics: Adolescent; Adult; Cyclophosphamide; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Prednison | 1991 |
Immunosuppressive treatment in multifocal motor neuropathy.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Cyclophosphamide; Female; Humans; Immunoglobulin M; Immunos | 1991 |
Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Topics: Adolescent; Adult; Aged; Clinical Protocols; Dexamethasone; Drug Resistance; Female; Follow-Up Studi | 1991 |
Acute asthma: emergency department management and prospective evaluation of outcome.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Asthma; Emergen | 1990 |
Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Therapy, Combination; Enema | 1990 |
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
Topics: Adrenocorticotropic Hormone; Adult; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Male; Me | 1990 |
Idiopathic anaphylaxis. A clinical summary of 175 patients.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Child; Emergencies; Epinephrine; Female; Follow-Up Studies; Hi | 1990 |
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfa | 1990 |
The treatment of acute Fasciola hepatica infection in children.
Topics: Acute Disease; Animals; Bithionol; Child; Child, Preschool; Emetine; Fasciola hepatica; Fascioliasis | 1990 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
Treatment of decompensated chronic obstructive pulmonary disease in the emergency department--correlation between clinical features and prognosis.
Topics: Aged; Bronchodilator Agents; Critical Care; Dyspnea; Emergencies; Female; Humans; Lung Diseases, Obs | 1991 |
Isotretinoin for refractory lupus erythematosus.
Topics: Adult; Female; Humans; Isotretinoin; Lupus Erythematosus, Cutaneous; Prednisone; Recurrence | 1991 |
Treatment of pemphigus.
Topics: Adult; Cyclophosphamide; Female; Humans; Male; Pemphigus; Prednisolone; Prednisone; Recurrence | 1991 |
Steroid-dependent postvaricella encephalomyelitis.
Topics: Adolescent; Adult; Brain; Chickenpox; Child; Child, Preschool; Diseases in Twins; Dose-Response Rela | 1991 |
Late relapse with nodular lymphoma after treatment for diffuse non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophospham | 1991 |
Weight gain with breast cancer adjuvant treatment.
Topics: Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
[Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
Topics: Adult; Drug Interactions; Drug Resistance; Female; Humans; Microsomes, Liver; Omeprazole; Pemphigoid | 1991 |
[Intensified therapy of severe lupus erythematosus].
Topics: Adolescent; Adult; Cyclophosphamide; Drug Administration Schedule; Evaluation Studies as Topic; Fema | 1991 |
[Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
Topics: Adolescent; Adult; Child; Chorioretinitis; Drug Therapy, Combination; Female; Follow-Up Studies; Hum | 1990 |
[The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Evaluat | 1990 |
Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
Topics: Acetaminophen; Adolescent; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antigens, CD; Antigen | 1990 |
Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplant.
Topics: Antibodies, Monoclonal; Biopsy; Cyclosporins; Female; Graft Rejection; Hepatitis, Viral, Human; Herp | 1990 |
[Clinical significance of detecting adrenal cortical function in children with steroid-responsive nephrotic syndrome].
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Child; Circadian Rhythm; Female; Humans; Hydrocortiso | 1990 |
Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cortodoxone; Female; Humans; Hydrocortisone; Hypotha | 1990 |
Familial pemphigus vulgaris.
Topics: Adult; Complement C3; Female; Fluorescent Antibody Technique; HLA Antigens; Humans; Immunoglobulin G | 1990 |
Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Effect on patients with a history of multiple relapses.
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aged; Bronchodilator Agents; Emergency | 1990 |
[Possibility of prednisone-omeprazole interference in bullous pemphigoid].
Topics: Adult; Drug Interactions; Female; Humans; Omeprazole; Pemphigoid, Bullous; Prednisone; Recurrence; U | 1990 |
Hemodialysis does not always protect against recurrence of Wegener's granulomatosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Kidney Diseas | 1990 |
[Inflammation proteins in Horton's disease. Prospective study of 25 patients].
Topics: Aged; Aged, 80 and over; Blood Proteins; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; | 1990 |
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc | 1990 |
Recurrent acute renal failure complicating IgG warm-type autoimmune intravascular haemolysis.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic, Autoimmune; Disseminated Intravascular Coagulation; F | 1990 |
Pituitary granuloma and pyoderma gangrenosum.
Topics: Adult; Deamino Arginine Vasopressin; Female; Gangrene; Granuloma; Humans; Hydrocortisone; Pituitary | 1990 |
[A case of recurrent circinate erythematous psoriasis (Lapière)].
Topics: Age Factors; Child; Female; Humans; Prednisone; Prognosis; Psoriasis; Recurrence; Skin; Syndrome | 1990 |
Malignant idiopathic anaphylaxis.
Topics: Acute Disease; Adult; Anaphylaxis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fema | 1990 |
Cyclosporine therapy for bullous erythema multiforme.
Topics: Adult; Blister; Cyclosporins; Erythema Multiforme; Female; Humans; Mouth Diseases; Prednisone; Recur | 1990 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
[Thrombotic thrombocytopenic purpura: a benign disease with a very severe acute phase].
Topics: Adult; Aspirin; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Plasmapheresis | 1990 |
Incidence, prognosis and recovery of Bell's palsy. A survey of about 1000 patients (1974-1983).
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Diabetes Complicat | 1990 |
Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Combinat | 1990 |
Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Clinical Protocols; Drug Administration Schedule; Femal | 1990 |
Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
Topics: Adult; Age Factors; Autoimmune Diseases; Azathioprine; Chronic Disease; Drug Combinations; Female; F | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Azathioprine therapy in chronic ulcerative colitis.
Topics: Adolescent; Adult; Azathioprine; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male | 1990 |
Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
Topics: Azathioprine; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Hepatitis; Hepat | 1990 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1990 |
Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb | 1990 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, | 1985 |
Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Le | 1989 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
The impact of prednisone in life-threatening idiopathic anaphylaxis: reduction in acute episodes and medical costs.
Topics: Acute Disease; Adolescent; Adult; Anaphylaxis; Emergencies; Epinephrine; Female; Histamine H1 Antago | 1989 |
Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cyta | 1985 |
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; | 1989 |
Familial hemophagocytic lymphohistiocytosis: therapy in the German experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Histiocytosis, Non-Langerhans-Cel | 1989 |
Idiopathic inflammatory orbital pseudotumor and low-dose cyclosporine.
Topics: Adolescent; Combined Modality Therapy; Cyclosporins; Diabetes Mellitus, Type 1; Drug Therapy, Combin | 1989 |
Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome.
Topics: Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Nephrosis, | 1989 |
Relapsing polyneuritis following classic Miller Fisher syndrome.
Topics: Administration, Oral; Adult; Female; Humans; Polyradiculoneuropathy; Prednisone; Recurrence; Syndrom | 1989 |
Recurrent fever in Sjøgren's syndrome.
Topics: Adult; Bone Marrow Examination; Diagnosis, Differential; Female; Fever of Unknown Origin; Humans; Ly | 1989 |
The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome.
Topics: Biopsy; Chlorambucil; Chronic Disease; Dermatitis; Female; Fever; Humans; Methylprednisolone; Middle | 1989 |
Linear growth of children with nephrotic syndrome: effect of alkylating agents.
Topics: Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Female; Growth; Humans; Infant; Kidney; Mal | 1989 |
Corticosteroid-dependent idiopathic anaphylaxis: a report of five cases.
Topics: Adult; Aged; Anaphylaxis; Dose-Response Relationship, Drug; Female; Humans; Male; Prednisone; Recurr | 1989 |
Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Topics: Administration, Oral; Child; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; Drug Eval | 1989 |
Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anaphylaxis; Cimetidine; Contrast Media; Diphenhydra | 1985 |
[Ulcerative colitis and Crohn disease. Early diagnosis and therapy].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Humans; Intesti | 1986 |
Cyclosporin in frequently relapsing minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Femal | 1986 |
Takayasu's arteritis associated with crescentic glomerulonephritis.
Topics: Adolescent; Aortic Arch Syndromes; Blood Sedimentation; Creatinine; Drug Administration Schedule; Fe | 1987 |
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
Topics: Aspirin; Autoantibodies; Female; Fetal Death; Humans; Lupus Erythematosus, Systemic; Phospholipids; | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
Ciclosporin in idiopathic nephrotic syndrome of children.
Topics: Child; Cyclosporins; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Male; | 1989 |
Functional properties in Sézary cells with an unusual phenotype.
Topics: Aged; Antibodies, Monoclonal; Chlorambucil; Dermatitis, Exfoliative; Drug Therapy, Combination; Huma | 1985 |
Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl.
Topics: Angioedema; Blood Proteins; Child, Preschool; Eosinophil Granule Proteins; Eosinophilia; Eosinophils | 1986 |
[Reinfarction after initially successful thrombolysis in acute myocardial infarct].
Topics: Adult; Aged; Angioplasty, Balloon; Combined Modality Therapy; Coronary Angiography; Drug Therapy, Co | 1986 |
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases].
Topics: Aged; Chloroquine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Giant Cell Arteriti | 1986 |
Noncaseating pulmonary granulomas associated with small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Diagnos | 1985 |
Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine.
Topics: Adolescent; Adult; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Cyclosporins; Cytomeg | 1986 |
Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy.
Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Electromyography; Female; Humans; Lupus Erythemat | 1986 |
Recurrent abdominal pain and ascites in an adolescent.
Topics: Abdomen; Adolescent; Ascites; Eosinophilia; Gastroenteritis; Humans; Male; Pain; Prednisone; Recurre | 1988 |
[Total pericardectomy. Exceptional treatment for recurrent idiopathic cortico-dependent pericarditis].
Topics: Humans; Male; Middle Aged; Pericarditis; Pericardium; Prednisone; Recurrence; Time Factors | 1987 |
Comparison of results of salvage therapy in adult acute myelogenous leukemia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubi | 1987 |
Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate.
Topics: Adolescent; Body Height; Child; Child, Preschool; Female; Humans; Infection Control; Male; Nephrotic | 1988 |
Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Resistance; Female; Humans | 1988 |
Clinical efficacy of levamisole in the treatment of primary nephrosis in children.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Levamisole; Male; Nep | 1988 |
Treatment of scleritis with combined oral prednisone and indomethacin therapy.
Topics: Administration, Oral; Drug Combinations; Female; Humans; Indomethacin; Male; Middle Aged; Prednisone | 1988 |
Idiopathic anaphylaxis: classification, evaluation, and treatment of 123 patients.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Anaphylaxis; Angioedema; Child; Drug Administration Sch | 1988 |
The course and prognosis of pemphigus. A review of 115 patients.
Topics: Adult; Age Factors; Azathioprine; Cause of Death; Drug Therapy, Combination; Female; Follow-Up Studi | 1988 |
Thrombotic thrombocytopenic purpura: clinical course and response to therapy in twelve patients.
Topics: Adolescent; Adult; Anemia, Hemolytic; Combined Modality Therapy; Dipyridamole; Female; Humans; Male; | 1988 |
The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
Topics: ABO Blood-Group System; Azathioprine; Blood Transfusion; Cadaver; Cyclosporins; Graft Rejection; HLA | 1988 |
Sterile eosinophilic pustulosis in dog and man: comparative aspects.
Topics: Animals; Biopsy; Dexamethasone; Dog Diseases; Dogs; Eosinophilia; Female; Folliculitis; Humans; Male | 1987 |
[Detection using scintigraphy with monoclonal anti-myosin in recurring myocarditis treated with cyclosporin A in a heart transplant candidate].
Topics: Adolescent; Antibodies, Monoclonal; Cyclosporins; Drug Therapy, Combination; Heart Transplantation; | 1987 |
[Idiopathic nephrosis in children and its treatment].
Topics: Alkylating Agents; Child; Drug Resistance; Humans; Nephrosis; Prednisone; Recurrence | 1988 |
[Nitrogen mustard as an alternative therapy in children with idiopathic nephrotic syndrome and recurrent infections].
Topics: Bacterial Infections; Child; Child, Preschool; Humans; Male; Mechlorethamine; Nephrotic Syndrome; Pr | 1988 |
Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
Topics: Allopurinol; Calcium Oxalate; Citrates; Citric Acid; Disease Susceptibility; Gout; Humans; Kidney Ca | 1988 |
[Corticotherapy and thrombocytopenic purpura in children: retrospective study].
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Female; Hemorrhage; Humans; Male; Platelet Cou | 1988 |
Cyclophosphamide in treatment of minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, C | 1988 |
Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Autoantibodies; Combined Modality The | 1988 |
[Follow-up in adolescents and adults with corticoid-sensitive nephrotic syndrome beginning in childhood].
Topics: Adolescent; Adult; Age Factors; Cyclophosphamide; Female; Humans; Male; Nephrotic Syndrome; Predniso | 1988 |
Chronic inflammatory demyelinating polyradiculoneuropathy: features and prognostic factors with corticosteroid therapy.
Topics: Action Potentials; Adult; Demyelinating Diseases; Dose-Response Relationship, Drug; Female; Follow-U | 1988 |
Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications.
Topics: Adult; Black People; Chloroquine; Chronic Disease; Female; Follow-Up Studies; Humans; Lung Diseases; | 1986 |
Recurrent transverse myelitis associated with collagen disease.
Topics: Adult; Antibodies, Antinuclear; Collagen Diseases; Female; Humans; Lupus Erythematosus, Systemic; Me | 1986 |
[Unilateral pseudotumor of the orbit--an autoimmune disease?].
Topics: Autoimmune Diseases; Child; Cryoglobulins; Fibroma; Humans; Immunoglobulin E; Male; Ophthalmoplegia; | 1986 |
Childhood membranoproliferative glomerulonephritis: an approach to management.
Topics: Aspirin; Azathioprine; Child; Cyclophosphamide; Dipyridamole; Drug Administration Schedule; Drug The | 1986 |
Severe condylomata acuminata in a renal transplant recipient.
Topics: Adult; Azathioprine; Condylomata Acuminata; Cyclosporins; Humans; Immunosuppressive Agents; Kidney T | 1986 |
[Isolated spinal cord involvement. Recurrence of sarcoidosis].
Topics: Adult; Humans; Male; Paraplegia; Prednisone; Recurrence; Sarcoidosis; Spinal Cord Diseases | 1986 |
Ligneous conjunctivitis.
Topics: Aged; Conjunctivitis; Diagnosis, Differential; Eyelid Diseases; Female; Granuloma; Humans; Microscop | 1986 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
[When is a patient with corticoid-sensitive nephrotic syndrome cured? Late recurrence after 17 years of complete remission].
Topics: Child; Follow-Up Studies; Humans; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1987 |
Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
Topics: Child; Cyclophosphamide; Diabetic Nephropathies; Humans; Male; Nephrosis, Lipoid; Nephrotic Syndrome | 1987 |
Giant cell arteritis causes recurrent posterior circulation transient ischemic attacks which respond to corticosteroid.
Topics: Aged; Giant Cell Arteritis; Humans; Ischemic Attack, Transient; Male; Prednisone; Recurrence | 1987 |
Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis.
Topics: Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myasthenia Gravis; | 1987 |
[Consideration of the epidemiological findings in the therapy of Crohn's disease].
Topics: Adult; Combined Modality Therapy; Crohn Disease; Humans; Intestines; Prednisone; Psychotherapy; Recu | 1986 |
Chronic eosinophilic pneumonia: a cause of adult respiratory distress syndrome.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Female; Humans; Infant, Newborn; Male; Methylprednisolo | 1986 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Late recurrence of childhood dermatomyositis.
Topics: Child; Dermatomyositis; Female; Humans; Prednisone; Recurrence; Time Factors | 1986 |
Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis, Chronic | 1987 |
[Treatment possibilities of recurrences of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1985 |
Long-term relapse-free survival in adult acute lymphoblastic leukemia.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Pro | 1985 |
Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; | 1985 |
Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine.
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Humans; Middle Aged; Prednisone; P | 1985 |
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.
Topics: Adolescent; Adult; Arteries; Cholangitis; Cholestasis; Cyclosporins; Drug Therapy, Combination; Fema | 1985 |
[Late recurrence of Wegener disease].
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Kidne | 1985 |
Allergic reaction to sulfiting agents.
Topics: Adult; Anaphylaxis; Emergency Medical Services; Food Hypersensitivity; Food Preservatives; Humans; M | 1986 |
Late resistance to corticosteroids in nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; Drug Therapy, C | 1986 |
Liver disease associated with anti-liver-kidney microsome antibody in children.
Topics: Adolescent; Autoantibodies; Autoimmune Diseases; Azathioprine; Child; Child, Preschool; Female; Hepa | 1986 |
Multisystemic disease with intracranial hypertension and autoimmune cytopenia in chronic active hepatitis.
Topics: Adolescent; Anemia, Hemolytic; Autoimmune Diseases; Chronic Disease; Cyclophosphamide; Female; Hepat | 1986 |
[Thrombosis of the inferior vena cava with successive lung embolization in a 15-year-old boy with nephrotic syndrome].
Topics: Adolescent; Combined Modality Therapy; Femoral Vein; Heparin; Humans; Iliac Vein; Male; Nephrotic Sy | 1986 |
Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Creatinine; Drug Resistance; Female; | 1986 |
Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy.
Topics: Adolescent; Adult; Camurati-Engelmann Syndrome; Child; Child, Preschool; Drug Administration Schedul | 1985 |
Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Eryt | 1985 |
Nephrotic syndrome in two patients with cured Hodgkin's disease.
Topics: Adult; Chlorambucil; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Nephro | 1985 |
Sarcoidosis, pulmonary hypertension, and acquired peripheral pulmonary artery stenosis.
Topics: Adult; Cardiac Catheterization; Constriction, Pathologic; Female; Heart Murmurs; Humans; Hypertensio | 1985 |
Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Nephrotic Syndrome; Prednisone; P | 1985 |
Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis.
Topics: Azathioprine; Blood Sedimentation; Creatinine; Humans; Hydronephrosis; Male; Middle Aged; Prednisone | 1985 |
[Long-term observations of Wegener's disease. Results of treating recurrences].
Topics: Adult; Aged; Cyclophosphamide; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; | 1985 |
[Recurrent polychondritis. A case resistant to corticoid treatment].
Topics: Aged; Drug Resistance; Humans; Male; Osteochondritis; Prednisone; Recurrence; Skin Diseases; Vasculi | 1985 |
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 1985 |
Polymyalgia rheumatica. Duration of therapy and long-term outcome.
Topics: Actuarial Analysis; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mid | 1985 |
Treatment of myasthenia gravis with prednisone.
Topics: Adult; Eye Manifestations; Female; Humans; Male; Middle Aged; Muscles; Myasthenia Gravis; Prednisone | 1972 |
Rhinoscleroma in Finland.
Topics: Adult; Female; Humans; Klebsiella; Klebsiella pneumoniae; Oxytetracycline; Prednisone; Recurrence; R | 1972 |
Chlorambucil in steroid-dependent nephrotic syndrome.
Topics: Adolescent; Beta-Globulins; Blood Pressure; Child; Child, Preschool; Chlorambucil; Drug Synergism; F | 1973 |
The nitroblue tetrazolium test in lymphoma.
Topics: Adult; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1973 |
Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient.
Topics: Ambenonium Chloride; Anemia, Aplastic; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Bronchop | 1973 |
Correlation between immunological parameters and cutaneous manifestations of systemic lupus erythematosus.
Topics: Antibodies; Complement System Proteins; DNA; Fluorescent Antibody Technique; gamma-Globulins; Lupus | 1973 |
Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Azathioprine; Bilirubin; | 1974 |
The value of anti-DNA antibody titers in the early diagnosis, treatment and follow-up of systemic lupus erythematosus.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Central Nervous System Diseases; Complement Sys | 1974 |
Long-term assessment of cyclophosphamide therapy for nephrosis in children.
Topics: Adolescent; Age Factors; Alopecia; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cystitis | 1974 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
Long-term immunosuppressive therapy of ulcerative colitis. Continuation of a personal series.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Child; Child, Preschool; Colitis, Ulcerative; Female | 1973 |
Crohn's disease: a clinical study of 75 patients.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Child; Crohn Disease; Female; Fol | 1973 |
[Crohn's disease (author's transl)].
Topics: Adolescent; Adult; Crohn Disease; Female; Humans; Male; Middle Aged; Postoperative Complications; Pr | 1974 |
[Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Cyclophosphamide; Female; Glomerulonephritis; Humans; | 1973 |
Giant cell arteritis--the need for prolonged treatment.
Topics: Age Factors; Aged; Betamethasone; Biopsy; Blindness; Chronic Disease; Female; Giant Cell Arteritis; | 1973 |
Plasma cell interstitial pneumonia and macroglobulinemia. A response to corticosteroid and cyclophosphamide therapy.
Topics: Aged; Biopsy; Cyclophosphamide; Female; Humans; Immunoelectrophoresis; Immunoglobulin M; Lung; Pneum | 1974 |
Acute arthritis caused by gram-negative bacilli: a clinical characterization.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Bacteria; Bacterial Infect | 1974 |
Chronic eosinophilic pneumonia, a manifestation of allergic aspergillosis.
Topics: Arteritis; Aspergillosis; Asthma; Biopsy; Bronchiectasis; Female; Humans; Immunodiffusion; Lung; Lun | 1974 |
Thyrotoxicosis and heart disease in a nine-year-old girl. Remission with corticosteroids.
Topics: Age Factors; Cardiomegaly; Child; Electrocardiography; Female; Heart Auscultation; Heart Failure; Hu | 1971 |
Delayed febrile pleuropericarditis after sepsis. A possible analogue of the postcardiotomy syndrome.
Topics: Adult; Aspirin; Blood Sedimentation; Cardiomegaly; Erythrocytes; Female; Fever; Heart Auscultation; | 1973 |
Myasthenia gravis and myasthenic syndromes treated with prednisone.
Topics: Adrenocorticotropic Hormone; Age Factors; Aged; Female; Humans; Male; Middle Aged; Myasthenia Gravis | 1971 |
[Dressler's syndrome relapsing during corticotherapy but cured with immunosuppressive agents].
Topics: Azathioprine; Humans; Indomethacin; Male; Middle Aged; Myocardial Infarction; Pericarditis; Pleurisy | 1972 |
Long-term follow-up of children with steroid-responsive nephrotic syndrome.
Topics: Adrenocorticotropic Hormone; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Female; Follo | 1972 |
Varicella reactivation in nephrotic syndrome treated with cyclophosphamide and adrenal corticosteroids.
Topics: Antibodies, Viral; Antibody Formation; Chickenpox; Child, Preschool; Cyclophosphamide; Female; Fluor | 1973 |
The treatment of ileocolitis with ACTH and prednisone: immediate and prolonged effect.
Topics: Administration, Oral; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Child; Colonic Diseases; | 1974 |
Fatal herpes hepatitis associated with pemphigus vulgaris and steroids in an adult.
Topics: Female; Hepatitis A; Herpes Simplex; Herpesviridae; Herpesviridae Infections; Humans; Liver; Microsc | 1974 |
Recurrent cutaneous herpes simplex in hairless mice.
Topics: Animals; Culture Techniques; Cytopathogenic Effect, Viral; Disease Models, Animal; Hair; Herpes Simp | 1974 |
Shedding patterns of herpes simplex virus and cytomegalovirus among chronic dialysis patients.
Topics: Biopsy; Blood; Cytomegalovirus; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; | 1972 |
[Relations between Hodgkin's disease and leukemia. Clinical case].
Topics: Adult; Antineoplastic Agents; Blood Transfusion; Hodgkin Disease; Humans; Leukemia, Lymphoid; Male; | 1974 |
Editorial: The management of traumatic hyphaema.
Topics: Humans; Hyphema; Prednisone; Recurrence | 1974 |
A vascular necrosis of the femoral head in childhood systemic lupus erythematosus.
Topics: Adolescent; Azathioprine; Child; Corticosterone; Female; Femur Head; Femur Head Necrosis; Glomerulon | 1974 |
Treatment of subacute polyneuritis with corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Child; Cranial Nerves; Dose-Response Relationship, | 1974 |
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Castration; Cyclophosphamide; Drug Therapy, Comb | 1974 |
Cyclophosphamide therapy in the management of nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; F | 1974 |
Azathioprine therapy in incomplete Behcet syndrome.
Topics: Adult; Azathioprine; Behcet Syndrome; Female; Humans; Mouth Mucosa; Prednisone; Recurrence; Skin; St | 1974 |
[Diagnosis and course evaluation in rheumatic fever].
Topics: Acute Disease; Adult; Aminopyrine; Child; Chloroquine; Humans; Penicillins; Phenylbutazone; Predniso | 1974 |
[Treatment of acute lymphoblastic leukosis: evaluation of the maintenance and reinduction standards. Analysis of 33 cases].
Topics: Acute Disease; Adult; Child; Daunorubicin; Humans; Leukemia, Lymphoid; Methotrexate; Prednisone; Rec | 1972 |
[Cytosine arabinoside in the polychemotherapy of acute leukemia].
Topics: Adolescent; Adult; Asparaginase; Child; Child, Preschool; Cytarabine; Drug Synergism; Female; Humans | 1972 |
Leukemia in arsenic poisoning.
Topics: Aged; Anemia, Aplastic; Arsenic; Arsenic Poisoning; Autopsy; Biopsy; Bone Marrow Cells; Cytarabine; | 1972 |
Relapsing herpes zoster myelitis.
Topics: Adult; Female; Herpes Zoster; Humans; Myelitis; Neurologic Manifestations; Prednisone; Recurrence; T | 1972 |
Factors that influence the appearance of central nervous system leukemia.
Topics: Central Nervous System Diseases; Cerebrospinal Fluid; Cobalt Radioisotopes; Daunorubicin; Humans; In | 1973 |
Fourteen relapses of acute lymphoblastic leukaemia in a child.
Topics: Agranulocytosis; Asparaginase; Blood Cell Count; Bone Marrow Examination; Child; Cyclophosphamide; C | 1973 |
The prognosis of acute leukaemia in childhood.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Examination; Brain Neoplasms; Child; Drug Therapy, | 1974 |
Daunorubicin-prednisone treatment of erythroleukemia.
Topics: Adolescent; Adult; Bone Marrow Examination; Carbenicillin; Cephalothin; Daunorubicin; Drug Evaluatio | 1974 |
Response to combination therapy after relapse in childhood acute lymphocytic leukemia.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Agents; Central Nervous System; Child; Child, Preschool | 1972 |
Löffler's endomyocardial fibrosis with eosinophilia in association with acute lymphoblastic leukemia.
Topics: Bone Marrow Examination; Child; Chromosome Aberrations; Drug Therapy, Combination; Endomyocardial Fi | 1974 |
Rheumatic fever.
Topics: Arthritis; Humans; Penicillin G Benzathine; Penicillin G Procaine; Prednisone; Recurrence; Rheumatic | 1973 |
Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.
Topics: Administration, Oral; Adult; Aged; Antibodies; Female; Fluorescent Antibody Technique; Humans; Injec | 1972 |
Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation.
Topics: Adult; Azathioprine; Biopsy; Blood Group Antigens; Blood Urea Nitrogen; Creatinine; Evaluation Studi | 1972 |
Steroid-resistant nephrotic syndrome: recurrence after transplantation.
Topics: Adult; Basement Membrane; Cadaver; Female; Fluorescent Antibody Technique; Humans; Immunoglobulins; | 1972 |
Liver transplantation: a clinical and immunological appraisal.
Topics: Adult; Animals; Autoantibodies; Azathioprine; Biliary Fistula; Cell Migration Inhibition; Complement | 1972 |
Urinary tract infection after renal transplantation.
Topics: Adolescent; Adult; Ampicillin; Azathioprine; Bacteriuria; Cadaver; Female; Glomerulonephritis; Human | 1973 |
Nasal septal perforation in systemic lupus erythematosus.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Epistaxis; Female; Fluorescent Ant | 1974 |
[Chemotherapy of lymphogranulomatosis].
Topics: Adolescent; Age Factors; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Combinations; D | 1974 |
A clinical study of the natural history of lymphosarcoma and reticulum cell sarcoma.
Topics: Adult; Aged; Chlorambucil; Cyclophosphamide; Female; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Mal | 1974 |
Relapsing tuberculous meningitis complicated by late sequelae.
Topics: Adult; Aminosalicylic Acids; Arachnoiditis; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Gluco | 1972 |
Cyclophosphamide in the treatment of childhood nephrotic syndrome.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclophosphamide; Female; Glomerulonephritis; Humans; I | 1972 |
Pregnancy in patients who have had the idiopathic nephrotic syndrome in childhood.
Topics: Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Nephrotic Syndrome; Prednisone; Pregnanc | 1972 |
Desquamative interstitial pneumonia. Report of a case.
Topics: Aged; Autopsy; Humans; Male; Prednisone; Pulmonary Fibrosis; Radiography; Recurrence; Respiratory In | 1972 |
Combination chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Child; Female; Hodgkin Disease; Humans; | 1973 |
Chronic active hepatitis associated with eosinophilia and Coombs'-positive hemolytic anemia.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies; Biopsy; Bone Marrow | 1973 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease.
Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoimmune Diseases; Blood Transfusion; Bone Marrow; | 1973 |
[Letter: Temporal arteritis].
Topics: Giant Cell Arteritis; Humans; Prednisolone; Prednisone; Recurrence | 1973 |
Interstitial cystitis following colocystoplasty.
Topics: Adolescent; Biopsy; Colon, Sigmoid; Cystitis; Female; Humans; Inflammation; Intestinal Mucosa; Methy | 1973 |
[Steroid therapy in pulmonary sarcoidosis].
Topics: Humans; Lung Diseases; Lymph Nodes; Organ Size; Prednisone; Pulmonary Fibrosis; Recurrence; Sarcoido | 1973 |
Idiopathic membranous nephropathy in children.
Topics: Adolescent; Age Factors; Aminohippuric Acids; Basement Membrane; Biopsy; Child; Child, Preschool; Cr | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |
A ten year study of corticosteroid treatment of pulmonary sarcoidosis.
Topics: Adolescent; Adult; Female; Humans; Lung Diseases; Male; Middle Aged; Prednisone; Recurrence; Respira | 1974 |
[Repetitive chronic atrial tachycardia].
Topics: Adult; Chronic Disease; Electrocardiography; Exercise Test; Humans; Hypoventilation; Male; Posture; | 1974 |
Testicular involvement in plasma-cell leukemia.
Topics: Allopurinol; Cyclophosphamide; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple Myeloma; N | 1974 |
Pemphigus and Hodgkin's disease.
Topics: Acantholysis; Adult; Biopsy; Blister; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Male; | 1974 |
The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases.
Topics: Adolescent; Antistreptolysin; Azathioprine; Bacteriuria; Blood Urea Nitrogen; Child; Child, Preschoo | 1974 |
[Subacute non-purulent thyroiditis].
Topics: Adult; Female; Humans; Prednisone; Recurrence; Remission, Spontaneous; Thyroiditis | 1974 |
Fluorescence angiography in unusual forms of idiopathic retinal vasculitis.
Topics: Adolescent; Adult; Fluorescein Angiography; Fundus Oculi; Humans; Male; Penicillins; Prednisone; Rec | 1974 |
Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Resistance; Follow-Up Stud | 1974 |
Chronic cutaneous herpes simplex.
Topics: Adult; Agammaglobulinemia; Chronic Disease; Facial Dermatoses; Herpes Simplex; Hodgkin Disease; Huma | 1971 |
Herpetic keratouveitis. Clinical experiences.
Topics: Adult; Atropine; Corneal Transplantation; Corneal Ulcer; Female; Herpes Zoster Ophthalmicus; Humans; | 1971 |
[Treatment of pemphigus and parapemphigus].
Topics: Aged; Antibodies; Antimetabolites; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; M | 1972 |
[Outlines for the use of immunosuppressive therapy in chronic aggressive hepatitis].
Topics: Azathioprine; Chronic Disease; Cortisone; Hepatitis; Hepatitis B virus; Immunoglobulin A; Immunoglob | 1972 |
Recurrent spontaneous pneumothoraces in systemic lupus erythematosus.
Topics: Adult; Cysts; Female; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Pneumothorax; Prednisone | 1971 |
Treatment of gangrene of the lower extremities.
Topics: Age Factors; Aged; Amputation, Surgical; Coronary Disease; Diabetes Complications; Female; Gangrene; | 1971 |
Cytogenetic studies and their clinical correlates in adults with acute leukemia.
Topics: Adolescent; Adult; Age Factors; Aneuploidy; Bone Marrow Cells; Chromosome Aberrations; Chromosome Di | 1971 |
Hyperleukocytosis before the beginning of treatment in acute leukaemia in children and its subsequent repetition at the onset of relapses.
Topics: Acute Disease; Antibiotics, Antineoplastic; Bone Marrow Examination; Child; Cytarabine; Humans; Leuk | 1970 |
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia.
Topics: Administration, Oral; Anemia, Aplastic; Aneuploidy; Bone Marrow Examination; Cell Transformation, Ne | 1971 |